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Abstract
Natural Killer (NK) cells are lymphocytes of the innate immune system. However, there is increasing
evidence that they can also play important roles in the adaptive immune system; as initiators, through
antigen presentation; as effectors, via early release of IFN-γ; and as immunoregulators, by eliminating
over-activated macrophages. The functions of NK cells in these roles are intimately linked to their
interactions with other cells during an immune response, for example recognition of target cells via
activating receptors.
The activating receptor NKG2D recognises proteins that are not normally expressed at the sur-
face of most cells but are up-regulated during a cellular ‘stress’ response. However, NKG2D ligands
can also be induced on human macrophages by TLR stimulation, leading to NK cell-mediated lysis.
Here, I clarify that ligation of TLR4 preferentially up-regulates MICA but not MICB, TLR7/8 ligation
up-regulated both MICA and MICB, while ligating TLR3, signalling through a MyD88-independent
pathway, up-regulated neither. TLR4 stimulation decreased expression of microRNAs, miR-17-5, miR-
20a and miR-93, which target MICA, implicating a novel role for microRNAs in post-transcriptional
regulation of NKG2D ligand expression. Moreover, the pathway involved IL-12/TNF-α-mediated
autocrine signalling, thus incorporating an intrinsic mechanism for NK cell-mediated elimination of
particularly activated macrophages.
In addition to this immunoregulatory role, NK cell activity can shape a subsequent adaptive
immune response. Subsets of NK cells can have distinct functions. Here, I demonstrate that following
culture with IL-2, >25% of human peripheral blood NK cells express HLA-DR, due to an expansion
of a small subset of NK cells expressing HLA-DR, in contrast to previous assumptions that HLA-
DR is upregulated on previously negative cells. HLA-DR-expressing NK cells exhibited enhanced
degranulation to susceptible target cells and expression of the chemokine receptor CXCR3, which
facilitated their enrichment following exposure to CXCL11/I-TAC. Suggestive of an immunological
role, stimulation of PBMCs with Mycobacterium bovis BCG triggered dramatic expansion of HLA-
DR-expressing NK cells. In addition, the magnitude of the NK cell IFN-γ secretion response in PBMC
triggered by BCG was associated with the proportion of HLA-DR-expressing NK cells ex vivo. A direct
contribution to the immune response was determined by specifically enriching the HLA-DR-expressing
NK cell compartment, which substantially augmented the total NK cell IFN-γ secretion response
to BCG. Thus, HLA-DR expression marks a distinct subset of NK cells, present at low frequency
in peripheral blood but readily expanded by IL-2, that can play a significant role during immune
responses.
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Chapter 1: INTRODUCTION
Although the behaviours of individual immune cell types are understood with increasing detail, the
immune system responds to challenge via the complex co-ordination and co-operation of many cell
types, mediated by direct cellular contacts and soluble factors. This investigation focuses on Natural
Killer (NK) cells, their interactions with T cells from the adaptive immune system and macrophages
from the innate, and how new roles for NK cells emerge from these interactions.
1.1 Natural killer cells
Human NK cells are bone marrow-derived large granular lymphocytes that account for 5–15% of
lymphocytes in peripheral blood, but are also found in significant number in secondary lymphoid
organs. In humans, they have classically been defined phenotypically in the lymphocyte compartment
by their expression of neural cell adhesion molecule 1 (NCAM-1/CD56) and absence of CD3 (part of
the T cell receptor complex) (Robertson and Ritz, 1990). However, this description does not extend
to rodent models, where the NK cells lack CD56 expression. Thus, a recent refinement, based on
genomic studies (Walzer et al., 2007b) and the activity of its promoter (Walzer et al., 2007a), suggests
that the expression of NKp46, a natural cytotoxicity receptor, should be used as a pan-species specific
marker of NK cells. Initially, they were identified in mice as “small lymphocytes of undefined nature
exerting spontaneous selective cytotoxic activity against Moloney leukemia cells” (Kiessling et al.,
1975), and named, as lymphocytes that killed transformed cells without prior sensitisation by specific
antigen (Herberman and Ortaldo, 1981). Their effector functions, cytotoxicity and pro-inflammatory
cytokine secretion, are triggered dependent on the integration of signals from activating and inhibitory
receptors as they encounter their ligands on potential target cells (Lanier, 2005).
Lymphocytes of the adaptive immune system, T cells and B cells, comprise a large number of
small clonal populations, each of which has undergone somatic recombination and hypermutation to
generate receptors capable of recognising a single, specific antigen. In contrast, the receptors on NK
cells are germ-line encoded and do not undergo somatic recombination, rather they have a repertoire
of different activating and inhibitory receptors that can detect cellular changes induced by infection,
transformation, or stress. Expansion of the appropriate clonal population of adaptive lymphocytes
is triggered by encountering the relevant antigen, and is required for a successful adaptive immune
response. This clonal expansion can take time, during which the NK cells, already present at relatively
high numbers, can help to limit infection, through their cytotoxic role, and enhance the adaptive
response, through secretion of IFN-γ. Therefore, they can play an essential role early in the course of
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an immune response, in particular to tumours, viral infections, and some bacterial infections.
1.2 NK cell effector functions
NK cells have two primary effector function, cytotoxicity and secretion of pro-inflammatory cytokines.
Their ability to eliminate tumours and infected cells is the foundation of their role in immunosurveil-
lance. Secretion of cytokines, particularly the rapid secretion of IFN-γ, enables them to enhance
the subsequent adaptive immune response, to directly assist other innate immune cells, such as
macrophages, to respond to infection, and exerts potent direct anti-viral activity.
1.2.1 Cytotoxicity
Cytotoxicity refers to direct killing of a target cell, or induction of apoptosis. Direct killing is achieved
through the delivery of secretory lysosomes, called lytic granules, across the contact formed with the
target, termed the immunological synapse (IS) . The lytic granules contain perforin, and granzymes
A and B. Within the low Ca2+ and acidic environment of the lysosome, perforin is maintained in an
inactive conformation; however, upon degranulation into the synaptic cleft between the NK cell and
the target cell, it become active (Urrea Moreno et al., 2009). Through a change in conformation, and
subsequent polymerisation, the perforin forms 13-20nm diameter holes in the target cell membrane
(Law et al., 2010), through which the granzymes can enter the target cell cytoplasm and initiate an
apoptotic cascade. Granzyme A can induce a caspase-independent programmed cell death pathway,
likely to be a result of accumulated DNA damage from its interference with histones and inhibition
of DNA repair (Lieberman, 2010). Granzyme B can directly activate the apoptotic pathway through
caspase-3 cleavage (Darmon et al., 1995).
NK cells can also induce target cell apoptosis through a lytic granule independent pathway, me-
diated by expression of FAS ligand (FASL), which engages the FAS receptor, a member of the death
receptor family. Similar to the activity of granzyme B, FAS receptor activation initiates an apoptotic
pathway via cleavage of caspase-3.
Degranulation by NK cells, is the final result of a series of cellular changes in NK cells that
occur rapidly after encountering a target cell (reviewed in Krzewski and Strominger, 2008; Orange,
2008a). This begins with adhesion, followed by assessment of the signals from activating and inhibitory
receptors after engagement of their ligands (Lanier, 2005), if expressed by the target cell. If integration
of these signals leads to NK cell activation, the NK cell spreads at the contact (Culley et al., 2009),
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and polarises the Golgi Apparatus and microtubule organising centre (MTOC) to the IS (Kupfer et al.,
1983). This is accompanied by, and partially driven by, cytoskeletal changes such as the formation of
an actin-rich ring around the IS (Orange et al., 2002), within 100nm of the cytoplasmic membrane
(Culley et al., 2009). Following this, the preformed lytic granules are polarised to the IS (Orange
et al., 2003), where degranulation releases them to the synaptic cleft (Stinchcombe et al., 2006).
Degranulation occurs through a distinct region of the central supramolecular activation cluster, call
the secretory domain (Stinchcombe et al., 2001).
As discussed later (Sect. 1.3), polarisation and degranulation are triggered by two distinct signals;
adhesion receptor engagement and activating receptor engagement respectively. Use of reductive
model systems has demonstrated that either can be induced separately, but that both polarisation and
degranulation together are required for target cell lysis (Bryceson et al., 2006a; Das and Long, 2010).
1.2.2 Cytokine secretion
In addition to cytotoxicity, the role for which they were named, NK cells have an equally important
function as an early source of pro-inflammatory cytokines, particularly IFN-γ. In addition to IFN-γ,
NK cells are a major source of TNF-α, and also secrete GM-CSF, IL-5, IL-13, MIP-1α and -β, and
RANTES (Fauriat et al., 2010). TNF-α has strong pro-inflammatory properties, and is capable of
initiating a cytokine cascade during an inflammatory response. Whilst IFN-γ can perform this func-
tion, it is also key in shaping the adaptive immune response, where it favours TH1 differentiation
of T cells in the lymph nodes and promotes up-regulation of class I MHC protein. In addition, it
has anti-viral properties and can activate neutrophils and macrophages. For example, IFN-γ can
specifically activate macrophages to resist mycobacterial infection through induction of reactive oxy-
gen and nitrogen species (Flynn and Chan, 2001), and to eliminate phagocytosed mycobateria, via
phagosomal–lysosomal fusion, or autophagy (Deretic et al., 2006).
These roles of IFN-γ are critical to successful clearance of many pathogens, and the capacity for its
secretion thus represents an important effector function. IFN-γ secretion can be induced indirectly, via
cytokines such as IL-12 and IL-18, where it functions to amplify a pro-inflammatory cytokine cascade.
The importance of this role can be inferred from the susceptibility to bacterial infections of patients
with IL-12 receptor deficiencies (de Jong et al., 1998), or pro-inflammatory cytokine deficiencies,
including IFN-γ (Ottenhoff et al., 1998). Furthermore, deficiencies in IL-12, IFN-γ, or their respective
receptors renders patients susceptible to viral and mycobacterial infections (Carneiro-Sampaio and
Coutinho, 2007; Davis, 2008).
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In addition, IFN-γ has recently been demonstrated to form an integral early component of an
adaptive immune response. Reports have demonstrated that in response to certain infections, NK cell
IFN-γ secretion is dependent on an antigen specific CD4+ T cell initiated pathway (Bihl et al., 2010;
Horowitz et al., 2010a), discussed in more detail later (Sect. 1.6.2).
1.3 NK cell recognition of targets
Unlike T and B lymphocytes, which undergo a process of somatic recombination and hypermutation to
generate a population wide range of receptors to a spectrum of antigens, NK cells express a repertoire of
invariant, germ line encoded receptors, both activating and inhibitory (Lanier, 2005). Their response
to target cells is controlled by the integration of diverse signals triggered by engagement of these
activating and inhibitory receptors (Vivier et al., 2004; Lanier, 2008).
1.3.1 Inhibitory receptors: “missing self” recognition
Inspired by the Swedish navy’s recruitment of patrolling fisherman to identify and report non-Swedish
submarines by issuing a card with three silhouettes to specifically recognise Swedish (“self”) submarines
(Kärre, 1997), the “missing self” hypothesis proposed that NK cells recognise and eliminate target cells
that have down-regulated surface expression of class I MHC, that otherwise marks them as healthy
“self” cells (Kärre et al., 1986; Ljunggren and Kärre, 1990). Class I MHC proteins are expressed
on most human cells and present cell-derived antigen to T cells via the endogenous pathway, thus
facilitating continual immunosurveillance for signs of transformation or viral infection. Consequently,
many viruses and tumours have adopted immunoevasion strategies that involve down-regulation of
class I MHC proteins from the surface, thus rendering them “invisible” to T cells.
To counter this, the NK cells express inhibitory receptors that recognise class I MHC proteins, such
that when their ligands are down-regulated, the cells become susceptible to NK cell mediated lysis.
These receptors include the killer-cell immunoglobulin-like receptors (KIRs), which recognise classical
class I MHC proteins (HLA-A, -B, -C), and the NKG2A/CD94 complex, which recognises non-classical
HLA-E (Long, 2008). There are several inhibitory KIRs, including KIR2DL1, KIR2DL2/3, KIR3DL1,
and KIR3DL2; however, individual NK cells only express a subset (Boyton and Altmann, 2007). In
addition to this level of variation, the KIRs are a strikingly polymorphic family of receptors, proposed
to be a result of strong selection pressure from pathogens, particularly viruses (Khakoo and Carrington,
2006).
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The inhibitory receptors all have transmembrane domains and signal through immunoreceptor
tyrosine-based inhibition motifs (ITIMs) on their cytoplasmic tails. After receptor engagement of
their ligands, the ITIMs are phosphorylated by Src kinases, resulting in recruitment of SHP-1, which
dephosphorylates and therefore inactivates the activating signalling molecule Vav1 (Stebbins et al.,
2003). Thus, the inhibitory receptors on NK cells, prevent inappropriate lysis of healthy cells, and
provide a countermeasure mechanism to the immunoevasion strategies of many tumours and viruses.
1.3.2 Activating receptors
Although NK cell recognition of targets was first described by the missing self hypothesis, it has since
emerged that in addition to the absence of inhibitory signals, NK cells can be activated through specific
activating receptors upon engagement of their ligands on target cells. Unlike the inhibitory receptors,
most NK cells express all of the activating receptors. Indeed, some of them, such as NKp46, have
been proposed as unique markers of NK cells (Sivori et al., 1997; Walzer et al., 2007b,a). There are a
range of activating receptors expressed on NK cells, including, among others: 2B4, which recognises
CD48 (Eissmann et al., 2005), DNAM-1, which recognises PVR and nectin-2 (Bottino et al., 2003),
CD44, which binds Hyaluronan (Galandrini et al., 1994), and BY55, which recognises HLA-C (Le
Bouteiller et al., 2002). In addition, there are a family of natural cytotoxicity receptors (NCRs) and
the NK group 2 member D (NKG2D) receptor (Raulet, 2003).
Natural cytotoxicity receptors
The NCRs, including NKp30, NKp44, and NKp46 appear to be expressed exclusively on NK cells, where
they trigger a cytotoxic response if a target cell expresses an appropriate ligand (Moretta et al., 2000).
The NCRs are transmembrane proteins that signal via immunoreceptor tyrosine-based activating motifs
(ITAMs) in their cytoplasmic tails. ITAM signalling is via recruitment of ZAP-70, leading to activation
of PI(3)K, which can also feed into the PLC-γ signalling pathway via phosphorylation PIP2 (Lanier,
2008).
The NCRs efficiently mediate NK cell lysis of tumour cell lines, an activity that is abrogated upon
receptor blocking (Vitale et al., 1998; Pende et al., 1999). However, ligands have also been identified
that are associated with viral or bacterial infection, such as influenza hemagglutinin recognised by
NKp44 and NKp46 (Mandelboim et al., 2001), or vimentin on Mycobacterium tuberculosis infected
monocytes, which is recognised by NKp46 (Garg et al., 2006). Interestingly, studies on the ligands
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for these receptors suggest they may act in a similar manner to, for example the TLRs, functioning
as general pathogen associated molecular pattern (PAMP) recognition receptors (PRRs) (Porgador,
2005; Arnon et al., 2006).
This is achieved via post-translational modifications of either the NCRs themselves, or their ligands.
For example, NKp46 and NKp44, but not NKp30, recognition of viral hemagglutinins depends on
sialylation of the glycosylated Thr225 residue of the receptor itself (Arnon et al., 2001; Mandelboim
et al., 2001). This is a functional recognition that exploits the mechanism of hemagglutinin-mediated
cellular entry by influenza, which depends on its ability to bind sialic acid on the target cell surface
(Gamblin and Skehel, 2010). Similarly, all three NCRs have been shown to recognise tumour cells in a
sialylation-independent mechanism (Arnon et al., 2004); however, here the receptors recognise heparan
sulphate moieties. Specifically, whilst the different NCRs preferentially recognise different patterns
of sulphation, they all share a specificity for heparan sulphate that is above averagely sulphated,
characteristic of functional changes in transformed cells (Hecht et al., 2009).
In addition to recognition of tumour associated heparan sulphation, NKp30 recognises a specific
ligand, B7-H6 (Brandt et al., 2009). B7-H6 is expressed on tumour cells, but not healthy cells, and
its recognition by NKp30 leads to target cell lysis. This is an example of “induced self” recognition,
whereby specific host proteins, ligands of NK cell activating receptors, are up-regulated on the surface
of cells to be eliminated, such as tumours or stressed cells (Eagle and Trowsdale, 2007). The main
NK cell activating receptor that mediates induced self recognition is NKG2D.
1.3.3 The NKG2D activating receptor: “induced self” recognition
NKG2D is a dominant activating receptor on NK cells, but is also expressed as a co-activation receptor
on CD8+ T cells and γδT cells (Bauer et al., 1999; Wu et al., 1999), and has been found to be expressed
on a subset of CD4+ T cells in patients with rheumatoid arthritis (Groh et al., 2003). NK cell activation
by NKG2D is critical for immunosurveillance, indeed NKG2D recognition of a ligand on a target cell
is sufficient to induce a cytotoxic response, even in the presence of class I MHC protein mediated
inhibitory signalling (Cerwenka et al., 2001; Diefenbach et al., 2001). The functional importance of
NKG2D mediated NK cell elimination of tumor cells was clearly demonstrated in NKG2D−/− knockout
mice, which suffered an increased number of early tumors, expressing NKG2D ligands (Guerra et al.,
2008). Thus, NKG2D recognition was instrumental in tumor “editing”, actively selecting for NKG2D
ligand negative tumors by eliminating the expressing ones.
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NKG2D receptor signalling
Encoded by the KIRK1 locus, NKG2D is a C-type lectin-like type II transmembrane anchored im-
munoreceptor, and is expressed at the surface as a disulphide bridge-linked homodimer. Unlike the
NCRs, its cytoplasmic tail lacks any ITAMs, instead its transmembrane domain has a charged residue
for association with adaptor signalling molecules.
NKG2D associates with the DNAX activating protein of 10kDa (DAP10) signalling molecule,
via the charged residue in its transmembrane domain, forming a hexameric complex of the NKG2D
homodimer with two DAP10 homodimers. Upon NKG2D ligation, phosphorylation of DAP10 recruits
the p85 subunit of phosphoinositide 3-kinase (PI3K) and the growth factor receptor-bound protein
2 (Grb2) via its YXXM motif (Champsaur and Lanier, 2010) resulting in downstream signalling via
Vav1 (Graham et al., 2006). This leads to the cytoskeletal reorganisation that is associated with a
cytolytic immune synapse, resulting in degranulation and target killing.
NKG2D ligands
NKG2D recognises a surprising diversity of ligands, associated with malignant transformation, viral
infection, and cellular stress (Radaev et al., 2002; Bahram et al., 2005; Eagle and Trowsdale, 2007;
Mistry and O’Callaghan, 2007; Gonzalez et al., 2008). In humans, these include proteins encoded
by two MHC class I chain-related (MIC) genes, MICA and MICB (Bahram and Spies, 1996; Bahram
et al., 1996; Groh et al., 1996; Gleimer and Parham, 2003), and six UL16-binding protein genes
(ULBP1-6, also known as Retinoic acid early transcript, RAET ) (Carayannopoulos et al., 2002; Eagle
et al., 2009). In addition to the variety of ligands for a single receptor, there is extensive variation
in the ligands themselves. In particular the MIC genes are highly polymorphic, with MICA, the most
polymorphic, having over 60 alleles reported (Stephens, 2001; Radosavljevic and Bahram, 2003).
Host regulation of NKG2D ligands
The expression of NKG2D ligands on most human cells is tightly regulated but stress inducible, by
DNA damage, heat shock, viral infection or malignant transformation. Their expression is regulated
at several levels, from transcription through to shedding of expressed protein from the cell surface
(Mistry and O’Callaghan, 2007; Cerwenka, 2009; Stern-Ginossar and Mandelboim, 2009). Before
considering the dysregulation that leads to aberrant expression, or absence of expression, it is important
to understand the normal regulation patterns in healthy cells.
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At the transcriptional level, the expression of MICA and MICB mRNA can be understood by
considering their promoter architecture. TheMIC genes are located within the major histocompatibility
complex; however, their promoters, which share 90% identity, lack the prototypical class I MHC
promoter elements, such as the binding sites for the MHC enhanceosome. Instead, their promoters
share a striking similarity to that controlling expression of the heat shock protein 70 (HSP70) gene.
Their promoters include Sp1 binding elements, which are constitutively occupied, and the heat shock
element (HSE), targeted by heat shock factor protein 1 (HSF1) (Venkataraman et al., 2007).
Their promoter sequences confer characteristic responses on their expression patterns, specifically,
when tested in the colon carcinoma line HCT116, they are expressed following heat shock, oxidative
stress, and during proliferation. Thus, at the transcriptional level, the regulation is in place to express
MICA and MICB proteins in response to defined cellular stresses, including oxidative stress, expected
in tumours. Interestingly, a short (14bp) sequence in the MICB promoter, but not MICA, alters
important characteristics of expression. MICA has a higher basal transcription rate, whereas MICB is
more stringently controlled, but also more potently induced (Venkataraman et al., 2007).
In addition to heat shock and oxidative stress, other factors have been found to drive MICA gene
expression. Particularly important is NF-κB, a transcription factor that is activated by release from
IKK and subsequently relocates to the nucleus to drive transcription of target genes. NF-κB was
found to drive MICA expression, at the mRNA and protein levels, upon T cell activation, via binding
to the long intron 1 of the MICA gene (Molinero et al., 2004). Furthermore, treatment with NF-κB
inhibitors indicated that it also mediated the constitutive MICA protein expression on HeLa cells, an
epithelial tumour cell line. NF-κB mediates many signalling pathways in human cells, including TLR
signalling, but it is also constitutively active in many tumours. Thus, a key signalling molecule was
found to directly bind and activate expression of MICA.
NF-κB is also involved in other pathways that lead to MICA expression, including the DNA
damage-sensing pathway. DNA damage can be induced by a range of genotoxic agents, including
ionising radiation, 5-FU, aphidicolin, and cisplatin. The up-regulation of NKG2D ligands in response
to DNA damage is mediated via the ataxia telangiectasia mutated (ATM) and ataxia telangiectasia and
Rad3 related (ATR) kinases (Gasser et al., 2005). Subsequently, ATM was found to activate NF-κB
following double-strand DNA breakage (Wu et al., 2006). In the response to T cell activation, it was
then demonstrated that the up-regulation of MICA, was via an ATM/ATR – NF-κB signalling pathway,
and that specific inhibition of ATM/ATR abrogated MICA up-regulation, and NF-κB activation, in
a dose dependent manner (Cerboni et al., 2007). This up-regulation was at the transcriptional level,
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elevating MICA mRNA levels, and was reflected as increased protein surface expression.
These studies suggest a broad role for the ATM/ATR, NF-κB-mediated, signalling pathway in
transcriptional regulation of MICA. Because of the broad role of NF-κB in signalling pathways, this
could represent a general signal integration mechanism to increase MICA protein expression in response
to a range of stimuli. For example, murine macrophages up-regulated NKG2D ligands in response to
TLR stimulation, in a MyD88-dependent manner (Hamerman et al., 2004). MyD88 is the adaptor
molecule for TLR signalling, and leads to activation via NF-κB. In particular, NF-κB signalling is
often involved in activation, therefore simultaneous up-regulation of MICA, at least at the mRNA
level, could be intrinsically linked to activation.
In summary, there are two primary transcriptional activation pathways driving expression of MIC
genes, one using a heat shock promoter (Venkataraman et al., 2007), and other via the ATM/ATR–
NF-κB mediated DNA damage sensing pathway (Gasser et al., 2005; Wu et al., 2006; Cerboni et al.,
2007). The result is that cells experiencing stresses including heat shock, oxidative stress, DNA damage
or even excessive activation, up-regulate surface proteins that target them for NK cell mediated lysis.
These stress signals can arise in their own right, or be an indication of other cellular hazards. For
example, tumours can be hypoxic microenviroments, leading to oxidative stress, whilst the transformed
cells will also accumulate damaged DNA, thus two pathways can be activated in tumours.
Furthermore, there are indications that the other NKG2D ligands may extend the coverage of
cellular assault markers, via their transcriptional regulation. For example, head and neck squamous
cancer cells express MICA, MICB, and ULBP-2, -3, but not ULBP-1. Upon treatment with proteasomal
inhibitors, the expression of ULBP-1 was strongly induced (Butler et al., 2009). However, using
inhibitors for the ATM/ATR pathway, such as caffeine and wortmannin, Butler et al. showed that
the up-regulation was mediated through an ATM/ATR-independent pathway. Importantly, in addition
to increased surface expression of ULBP-1, there was an increase at the mRNA level, resulting from
increased transcription induced by activity at a specific point in its promoter sequence . Thus, ULBP-1
is under transcriptional control of disruption to the proteasome, which is a strategy employed by some
viruses, such as Hepatitis B, to prevent class I MHC sampling of cellular proteins via the endogenous
pathway (Hu et al., 1999).
Tumour dysregulation of NKG2D ligands
Because of the selective pressure exerted by NKG2D mediated NK cell immunosurveillance, there
are several mechanisms by which transformed cells can limit the expression of stress ligands. The
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most notable are up-regulation of microRNAs that specifically target MICA/B and thus result in
translational repression (discussed below (Stern-Ginossar et al., 2008)), and enzymatic shedding of
surface MICA protein.
Enzymatic shedding of membrane-bound MICA from the surface of tumour cells is striking ex-
ample of immunoevasion and immunosupression. First described in 2002, this has now been well
characterised, and appears to be a relatively common step in tumourigenesis. Serum from patients
with a range of tumours was found to contain a soluble form of MICA (sMICA) (Groh et al., 2002;
Salih et al., 2002). This lead to down-regulation of NKG2D from the surface of CD8+ T cells and
NK cells, via internalisation and lysosomal degradation (Groh et al., 2002; Kaiser et al., 2007).
Several molecular mechanisms have been identified that can mediate this shedding, suggesting
there are multiple tumourigenic mutations that can yield this immunoevasion strategy. Endoplasmic
reticulum protein 5 (ERp5) was shown to be expressed at the surface and form transient disulphide-
liked complexes with the membrane bound form of MICA, resulting in the release of sMICA (Kaiser
et al., 2007). A distinct molecular mechanism involving the “a disintegrin and metalloproteinase”
(ADAM) proteolytic enzymes, specifically ADAM10 and ADAM17, was found to operate by surface
association with membrane bound MICA in detergent-resistant membrane microdomains (Waldhauer
et al., 2008; Boutet et al., 2009).
Shedding of sMICA is a particularly potent mechanism for the survival and progression of tumours.
Initially, it facilitates immunoevasion, by decreasing the surface expression of MICA on the tumour
cells, and therefore rendering them less susceptible to direct lysis by NK cells and CD8+ T cells. This
is important in the early stages of tumour formation. However, it also operates as a mechanism of
wider immunosuppression, supported by its association with more advanced tumours (Groh et al.,
2002). This mechanism operates by the sMICA inducing internalisation and degradation of NKG2D
on the cytotoxic cells, acting as a “countermeasure” to exhaust them, resulting in generally impaired
immunosurveillance.
Pathogen regulation of NKG2D ligands
In addition to being a first line of defense against tumours, NK cells, via NKG2D, play an important
role in the early response to intracellular infections, particularly, though not exclusively, viruses. As
discussed in the previous section, the regulation of MICA, via the ATM/ATR pathway, enables cells
to detect DNA damage, which can result from viral infection. However, there is a more fundamental
issue for many viruses: transcriptional trans activation, whereby viral transcription factors activate
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Mechanism Ligand Agent Reference
post-transcription:
microRNA MICA/B
Tumour:
MICA/B targeting miR17-5, miR20a,
miR93, and miR106b
(Stern-Ginossar
et al., 2008)
MICB
Virus: herpesviruses
hcmv-miR-UL112, miR-K12-7,
miR-BART2-5p
(Stern-Ginossar
et al., 2007a;
Nachmani et al.,
2009)
Post-translation:
ER retention
MICB
ULBP-1, -2
Virus: HCMV
UL16 glycoprotein
(Dunn et al., 2003;
Welte et al., 2003;
Wu et al., 2003)
MICA Virus: HCMVMHC class I-like molecule UL142
(Wills et al., 2005;
Ashiru et al., 2009)
MICA/B Virus: AdenovirusE3/19K gene product
(McSharry et al.,
2008)
Post-translation:
Ubiquitination MICA/B
Virus: KSHV
E3 ubiquitin ligase K5
(Thomas et al.,
2008)
Post-translation:
Surface shedding MICA/B
Tumour:
ADAM10, ADAM17, or ERP5
proteolytic cleavage of ectodomain
stalk region
(Groh et al., 2002;
Salih et al., 2002;
Kaiser et al., 2007;
Waldhauer et al.,
2008; Boutet et al.,
2009)
MICA Virus: HIV-1MMP-2, -7 (Nolting et al., 2010)
Table 1.1 : Tumour and viral mechanisms to suppress surface expression of NKG2D ligands. Examples
of post-transcriptional and post-translational mechanisms, deployed by malignant tumours and
viral infections, to reduce surface expression of ligands for the NK cell activating receptor NKG2D.
By down-regulation of expression of NKG2D ligands, transformed and virally infected cells can
escape immunosurveillance by NK cells.
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host genes that may not be their intended target.
For replication, HCMV expresses the nuclear phosphoproteins IE1 and IE2, which are promiscuous
activators of the viral genes, but also activate host genes. One of the host genes activated is HSP70,
but they also interact with a range of transcription factors to activate expression of genes via their
basal promoter sequences (Hagemeier et al., 1992). Furthermore, one of their mechanisms of gene
activation involves displacement of the histone deacetylases, leading to chromatin remodelling, which
could potentially activate the MIC genes. Indeed, treatment of cells with a histone deacetylase
inhibitor, such as sodium valproate, similarly induces expression of MICA and MICB (Armeanu et al.,
2005).
Therefore, because CMV’s replication cycle inescapably activates transcription of theMIC genes, it
has evolved a repertoire of mechanisms to regulate their expression post-transcriptionally. That other
infectious agents, particularly viruses, have also evolved mechanisms of post-transcriptional regulation
of NKG2D ligands, supports the fact that activation of these genes is similarly inescapable during an
essential part of their lifecycle. Examples of viral suppression of MICA surface expression can be found
at each step in the process from gene to surface protein.
Indeed, even once MICA is expressed on the surface, HIV-1 adopts a strategy comparable to
that used by many tumours, it can induce enzymatic cleavage of the extracellular MICA stalk region
leading to shedding of sMICA. This is mediated via the matrix metalloproteinases (MMPs), specifically
MMP-2 and MMP-7. HIV-1 infection of CD4+ T cells induced an up-regulation of MICA, but not
MICB, transcripts but did not increase the surface expression of MICA. However, when the cells were
simultaneously treated with a general MMP inhibitor the surface expression of MICA was significantly
up-regulated (Nolting et al., 2010).
The final stage of surface expression is known to be targeted by Kaposi’s Sarcoma herpesvirus
(KSHV). KSHV encodes two E3 ubiquitin ligases, K3 and K5, that target class I MHC protein for
ubiquitination and subsequent down-regulation. However, K5 also down-regulates MICA and MICB
expression via ubiquitination of lysine residues in their cytoplasmic tails, resulting in their relocation
to an intracellular compartment, though not degradation (Thomas et al., 2008). This mechanism
resembles that used by healthy murine cells for normal regulation of MULT1 expression, which is
mediated via constitutive expression and ubiquitination (Nice et al., 2009). Although this strategy
re-internalises MICA and MICB after surface expression, a more widely documented approach prevents
them ever reaching the surface.
Adenovirus not only down-regulates surface expression of class I MHC protein, but also induces
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expression of MICA and MICB, via its E1A gene. However, the adenovirus gene responsible for down
regulation of class I MHC protein on the surface, E3/19K, also down-regulated MICA and MICB, which
were retained in the endoplasmic reticulum in their endo-H-sensitive immature forms (McSharry et al.,
2008). Similar endoplasmic reticulum retention has been documented for HCMV, which uses the UL-
16 glycoprotein to sequester MICB, ULBP-1, and ULBP-2 (Dunn et al., 2003; Welte et al., 2003; Wu
et al., 2003), but also retains MICA intracellularly through its MHC class I-like molecule UL142 (Wills
et al., 2005; Ashiru et al., 2009).
The NKG2D ligands, exemplified by MICA and MICB, have evolved to be transcriptionally activated
during replication of viruses, particularly the herpesviruses. Because replication is essential for the
viruses, they have evolved to target expression of the NKG2D ligands at various post-transcriptional
steps. These hijack mechanisms that are used by the host cell to prevent aberrant NKG2D ligand
expression, and through their study have led to a better understanding of these host mechanisms. A
particularly striking example of this research approach was the discovery of microRNA regulation of
MICA and MICB.
MicroRNA regulation of NKG2D ligands: host and virus
MiRNAs are a recently described species of small RNAs (∼22nt), that can target the 3’ UTR of mRNA
molecules in a sequence specific manner to target the transcripts of specific genes (Bartel, 2004;
Brennecke et al., 2005). Binding of the miRNA to the 3’UTR of a transcript reduces expression of
that gene, either via reduced stability, or inhibition of translation (reviewed in Bartel, 2009; Brodersen
and Voinnet, 2009; Carthew and Sontheimer, 2009). For a recently discovered mechanism of gene
regulation, they are proving to play a role in a wide range of processes, including hematopoesis,
development, cardiovascular function (Ambros, 2004), and the immune system (Baltimore et al.,
2008; Lindsay, 2008; Xiao and Rajewsky, 2009). Of particular interest to this investigation is the
discovery of their role in the regulation of the NKG2D ligands, MICA and MICB. This strategy was
first identified because of intervention by viral miRNAs, but was subsequently found to be a host
mechanism too, and one which is exploited by tumours for immunoevasion.
It was discovered that the human CMV genome encoded viral miRNAs that specifically targeted
MICB mRNA, suppressing surface expression of the protein and leading to a corresponding decrease
in NK cell mediated lysis (Stern-Ginossar et al., 2007a). The regulation of host stress ligands through
virally encoded miRNAs has since been demonstrated in diverse members of the herpesvirus family
including Kaposi’s Sarcoma virus and Epstein-Barr virus (Nachmani et al., 2009), suggesting that it
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may be a common mechanism of immunoevasion. The conservation of the target sites for the virally
encoded miRNAs in the 3’ UTRs of MICB and MICA, suggested that the same sites may also be
critical for host regulation.
Indeed, the specific target sites in the 3’ UTR were identified and used as theoretical targets to
probe the human miRNA database (Griffiths-Jones et al., 2006). Together with sequence comparison
to the virally encoded miRNA, several human miRNAs that targeted the same sequences in the 3’
UTRs of MICB and MICA transcripts were identified (Stern-Ginossar et al., 2008). Over-expression of
these human miRNAs, specifically miR17-5, miR20a, miR93 and miR106b, was sufficient to suppress
MICB expression, again rendering the cells less susceptible to NK cell mediated lysis, in an NKG2D-
dependent manner. Additional human miRNAs that target MICA have been discovered (Nachmani
et al., 2010), including one that mediates a down-regulation of MICA protein in response to IFN-γ
stimulation (Yadav et al., 2009).
The model that has emerged from these results is of miRNAs imposing a threshold on the trans-
lation of MICA and MICB transcripts, similar to that already well characterised in bacterial gene
regulation (Levine and Hwa, 2008). Although the expression of viral miRNAs could suppress MICA
and MICB translation, the levels of relevant host miRNAs did not change in response to genotoxic
stress, rather increased transcription occurred, overwhelming the miRNA threshold and leading to
up-regulation of MICA and MICB (Stern-Ginossar et al., 2008). Thus, the miRNA threshold may
function to limit spurious expression; a particularly important role because the promoter sequence of
MICA drives a low basal, but constitutive transcription (Venkataraman et al., 2007). In addition, it
may allow a continuous low level of constitutive transcription to facilitate rapid up-regulation following
stimulation.
This model is supported by the finding that in several tissues, MICA mRNA is constitutively
present in cells, without prior stimulation, even though they lack surface expression of the protein
(Groh et al., 1996; Boissel et al., 2006; Schrambach et al., 2007). Indeed, in the system that this
current investigation specifically studies, human macrophages stimulated through the TLRs, it has
previously been shown that MICA transcript is expressed in unstimulated macrophages, but without
surface expression of the protein (Nedvetzki et al., 2007). Thus, in human macrophages there is at
least one mode of post-transcriptional regulation of MICA, but it remains to be tested whether this
could be miRNA.
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1.4 Cytokine mediated communication with NK cells
An immune response doesn’t involve one cell type in isolation, rather it requires the co-ordinated,
reciprocal communication of many immune cell types, in part mediated by cytokines. Although there
are a wide range of cytokines and chemokines, with different pro- and anti-inflammatory effects
to co-ordinate different types and aspects of an immune response, namely initiation, amplification,
resolution, here the discussion focusses on those directly related to NK cells. One of the most notable
cytokines in the context of NK cells is IFN-γ, which has wide ranging pro-inflammatory and anti-
infection effects. The secretion of IFN-γ by NK cells, and its subsequent effects has been discussed
earlier as one of the key effector functions of NK cells. However, several cytokines are critical to the
development, survival, and in certain cases, activation, of NK cells, in particular, IL-2, IL-12, IL-15,
and IL-18. Given the effector functions of NK cells, particularly their secretion of IFN-γ and TNF-α, it
is not surprising that the cytokines involved in priming them to respond are similarly pro-inflammatory
in nature.
IL-15 is particularly important, because it is required for NK cell development, knockout mice
lacking IL-15 (Kennedy et al., 2000), or its receptor IL-15Rα (Lodolce et al., 1998), are NK cell
deficient. This is consistent with studies of human immunodeficiencies in which NK cells are absent in
patients lacking the common gamma chain receptor component (γc), the IL-2/15Rβ, or the signalling
molecule JAK3, all of which are involved in IL-15 signalling (Gilmour et al., 2001; Buckley, 2004). This
may be in part because of its requirement for expression of LFA-1 to confer cytotoxicity (Barao et al.,
2003). IL-15 is also required for NK cell homeostasis, mediated, in part, through its maintenance of
the anti-apoptotic Bcl-2 (Ranson et al., 2003). Interestingly, many of its effects may actually require
it not to act as a soluble mediator, but rather to be presented to NK cells in trans from accessory cells,
where it is produced and complexed with the high affinity, non-signalling IL-15Rα (Stonier and Schluns,
2010). This has been demonstrated in humanised mice (Huntington et al., 2009), and implicated in
NK cell survival in the periphery in mice (Koka et al., 2003). Koka et al. demonstrated that IL-15Rα
is required for peripheral NK cell survival, but not on the NK cells themselves. However, IL-15 is also
involved in NK cell activation during infection.
IL-15 can enhance the cytotoxicity of peripheral blood NK cells, and induce IFN-γ and TNF-α
secretion (Carson et al., 1994). Specifically, it acts synergystically with IL-12, for example following
LPS stimulation, human monocytes secrete IL-12 and IL-15, which elicits IFN-γ secretion by NK cells
(Carson et al., 1995). Indeed, IL-12 is a core activating cytokine of NK cells, and can synergise with
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IL-2, IL-15 or IL-18 to activate NK cells (Caligiuri, 2008). Together, exogenous IL-12 and IL-18 can
activate NK cells, indicated by CD69 expression, and induce a high level of IFN-γ secretion, a feature
often used as a positive control for other stimuli (for example, Newman et al., 2006). In addition to
its use as a positive control, Newman et al. demonstrated that following the stimulation of whole
PBMC with P. falciparum, the NK cell secretion of IFN-γ correlated with the accessory cell production
of IL-12.
A common source of IL-12, particularly for NK cells, is the DC population. Indeed DCs have
been demonstrated to directly activate NK cells cytotoxicity and to produce IFN-γ in a protective
mechanism against viruses (Andrews et al., 2003) and tumours (Fernandez et al., 1999). Fernandez
et al. also demonstrated that this was IL-12 mediated, a signal later confirmed in other investigations
(Yu et al., 2001; Jinushi et al., 2003). In addition, NK cell IFN-γ secretion was abrogated in IL-
12p35−/− knockout mice, and human NK cells incubated with activated DCs did not secrete IFN-γ
in the presence of an anti-IL-12 neutralising mAb (Borg et al., 2004). Similarly, human macrophages
infected with Salmonella induced NK cell IFN-γ secretion, and were also directly killed by the NK cells,
in an IL-12 dependent manner (Lapaque et al., 2009). This is consistent with observations of human
immunodeficiencies, which identified impaired IL-12 receptor complex formation with susceptibility
to non-tuberculous mycobacterial infections and Salmonella infections, suggesting a non-redundant
mechanism for control of intracellular bacterial infections (de Jong et al., 1998).
IL-2 is another important cytokine mediating NK cell responses. It is commonly used to maintain
and expand isolated NK cells in culture, and is implicated in the activation of NK cells in a range of
scenarios. Its role in immune responses has been recognised for some time; however, its importance in
the context of NK cells has only emerged in the last decade (Fehniger et al., 2000). This importance
relates to the source of IL-2; namely CD4+ T cells, positioning IL-2 as a mediating link between the
adaptive and innate immune responses, following their encounter in the parafollicular T cell region
of lymph nodes (Fehniger et al., 2003). Indeed, T cell-derived IL-2 has been found to be important
in an increasing number of responses to infection, where NK cells are recruited as early effectors of
the adaptive immune system for their rapid deployment of IFN-γ (He et al., 2004; Long et al., 2008;
Bihl et al., 2010; Horowitz et al., 2010b,a), discussed in detail later (Sect. 1.6.2). This requirement
for IL-2 co-stimulation may be more broad than previously considered. For example, in the model of
Salmonella-infected macrophages killed by autologous NK cells in an IL-12-dependent manner, it was
necessary for the NK cells to be IL-2 activated (Lapaque et al., 2009).
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1.5 Diversity of NK cells
1.5.1 NK cell subsets
NK cells are heterogeneous in phenotype with different subsets expressing different combinations of
surface receptors (Cooper et al., 2001a; Cheent and Khakoo, 2009). Notable definitions of subsets
identified so far include the CD56dim and CD56bright subsets (Ellis and Fisher, 1989; Nagler et al.,
1989; Cooper et al., 2001b), and another based on the expression of different chemokine receptors
(Inngjerdingen, 2001; Berahovich et al., 2006; Grégoire et al., 2007).
CD56 is the identifying marker for NK cells within the human lymphocyte population. It was noted
early in the characterisation of NK cells that there are two populations, expressing different surface
densities of CD56: the CD56dim, which make up about 90-95% of peripheral blood NK cells, and the
CD56bright, which express a 5-10 fold greater level of CD56 and represent about 5-10% of peripheral
blood NK cells (Cooper et al., 2001a). Although identified by their expression level of CD56, this
protein has no known function in NK cells, and so they have been extensively characterised in terms of
their different functional capacities and expression of other surface markers. In the context of the main
effector mechanisms of NK cells, it is generally considered that the CD56dim are primarily cytotoxic
lymphocytes (Nagler et al., 1989; Jacobs et al., 2001), whereas the CD56bright subset preferentially
secrete cytokines such as IFN-γ and TNF-β (Cooper et al., 2001b; Jacobs et al., 2001).
Additionally, whilst the CD56dim express a high level of the FcγIII receptor, CD16, the CD56bright
express much lower levels, or none at all (Nagler et al., 1989). Expression of CD16 renders the
CD56dim NK cells the primary mediators of antibody-dependent cellular cytotoxicity (ADCC) (Baume
et al., 1992), which corresponds with their documented enhanced cytolytic effector mechanism. In
contrast, the CD56bright NK cells express the high affinity IL-2 receptor (Caligiuri et al., 1990), CD25,
which sensitises them to IL-2 stimulation more readily, and at picomolar concentrations (Fehniger
et al., 2003). Furthermore, varying proportions of the CD56bright subset express CXCR3, CCR7 and
CD62L, which are associated with trafficking to the lymph nodes.
1.5.2 NK cell trafficking
Expression of different chemokine receptors has been used to discriminate additional NK cell subsets
(Campbell et al., 2001; Inngjerdingen, 2001; Berahovich et al., 2006). The localisation of NK cells
to different tissues, or inflammatory states is likely to relate to their functional roles, and will be
influenced by their chemokine receptor repertoires; therefore, expression of chemokine receptors was
J. Henry Evans 33
Chapter 1: INTRODUCTION
used to identify NK cell subsets to anticipate their possible roles. The most recent, and thorough,
of the descriptions of NK cell expression of chemokine receptors segregated the NK cells by CD56
intensity and CD16 expression before analysis of the chemokine receptor expression (Berahovich et al.,
2006). Although they found that in fresh NK cells many of the chemokine receptors, including CCR1,
CCR5, and CXCR6, were expressed on both the CD56dim and CD56bright subsets, each was only
expressed on a proportion of the cells, thus the expression of chemokine receptors defines a different
grouping of NK cells than the intensity of CD56 expression. The expression of other chemokine
receptors, such as CCR6 and CCR7, was virtually restricted to the CD56bright subset, but again was
not expressed on all of the cells, thus suggesting a further subset defined within the CD56bright subset.
Therefore, the characterisation of NK cells based on their chemokine receptor expression profiles has
identified both subsets that are independent of the CD56 intensity classification, and those that form
subsets within the different CD56 populations. An example of the impact of differential trafficking
programs can be seen with the lymph node enrichment of the CD56bright NK cells.
NK cells have been identified in the DC associated medulla region (Bajénoff et al., 2006) and the
parafollicular T cell areas of histologically normal lymph nodes (Fehniger et al., 2003). Nearly all of
these lymph node NK cells are CD56bright (>95%) (Fehniger et al., 2003), in contrast to circulating
NK cells which are mostly (≈90%) CD56dim, therefore a distinct population of CD56bright NK cells
are found in the anatomic site of ongoing adaptive immune responses. Their presence in T cell region
of lymph nodes raises an interesting question regarding the interactions occurring. Activated CD4+
T cells are potent IL-2 secretors, so the proximity of this CD56bright enriched NK cell population
may be expected to be responsive to IL-2 stimulation. Indeed, there are two forms of the IL-2
receptor (IL-2R); an intermediate affinity (IA), and a heterodimeric high affinity (HA) form. On resting
lymphocytes, the latter is found exclusively on the CD56bright NK cell population (Fehniger et al.,
2003), making them more sensitive to IL-2 stimulation than their CD56dim counterparts. The IL-2 can
co-stimulate them to secrete IFNγ, thereby establishing an immunoregulatory feedback loop to drive a
pro-inflammatory immune response. Thus, distinct chemokine receptor mediated trafficking programs
lead to the enrichment of an unusually IL-2 sensitive population of NK cells in a microenvironment
particularly likely to experience IL-2 stimulation, and consequently lead to NK cell activation.
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1.6 The roles of NK cells in immunity
1.6.1 Innate immunity
NK cells were initially characterised for their role in anti-tumour immunity. In particular, they were
identified as cytotoxic lymphocytes that could kill target tumour cells with prior antigen sensitisation
(Herberman and Ortaldo, 1981). However, they also have a clearly established role during viral
infection and even in some bacterial and mycobacterial infections. The importance of NK cells to
control these diseases is clarified by the susceptibility to certain infections suffered by patients with
NK cell deficiencies (Orange, 2002; Orange and Ballas, 2006).
NK cell anti-tumour activity
NK cells have a significant role in the elimination of transformed cells (Kim et al., 2000; Smyth
et al., 2000). This role is mediated through two key aspects of their target recognition: “missing
self” detection of down-modulated class I MHC proteins, and “induced self” up-regulation of stress
inducible NKG2D ligands (Arnon et al., 2006). The inhibitory signalling triggered by KIR engagement
of class I MHC proteins is absent with tumour cells that have down-regulated it to evade CD8+
cytotoxic T cell mediated elimination, thus rendering the tumours susceptible to NK cell mediated
lysis. The up-regulation of the stress inducible NKG2D ligands on tumours is an independent pathway
by which NK cells can target them, and is acutely sensitive to conditions arising in transformed cells
and progressing tumours.
The role of NKG2D mediated NK cell lysis of tumours was clearly demonstrated by the increased
rate of spontaneous, NKG2D ligand bearing, tumours that developed in NKG2D−/− knockout mice
(Guerra et al., 2008). In addition, NKG2D neutralisation increased the rate of de novo tumourige-
nesis: MCA-induced fibrosarcomas were more common in NKG2D neutralised mice (Smyth et al.,
2005). Furthermore, although in wild type mice the fibrosarcomas exhibited no NKG2D ligand expres-
sion, in perforin-deficient mice Smyth et al. found strong expression of Rae-1, which rendered them
immunogenic when transferred to wild-type mice.
As discussed previously (Sect. 1.3.3), the transcriptional regulation of MICA and MICB, under
the control of the heat shock promoter and NF-κB regulation, is appropriate to their role as markers
of cellular stress. Their promoter sequences exhibit striking symmetry with that of the heat shock
gene HSP70, and consequently respond to heat shock, oxidative stress, hypoxia and even excessive
proliferation (Venkataraman et al., 2007). Furthermore, they have a functional intronic activating site
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for NF-κB binding, which mediates their expression in response to DNA damage, or T lymphocyte
activation, via phosphorylation of the ATM/ATR kinases (Molinero et al., 2004; Cerboni et al., 2007).
Thus, even in MHC class I expressing cells, transformation and tumour development can be prevented
by NK cells responding to the NKG2D ligands (Cerwenka et al., 2001) induced by the proliferation,
accumulated DNA damage, over-activation, and the hypoxic tumour microenvironment.
NK cell anti-viral activity
Patients with complete NK cell deficiencies are rare, suggesting they are key components of the immune
system, and the limited available data is consistent with an anti-viral role (Orange, 2002). Specifically,
patients with complete or functional NK cell deficiencies are more susceptible to CMV and HSV
infections (Biron et al., 1989; Orange, 2002; Orange and Ballas, 2006). However, a different picture
emerges when analysing patients with NK deficient severe combined immunodeficiency, for example
from lack of IL-2R or JAK3 signalling, who are treated with allogeneic hematopoietic transplantation.
Approximately half of these patients, who lack NK cells, or have vastly reduced numbers, show no
increased susceptibility to viral infections (Fischer, 2007). Together, these suggest that NK cells do
play an important role, but one that is to some extent redundant, with perhaps CD8+ cytotoxic T
cells or NKT cells. The extensive range of mechanisms employed by herpes viruses to limit expression
of ligands for the NK cell activating receptor NKG2D (Sect. 1.3.3) provides indirect evidence that NK
cells exert significant selective pressure on this family of viruses.
Results in mice strongly support the limited evidence in humans for an NK cell role in the control of
viral infection, particularly by herpes viruses. The defense mounted by NK cells takes three main forms:
secretion of anti-viral IFN-γ, cytotoxicity, and induced apoptosis of the infected target cell. IFN-γ can
induce anti-viral mechanisms in sensitive cells, such as macrophages (Samuel, 2001). Many viruses
have mechanisms to overcome these inducible mechanisms once they have infected a macrophage
(García-Sastre and Biron, 2006); however, by secretion of IFN-γ in to the interstitial fluid NK cells
can limit the spread of the virus to nearby cells. MCMV-infected cells can be targeted directly for
lysis, either because they have suppressed expression of class I MHC proteins, leading to missing self
recognition, or through induced up-regulation of NKG2D ligands (López-Botet et al., 2004). Indeed,
NK cell deficient, or depleted, mice exhibit increased susceptibility to MCMV infection. Furthermore,
specific targeted depletions and knockouts have demonstrated roles for perforin, therefore cytotoxicity,
and IFN-γ secretion, thus confirming the proposed mechanisms.
Whilst depletions and gene knockouts in mice convincingly support a role for NK cells to limit
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herpes virus infections, specific receptor interactions support a wider anti-viral role. For example,
NKp46 in humans is specific to NK cells, and mediates killing of influenza infected cells, via binding
of hemagglutinins (Arnon et al., 2001; Mandelboim et al., 2001). However, no susceptibility to flu
has been recorded in NK deficient patients, so this may not be essential, although it could also be a
reflection of the tightly controlled pathogen-limited environments these patients often experience.
NK cell anti-bacterial activity
Though less well studied, NK cells also have a role in the control of some parasitic, bacterial and my-
cobacterial infections. For example, infection of epithelial cells with bacteria of the diffusely adherent
Escherichia coli (DEAC) diarrheagenic group can lead to NK cell production of IFN-γ via induced
up-regulation of the NKG2D ligand MICA (Tieng et al., 2002). In this study, the cytolytic response
of NK cells was not studied so no conclusions can be drawn regarding the control of bacterial repli-
cation. Interestingly, DEAC infection has been linked with the development of Crohn’s disease (CD),
an autoimmune condition characterised by excessive inflammation in the gut, and Tieng et al. used
tissue sections to identify enhanced MICA expression on the colonic glandular epithelial cells from CD
patients relative to healthy individuals.
Similarly, evidence suggests that NK cells play a role in the resolution of shigellosis, caused by
colonic and rectal mucosal invasion by Shigella flexneri. During infection, S. flexneri invades, disrupts
and induces inflammatory damage to the epithelial barrier of the intestine. Unlike the autoimmunity
arising from DEAC infection, the acute and damaging inflammatory response here restricts S. flexneri
to the intestine and leads to successful bacterial clearance (Le-barillec et al., 2005). As with the
study into DEAC infection, Le Barillec et al. only considered the IFN-γ secretion response of the
NK cells, not their cytotoxicity. Nonetheless, using a murine model, they demonstrated that NK
cells are early producers of IFN-γ, that drives a pro-inflammatory response and recruits monocytes
and neutrophils. Consequently, NK cells represent a component of innate anti-bacterial immunity;
however, their activity can clearly become immunopathologic in certain circumstances.
NK cells also play an important role in the control of Salmonella infection of human macrophages.
After demonstrating a role for NK cells, by showing that NK cell depletion impaired the survival
of Salmonella-infected mice, Lapaque et al. showed that in humans this involved IFN-γ secretion
and degranulation by the NK cells, in an IL-12/IL-18-dependent, NCR-independent manner (Lapaque
et al., 2009). Specifically, of the total lymphocyte population, NK cells were the key producers of
IFN-γ, responsible for over 50% of the secreting cells, and this was abrogated by blocking mAbs to
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IL-12 or IL-18, or physical separation using a transwell. However, the study also demonstrated that
in this system, IFN-γ was not directly responsible for controlling the infection: co-incubation with an
anti-IFN-γ mAb did not result in increased bacterial replication. Instead, it was the NK cell cytolytic
response that limited bacterial replication by killing infected macrophages. This was indicated by
an increase in perforin and granzyme B staining, and its polarisation to the IS formed between the
infected macrophages and NK cells. Therefore, NK cells can play an important role in controlling a
bacterial infection, via interaction with the infected monocyte.
This regulation of infection of monocytes is not limited to bacteria, it has also clearly been
demonstrated for mycobacteria, specifically Mycobacterium tuberculosis. Unlike Salmonella infection,
which activated NK cells “indirectly” via IL-12/IL-188 secretion from the monocytes, M. tuberculosis
infection induced up-regulation of the NKG2D ligand ULBP-1 (Vankayalapati et al., 2005). NK
cells subsequently lysed the infected monocytes in a ULBP-1–NKG2D-dependent manner, this was
confirmed with infected alveolar macrophages, the physiological target during infection. In addition,
the NCR NKp46 also played a dominant role, although its ligand, vimentin, was only identified in a
later study (Garg et al., 2006).
All these examples show NK cells responding to bacterial infection of other cells; however, one
group has demonstrated direct recognition of bacteria and mycobacteria by NK cells, eliciting degran-
ulation and IFN-γ secretion. NK cells can directly recognise free, extracellular BCG and produce IFN-γ
peaking at 24h–30h post-stimulation (Esin et al., 2004). This was mediated through the NCR NKp44,
but not NKp30 or NKp46, binding a non-proteic component of the mycobacterial cell wall, most likely
mycolic acids (Esin et al., 2008). Moreover, NKp44 also bound the cell walls of other mycobateria,
and even Pseudomonas aeruginosa. Thus, NK cells may directly recognise bacterial pathogens and,
via secretion of IFN-γ to initiate a pro-inflammatory response, represent an additional component of
immediate antibacterial innate immunity.
1.6.2 Adaptive immunity
NK cells as effectors of an adaptive immune response
There is controversial evidence that a compartment of “memory” NK cells exists (O’Leary et al.,
2006; Cooper et al., 2009b,a; Cooper and Yokoyama, 2010). One study demonstrated that following
MCMV infection, MCMV specific NK cells expanded massively (100–1000 fold) up to 7d, followed
by a contraction phase lasting months, during which a higher number of specific NK cells were
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still maintained. These NK cells responded rapidly upon re-stimulation with MCMV, and similarly
conferred protection when adoptively transferred to a naive mouse, at 10-fold lower numbers than
naive NK cells from the same background (Sun et al., 2009).
In addition to the possibility of memory-like NK cells, there is gathering evidence for NK cells
functioning as effector cells of a T cell mediated antigen specific adaptive immune response. This has
been implicated in immune responses to infection by specific pathogens, such as Leishmania major
(Bihl et al., 2010), and Plasmodium falciparum (Horowitz et al., 2010b), and also during vaccine recall
responses to influenza A (He et al., 2004; Long et al., 2008), and rabies (Horowitz et al., 2010a).
Upon stimulation of whole PBMC with P. falciparum infected erythrocytes (iRBCs), the NK cells
secrete IFN-γ after 12-18h (Artavanis-tsakonas and Riley, 2002; Korbel et al., 2005). Although T cells
also secrete IFN-γ, this follows later (>24h), thus NK cells are an important early source of IFN-γ,
which is implicated in improved prognosis to malaria infection (Deloron et al., 1991; Luty et al., 1999;
Dodoo et al., 2002). The secretion of IFN-γ by NK cells was found to be dependent on monocytes,
depletion of which abrogated the response, and on the cytokines produced by them, such as IL-12 and
IL-18 (Newman et al., 2006). Strikingly, the response was also abrogated by depleting CD4+ T cell,
blocking class II MHC proteins, or neutralising IL-2, suggesting an antigen specific component to the
pathway leading to the NK cell response (Horowitz et al., 2010b).
This finding was complemented by a similar result following infection with L. major. Here, antigen
specific CD4+ T cells were necessary for early NK cell activation in the draining lymph nodes of infected
mice (Bihl et al., 2010). This activation, resulting in IFN-γ secretion, was similarly dependent on IL-2,
although also dependent on the DC derived IL-12. Thus, in a second, independent study, an important
adaptive immunity mediated pathway was revealed for the activation of NK cells.
In addition, the NK cell lysis of Salmonella-infected monocytes, discussed earlier (Sect. 1.6.1),
whilst dependent on monocyte-derived IL-12 and IL-18, was also dependent on IL-2 (Lapaque et al.,
2009). Lapaque et al. suggested a “menage a trois” of cellular interactions, requiring infected-
monocytes, NK cells, and a source of IL-2. In light of this emerging data, CD4+ T cells are a likely
candidate for the IL-2 source, though this remains to be tested. Such a role for NK cells as early
effectors of adaptive immunity had been previously suggested by studies of vaccination recall responses.
As early as 2004, it was reported that in PBMC from donors previously vaccinated with whole
inactivated influenza A virus, the NK cells secreted IFN-γ in response to stimulation with influenza
A virus (He et al., 2004). After demonstrating that isolated NK cells did not respond to the virus,
thus eliminating the possibility of memory-like NK cell response, He et al. showed that the NK cell
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secretion of IFN-γ was dependent on T cells, and IL-2. This was followed later by a study showing
that PBMC from donors vaccinated with the trivalent flu vaccine exhibited a more robust NK cell
IFN-γ secretion response than PBMC from unvaccinated donors. Indeed, the percentage of IFN-γ
secreting NK cells was up to 70-fold higher in vaccinated than unvaccinated individuals (Long et al.,
2008).
The response is not limited to influenza vaccine, recently it was demonstrated for the rabies virus
too. Here, potent NK cell cytokine production and degranulation was observed following stimulation
with inactivated rabies virus of PBMC from vaccinated, but not unvaccinated donors. Consistent with
the previous studies, this NK cell IFN-γ secretion was dependent on the CD4+ T cells, in particular
the antigen specific CD45RO+ memory cells, and the IL-2 that they secrete (Horowitz et al., 2010a).
Together, these reports present a model in which NK cells routinely function as critical early effectors
of the antigen specific CD4+ T cell response, and through their secretion of IFN-γ can help to amplify
the pro-inflammatory response for pathogen clearance.
NK cells initiating an adaptive immune response
Clearly, NK cells play an important role, in responses to at least some infections, as effectors of
adaptive immunity, that is to say, an immune response mounted following recognition of specific non-
host derived antigen. However, they may be critical to initiating the adaptive immune response too.
For CD4+ T cells to recognise antigen, it must be presented to their TCR via class II MHC proteins,
such as HLA-DR, classically expressed by the professional antigen presenting cells (APCs), a group
that includes monocytes, macrophages, DCs and B cells. However, there is emerging evidence that
this role could also be performed by NK cells that express HLA-DR upon activation.
Expression of HLA-DR on NK cells has long been regarded as a marker of activation (Galea-Lauri
et al., 1999; Ferlazzo et al., 2003; Bozzano et al., 2009; Ingram et al., 2009; Li et al., 2009a; Neves
et al., 2009; Pokkali et al., 2009; Rutjens et al., 2010). However, its expression has been detected
on a small percentage of circulating NK cells in peripheral blood (D’Orazio and Stein-Streilein, 1996;
Yano et al., 1996; Skak et al., 2007; Burt et al., 2008). Moreover, a range of studies have assigned
it a functional role in antigen presentation under certain circumstances. As early as 1991, NK cell
clones, populations derived from a single seed cell, expressing HLA-DR were shown to be capable
of presenting antigen (Roncarolo et al., 1991). They could process and present tetanus toxin (TT)
to specific T cell clones, in an HLA-DR restricted manner, resulting in T cell proliferation and IL-2
secretion. The antigen presentation was not limited to TT, but also included house dust mite allergen,
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and Mycobacterium leprae derived peptide.
A more recent study confirmed the ability of HLA-DR expressing NK cells, activated by LPS
matured DCs, to present antigen to relevant T cell clones, again stimulating proliferation and IL-2
secretion (Hanna et al., 2004). In addition to extending the range of antigens presented, confocal
imaging was used to track antigen acquisition, internalisation and trafficking to the MHC class II
loading compartment of NK cells. This occurred via the activating receptors, including NKG2D,
NKp40, NKp44, and CD16, and was consequently termed “Presentation after killing” (Hanna and
Mandelboim, 2007). Indeed, a very recent study has indicated that murine NK cells expressing
class II MHC protein contribute to presentation of influenza antigen to CD4+ T cells in the lung
(GeurtsvanKessel et al., 2009).
This process is not restricted to classical antigen, but has also been described for the super-
antigen, staphylococcal enterotoxin B (SEB), which cross-links HLA-DR and the TCR in an antigen-
independent manner (Herman et al., 1990). It was shown that SEB stimulation of whole human PBMC
induced secretion of IL-2, and also activated the NK cells, leading to enhanced lytic ability against
the K562 target cell line (D’Orazio et al., 1995). Furthermore, this was specifically dependent on the
expression of HLA-DR on peripheral blood NK cells, depletion of which reduced the SEB-mediated T
cell activation (D’Orazio and Stein-Streilein, 1996).
Thus, HLA-DR-mediated antigen presentation by NK cells has been described in vitro (Roncarolo
et al., 1991; Hanna et al., 2004) and in vivo (GeurtsvanKessel et al., 2009). However, it remains a
much overlooked function and understanding its contribution to specific immune responses remains a
challenge in immunological research.
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1.7 Aims
Human NK cells have well defined roles in innate immunity, and a growing body of evidence supports
their involvement in adaptive immunity. Within their capacity as lymphocytes of the innate immune
system, their role is primarily discussed in terms of their cytotoxicity, eliminating transformed and
virally infected cells, and their secretion of IFN-γ, to drive a pro-inflammatory response, activate
infected myeloid cells, and direct TH 1 development. However, as unexpected observations are made,
and previously described features reconsidered in the light of new findings in NK biology, NK cells are
increasingly recognised to have potential roles beyond their classical description.
In order to explore potential new roles for NK cells, it is important to consider them in the context
of the immune system, where they interact with other immune cells, both of the innate and adaptive
compartments. The modes of interactions are diverse, from cytokine secretion into the cellular milieu
to direct and specific interactions via immunological synapses. Thus, in this investigation, I study
the interactions of (1) NK cells with macrophages, specifically the mechanisms regulating expression
of the NKG2D ligand MICA on the macrophages (Ch. 3), and (2) of NK cells with T cells (Ch. 4),
specifically analysing the expression of HLA-DR on NK cells, and the secretion of IFN-γ by NK cells in
PMBC stimulated with BCG. In addition to these specific interactions, I investigate (3) the strategy
of directed, trans-synaptic cytokine delivery, and how it could relate to NK cell functions (Ch. 5).
1. Multiple mechanisms control up-regulation of MICA on human macrophages stimulated
with TLR agonists
Recently, activation of TLR signalling has been identified as a novel stimulus for NKG2D ligand up-
regulation on human monocytes and macrophages (Nedvetzki et al., 2007; Kloss et al., 2008; Basu
et al., 2009), and murine macrophages (Hamerman et al., 2004). On human macrophages high doses
of LPS induced up-regulation of surface MICA expression, rendering them susceptible to NK cell
mediated lysis (Nedvetzki et al., 2007). Thus NK cells were proposed to play an immunoregulatory
role to limit the extent of particularly strong inflammatory responses.
In this investigation, I study the expression of NKG2D ligands on human macrophages stimu-
lated with different TLR agonists, and the mechanisms that regulate expression of MICA on human
macrophages following LPS stimulation. Specifically:
• LPS-induced NKG2D ligand up-regulation. Expression of MICB protein following LPS stim-
ulation has not been reported, therefore this is compared to up-regulation of MICA on the same
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macrophages. Flow cytometry is used to compare the surface expression of MICA and MICB
proteins following LPS stimulation. In addition, heterogeneity between donors in the magnitude
of MICA up-regulation is tested.
• Transcriptional regulation of MICA and MICB. MICA and MICB mRNA are constitutively
present in unstimulated human macrophages; therefore, transcription of MICA and MICB in
response to LPS stimulation is tested to determine whether it contributes to the subsequent
up-regulation of MICA protein expression. This is assessed by quantifying MICA and MICB
mRNA levels in unstimulated and LPS-stimulated human macrophages, and by comparing the
stabilities of MICA and MICB mRNA.
• MiRNA control of MICA mRNA translation. The absence of MICA protein expression
on unstimulated human macrophages that constitutively express MICA mRNA implicates a
post-transcriptional mechanism of regulation. MiRNAs that are known to target MICA mRNA
are a potential candidate for this post-transcriptional regulation mechanism. This study uses
quantitative real-time PCR to analyse the levels of MICA-targeting miRNAs in unstimulated and
LPS-stimulated human macrophages to test their mode of regulation. Specifically, quantitation
of miRNA levels is used to test whether the levels of miRNA remain constant to act as a threshold
for translation, as has been previously reported, or whether they can be down-modulated to
contribute to the increase in MICA protein expression.
• Different TLR-induced NKG2D ligand expression profiles. The up-regulation of MICA and
MICB proteins is compared on human macrophages stimulated through different TLRs. TLR4,
stimulated by LPS, can signal through a MyD88-dependent pathway, or a MyD88-independent
TRIF-mediated pathway. Therefore, up-regulation of NKG2D ligands following TLR4 stimu-
lation is compared to TLR7/8 stimulation, that signals exclusively via the MyD88-dependent
pathway, and TLR3 stimulation, that signals exclusively via the TRIF-mediated pathway. This
is to test which of the signalling pathways is involved in the LPS-induced up-regulation of MICA
expression. In addition, secreted IL-10 and IL-12 concentrations are compared to enable classifi-
cation of macrophages as classically or alternatively activated, corresponding to a microbicidal,
pro-inflammatory phenotype, or an anti-inflammatory phenotype respectively.
• Autocrine signalling for MICA and MICB up-regulation. Up-regulation of NKG2D ligands
on LPS-stimulated macrophages has been proposed as a mechanism for NK cell-mediated control
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of excessive inflammation. Therefore, the secretion of IL-10, IL-12, and TNF-α is compared
to up-regulation of MICA and MICB expression on the same macrophages stimulated with
different TLR agonists. Furthermore, prompted by correlations between the magnitude of MICA
up-regulation and concentrations of pro-inflammatory IL-12 and TNF-α, these cytokines are
tested directly for their capacity to induce LPS-independent MICA up-regulation.
2. A subset of NK cells that express HLA-DR, and their role in the adaptive immune response
Within the context of an antigen-specific adaptive immune response, NK cells have been demonstrated
to act as effector cells, secreting IFN-γ, and as antigen presenting cells, via expression of the class
II MHC protein HLA-DR (Roncarolo et al., 1991; D’Orazio and Stein-Streilein, 1996; Hanna et al.,
2004). NK cells are early secretors of IFN-γ following stimulation of PBMC with L. major (Bihl
et al., 2010), P. falciparum (Horowitz et al., 2010b), or challenge of vaccinated individuals with rabies
virus (Horowitz et al., 2010a)or Influenza A (He et al., 2004; Long et al., 2008). This occurs in an
antigen-specific CD4+ T cell, IL-2, and class II MHC-dependent manner.
HLA-DR expression on human NK cells is used as a marker of activation, although unlike CD69 up-
regulation, its expression takes 3d–6d following stimulation, and only occurs on a limited proportion of
NK cells. Furthermore, NK cells expressing HLA-DR have been demonstrated to functionally present
antigen to T cells, driving proliferation and IL-2 secretion (Hanna et al., 2004; Roncarolo et al., 1991).
Long overlooked, it remains to be explained why HLA-DR expression on activated NK cells exhibits
characteristics unsuitable to its use as an activation marker.
In this investigation, both of these roles of NK cells are studied, specifically:
• Expression of HLA-DR on human NK cells. The delayed increase of HLA-DR expression,
and its restriction to a limited proportion of the population, on isolated NK cells stimulated
with IL-2 is studied. In particular, the expression of HLA-DR is compared to proliferation, using
CFSE labelling to monitor cell division, and contrasted between different cytokine stimulations.
The proposed model, in which a small circulating population of HLA-DR-expressing NK cells in
peripheral blood undergoes preferential expansion is tested directly using NK cell clones. Analysis
of NK cell clones is used to test clonal restriction of HLA-DR expression, and the results are
used as an input to a mathematical model to test whether preferential expansion of the small
circulating population of HLA-DR-expressing NK cells is sufficient to yield the observed levels
of HLA-DR expression.
J. Henry Evans 44
Chapter 1: INTRODUCTION
• Functional characteristics of HLA-DR-expressing NK cells. Functional responses, including
degranulation, IFN-γ secretion, and chemotaxis, are analysed using flow cytometry based assays
in which NK cells can be distinguished by their expression of HLA-DR. Degranulation and
IFN-γ secretion against target cells are compared between NK cells that express HLA-DR and
those that do not. Furthermore, expression of the chemokine receptor CXCR3, associated with
recruitment to sites of inflammation and lymph node homing, is analysed on HLA-DR-expressing
NK cells. Moreover, the functionality of CXCR3 expression is tested; specifically, whether its
expression can drive enrichment of the HLA-DR-expressing compartment of IL-2 cultured NK
cells in response to the chemokine I-TAC/CXCL11.
• NK cell secretion of IFN-γ in response to BCG stimulation of human PBMC. NK cells in
human PBMC have recently been shown to secrete IFN-γ following BCG stimulation, a response
also observed following stimulation with P. falciparum, L. major, and challenge of vaccinated
individuals with influenza A, or rabies. The NK cell response to these other challenges is
dependent on CD4+ T cells, class II MHC protein, and IL-2; thus, the response of NK cells in
PBMC stimulated with BCG is tested for the same characteristics. Variation in the magnitude
of the NK cell IFN-γ secretion response between donors is also assessed because of known
heterogeneity in the efficacy of the BCG vaccine.
• Immunological role of HLA-DR-expressing NK cells. Expansion of the HLA-DR-expressing
NK cell population, observed following IL-2 stimulation of isolated NK cells, is tested in infection
scenarios. Specifically, the proportions of HLA-DR-expressing NK cells in whole PBMC are
assessed following stimulation with superantigen or with BCG. Heterogeneity between individuals
exists in both the magnitude of NK cell IFN-γ secretion in response to BCG, and in the size of
the HLA-DR-expressing NK cell population in peripheral blood. These two sources of variation
are compared in PBMC from the same individuals to determine whether there is an association.
Furthermore, the size of the HLA-DR-expressing NK cell compartment in PMBC is artificially
modulated to investigate the impact that this has on the subsequent secretion of IFN-γ by the
total NK cell population in PBMC stimulated with BCG.
3. Trans-synaptic secretion of cytokines as a targeted communication mechanism
Cytokines are fundamental mediators of intercellular communication, but because of their nature as
soluble molecules released into the blood or interstitial fluid can activate a range of bystander cells.
J. Henry Evans 45
Chapter 1: INTRODUCTION
In light of this, a targeted delivery of cytokines was proposed to narrow and enhance their activity.
As early as 1988, polarised secretion of IL-4 to the site of TCR engagement was demonstrated by a
non-imaging based approach (Poo et al., 1988). However, advances in imaging techniques, particularly
fluorescence confocal microscopy, have revealed that several cytokines, including IFN-γ and IL-2, are
not only polarised, but are secreted directly across the immunological synapse (Huse et al., 2006;
Barcia et al., 2008), leading to receptor clustering in the cSMAC of the recipient cell (Maldonado
et al., 2004; Lapaque et al., 2009).
Such a mode of cytokine targeting has been demonstrated for IL-2 in murine T cells (Huse et al.,
2006), but the pathway remains to be tested in human T cells, and may be of relevance to the CD4+
T cell derived IL-2 activation of NK cells to initiate their role as IFN-γ secreting effectors during
an adaptive immune response. Furthermore, IFN-γ has been shown to polarise to the lytic synapse
formed between CD8+ T cells and infected astrocytes in rats (Barcia et al., 2008). Although, the
secretion of IFN-γ is one of the key effector responses of NK cells, and is employed in a diverse range
of immune responses, the directed IFN-γ secretion pathway has not been demonstrated in human NK
cells.
The hypothesis is that directed, trans-synaptic secretion of cytokines is an important mechanism
to refine cytokine mediated interactions between human immune cells. In this study, I investigate the
possibility of polarised secretion of cytokines in human T cells and human NK cells, specifically:
• The subcellular distribution of IL-2 in human T cells that form conjugates with B cells, mediated
by superantigen. This is to test whether IL-2 polarises to the immune synapse formed between
the cells, as has been demonstrated for murine T cells.
• The subcellular distribution of IFN-γ in human NK cells forming activating immune synapse-
like contacts with planar surfaces that engage the NK cell activating receptor NKG2D, and the
adhesion receptor LFA-1. This is to test whether human NK cells can secrete IFN-γ through a
directed pathway, in a manner described for CD8+ T cells in rats.
J. Henry Evans 46
Chapter 2
Materials and Methods
47
Chapter 2: MATERIALS AND METHODS
2.1 Cells
2.1.1 Human peripheral blood mononuclear cells (PBMC)
Blood was received from three sources: Leukopack (Buffy Coat) from the National Blood Service, and
anonymous healthy adult donors from Imperial College, or from the London School of Hygiene and
Tropical Medicine. All donors gave fully informed consent and ethical approval was given by London
School of Hygiene and Tropical Medicine Ethics Committee or the Riverside Ethics Committee.
Leukopack blood was diluted 1:1 with room temperature (RT) RPMI and PBMCs were isolated
by FICOLL density gradient centrifugation. Briefly, diluted blood was carefully layered on top of
Ficoll-PaqueTM PLUS (GE healthcare) and centrifuged at 1600rpm for 30m without active braking.
The PBMC formed a distinct buffy coat layer, at the interface of the Ficoll-Paque and serum, which
was collected by slow pipetting after gentle tilting of the tube to loosen the layer. The PBMC were
transferred to a fresh 50ml Falcon tube and topped up with RPMI (RT); cells were washed three times
in RPMI (RT). Serum was collected, heat inactivated for 1h at 56°C, and centrifuged at 3000rpm for
30m. PBMC were cultured in X-vivo 10 media (Bio-Whittaker, Walkersville, MD) supplemented with
10% autologous serum.
For anonymous donors, venous blood was collected into sodium heparin (10IU/ml blood) and then
PBMCs were isolated as for Leukopack blood. After isolation, the PBMC were analysed for expression
of CD3 and CD56 to check lymphocyte populations (Fig. 2.1)
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Figure 2.1 : Human PBMC purified from blood. PBMC were isolated from human blood by density
centrifugation on Ficoll-Paque PLUS to remove erythrocytes, granulocytes and neutrophils. A
The PBMC were analysed by flow cytometry, where the lymphocyte population (LCs) was readily
identifiable. B The lymphocytes were analysed for CD3 and CD56 expression (indicated by arrow)
to identify CD56+CD3− NK cells, CD56−CD3+ T cells and CD56+CD3+ double positive (DPs)
cells.
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2.1.2 Human monocytes isolated from PBMC
Monocytes were isolated from PBMCs by incubation for 1h in tissue culture plates previously coated
overnight with 2% gelatin (Sigma-Aldrich, St Louis, MO). After 1h, the plates were washed thoroughly
to remove non-adherent cells and fresh X-vivo 10 with 2% autologous serum was added. After
overnight incubation, non-adherent cells were removed by washing plates 3 times with RPMI, and then
adherent cells, monocytes, were harvested by gentle scraping. Monocytes were plated at 2–3×106 per
10 cm tissue culture plate or 5×105per well of 12-well plates and differentiated to macrophages by
incubation for 10d, in X-vivo 10 with 2% autologous serum.
After gentle scraping of the adherent cells to resuspend, a sample was retained to analyse by flow
cytometry for CD14 expression, a monocyte marker (Fig. 2.2B). The non-adherent cells, that were
washed off, were analysed in parallel to check the size and identity of contaminating populations.
Monocytes form a readily identifiable population (gated in Fig. 2.2A) distinct from the lymphocyte
population when analysed by flow cytometry for forward scatter and side scatter. Optimisation of
the protocol increased the CD14+ purity from ≈40% to a regular and consistent yield of over 80%
(Fig. 2.2C).
To identify contaminating populations, the samples were stained with CD3 and CD19, markers for
T cells and B cells respectively. In the adherent cells, from which macrophages were differentiated,
the contaminating population was mostly negative for these markers (Fig. 2.2D). Because of their
similarity in the FSC/SSC plot, it seems likely that the contaminating fraction in these adherent cells
may be neutrophil granulocytes. This could be tested directly by analysing expression of CD15, a
marker of neutrophil granulocytes. Of greater relevance to this study was the characterisation of the
detached cell fraction. Initially, the protocol stated that the monocytes detach from the gelatin during
the overnight incubation and it is these detached cells that are plated to differentiate macrophages. It
is clear from these results that the majority of monocytes remain tightly adhered to the gelatin coated
surface, and that it is the contaminants that detach overnight (Fig. 2.2D).
One of the key limiting factors in these experiments is the availability of macrophages, in particular
having sufficient from a single donor to assess multiple stimulation conditions. These results suggest
that although the total macrophage yield could be increased by retaining the detached cells, this would
be accompanied by a disproportionate increase in contaminating cells. Consequently, all subsequent
monocyte isolations discarded the detached cells to maintain a higher purity of CD14+ cells.
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Figure 2.2 : Monocytes were isolated with 80% purity. Monocytes were isolated from PBMCs from
anonymous buffy coat using a 1h incubation on gelatin coated plates followed by thorough washing
and a further 24h incubation. After the 24h incubation the detached cells were aspirated and the
adherent cells scraped and replated to differentiate. During the replating step, a sample of the
adherent cells was retained for analysis by flow cytometry. A The constituent cells of the detached
and adherent populations were identified by flow cytometry, which showed an enrichment in the
monocyte population of adherent cells in the forward scatter (FSC) / side scatter (SSC) plots.
B A corresponding reduction in the CD14− (monocyte marker) population was observed. C
Initial monocyte isolations yielded a low purity (40%) of CD14+ cells, but this increased through
optimisation of the protocol and purity was regularly 80% CD14+. D In isolations with purity
of 80% CD14+, the contaminating populations were characterised by their expression of CD3 (T
cell marker) and CD19 (B cell marker); B cells represent the main contamination in the detached
cells but these do not remain in significant numbers in the adherent population.
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2.1.3 Human NK cells isolated from PBMC
NK cells were isolated from PBMCs by magnetic activated cell sorting using negative selection (“Un-
touched” human NK cell isolation kit, Miltenyi Biotech), following manufacturer’s protocol. Briefly,
this used a cocktail of antibodies to retain all cells except NK cells in the selection column, conse-
quently the isolated NK cells, which remain unbound by any antibody (“untouched”), passed through
the column for collection. After isolation, the NK cells were analysed by flow cytometry for expression
of CD56 and CD3 on PI− lymphocytes (Fig. 2.3). They were maintained in NK cell line media: DMEM
(GIBCO-BRL, Gaithersburg, MD) supplemented with 10% human serum, 1mM L-glutamine, 1mM
sodium pyruvate, 1mM penicillin-streptomycin and 1mM MEM non-essential amino acids. Isolations
from PBMC yielded >95% viable NK cells (Fig. 2.3 right).
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Figure 2.3 : NK cell isolation from PBMC. NK cells were isolated by negative selection using magnetic
separation (MACS) from PBMC. Plots show forward scatter/side scatter gates (left), propidium
iodide gating for live cells (middle), and CD56/CD3 gating for NK cells (right). Arrows indicate
gated population displayed in target plots.
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2.1.4 Human NK cell clones
Within an individual, NK cells form a heterogeneous population expressing different subsets of re-
ceptors, particular inhibitory receptors (Boyton and Altmann, 2007), from a total repertoire present
in the individual. To analyse the functional impacts off specific receptors, clonal populations can be
generated, in which all of the NK cells derive from a single seed cell and express the same repertoire of
receptors (Fig. 2.4). This is performed by limiting dilution (Cella and Colonna, 2000). Briefly, freshly
isolated human NK cells were resuspended at 3 cells per ml in clone media: NK cell line media, PHA
(1U/ml), irradiated PBMC from mixed donors (2×106ml−1). These were thoroughly resuspended and
plated in 96-well round bottom plates, at 100µl per well, with an average of 0.3 NK cells per well.
Five 96-well plates were prepared per donor. After one week, an additional 100µl of clone media was
added to each well. After two weeks, wells in which the media had turned yellow were resuspended
and transferred to a new 96-well plate with additional NK cell line media (no PHA or mixed irradiated
PBMC).
Figure 2.4 : Human NK cell clones. Human NK cells isolated from peripheral blood express different com-
binations of activating and inhibitory receptors (represented by differently shaded cells, top). To
generate clonal lines, in which all the cells of a population express the same repertoire, individual
NK cells were isolated, by limiting dilution, and used to seed new clonal populations (bottom).
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2.1.5 Human PBMC depleted of CD56+ NK cells
Human PBMC were depleted of CD56+ NK cells by magnetic activated cell sorting (CD56 mi-
crobeads kit, Miltenyi Biotech), following manufacturer’s protocol. Briefly, the PBMC were purified
from Leukopack blood or anonymous donors, as described, and resuspended in MACS buffer (0.5%
BSA/2mM EDTA/PBS) and incubated at 4oC with CD56 microbeads for 15m. The microbeads
bound CD56+ cells, which were then retained when the suspension was passed through a depletion
column loaded with magnetic beads. All CD56+ cells were retained in the column and the CD56−
cells were collected for use. It is important to note that this selection process depleted the PBMC
of all CD56+ cells, including the CD3+/CD56+ population. After depletion, the resulting population
was analysed by flow cytometry to confirm depletion of CD56 expressing cells (Fig. 2.5).
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Figure 2.5 : Depletion of CD56+cells from human PBMC. Freshly isolated human PBMC were depleted
of CD56+ NK cells using anti-CD56 microbeads for magnetic separation. A The freshly isolated
PBMC were analysed by flow cytometry for expression of CD3 and CD56 before CD56 depletion.
B Depletion of CD56+cell depletion was confirmed by flow cytometry for CD3 and CD56.
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2.1.6 Separation of HLA-DR positive and negative NK cells
Freshly isolated human NK cells were separated by their expression of HLA-DR using by magnetic
activated cell sorting (HLA-DR microbead kit, Miltenyi Biotech), following manufacturer’s protocol.
Briefly, the isolated NK cells were resuspended in MACS buffer (0.5%BSA/2mM EDTA/PBS) and
incubated at 4oC with HLA-DR microbeads for 15m. The microbeads bound HLA-DR+ cells, which
were then retained when the suspension was passed through a separation column loaded with magnetic
beads. The NK cells that expressed HLA-DR were retained in the column and those that did not were
collected in the flow-through. After collection of the HLA-DR− NK cells, the column was removed from
the magnetic holder, which demagnetises the beads. Fresh MACS buffer was added to the column and
the plunger applied to collect the HLA-DR+ NK cells from the column. Thus, the process yielded two
fractions: the HLA-DR− and HLA-DR+ NK cells. It is important to note that this separation process
was not as efficient as the other cell isolations/depletions. The intensity of HLA-DR expression on
NK cells is low, meaning individual HLA-DR+ NK cells did not bind many microbeads, and therefore
the cells were not well retained in the separation column.
2.1.7 Reconstituting human PBMC from isolated and depleted cell populations
In order to assess the contribution of the HLA-DR+ NK cells to an immune response in vitro, they were
either enriched in PBMC, or selectively blocked with an anti-HLA-DR neutralising mAb. For these
experiments it was necessary to isolate and modify specific cell populations, either by enrichment or
antibody treatment. This was performed by successive rounds of cell isolations or depletions applied
to parallel samples of PBMC, followed by reconstitution of the PBMC to approximately ex vivo
proportions. Specifically, the approaches taken for the two experiments were as follows.
Artificial enrichment of HLA-DR+ NK cells in PBMC
Freshly isolated PBMC were resuspended in MACS buffer and divided into two samples at a ratio of
9:1. The smaller sample was depleted of CD56+ cells and NK cells were negatively isolated from the
larger sample. Separation of NK cells based on expression of HLA-DR was then used to enrich the
HLA-DR+ NK cells. The HLA-DR enriched fraction from the whole sample was combined with 19
of the HLA-DR reduced fraction. This was then recombined with the CD56− sample to reconstitute
PBMC at approximately ex vivo proportions (<10% difference) of different lymphocyte populations,
but with an enriched HLA-DR+ NK cell compartment.
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Figure 2.6 : Selectively blocking HLA-DR on NK cells. PBMC were processed according to the schematic.
Briefly, 1×107 PBMC were retained and used unfractionated, NK cells were isolated by negative
isolation from half of the remaining PBMC, the other half was depleted of CD56+cells. The NK
cells and CD56−cells were each treated with anti-HLA-DR neutralising mAb (α-HLA-DR), or an
isotype control (IC), for 30m and then washed to remove excess. PBMC were reconstituted from
these populations at the same ratios used to separate, in which HLA-DR was blocked on NK
cells only (4), CD56−cells only (5), both sets (6) or neither (4). The unfractionated PBMC were
treated with α-HLA-DR (2) or isotype control (IC, 1) using the same protocol.
Selective HLA-DR blockade on subsets of APCs
Freshly isolated PBMC were resuspended in MACS buffer and divided into two equal samples. One
sample was depleted of CD56+ cells, and NK cells were negatively isolated from the other. This
ensured that when the two populations were recombined none of the cells in the samples would have
been bound by antibody. Each of the cell fractions, CD56− PBMC or NK cells, were then divided into
two further samples, one of which was incubated for 30m with an anti-HLA-DR blocking mAb and
the other with an isotype matched control mAb. After blocking, the samples were washed and then
recombined in the four possible combinations to restore PBMC with HLA-DR selectively blocked on
no cells, all HLA-DR expressing cells, just HLA-DR+ NK cells, or all HLA-DR+ cells except the NK
cells (Fig. 2.6).
Lymphocyte populations in reconstituted PBMC
PBMC were reconstituted from isolated NK cells and CD56-depleted PBMC after the individual
compartments were treated according to the specific experiment. By dividing the samples into specific
proportions at each fractionation, and then reconstituting at the same ratios, the proportions of
the different lymphocyte populations was kept approximately the same (<10% difference) between
unfractionated PBMC and the reconstituted PBMC (Fig. 2.7). The exception was the double positive
CD56+CD3+ cell population. Because of the combinations of antibodies in the cell separation kits,
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Figure 2.7 : Reconstituting PBMC from isolated NK cells and CD56-depleted cells. PBMC were sepa-
rated into 2 parallel samples. NK cells were isolated from one sample, CD56+ cells were depleted
from the other half. PBMC were reconstituted from these cell preparations by combining at the
same ratio, i.e. equal contributions. Isolated NK cells (top left), CD56-depleted cells (bottom
left), unfractionated PBMC (top right) and reconstituted PBMC (bottom right) were analysed
by flow cytometry for surface expression of CD56 and CD3.
these cells are removed from PBMC by the CD56 depletion, but are also removed from the isolated
NK cells by their expression of the T cell marker CD3. Therefore, the reconstituted PBMC lack the
CD56+CD3+ lymphocyte population. The reconstituted PBMC samples were subsequently used for
functional assays following stimulation with BCG or SEB (Sect. 2.4.4).
2.1.8 Immortalised cell lines
Jurkat T cells, Raji B cells and 721.221 B cells (hereafter 221) (kind gifts from Marco Purb-
hoo, Imperial College) were maintained in R10 media: RPMI 1640 (GIBCO-BRL, Gaithersburg, MD)
supplemented with 10% fetal calf serum (FCS), 1% L-glutamine, 1% Penicillin/Streptomycin.
NKL and NK92-MI cells, immortalised NK cell lines, were maintained in R10 media. NKL (kind
gift from Carsten Watzl) were supplemented with 100U/ml human recombinant IL-2 (Roche, Basel,
Switzerland). NK92-MI (ATCC, #CRL-2408) are stably transfected to express IL-2 so no additional
IL-2 was required in the media.
Human embryonic kidney HEK 293T (hereafter 293T), an adherent cell line expressing no en-
dogenous toll-like receptors (TLRs), were maintained in R10 media and passaged using non-enzymatic
cell dissociation solution (Sigma Aldrich) to detach them. Stable transfectants, expressing the com-
ponents of the LPS recognition complex, TLR4, CD14 and MD-2 (hereafter 293T-TLR4, Invivogen),
were maintained in R10 media supplemented with hygromycin (50µg/ml, Invitrogen) and blastocidin
(10µg/ml, Invitrogen).
THP-1 cells, a semi-adherent monocytic cell line (kind gift from George Tzircotis, Imperial Col-
lege), were maintained in R10 media and passaged using non-enzymatic cell dissociation solution to
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detach them. THP-1 were terminally differentiated from a monocyte-like cell line to an adherent
macrophage-like cell using 5ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma Aldrich). Briefly,
the THP-1 cells were split 1:2 on the day before differentiation and the next day they were harvested
by removing the non-adherent cells and treating the flask with non-enzymatic cell dissociation solution
(Sigma Aldrich) for 10m at room temperature. The detached and non-adherent THP-1 were washed
once in R10 media and resuspended in fresh, warm R10 media. The resuspended THP-1 were plated
in wells of a 12-well plate at 0.5×106 per well in 3mls of R10 media. Unless otherwise stated, PMA
was added at 5ng/ml and the cells were differentiated for 48h at 37oC/5%CO2 (Park et al., 2007).
After 48h the differentiated THP-1 (dTHP-1) were inspected by light microscope for morphological
signs of differentiation, and by flow cytometry for surface expression of CD14 and up-regulation of
surface CD11c and CD54. The supernatant was also tested for TNF-α secretion by ELISA.
U937 cells, a non-adherent monocytic cell line (kind gift from James Pease, Imperial College),
were maintained in R10 media and passaged using non-enzymatic cell dissociation solution to detach
them.
2.1.9 Mycobacterium bovis Bacillus Calmette-Guérin
Mycobacterium bovis Bacillus Calmette-Guérin (BCG, Pasteur strain; kind gift from U. Schaible)
was cultured by my collaborator Amir Horowitz, and all infection experiments were conducted at the
LSHTM. Briefly, BCG was grown in Difco Middlebrook 7H9 Broth (Becton Dickinson) complemented
with 0.05% Polysorbate 80 (v/v) BDH, UK) and 10% (v/v) BBL oleic acid, bovine albumin, dextrose,
and catalase (OADC, Becton Dickinson). BCG cultures were incubated at 30oC with gentle shaking
to avoid cell clumping. Cultures were typically grown until the medium appeared very murky. Cultures
were then allowed to settle and passed through a 25-gauge needle 15–20 times. Finally the suspension
was aliquoted into 1ml cryovials and frozen at -80oC. Three randomly selected vials were grown on
agar plates in a dilution series to allow enumeration of viable bacteria/ml.
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2.2 Antibodies
Flow cytometry and imaging were performed using either antibodies directly conjugated to fluorophores
or a combination of primary antibodies followed by fluorophore-conjugated secondary detection anti-
bodies.
Up-regulation of NKG2D ligands on human macrophages stimulated with TLR agonists
The antibodies to study the activation of human macrophages by TLR agonists, and subsequent
NKG2DL up-regulation, were diluted to the specified concentrations (Table 2.1) in FACS buffer
(2%BSA/0.01%Azide/PBS) and samples were stained in 50µl volumes in 96-well V-bottom plates.
Antigen Clone Isotype Conjugate Concentration Source
Isotype control P3 IgG1 APC 10µg/ml eBiosciences
CD14 61D3 IgG1 APC 10µg/ml eBiosciences
Isotype control MOPC-21 IgG1 Purified 10µg/ml BD Bioscience
Isotype control 20102 IgG2a Purified 10µg/ml R&D Systems
Isotype control 20116 IgG2b Purified 10µg/ml R&D Systems
CD54 HA58 IgG1 Purified 10µg/ml BD Bioscience
ULBP-1 170818 IgG2a Purified 10µg/ml R&D Systems
ULBP-2 165903 IgG2a Purified 10µg/ml R&D Systems
ULBP-3 166510 IgG2a Purified 10µg/ml R&D Systems
MICA BAM195 IgG1 Supernatant 10µg/ml Daniela Pende
MICA 159227 IgG2b Purified 10µg/ml R&D Systems
MICB 236511 IgG2b Purified 10µg/ml R&D Systems
MICA/B 159207 IgG2a Purified 10µg/ml R&D Systems
MHC-I W6/32 IgG1 Purified 10µg/ml Davis Lab
CD11a 27/CD11a IgG1 Purified 10µg/ml BD Bioscience
CD11c B-ly6 IgG1 Purified 10µg/ml BD Bioscience
Mouse IgG (H+L) ND Rabbit Cy5 3µg/ml Stratech
Table 2.1 : Antibodies for the study of NKG2DL up-regulation on human macrophages. The anti-
bodies listed above were used for the investigation of the up-regulation of NKG2DLs on human
macrophages stimulated with TLR agonists. Unless otherwise specified, all antibodies are mouse
monoclonal. All were diluted in FACS buffer at the specified concentrations and used to analyse
harvested macrophages by flow cytometry.
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Analysis of the HLA-DR expressing subset of human NK cells
The antibodies to study the phenotype, activation and effector functions of human NK cells expressing
HLA-DR, were diluted to the specified concentrations (Table 2.2) in FACS buffer (2%BSA/0.01%Azide/PBS)
and samples were stained in 50µl volumes in 96-well V-bottom plates. Purified anti-HLA-DR (TÜ36,
BD Bioscience), and the isotype matched control, were also used for blocking experiments (Sect. 2.1.7).
Antigen Clone Isotype Conjugate Concentration Source
Isotype control G155-178 IgG2a FITC 15µg/ml BD Bioscience
Isotype control MOPC-21 IgG1 APC 15µg/ml BD Bioscience
Isotype control MOPC-21 IgG1 PE 15µg/ml BD Bioscience
Isotype control MOPC-21 IgG1 FITC 15µg/ml BD Bioscience
Isotype control X39 IgG2a PerCP 15µg/ml BD Bioscience
Isotype control 27-35 IgG2b Purified 10µg/ml BD Bioscience
CD56 B159 IgG1 APC 15µg/ml BD Bioscience
CD56 B159 IgG1 PE 15µg/ml BD Bioscience
CD3 HIT3a IgG1 FITC 15µg/ml BD Bioscience
CD3 HIT3a IgG1 PE 15µg/ml BD Bioscience
CD3 UCHT1 IgG1 APC 15µg/ml BD Bioscience
HLA-DR TÜ36 IgG2b Purified 10µg/ml BD Bioscience
HLA-DR L243 (G46-6) IgG2a FITC 15µg/ml BD Bioscience
HLA-DR L243 (G46-6) IgG2a PerCP 15µg/ml BD Bioscience
HLA-DP/Q/R TÜ39 IgG2a FITC 15µg/ml BD Bioscience
CXCR3 49801 IgG1 APC 15µg/ml R&D Systems
CD16 3G8 IgG1 Purified 10µg/ml BD Bioscience
IgG1 (IC) P3 IgG1 APC 15µg/ml eBiosciences
CD69 FN50 IgG1 APC 10µg/ml Biolegend
IFN-γ B27 IgG1 APC 10µg/ml BD Bioscience
LAMP-1 H4A3 IgG1 PE 210ng/ml BD Bioscience
CD19 H1B19 IgG1 PE 15µg/ml BD Bioscience
CD19 H1B19 IgG1 FITC 15µg/ml BD Bioscience
Table 2.2 : Antibodies for the study of HLA-DR expressing human NK cells. The antibodies listed above
were used for the characterisation of HLA-DR expression on human NK cells, and an appraisal of
their functional capacities. Unless otherwise specified, all antibodies are mouse monoclonal. All
were diluted in FACS buffer at the specified concentrations and used to analyse PBMC or isolated
NK cells by flow cytometry.
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Imaging intracellular cytokines by confocal microscopy
To image intracellular cytokines in human T cells and NK cells the samples were fixed and perme-
abilised and then stained for actin with Phalloidin and an antibody for the cytokine of interest. The
antibodies were diluted in blocking buffer (5%Horse serum/2%BSA/PermWashTM ) at the specified
concentrations (Table 2.3), and 150µl of the solution was applied to the chamber-slide well.
Antigen Clone Isotype Conjugate Concentration Source
Isotype control R35-95 Rat IgG Purified 5µg/ml BD Bioscience
Isotype control MOPC-21 IgG1 Purified 5µg/ml BD Bioscience
IL-2 MQ1-17H12 Rat IgG2a Purified 5µg/ml BD Bioscience
IFN-γ 4S.B3 IgG1 Purified 5µg/ml BD Bioscience
CD25 M-A251 IgG1 Purified 10µg/ml BD Bioscience
1Actin Phalloidin Alexa 488 7.5U/ml Invitrogen
2NKG2D 149810 IgG1 Purified 10µg/ml R&D Systems
Table 2.3 : Antibodies for imaging intracellular cytokines. The antibodies listed above were used in fixed
and permeabilised samples to image intracellular cytokines in human T cells and NK cells. The
samples were analysed by confocal microscopy. All were diluted in blocking buffer (5%Horse
serum/2%BSA/PermWashTM ) at the specified concentrations. Unless otherwise stated, all pri-
mary antibodies were raised in mice. 1 Filamentous actin was stained using Phalloidin, not an
antibody. 2 anti-NKG2D antibody was used to coat coverglass to use as an activating planar
surface for human NK cells.
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2.3 Analytical techniques
2.3.1 Flow cytometry
Analysis of protein surface expression
Human macrophages, dTHP-1, and 293T/293T-TLR4 cells were analysed for surface expression of
activation markers and NKG2D ligands by flow cytometry. Human NK cells were analysed by flow
cytometry for surface expression of activation markers, adhesion molecules, chemokine receptors,
HLA-DR, and NK cell receptors, as specified in the results section. Macrophages were harvested by
gentle mechanical scraping in cold PBS on ice, and 293T and 293T-TLR4 were harvested by gentle
pipetting to resuspend them in cold PBS. Although not an adherent cell type, primary human NK cells
required pipetting to fully resuspend prior to harvesting to ensure full detachment from the culture
vessel. Samples were resuspended in FACS buffer (2%BSA/0.01% Azide/PBS), loaded into V-bottom
96-well plates and incubated with antibodies at specified concentrations in 50µl of FACS buffer for
30m on ice. For antibodies not directly conjugated, samples were washed once with 200µl FACS
buffer, then resuspended in 50µl of FACS buffer with secondary antibody at specified dilution and
incubated on ice for 30m. After staining, samples were washed a final three times in 200µl FACS buffer
and transferred to FACS microtubes for data acquisition (FACSCalibur, Becton Dickinson). Where
stated, samples were resuspended finally in 2%PFA/PBS for fixation, thus allowing simultaneous data
acquisition of samples from multiple time points to minimise possible sources of error. Unless using
fixed cells, propidium iodide (PI) was added to the samples during the final resuspension in FACS
buffer prior to data acquisition; PI is a marker of apoptotic and dead cells so during analysis PI+ cells
were excluded by gating.
The study of HLA-DR expression on human NK cells included many experiments that used directly
conjugated antibodies, enabling analysis of the expression of multiple proteins on the same samples. In
this investigation, up to four proteins were analysed on the same sample. Where this was performed,
the fluorophores used were FITC (FL-1), PE (FL-2), PerCP (FL-3) and APC (FL-4), the fluorescence
acquisition channel for flow cytometry is indicated in brackets (FACSCalibur, Becton Dickinson). There
is significant bleed-through of fluorescence between these channels, where the emission spectrum of
one fluorophore extends into the acquisition range of an adjacent channel. Therefore, compensation
needed to be applied to multiply stained samples so that the genuine fluorescent signals could be
discerned.
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Figure 2.8 : Determining compensation for 4 channel flow cytometry. When samples were analysed
by flow cytometry using 3 or 4 colours, it was necessary to apply compensation for the bleed-
through between channels. To set-up the compensation samples of unfractionated PBMC were
left unlabelled or labelled with either HLA-DR::FITC (FL-1), CD19::PE (FL-2), HLA-DR::PerCP
(FL-3), or HLA-DR::APC (FL-4) and then analysed by flow cytometry. With each sample, the
gain and compensation in adjacent channels was adjusted, the FACS plots are displayed prior to
compensation (BEFORE, left) and after (AFTER, right). A HLA-DR::FITC labelled samples were
tested in FL-1 and FL-2. B CD19::PE labelled samples were tested in FL-2 and FL-1 (top) or
FL-3 (bottom). C HLA-DR::PerCP labelled samples were tested in FL-3 and FL-2 (top) or FL-4
(bottom). C HLA-DR::APC labelled samples were tested in FL-4 and FL-3. E A portion was
retained from each individually labelled sample and combined in one tube and then analysed to
validate the final compensation settings, by checking that there were no cells detected as positive
in more than one channel.
J. Henry Evans 62
Chapter 2: MATERIALS AND METHODS
Compensation was performed before acquisition of the labelled samples. Compensation samples
were prepared by using a mixed population of cells stained with antibodies to proteins that were only
on a subset of the population. Each sample was labelled with a directly conjugated antibody to
a different fluorophore. For example, PBMC were stained with anti-CD3 conjugated to FITC, PE,
PerCP, or APC, with each sample stained using a different conjugation. The samples were prepared
as normal, and fixed if the experimental samples were fixed, and then acquired sequentially. For each
sample, the gain was adjusted in the target acquisition channel to separate negative and positive
populations, and then compensation was applied to the acquisition channels on either side so that
no bleed-through fluorescence was detected in them (Fig. 2.8A-D). For example, if PBMC labelled
with α-CD3-PE was being acquired in FL-2 (Fig. 2.8A), the compensation would be applied to FL-1
and FL-3 such that they detected no fluorescence (Fig. 2.8B). After each individually labelled sample
had been acquired and the compensations set, the individually labelled samples were pooled and the
compensations tested by analysing this sample to ensure no individual cells fluoresced in more than
one channel (Fig. 2.8E).
Detection of NK cell intracellular IFN-γ by flow cytometry
IFN-γ secretion is an important effector function of NK cells. It can be detected in the supernatant of
stimulated cells by ELISA; however, it can also be detected within the individual cells that produce it.
This enables the identification of the cell type, or subset specifically responsible for its secretion. After
co-incubation of the NK cells with target cells or PMA/ionomycin, the samples were resuspended in
FACS buffer with antibodies for surface markers to distinguish NK cells from targets, or subsets of NK
cells: the surface markers used depended on the combination of cells being analysed. After 30m incu-
bation on ice, the samples were washed and fixed in 150µl Cytofix/CytopermTM (BD Bioscience) for
20m on ice. Cells were washed twice in Perm/Wash (BD Bioscience), resuspended in 50µl Perm/Wash
with APC conjugated anti-IFN-γ (10µg/ml, BD Pharmingen) and incubated for 30m on ice. After
intracellular staining, the samples were washed two times in Perm/Wash and resuspended in FACS
buffer for analysis by flow cytometry. Cytofix/Cytoperm and Perm/Wash contain saponin, so all steps
following permeabilisation must include Perm/Wash. This protocol was tested using NKL cells and
221 and Raji target cells (Fig. 2.9). Both Raji and 221 cells are CD19+ so NKL were identified as
the CD19− population (Fig. 2.9A). The percentage of IFN-γ+ NKL cells was assessed for each target
cell, and compared to the negative (NKL alone) and positive (PMA/Ionomycin stimulation) controls
(Fig. 2.9B). The PMA/Ionomycin stimulated positive control yielded over 90% IFN-γ+ NKL cells.
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Figure 2.9 : Detection of intracellular IFN-γ by flow cytometry. NKL cells were incubated for 5h in the
presence of BFA (10µg/ml) alone, with 221 target cells, with Raji target cells or with a PMA
(10ng/ml) and Ionomycin (500ng/ml) positive control. After incubation the cells were stained for
CD19 and intracellular IFN-γ before being analysed by flow cytometry. A The CD19− NKL cells
were gated from the mixed population (Raji target cell example shown). B The IFN-γ+ NKL cells
were collected as a percentage of total NKL cells.
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2.3.2 Imaging
Widefield Imaging
THP-1 cells, cultured in 12-well plates, were imaged for morphological changes following differentiation
with PMA. Live samples were imaged by widefield microscopy (Zeiss Axiovert 200), acquired with
Simple PCI (Hammatsu Corporation) and analysed using ImageJ (U. S. National Institutes of Health,
Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/).
Confocal imaging
Cells were incubated in round-bottom 96-well plates, then gently resuspended in warm PBS and trans-
ferred to poly-L-Lysine coated 8-well chamber slides (LabTec, Nunc). When applicable, Brefeldin A
(10µg/ml) was added 4h before harvesting. After 15m, for the cells to settle, they were fixed in
2% PFA/PBS at room temperature for 45m, then gently washed with PBS and permeabilised with
PBS/0.05%Triton X (Sigma) for 5m. Samples were carefully washed with blocking buffer (5%horse
serum/2%BSA/PermWash (BD Bioscience)), 2 times then blocked for 30m at room temperature.
Samples were labelled with primary antibody at the specified concentration Table 2.3 in blocking
buffer for 1h at room temperature. After washing 2 times with blocking buffer, samples were sec-
ondary stained using detection antibody diluted in blocking buffer, and incubated for 45m at room
temperature. Samples were washed a final 3 times and then just covered in 150µl cold PBS, and
stored at 4◦C in the dark until imaged. During all washing and labelling steps, the minimum fluid was
always maintained in the chambers to ensure none of the plate surface or cells were exposed.
Samples were imaged by confocal microscopy (TCS SP5, Leica) and images analysed using
Volocity (Improvision) or ImageJ (U. S. National Institutes of Health, Bethesda, Maryland, USA,
http://rsb.info.nih.gov/ij/).
2.3.3 Supernatant cytokine quantification by ELISA
After stimulation of cells the supernatant was harvested and analysed for the concentration of various
cytokines by Enzyme-linked immunosorbent assay (ELISA), according to the manufacturer’s protocol
(BD Bioscience). Briefly, Maxisorb 96-well plates (Nunc, Wiesbaden, Germany) were coated overnight
at 4◦C with 100µl per well of capture antibody (1µg/ml) in PBS. The following day the wells were
washed once with 200µl of wash buffer (0.05%Tween/PBS) and then blocked with 200µl blocking
buffer (1% BSA/0.05%Tween/PBS) for 3h at room temperature. After washing 3 times with wash
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buffer, triplicate supernatant samples were loaded at 100µl per well, and incubated overnight at 4◦C.
Plates were washed 4 times with wash buffer and incubated with 100µl per well of biotinylated detection
antibody (0.5µg/ml) in loading buffer (1% BSA/0.05%Tween/PBS) for 1h at room temperature. Next
the wells were washed 5 times with wash buffer and then incubated with 100µl per well of streptavidin-
conjugated horseradish peroxidase (Chemicon, 1/2000 dilution) in loading buffer for 30m at room
temperature. After 6 washes with wash buffer, 100µl of HRP substrate 3,3´,5,5´-tetramethylbenzidine
substrate (TMB, Sigma) was added to wells and incubated at room temperature for colour to develop.
The reaction was terminated with 100µl per well of 1M HCL and plate read for absorbance at 450nm.
The ELISAs were performed using antibody kits, containing purified capture and biotinylated
detection antibodies, for human IL-2, TNF-α, IL-10 (all BD Bioscience) and IL-12 (Autogen Bioclear).
Concentrations of samples were determined from absorbances at 450nm by interpolation from
a standard curve (Prism, Graphpad). Standard curves were produced for each plate of samples by
inclusion of standards of known concentrations, generated by serial 1:2 dilutions over the appropriate
range.
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2.4 Assays
2.4.1 TLR agonist stimulation of macrophages
The effect of TLR ligation on the expression of NKG2D ligands by human macrophages was studied
using a range of agonists to different TLRs to stimulate: in vitro 10d matured human macrophages,
THP-1, dTHP-1, U937, dU937, 293T or 293T-TLR4. Cells were stimulated with 200ng/ml LPS from
Salmonella enterica serotype minnesota (Sigma Aldrich), 2.5µg/ml CL097, or 50µg/ml Poly(I:C) (both
from Autogen Bioclear), each reconstituted and aliquoted in endotoxin free water and then diluted
in X-vivo 10 (GIBCO). Media on the macrophages was replaced and they were stimulated for 48h,
unless otherwise stated. After stimulation, the supernatant was collected for cytokine quantification
by ELISA (Sect. 2.3.3), and the cells were harvested by mechanical scraping (macrophages, dTHP-
1, dU937) or pipetting (293T, 293T-TLR4), for analysis of activation and up-regulation of NKG2D
ligands by flow cytometry (Sect. 2.3.1).
2.4.2 MyD88 inhibitor treatment of TLR stimulated macrophages
MyD88 is an adaptor protein that links TLRs with downstream signalling molecules. Homodimerisa-
tion of MyD88 is a critical step in the signaling process, and allows the recruitment and activation of
the kinase IRAK. MyD88 exists as a homodimer when recruited to activated TLRs (excluding TLR3).
The inhibitor peptide contains a sequence from the MyD88 TIR homodimerisation domain (Loiarro
et al., 2005, underlined in Table 2.4), which binds to endogenous MyD88, thereby blocking MyD88
homodimerisation and signalling. The MyD88 homodimerisation inhibitory peptide (MyD88-I) con-
tains a protein transduction (PTD) sequence (DRQIKIWFQNRRMKWKK) derived from antennapedia
which renders the peptide cell permeable (Derossi et al., 1994). A control peptide (MyD88-C), which
consisted of only the PTD sequence, was also used.
The media was replaced on matured macrophages and then they were incubated overnight with the
MyD88-I, or control, peptide. The following day, LPS (200ng/ml) was added to the same media, so
that excess inhibitor remained in solution, and the macrophages incubated for 48h. The macrophages
were then harvested by gentle mechanical scraping and analysed by flow cytometry for up-regulation
of the CD54 activation marker and NKG2D ligands (Sect. 2.3.1).
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Name Sequence Molecular Weight
MyD88-I DRQIKIWFQNRRMKWKKRDVLPGT 3100
MyD88-C DRQIKIWFQNRRMKWKK 2361
Table 2.4 : MyD88 inhibitor peptide and control. The MyD88 homodimerisation inhibitory peptide contains
a protein transduction (PTD) sequence (DRQIKIWFQNRRMKWKK) which renders the peptide
cell permeable, and a MyD88 TIR homodimerisation domain (underlined). The control peptide
consists of only the PTD sequence.
2.4.3 Quantitative Real-Time PCR of microRNAs
The relative levels of microRNA in differently stimulated macrophages were determined by quantitative
real-time PCR (qRT-PCR). The microRNAs tested were miR-17-5p, miR-20a, miR-93, miR-106b
and a control miR-16 (Taganov et al., 2006). The total RNA, including short RNA molecules, was
isolated from cultured macrophages using mirVANA PARIS (Ambion, Applied Biosystems). The
reverse transcription (RT) reaction and quantitative real-time PCR (qRT-PCR) was performed using
TaqMan TM microRNA assays (Applied Biosystems), all according to the manufacturer’s protocols.
Briefly, the macrophages were cultured in 24-well plates and washed once in the plate with cold
PBS and incubated on ice for 5m before lysis with 350µl of ice cold Cell Disruption Buffer. The
cell lysate was immediately transferred to an equal volume of 2X Denaturation Buffer, containing
β-mercaptoethanol, to inhibit cellular ribonucleases.
The stabilised lysate was then added to 700µl acid-phenol:chloroform, mixed well by vortexing and
centrifuged at 13,000rpm for 5m. the aqueous phase (top) was carefully removed to a clean tube
without disturbing the organic phase or interphase layer. The volume of the aqueous phase recovered
was noted and 1.25 volumes of 100% ethanol were added and mixed thoroughly. The lysate/ethanol
mix was applied to a glass-fibre filter column and then washed three times with the wash solutions,
centrifuging at 13,000rpm for 1m between each application. The total RNA was eluted finally in
ddH2O (95oC) and quantified using a NanoDrop spectrophotometer (Thermo Scientific).
The TaqMan microRNA assays used microRNA specific RT primers and separate microRNA spe-
cific qRT-PCR primers. The assays used were as follows: miR-17-5p, ID# 000393; miR-20a, ID#
000580; miR-93, ; miR-106b, ID# 000442; and a control miR-16, ID# 000391. The RT reactions were
performed in 15µl volumes comprised of 100mM dNTPs (0.15µl), MultiScribe reverse transcriptase
(1µl), 10X RT buffer (1.5µl), RNase inhibitor (0.2µl), microRNA specific RT primer (3µl), template
RNA (5ng in 5µl), and nuclease free water (4.15µl). After vortexing to mix and centrifuging to settle
the mixture the tubes were incubated on ice for 5m and then loaded into the thermal cycler. Reverse
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transcription used the following program: 30m at 16oC; 30m at 42oC; 5m at 85oC; and then hold
at 4oC until removed and stored on ice until the qRT-PCR. qRT-PCR reactions were performed in
20µl and in triplicate for each sample/microRNA combination. Each reaction was comprised of 20X
TaqMan qRT-PCR microRNA specific primer (1µl), RT reaction product (1.33µl), TaqMan Universal
PCR Master Mix II no Amperase UNG (10µl), and nuclease free water (7.67µl). The program used
for the qPCR reaction was: enzyme activation, 10m at 95oC; PCR (40 cycles), 15s at 95oC; then
60s at 60oC. All steps of the process were performed in an RNase free environment, pre-treated with
RNaseZap (Applied Biosystems).
The results were exported as the cycle at which the critical threshold of detection was exceeded.
The triplicates were compared and outliers were removed, if different by more than 1 standard de-
viation . Data was analysed by the CT method, briefly, different samples were standardised to a
miR-16 control, which has been demonstrated not to respond to LPS stimulation (Taganov et al.,
2006), to adjust for different total RNA concentrations, and the standardised values compared to the
unstimulated samples to determine relative up or down regulation of individual microRNAs.
2.4.4 PBMC stimulation by BCG or superantigen
Staphylococcal enterotoxin E (SEE, Toxin Technology Inc.) and Staphylococcal enterotoxin B (SEB,
Sigma Aldrich) are superantigens, capable of binding the invariant chain of class II MHC proteins and
the TCR, thus activating T cells in a specific antigen independent manner.
Freshly isolated unfractionated, or reconstituted, PBMC were stimulated with superantigens, SEB
and SEE, or with live BCG and then analysed by flow cytometry. The PBMC were plated at 2×105
per well in round-bottomed 96-well plates and stimulated with superantigen (SEE, 100ng/ml; SEB,
1µg/ml) or live BCG. BCG was used at an optimised multiplicity of infection (MOI, BCG:PBMC) of
10:1 (determined by Amir Horowitz). The samples were incubated for 24h or 48h before analysing the
cells by flow cytometry (Sect. 2.3.1), and the supernatant cytokine concentrations were determined
by ELISA (Sect. 2.3.3). All samples were stained for expression of CD56 and CD3, to identify lym-
phocyte populations, and for expression of HLA-DR, CD69, intracellular IFN-γ, or intracellular IL-2,
as specified. For samples to be analysed for intracellular IFN-γ, Brefeldin A (10µg/ml, Sigma Aldrich)
was added 4h before harvesting, and for intracellular IL-2, monensin (GolgiPlug, BD Bioscience) was
added 4h before harvesting.
As discussed earlier (Sect. 2.1.7), reconstituting PBMC from CD56 depleted samples and isolated
NK cells yields a population lacking the double positive CD56+CD3+ lymphocyte population (Fig. 2.7).
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Figure 2.10 : BCG and SEB elicit a greater NK cell IFN-γ secretion response in reconstituted PBMC
than whole PBMC. A Unfractionated PBMC (top) or reconstituted PBMC (bottom, see
Fig. 2.7) were stimulated with BCG (MOI 10:1), SEB (100µg/ml), or left unstimulated for 24h.
BFA (10µg/ml) was added 4h before harvesting. PBMC were analysed by flow cytometry for
expression of CD56 and CD3, CD56+CD3− NK cells were analysed for intracellular IFN-γ, gates
indicate percentage of IFN-γ+ NK cells. B Data for 3 donors showing percentage of IFN-γ+
NK cells in unfractionated (U) or reconstituted (R) PBMC stimulated with BCG (left) or SEB
(right). Experiments performed with Amir Horowitz.
Interestingly, when stimulated with BCG or SEB there was a modestly increased percentage of IFN-γ+
NK cells in these reconstituted PBMC relative to unfractionated PBMC (Fig. 2.10). This suggests that
the CD56+CD3+ lymphocytes may play an immunoregulatory role, although this was not explored in
this study. Consequently, in all assays, unfractionated and reconstituted PBMC samples were included
as controls; specific effects were compared to the reconstituted PBMC, because these accounted for
the possibly confounding influence of the lack of the CD56+CD3+ cells.
2.4.5 Cytokine stimulation of isolated human NK cells
Freshly isolated NK cells were resuspended in culture medium and stimulated with IL-2 (200U/ml,
Roche), IL-12 (10ng/ml, R&D Systems), IL-15 (10ng/ml, R&D Systems), IL-18 (100ng/ml, R&D
Systems), or IL-21 (10ng/ml, R&D Systems). The stimulated NK cells were cultured for up to 6d
before analysis by flow cytometry for expression of phenotypic markers, markers of activation, and
HLA-DR (Sect. 2.3.1).
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2.4.6 Degranulation assay (LAMP-1/CD107a staining)
Classically, the cytolytic capacity of NK cells against targets or upon stimulation has been tested in
vitro using radioactive release assays, such as the S35-Methionine release assay. However, this has two
limitation; it requires use of hazardous radioactive material, and it only gives the net response of the
total NK population present. A recent alternative assesses the cytolytic response via degranulation,
staining for the lysosomal marker CD107a (LAMP-1, Lysosomal-associated membrane protein 1).
Upon degranulation of the lytic granules towards the targets, CD107a is exposed on the surface, where
it is bound by a fluorophore conjugated antibody added to the incubation medium at the beginning
of the assay. Thus, the specific cells that are responsible for the cytotoxicity can be identified in
the population by flow cytometry. Degranulation, measured by CD107a staining, has been shown to
reflect cytotoxicity in NK cells (Alter et al., 2004), but not IFN-γ secretion (Anfossi et al., 2006).
7.5×104 NK cells were co-incubated with 2.25×105 target cells for 1m, 1h and 2h at 37oC/5%
CO2 in 100µl of R10 media in round bottom 96-well plates. At the beginning of the assay 7µl
of PE conjugated anti-CD107a antibody (BD Pharmingen) was added to each well to give a final
concentration of 210ng/ml. Two wells were plated for each condition. In addition to the 1m incubation
control, NK cells were incubated without target cells as a negative control, and as a staining control
the setup was replicated but without the addition of the anti-CD107a antibody. After incubation the
plates were placed on ice for 20m and then cells were resuspended and transferred to V-bottom wells,
combining 2 wells into 1 to ensure sufficient cells for analysis. The samples were resuspended in FACS
buffer with antibodies for surface markers to distinguish NK cells from targets; surface markers used
depended on combination of cells being analysed. After 30m incubation on ice, the samples were
washed three times and analysed by flow cytometry for surface expression of CD107a (Sect. 2.3.1).
Staining for different surface markers was also used to determine the contribution of different NK cell
subsets to the cytolytic response.
2.4.7 IFN-γ secretion assay
One of the key effector functions of NK cells, IFN-γ secretion, can be detected by ELISA to analyse
its concentration in the supernatant, or by flow cytometry for intracellular IFN-γ. To determine the
NK cell IFN-γ secreting capacity of different subsets, namely the HLA-DR expressing cells, human NK
cells that had been cultured for 6d with IL-2 were used. These were plated in round-bottomed 96-well
plates at 7.5×104 NK cells per well and were co-incubated with 2.25×105 K562 target cells or left
J. Henry Evans 71
Chapter 2: MATERIALS AND METHODS
unstimulated for 5h. Brefeldin A (10µg/ml, Sigma) was added 4h before harvesting. A positive control
sample was included by stimulating the NK cells with PMA (10ng/ml) and ionomycin (500ng/ml) to
induce IFN-γ secretion in a target independent manner. After 5h, the samples were harvested and
analysed by flow cytometry for intracellular IFN-γ (Sect. 2.3.1).
2.4.8 Chemotaxis assay
NK cells expressing the chemokine receptor CXCR3 were assessed for their chemotactic migration
response to the ligand I-TAC (CXCL11) by standard transmigration chemotaxis assays. The assays
used the ChemoTx disposable chemotaxis system (NeuroProbe), specifically 30µl well capacity plates
using a 5µm pore filter with a 8 mm2 exposed filter area bounded by a hydrophobic mask. The
wells were blocked with 30ul 1% BSA/PBS for 30m at room temperature, then all blocking buffer
was carefully removed by pipetting. Next, the wells were carefully loaded with 30µl I-TAC at the
specified concentrations, each concentration was loaded into triplicate wells. The wells were checked
to ensure no bubbles were present. After attaching the filter membrane carefully to ensure that a good
contact was made between the filter and the chemokine solution in each well, the NK cells were loaded
onto the filter. The NK cells were prepared to 107per ml in 0.1%BSA/RPMI, and 20µl was carefully
pipetted on to each exposed filter area bounded by the hydrophobic border, resulting in 2×105 NK
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Figure 2.11 : Chemotaxis transmigration assay setup. The directed migration of cells in response to
a chemotactic signal was tested using a chemotaxis transmigration assay. A After blocking
(RPMI/1%BSA, 30m, RT) the chemokine loading wells of a ChemoTx plate (NeuroProbe), 30µl
of chemokine diluted in RPMI/0.1%BSA was added to each well. A dose curve was generated
over a log scale, and triplicate wells were prepared for each concentration. The membrane was
attached over the wells and a 20µl drop of NK cells (107ml−1in RPMI/0.1%BSA) was carefully
loaded over each well and the plate incubated (2h, humid chamber, 37◦C, 5%CO2). B During
the incubation, the NK cells expressing the relevant chemokine receptor migrated across the
membrane into the well below. After incubation the membrane, and all NK cells still on it,
was removed. The NK cells in the wells below were collected and analysed by counting on
a haemocytometer to determine total migration levels, and by flow cytometry to determine
expression of surface markers on the chemoresponsive cells.
J. Henry Evans 72
Chapter 2: MATERIALS AND METHODS
cells loaded on to each well. The plates were incubated for 2h or 5h at 37oC/5%CO2 in a chamber,
with moistened blue roll to prevent evaporation of the small loaded volume.
After incubation the liquid and cells remaining on top of the membrane were removed by care-
fully wiping and then the filter plate detached. The bottom plate was loaded into a funnel plate
with a recipient 96-well V-bottom plate and centrifuged for 5m/1000rpm. The harvested cells were
resuspended in FACS buffer and divided into 2 samples. Half were counted by haemocytometer to
determine the total number of cells that had migrated across the membrane ( cells per ml1000 × 30), this
was then expressed as a percentage of the total cells loaded (2×105 per well). The other half was
analysed by flow cytometry for the expression of HLA-DR and CXCR3. Before running the assay, a
sample of the total NK population was analysed by flow cytometry for the expression of HLA-DR and
CXCR3.
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Figure 2.12 : CFSE dilution to monitor cell proliferation. Carboxyfluorescein succinimidyl ester (CFSE)
covalently links to cytoplasmic proteins and once a cell is loaded, the total amount remains
approximately constant. A Thus, with each cell division, the CFSE content of the daughter
cells is each half that of the parent. After culturing a cell population for sufficient time for cell
proliferation to have occurred, the population can be analysed by flow cytometry for the intensity
of CFSE label in each cell. B The most intense peak (brightest staining in FL-1) represents the
cells that have not divided, each subsequent peak of decreasing brightness indicates the next
generation of cells.
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2.4.9 Cell proliferation tracking by CFSE dilution
To study the proliferation of primary human NK cells expressing HLA-DR, carboxyfluorescein diac-
etate succinimidyl ester (CFDA-SE) was used. CFDA-SE is a non-fluorescent cell-membrane permeable
molecule that can be used to label cells. Once CFDA-SE has entered cells, the acetate groups are
removed by cellular esterases thus becoming carboxyfluorescein succinimidyl ester (CFSE), which is flu-
orescent and cell-membrane impermeable. Once a cell has been labelled, the CFSE remains a constant
measure of the cytoplasm. Importantly, if a cell undergoes division, and each daughter cell receives
half of the parent cytoplasm, the CFSE content of each daughter cell is also halved (Fig. 2.12A).
Thus, CFSE labelling can be used to monitor a population for cell proliferation (Fig. 2.12B).
To label the cells, freshly isolated primary human NK cells were incubated with 1µM CFSE in
serum-free RPMI for 10m/5% CO2/37oC and then washed three times with warm RPMI before being
cultured as usual. The NK cells were not stimulated with IL-2, or any other cytokine, until after the
CFSE labelling was complete. After culture, the cells were analysed by flow cytometry (Sect. 2.3.1)
for intensity of CFSE staining, which is excited by the 488nm laser and has an emission spectrum
peak of 512nm, so is acquired in the FL-1 channel of a FACSCalibur (BD). If necessary, to compare
expression of surface molecules between cells in different generations of the population, samples were
also stained with the relevant antibodies. CFSE emission bleeds through to FL-2 and FL-3 on the
flow cytometer, so where possible the staining used a fluorophore in FL-4, such as APC, Cy5 or A633,
or appropriate compensation was applied.
2.4.10 Conjugate formation stimulated by superantigen
To drive T cell–B cell conjugate formation, the B cells were pulsed with superantigen prior to co-
incubation with the T cells. SEE was diluted to 1ng/ml, or SEB to 100ng/ml, in warmed conjugate
media (1% FCS/RPMI) and used to resuspend antigen presenting cells at 2×106 ml−1. These were
incubated for 1h at 37◦C before washing three times in conjugate media to remove excess superantigen.
They were resuspended in conjugate media at 2×106 ml−1 to be co-incubated with Jurkat T cells,
also prepared to 2×106 ml−1 in conjugate media. The antigen presenting B cells tested included Raji
and 221 B cells.
The conjugates formed were either imaged by confocal microscopy for intracellular IL-2 after fixing
and permeabilising the samples, or were analysed for percentages of conjugated cells by flow cytometry.
J. Henry Evans 74
Chapter 2: MATERIALS AND METHODS
2.5 Bioinformatics
The use of bioinformatics, computational biology, is a powerful technique. It can be used to generate
predictions to be tested experimentally, or it can generate models using known values for different
parameters. Both uses are employed in this investigation; however, in both situations, the results are
only as good as the model and the data used. Consequently, the model forms an integral part of the
result and is detailed in the relevant results section. Briefly, the two models used were:
1. the predicted distribution of microRNA targets, against which various NKG2D ligands were
compared, and,
2. the clonal expansion of HLA-DR expressing primary NK cells during culture with IL-2.
2.6 Statistical Analysis
For surface protein expression levels, the geometric mean of fluorescence intensity was exported from
FlowJo (TreeStar). To account for variation between staining intensities between experiments, the
mean fluorescence intensity (MFI) was calculated as difference between the geometric means of the
specific and the isotype control staining. Fold increase in MFI was calculated as the MFI of the
stimulated sample divided by the unstimulated.
Unless stated otherwise, sample sizes had n<30, therefore normality of data could be assumed,
consequently non-parametric tests for significance were used. When known heterogeneity between
data points existed, for example between donors, the Wilcoxon matched pairs non-parametric test was
used, otherwise the Mann-Whitney test was used to test for significance.
When sample sizes were greater than 30 and normally distributed, the significance of differences
was calculated by the student t-test.
Correlation strengths between two variables were calculated using the non-parametric Spearman
rank correlation test. Exact significance was determined by permutation.
All graphs were prepared and statistical analyses were performed in Prism (Graph Pad).
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Chapter 3: MULTIPLE MECHANISMS REGULATE TLR-INDUCED MICA UP-REGULATION
3.1 Introduction
As detailed in the introduction (Ch. 1), NK cells play a critical immunosurveillance role, patrolling the
body for signs of malignant transformation or infection (Caligiuri, 2008; Vivier et al., 2008). One of
the key mediators of this recognition is the activating receptor NKG2D (Raulet, 2003), the ligands for
which can be induced by viral infection, DNA damage, hypoxia, heat shock, and oncogene expression
or activation (Eagle and Trowsdale, 2007; Mistry and O’Callaghan, 2007; Nausch and Cerwenka,
2008; Raulet and Guerra, 2009). Through expression of NKG2D ligands, aberrant cells are targeted
for NK cell-mediated lysis, thus removing the threat. However, NKG2D ligands are also up-regulated
on macrophages following stimulation of their TLRs (Hamerman et al., 2004; Nedvetzki et al., 2007;
Basu et al., 2009; Eissmann et al., 2010).
3.1.1 NKG2D ligand expression on macrophages: restricting inflammatory tissue
damage
Macrophages, phagocytic cells of the myeloid lineage (Gordon, 2007), detect characteristic, conserved
molecular patterns on a wide range of pathogens via pattern recognition receptors, most importantly
the Toll-like receptors (TLR) (Takeda, 2004). Lipopolysaccharide (LPS), a component of the gram-
negative bacterial wall, is recognised specifically by TLR4 (O’Neill, 2008). Other TLRs recognise
conserved patterns such as double stranded (ds)RNA and single stranded (ss)RNA, characteristic of
viral infections and recognised by TLR3 and TLR7/8 respectively. Specifically, TLR7/8 are reported to
recognise GU-rich ssRNA, characteristic of viral infection with, for example HIV-1 (Heil et al., 2004).
TLR3 recognises dsRNA (Leonard et al., 2008; Botos et al., 2009), a characteristic intermediate of
viral replication of DNA and positive-strand RNA viruses, but not negative-strand RNA viruses (Weber
et al., 2006). With the exception of TLR3, TLRs signal through the myeloid differentiation (MyD)88
adaptor molecule. TLR3, in common with TLR4, signals via the MyD88-independent TRIF pathway.
Both the MyD88-dependent and -independent signalling pathways result in activation and nuclear
translocation of the transcription factor NF-κB (Alexopoulou et al., 2001; Banerjee and Gerondakis,
2007; Watters et al., 2007), however, there are differences in the other transcription factors they
induce, particularly the interferon regulatory factor (IRFs) family. Whilst TLR3, and TLR4, activate
IRF3 and -7 via TRIF, the MyD88-dependent pathway activates IRF1, -5, and -7, resulting in different
responses by the macrophages (O’Neill and Bowie, 2007).
Engagement of TLRs by their ligands activates macrophages, leading to upregulation of surface
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molecules, such as class II MHC proteins, and triggers the initiation of a proinflammatory response,
including the release of inflammatory mediators, such as IL-12 and TNF-α (Banerjee and Gerondakis,
2007). Through the recruitment of additional effector cells, including NK cells, and cells of the
adaptive immune system, this ultimately leads to the clearance of the pathogen and resolution of
disease (Medzhitov, 2008). Nonetheless, it is crucial to restrict immune responses temporally and
locally prevent immunopathology arising from excessive, inappropriate inflammation leading to tissue
damage, such as can occur in sepsis (Rittirsch et al., 2008), atherosclerosis (Ross, 1999), or TNF-
mediated inflammatory disease (Bradley, 2008).
Sepsis is a multifactorial syndrome, encompassing a range of symptoms characterised by a severed
inflammatory response (Hotchkiss and Karl, 2003; Rittirsch et al., 2008), primarily driven by TNF-a
(Cai et al., 2010). It can be initiated by high levels of macrophage stimulation, frequently through
their TLRs, and a common cause is recognition of gram-negative bacteria through TLR4. This is
common in patients with severe burns, or other failures in natural epithelial barriers, where bacteria
can invade tissue at unusually high titres. The heterogeneous nature of sepsis has made defining it,
and treating it, difficult. Although it is primarily recognised as an excessively inflammatory condition,
reports of immunosuppression, or “immunoparalysis” that follow the inflammatory state have emerged
recently (Hotchkiss et al., 2009).
This progression is consistent with the elevated frequency of secondary, or nosocomial infections
associated with septic patients, and even with the common reactivation of latent infections such as
CMV (Schneider et al., 2007). The clinical outcome can vary dramatically with factors such as age,
gender, genetic disorders, and existing infections. This has hampered the development of therapeutic
interventions, a range of which have only shown efficacy in a subset of patients, with some even
enhancing septic shock. An additional complexity is that the progress of septic shock involves the
interactions of many immune cells, making the impact of each one difficult to determine, even in
highly controlled model systems such as in mice. Thus, new insights into how inflammation can be
controlled may help to develop new therapeutic targets, for example by harnessing NK cell activity.
The role of NK cells during excessive inflammatory responses was proposed after several reports
of their interactions with TLR stimulated macrophages. In vitro stimulation of murine peritoneal
macrophages with TLR agonists induced the up-regulation of NKG2D ligand surface expression, in a
MyD88-dependent manner, leading to increased NK cell-mediated lysis (Hamerman et al., 2004). Up-
regulation of NKG2D ligands on human monocytes was also induced by TLR stimulation, resulting in
enhanced NK cell IFN-γ secretion (Kloss et al., 2008). Nedvetzki et al. demonstrated that stimulation
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of human macrophages with a high dose of LPS, but not a low dose, induced MICA up-regulation
and rendered the macrophages susceptible to NK cell-mediated lysis (Nedvetzki et al., 2007). The
response to a high LPS dose was independently confirmed in a subsequent study, and was extended
to human uterine macrophages (Basu et al., 2009). In addition, a similar response has been observed
on monocyte-derived DCs (mDCs), which up-regulated ULBP-1 and -2 following LPS stimulation and
ULBP-1 following poly(I:C) stimulation (Ebihara et al., 2007). Thus, up-regulation of NKG2D ligands
by over-activated macrophages, resulting in their lysis by NK cells, could constitute an important
regulatory component of the inflammatory response.
Interestingly, the inverse model has been proposed for the interaction of NK cells with microglia,
macrophages resident in the brain. Whilst confirming that a high dose of LPS induced NKG2D
ligand on human macrophages, in the same experiment they demonstrated that LPS induced a down-
regulation of constitutively expressed NKG2D ligands on microglia, reducing their susceptibility to NK
cell-mediated lysis (Lunemann et al., 2008). Although the expression profile of the NKG2D ligands
following LPS stimulation was reversed, it demonstrated the principle of NKG2D-mediated macrophage
“editing” by NK cells as a mechanism to shape immune responses. In this scenario, the NK cells limited
the pool of microglia but permitted survival of those that become specifically activated and can present
antigen. Thus careful control of NKG2D ligand expression can shape immune responses.
3.1.2 Regulation of NKG2D ligands
One aim of current NK cell biology is to understand relevance of the diversity of ligands for the NKG2D
receptor (Radaev et al., 2002; Eagle and Trowsdale, 2007), eight are currently known, and the manner
of their regulation may contribute to this. MICA and MICB are known to be transcribed in the
tissues of most organs, except the brain (Schrambach et al., 2007), but expression of their proteins in
healthy tissues are not so widespread, being limited mostly to the intestinal epithelium (Perera et al.,
2007). This observation was also made in the context of the NKG2D-mediated interaction of NK cells
and macrophages; whilst MICA protein is up-regulated on the surface following LPS stimulation, the
transcript is constitutively present in unstimulated macrophages (Nedvetzki et al., 2007). Thus, one
or more mechanisms of post-transcriptional regulation of MICA expression are likely to be involved in
limiting basal MICA expression, and may contribute to its up-regulation following stimulation by LPS.
Several mechanisms of post-transcriptional regulation of NKG2D ligands have been described.
These include endogenous regulation in healthy cells, and aberrant suppression of expression in tumours
and virally infected cells. Numerous insights into host regulation have derived from discoveries in how
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viruses or tumours can exploit the same mechanisms. For example, ubiquitination and internalisation
of MICA by KSHV (Thomas et al., 2008), has been described as a constitutive mechanism for MULT1
regulation in murine thymocytes (Nice et al., 2009), and is similar to an immunoevasion mechanism
employed by tumours for ULBP-1 expression (Butler et al., 2009). However, whilst MICA mRNA
is present in unstimulated human macrophages, the protein, including intracellular stores, was only
detected by Western blot in those stimulated with LPS (Nedvetzki et al., 2007), thus the expression
is likely mediated, at least in part, by a post-transcriptional mechanism, such as can be mediated by
miRNA.
As discussed in greater detail in the introduction (section 1.3.3), although miRNAs were discov-
ered recently, they are reported to regulate many aspects of human biology (section 1.3.3; Ambros,
2004; Bartel, 2009), including the immune system (Baltimore et al., 2008; Lindsay, 2008; Xiao and
Rajewsky, 2009). A set of 4 human miRNAs that target MICA mRNA have been determined ex-
perimentally (Stern-Ginossar et al., 2008), following identification of miRNAs encoded by CMV that
targeted conserved sites in the 3’ UTRs of MICA and MICB mRNA (Stern-Ginossar et al., 2007a).
These miRNAs acted by imposing a threshold on translation, and were found to over-expressed in some
tumours (Stern-Ginossar et al., 2008). This translational threshold model is comparable to that iden-
tified for small RNAs (sRNA) in bacteria, which prevent spurious protein expression from short signals
that lead to transient transcriptional activity (Levine and Hwa, 2008). Limiting spurious expression
is critically important to control expression of proteins that specifically target the cell for elimination,
so miRNAs are well suited to such a role. Therefore, the basal transcription of MICA (Venkataraman
et al., 2007), confirmed by detection of MICA mRNA in many tissues (Schrambach et al., 2007), but
without protein expression, is consistent with constitutive miRNAs inhibiting translation.
However, using the modelling of sRNA regulation of translation in bacteria, Levine et al. also
proposed that in response to certain stimuli down-modulation of the same sRNAs could contribute
to enhanced protein expression. TLR4-induced MICA up-regulation is likely to be healthy cellular
response, unlike the dysregulation of MICA following malignant transformation or viral infection.
Thus, it can be speculated that the macrophages may use any regulatory mechanisms available to
them, including miRNA. Therefore, it remains to be determined whether human miRNAs, specifically
those targeting MICA mRNA, can function as more than just a threshold mechanism; in particular,
whether they can be specifically down-modulated to enhance protein expression.
Indeed, a recent report, published during this current investigation, demonstrated that miRNAs
can be modulated by external signals. IFN-γ up-regulated miRNAs, including miR-520b, which target
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MICA mRNA, leading to a down-regulation of MICA expression at the surface of tumour cell lines,
HeLa and MelJuSo (Yadav et al., 2009). Interestingly, in this situation MICA transcription was also
impacted; Yadav et al. proposed that this could be via miRNA regulation of transcription factors for
MICA, such as Sp1, Sp3, or NF-κB. However, whilst miR520b was sufficient to mediate the response,
demonstrated by transfection with the miRNA or the corresponding antagomir, pre-treatment of the
cells with the miR-520b antagomir did not affect the net IFN-γ-induced MICA down-regulation. Thus,
there is a precedent for miRNAs directly regulating MICA, but this was in a tumour cell line in which
MICA protein was already constitutively expressed, and it is clear that they operate as part of a wider,
partially redundant, regulatory pathway.
In addition to post-transcriptional regulation of TLR-induced MICA protein expression, transcrip-
tion may also be involved. TLR signalling is known to involve activation and nuclear localisation of
the transcription factor NF-κB. In T cells, MICA protein up-regulation following activation is medi-
ated by NF-κB (Molinero et al., 2004; Cerboni et al., 2007), which binds a site in intron 1 of MICA.
Thus, it seems likely that although MICA mRNA is constitutively expressed in unstimulated human
macrophages (Nedvetzki et al., 2007), LPS-induced up-regulation of the protein may, at least in part,
involve increased transcription, mediated via NF-κB activation.
Indeed, in murine macrophages, LPS induced elevated levels of mRNAs of the NKG2D ligands
RAE-1α, RAE-1β, and RAE-1γ, as tested by quantitative real-time PCR (qRT-PCR) (Hamerman
et al., 2004). qRT-PCR quantifies the levels of mRNAs, not the rate of transcription per se: the
elevated mRNA levels could instead be caused by increased mRNA stability, for example if miRNAs
that were targeting mRNA for degradation had themselves been down-modulated. Other reports of
human macrophages stimulated with TLR agonists have not used qRT-PCR to quantify MICA mRNA
levels, analysing functional protein at the surface by flow cytometry instead (Basu et al., 2009). Thus,
it remains to be tested in human macrophages whether increased transcription, even against the
background of constitutive MICA mRNA, contributes to up-regulation of MICA protein expression at
the surface.
3.1.3 Aims
The immediate functional consequences of MICA up-regulation on human macrophages, following
LPS stimulation of TLR4, have been studied, showing that it renders them susceptible to NKG2D-
mediated NK cell lysis, and can promote IFN-γ secretion. However, the mechanisms controlling this
upregulation have not been investigated. There are many examples of post-transcriptional regulation
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of NKG2D ligands by tumours and viruses, and the detection of constitutive MICA mRNA in unstim-
ulated macrophages that don’t express MICA protein suggests that at least one post-transcriptional
mechanism operates during LPS-induced MICA up-regulation. In addition, results from mice suggest
that increased transcription may contribute to increased expression of NKG2D ligands.
Therefore, the aim of this investigation is to identify the mechanisms controlling expression of
MICA protein on human macrophages stimulated with LPS. In addition, comparison with stimulation
by other TLR agonists, and direct cytokine stimulations, is used to access the signalling pathways
involved. The emergent properties of the multiple mechanisms that control up-regulation of MICA
expression are used to gain insight into possible immunological roles for the response. In particular,
whether NK cells could function as immunoregulators of excessive inflammation, via their elimination
of over-activated macrophages, termed macrophage “editing” (Lunemann et al., 2008). The specific
aims are as follows:
• To characterise the NKG2D ligand expression profile following LPS stimulation of primary human
macrophages.
• To investigate whether this is a common response to all donors, or whether variation can be
observed and quantified.
• To test whether LPS induces MICA transcription. Although MICA mRNA is detectable in
unstimulated human macrophages, in mice there are increased levels of NKG2D ligand mRNAs
following LPS stimulation. Furthermore, TLR signalling activates NF-κB, which is known to
promote MICA expression in T cells. Thus increased transcription may contribute LPS-induced
up-regulation of MICA protein expression.
• To test the role of miRNAs in post-transcriptional regulation ofMICA. Recently identified MICA-
targeting miRNAs are a possible mechanism to restrict translation of constitutively expressed
MICA mRNA in human macrophages. Here, the MICA-targeting, miRNAs are quantified to
determine whether they act as a constant threshold for translation, as in other systems, or
whether their levels can be modulated by LPS stimulation as part of a co-ordinated response.
• To compare the up-regulation of NKG2D ligands between macrophages stimulated with agonists
to different TLRs. Specifically, to determine whether there are differences between the up-
regulation following signalling through the MyD88-dependent pathway (TLR4/7/8) and the
MyD88-independent pathway (TLR3).
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• To compare the up-regulation of NKG2D ligands with the activation state and inflammatory
response of macrophages. Thus, to explore whether the characteristics of MICA up-regulation
on human macrophages following TLR stimulation are consistent with a role for NK cells to
control an excessive inflammatory response.
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3.2 Results
3.2.1 LPS induces expression of MICA but not MICB on human macrophages
Previously, it was demonstrated that stimulation of primary human macrophages with a high dose
of LPS (200ng/ml) for 48h induced the up-regulation of MICA, but the response of MICB was not
assessed specifically (Nedvetzki et al., 2007). Therefore, here the expression of MICB was compared
to the expression of MICA on the same LPS activated macrophages (Fig. 3.1A).
Analysis of macrophages from 63 donors clarified that whilst LPS stimulation induced significant
0-76% up-regulation of MICA (median 33%) relative to unstimulated macrophages, MICB exhibited
no significant up-regulation (Fig. 3.1B). There was a high level of heterogeneity in the NKG2D ligand
response, of both MICA and MICB, to LPS (Fig. 3.1B). Indeed, macrophages from over half the
donors (35/63) tested did not up-regulate MICA at all (Figs 3.1B, 3.2A). To confirm these negative
data, HCT116 cells were used as a positive control, because they constitutively expressed both MICA
and MICB (Fig. 3.2B). Thus, absence of detectable MICA on LPS-stimulated macrophages from some
donors was not likely to be a because of a technical issue.
Because of this heterogeneity in MICA expression, in particular a lack of response from a significant
number of donors, it was necessary to confirm successful activation of the macrophages by LPS. Several
markers of activation have been used for stimulated human macrophages, including the secretion of
TNF-α (Tracey and Cerami, 1994), up-regulation of class II MHC proteins (Gordon, 2003), and even
some co-stimulatory molecules have been used in antigen presenting situations, such as members of
the B7 family (Greenwald et al., 2005). CD54/ICAM-1 was recently shown to be the best surrogate
marker for macrophage activation, particularly understandable because of its biological role as both
an adhesion molecule, recognised by CD11a/LFA-1 and a co-stimulatory molecule in certain cellular
interactions (Sheikh and Jones, 2008). Thus, up-regulation promotes stable conjugate formation
and enhanced signalling in the appropriate context. Therefore, to ensure that macrophages that did
not up-regulate expression of MICA at all, had been been appropriately stimulated with LPS, the
samples were also analysed for expression of CD54. Here, CD54 was also consistently up-regulated
2–3.4 fold (median 2.4 fold) following 48h stimulation of the macrophages by LPS (Fig. 3.1) even
in samples exhibiting no MICA up-regulation (Fig. 3.2). up-regulation of CD54 was a control for
activation, consequently, samples in which there was no up-regulation of CD54 (<50% increase relative
to unstimulated) were not included in this investigation.
Of the 28 donors that did up-regulate MICA, there was a significant 1.3–3.8 fold up-regulation
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Figure 3.1 : LPS activates human macrophages and induces the up-regulation of MICA, but not
MICB. Human macrophages, matured from isolated monocytes, were stimulated with LPS
(200ng/ml), or left unstimulated, for 48h and then analysed by flow cytometry for expression
of MICA, MICB, and CD54. A Representative plots showing up-regulation of MICA (using an-
tibody clones 159227 and BAM195), MICB, and the activation marker CD54 (ICAM-1) (black
lines) and the isotype matched controls (grey shaded). B Data for up to 63 donors, showing the
fold increase in expression relative to the unstimulated macrophages. ***P<0.0001, tested by
Mann-Whitney.
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Figure 3.2 : Macrophages from some donors do not up-regulate MICA in response to LPS stimulation.
Matured human macrophages were stimulated with LPS (200ng/ml), or left unstimulated, for
48h and then analysed by flow cytometry for expression of MICA, MICB, and CD54. Plots show
up-regulation of CD54, but not MICA (using antibody clones 159227 and BAM195), or MICB
(black) and the isotype matched controls (grey shaded). Representative of 35/63 donors tested.
B HCT116 cells, which constitutively express MICA and MICB, were included as a positive control
for MICA and MICB staining.
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Figure 3.3 : LPS induced MICA up-regulation exhibits inter-donor heterogeneity. Human macrophages,
matured from isolated monocytes, were stimulated with LPS (200ng/ml), or left unstimulated,
for 48h and then analysed by flow cytometry for expression of CD54, MICA, and MICB. Data
for >28 donors, showing fold increase in expression relative to the unstimulated macrophages.
***P<0.0001, tested by Mann-Whitney.
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Figure 3.4 : LPS does not induce up-regulation of other NKG2D ligands on human macrophages.
Human macrophages, matured from isolated monocytes, were stimulated with LPS (200ng/ml),
or left unstimulated, for 48h and then analysed by flow cytometry for expression of the NKG2D
ligands ULBP-1, -2, -3. Graphs show the level of expression (geomean of fluorescence) of A ULBP-
1 (n=6), B ULBP-2 (n=4), and C ULBP-3 (n=6), significance tested by Wilcoxon matched pairs.
of MICA (median 1.8 fold), confirmed by two different antibodies, but no significant up-regulation
of MICB (Fig. 3.3). Thus, even in macrophages from responding donors, there was heterogeneity in
the level of MICA up-regulation. In contrast to one previous report into LPS-induced NKG2D ligand
expression on macrophages (Nedvetzki et al., 2007), but consistent with results on monocytes (Kloss
et al., 2008), there no significant up-regulation of ULBP-1, -2, or -3 was observed following LPS
stimulation (Fig. 3.4); however, the sample sizes here were small.
Although the macrophages from all donors analysed were activated by LPS, as confirmed by
up-regulation of CD54, there was a high level of donor heterogeneity observed in the extent of the up-
regulation of MICA in response to LPS. It was important to understand the source of this heterogeneity;
whether it was a consequence of inconsistencies in the isolation, maturation and stimulation of the
human macrophages, or whether it was inherent to each donor. This was approached by analysing
the reproducibility of the up-regulation on macrophages isolated from the same donors.
First, to eliminate the possibility of inconsistencies in the isolation, maturation, stimulation and
analysis of the macrophages, the whole protocol was performed in parallel by two different researchers
(JHE and PE). Here, the blood was received, and immediately divided into two equal samples. These
were then used separately by the two researchers for the entire process up to and including analysis
of the results. The isolation, maturation and stimulation of the macrophages was performed in differ-
ent tissue culture laboratories with different reagents and matured in different incubators. Different
aliquots of LPS were used to stimulate the macrophages, and the harvesting, staining and flow cy-
tometry was performed using different preparations of FACS buffer and antibodies. With all aspects
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Figure 3.5 : Macrophages from the same individual, prepared and stimulated independently, respond
consistently to LPS stimulation. Blood was isolated from an individual and divided into two
equal volumes; isolation of the monocytes, maturation of the macrophages, stimulation of the
macrophages and data acquisition was performed independently by two researchers (JHE and
PE). The matured macrophages were stimulated with LPS (200ng/ml), or left unstimulated, for
48h and then analysed by flow cytometry for expression of MICA, MICB and CD54. Plots show
specific staining (black) and isotype controls (grey shaded). Data representative of 3 experiments.
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of the experiments, other than the source of the blood, performed independently the results were still
the same regarding the up-regulation of NKG2D ligands. MICA was up-regulated in both experiments,
whilst MICB was not up-regulated in either (Fig. 3.5). Thus the heterogeneity was unlikely to be a
technical artifact.
Having established that the heterogeneity in MICA up-regulation was not a consequence of incon-
sistencies in the protocols, there were two other main sources of potential differences: inflammatory
status of the individual at the time of bleeding, and inherent genetic differences. The up-regulation of
MICA on human macrophages was proposed as a mechanism to initiate NK cell-mediated elimination
of over-activated macrophages. Thus, macrophages isolated from a donor during, or shortly after,
an infection may have already been primed, and therefore may be expected to be more responsive,
in terms of MICA up-regulation, to additional stimuli, such as LPS. In this scenario, it is likely that
macrophages derived from the same donor, but isolated at distinct times, may show differences in
their responses.
To investigate the possibility of the inflammatory status of the donor at the time of isolation being
a cause of heterogeneity, the same donors were bled three times, with intervals of at least 6 weeks
between. At each bleed, the macrophages were prepared and the experiments performed at the time
of bleeding, rather than using cryopreservation to analyse them in parallel. The experiments were
performed as before and the up-regulation of CD54, MICA and MICB analysed by flow cytometry.
Here, the same donor consistently up-regulated CD54 and MICA, but not MICB, at all three repeats
(Fig. 3.6). Thus, it is likely that the heterogeneity observed between experiments was genuine inter-
donor heterogeneity, rather than the lack of a robust protocol, or MICA up-regulation being indicative
of a prior inflammatory condition in the donor. Although it would have been very interesting, the
identification of a genetic polymorphism, responsible for the inter-donor differences was outside the
scope of this investigation.
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Figure 3.6 : Macrophages from the same individual respond consistently over repeat stimulations.
Human macrophages were matured from monocytes isolated from the same donor at intervals of
over 6w (indicated as I, II, III) and stimulated with LPS (200ng/ml) or left unstimulated for 48h.
After stimulation, the macrophages were analysed by flow cytometry for expression of the NKG2D
ligands MICA and MICB, and the activation marker CD54. Plots show specific staining (black)
and the isotype control staining (grey shaded).
J. Henry Evans 90
Chapter 3: MULTIPLE MECHANISMS REGULATE TLR-INDUCED MICA UP-REGULATION
3.2.2 PMA induces differentiation of THP-1 cells to a macrophage like cell
LPS stimulation induces the up-regulation of MICA, but not MICB, on human macrophages after
48h. However, the extent of the up-regulation of MICA is heterogeneous, with some donors (35/63)
exhibiting no up-regulation at all, despite being activated as indicated by up-regulation of CD54.
Having demonstrated that this donor heterogeneity is genuine, a model cell line in which the MICA
up-regulation response could be studied readily was sought. Having a cell line with which to study the
response would provide a consistent, reproducible response to LPS. Furthermore, the volume and rate
of experimentation would not be limited by the availability and quality of human samples. Therefore
two myeloid-derived monocyte-like cell lines, THP-1 and U937 cells, were tested for their response to
LPS.
THP-1 cells are a non-adherent, monocyte-like cell line (Tsuchiya et al., 1980) that can be induced
by PMA treatment to terminally differentiate into an adherent macrophage-like cell line (Tsuchiya
et al., 1982). LPS is detected by macrophages via the LPS recognition complex, comprising TLR4,
MD2 and CD14. Undifferentiated THP-1 cells characteristically don’t express CD14; however, one of
the markers of differentiation following PMA treatment is the up-regulation of CD14 surface expression
(Park et al., 2007). Also, the up-regulation of MICA in response to LPS stimulation was characterised
here in human macrophages, rather than monocytes. Therefore, up-regulation of MICA in response to
LPS stimulation was studied in differentiated THP-1 (dTHP-1) cells rather than the undifferentiated
cells.
The differentiation of THP-1 cells by PMA is an established protocol, using a 48h treatment
of cells in culture. However, the up-regulation of MICA on the human macrophages is a modest
response, so the detection of such a response in differentiated THP-1 cells was anticipated to be
similar. A recent report demonstrated that whilst THP-1 cells are routinely differentiated with PMA
at concentrations from 10–400ng/ml, a dose as low as 2.5–5ng/ml is sufficient to induce characteristics
of differentiation (Park et al., 2007). Furthermore, Park et al. showed that using a concentration
above 5ng/ml activates the THP-1 cells, in addition to differentiating them. Differentiation of THP-1
cells is a terminal process characterised by morphological changes, such as development of lamellipodia
and adherence, and by the upregulation of CD14. In contrast, activation is identified by the induction
of genes that are up-regulated in differentiated THP-1, or macrophages, by stimuli other than PMA,
such as LPS. For example, IL-8, IL-1β, MIP-1α, and TNF-α are strongly induced by LPS stimulation
of differentiated THP-1 cells. However, differentiating THP-1 with PMA at concentrations greater
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than 5ng/ml also induced these genes, thus masking the effects of subsequent weak stimuli used on
the differentiated THP-1 cells, including LPS stimulation. The consequence was that many of the
previous studies had had to use an unphysiologically high concentration of the stimulus in order to
elicit a response. The up-regulation of MICA on primary macrophages following LPS stimulation is
likely to a consequence of over-activation, and thus the differentiation of THP-1 cells by PMA needed
to be tightly controlled to limit the confounding influence of PMA-induced activation.
To minimise the risk of PMA-induced activation, the differentiation of THP-1 cells was analysed
with increasing doses of PMA to optimise the differentiation without activation, and to establish
whether the differentiation protocol itself induced changes in NKG2D ligand expression. Based on the
previous report, which demonstrated that 2.5–5ng/ml of PMA was sufficient to differentiate THP-1,
a relatively narrow range of PMA concentrations was tested here. In addition to comparing the state
of differentiation between 2.5ng/m and 5ng/ml, a 2-fold higher dose of 10ng/ml was included to
confirm possible negative data at the lower doses. Undifferentiated THP-1 cell cultures were diluted
1:2 and incubated overnight. The following day they were plated in 12-well plates and treated with
different concentrations of PMA (2.5, 5, or 10ng/ml), or left untreated, and incubated for 48h. After
differentiation, the cells were imaged to check for morphological signs of differentiation, and analysed
by flow cytometry for expression of different activation markers, and expression of NKG2D ligands.
Undifferentiated THP-1 cells are non-adherent, treatment with PMA has been shown to increase
their adherence (Tsuchiya et al., 1982; Park et al., 2007). Here, it was shown that after 48h incubation,
whilst untreated THP-1 cells remained rounded and non-adherent (Fig. 3.7 left), even a low dose
of PMA (2.5ng/ml) was sufficient to induce a change in THP-1 cell morphology, consistent with
differentiation to a macrophage-like cell type (Fig. 3.7). With even a low dose of PMA, the cells
flattened and extended lamellapodia, at doses up to 10ng/ml this effect remained. The extent of
differentiation of individual cells did not increase with the dose of PMA; however, at the low dose
(2.5ng/ml) more cells remained that exhibited the monocyte-like undifferentiated morphology.
Post-PMA treatment, the THP-1 cells were analysed by flow cytometry. They were stained with
propidium iodide to identify apoptotic and dead cells (Fig. 3.8A), which showed that PMA treatment
lowered the survival of the THP-1 cells in a dose-dependent manner (Fig. 3.8B). This suggested
that using a lower concentration of PMA to differentiate the cells would be preferable to maximise
the healthy cells available for subsequent LPS stimulation. In addition, it confirmed that extending
the range of the doses analysed was not necessary. The morphological changes observed by imaging
(Fig. 3.7), were confirmed by the changes in forward and side scatters when the cells were analysed
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Figure 3.7 : Low doses of PMA induce morphological changes in THP-1 cells consistent with differ-
entiation. THP-1 cells were treated with 2.5, 5, or 10 ng/ml of PMA, or left untreated, for 48h.
After 48h, the cells were imaged by widefield microscopy for morphological signs of differentiation.
Images from 2 experiments. Scale bars = 100µm.
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Figure 3.8 : Low doses of PMA differentiate the monocytic cell line, THP-1. THP-1 cells were plated
at 0.5×106per well of a 12-well plate in 2ml R10 media and treated with 2.5, 5, or 10 ng/ml of
PMA, or left untreated, for 48h. After 48h, they were harvested by gentle scraping and analysed
by flow cytometry. A They were gated for propidium iodide (PI) negative cells, which are non-
apoptotic, and then gated by forward scatter (FSC) and side scatter (SSC) for cells in the THP-1
population. B The percentage of live cells was calculated as the percentage of total events
acquired that were PI− and in the gated FSC/SSC population. C Representative FACS plots, of
three independent experiments, showing the PMA dose responsive change in FSC/SSC. D After
the 48h PMA treatment, the supernatants were harvested and tested for TNF-αconcentration by
ELISA. Graph shows median values of TNF-αconcentration from three independent experiments,
error bars show the range.
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Figure 3.9 : Differentiated THP-1 cells display an activated phenotype. After 48h treatment with PMA at
2.5, 5, or 10 ng/ml, THP-1 cells were analysed by flow cytometry for surface expression of CD11c,
CD54, CD11a, HLA-DR and class I MHC protein. A Representative FACS plots show isotype
control (grey shaded) and specific staining (black). B Graphs showing median surface expressions,
calculated as geomean fluorescence on the flow cytometer, for two independent experiments. Error
bars show range.
by flow cytometry (Fig. 3.8B). This showed that the cells enlarged and became more granular when
treated with PMA, relative to untreated samples.
In addition to morphological changes, PMA-differentiated THP-1 cells have been shown to secrete
TNF-α (Park et al., 2007). Therefore, the supernatant of the PMA treated cells was analysed by
ELISA for the concentration of secreted TNF-α. This confirmed that after 48h, whilst untreated
THP-1 cells did not secrete TNF-α, PMA-induced TNF-α in a dose-dependent manner (Fig. 3.8D).
Furthermore, differentiation of the THP-1 cells by PMA was confirmed by changes in expression
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of a range of surface differentiation markers (Fig. 3.9A). Although they were already expressed on
undifferentiated THP-1 cells, PMA induced the up-regulation of CD11c, CD54 and CDlla (Fig. 3.9B-
D). In contrast, the high level of expression of the class II MHC protein HLA-DR on undifferentiated
THP-1 cells underwent a four-fold reduction upon PMA differentiation (Fig. 3.9E), consistent with
previous reports (Reyes et al., 1999). As a control, the expression of class I MHC protein was
not modified by PMA treatment (Fig. 3.9F). All these changes in expression of surface markers
were observed with even the lowest dose of PMA (2.5ng/ml); however, they responded differently
to the increasing concentrations. Whilst CD11c expression continued to rise in a dose-dependent
manner up to the top dose of PMA (10ng/ml) (Fig. 3.9B), the maximum CD54 up-regulation was
observed by 5ng/ml, with no additional increase at 10ng/ml (Fig. 3.9C). Indeed, CD11a was maximally
up-regulated at 2.5ng/ml with a subsequent decrease at higher PMA concentrations, although still
elevated relative to the untreated samples (Fig. 3.9D). Therefore, the different doses of PMA induced
different profiles of activation markers on the differentiated THP-1 cells, demonstrating that PMA
does affect the THP-1 cells more than simply differentiating them. Thus, determining the optimal
dose of PMA for differentiation is important for subsequent stimulations.
Although the expression of markers of differentiation is an important indication of differentiation,
the purpose of the differentiation protocol was to yield a cell type that could be used to model the
up-regulation of MICA in response to LPS. For this, it was essential that the differentiated cells ex-
pressed TLR4 and CD14, components of the LPS recognition complex (Jerala, 2007). Flow cytometric
analysis showed that TLR4 was expressed on undifferentiated THP-1 cells, and was maintained follow-
ing differentiation, whereas CD14 was absent on undifferentiated THP-1 cells but was up-regulated
following 48h treatment with PMA (Fig. 3.10A). Moreover, the expression was highest after treatment
with 5ng/ml (Fig. 3.10B).
The ultimate objective of differentiating the THP-1 cells to a macrophage-like cell type, was to
determine whether they exhibited MICA up-regulation in response to LPS stimulation similar to that
on primary human macrophages. Therefore, the effect of PMA treatment on the expression of NKG2D
ligands was also checked (Fig. 3.11A). Undifferentiated THP-1 cells did not express either MICA or
MICB, and the PMA differentiation did not induce expression of MICA (Fig. 3.11B). However, a very
slight increase in MICB expression was observed, in a PMA dose-dependent manner (Fig. 3.11C).
Analysis of these various indicators of differentiation, morphological changes, expression of surface
markers, and critically, the expression of CD14, confirmed that PMA treatment over 48h induces a
macrophage-like phenotype in the terminally differentiated THP-1 cells. Specifically, this was charac-
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Figure 3.10 : Differentiated THP-1 cells express TLR4 and CD14. After 48h treatment with PMA at 2.5,
5, or 10 ng/ml, THP-1 cells were analysed by flow cytometry for surface expression of TLR4 and
CD14, a macrophage marker. A Plots show expression of TLR4 (black) and isotype control (grey
shaded). B Representative FACS plots show CD14 (black) and isotype control (grey shaded). C
Data for 3 independent experiments showing level of CD14 expression (geomean). Graph shows
medians and ranges.
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Figure 3.11 : Differentiated THP-1 cells do not express MICA. After 48h treatment with PMA at 2.5, 5,
or 10 ng/ml, THP-1 cells were analysed by flow cytometry for surface expression of the NKG2D
ligands MICA and MICB A Representative FACS plots showing isotype control (grey shaded)
and specific staining (black). B Graphs show median surface expressions, calculated as geomean
fluorescence on the flow cytometer, for two independent experiments. Error bars show range.
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terised by upregulation of CD14, adherence and changes from a rounded cell body to one extending
lamellipodia. Importantly, when determining the concentration of PMA to use for further experiments
to look at the response of these differentiated THP-1 cells to LPS stimulation, a balance needed to
be established. As the dose of PMA increases, the survival of the treated cells decreases, and at the
top dose (10ng/ml) the expression of CD14, and CD11a began to decrease again. In contrast, at
2.5ng/ml the up-regulation of CD11c and CD54 was only partial, and the images revealed that not
all cells exhibited morphological signs of differentiation. Therefore, the intermediate concentration of
5ng/ml was used to differentiate the THP-1 cells for subsequent experiments. Although this is much
lower than the concentrations used for many macrophage studies (10–400ng/ml), it is consistent with
a previous report on optimised THP-1 cell differentiation for stimulation with weak stimuli (Park et al.,
2007). Furthermore, it does not induce an up-regulation of MICA, the ligand that the subsequent
experiments would be analysing.
3.2.3 LPS does not induce expression of MICA on differentiated THP-1 cells
Having optimised the protocol for using PMA treatment over 48h to differentiate the monocyte-like
THP-1 cells to macrophage-like dTHP-1 cells, which expressed CD14, the next step was to confirm
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Figure 3.12 : Differentiated THP-1 cells secrete TNF-α in response to LPS stimulation. dTHP-1 cells
were stimulated with different doses of LPS (20, 200, 1000ng/ml), or left unstimulated, for
48h, and then the supernatant was analysed by ELISA for the concentration of secreted TNF-α.
Graph shows data from 3 independent experiments, displaying medians and ranges.
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Figure 3.13 : LPS stimulation activates differentiated THP-1 cells. dTHP-1 cells were stimulated for
48h with different doses of LPS (20, 200, 1000ng/ml), or left unstimulated, and then analysed
by flow cytometry for expression of the activation markers CD11c, CD54, CD11a, HLA-DR, and
class I MHC protein. Expression was compared to undifferentiated THP-1 cells (top). Plots
show specific staining (black) and isotype control staining (grey shaded), representative of 3
experiments.
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Figure 3.14 : LPS does not stimulate NKG2D ligand up-regulation on differentiated THP-1 cells.
dTHP-1 cells were stimulated for 48h with different doses of LPS (20, 200, 1000ng/ml), or left
unstimulated, and then analysed by flow cytometry for expression of the NKG2D ligands, MICA
and MICB. Expression was compared to undifferentiated THP-1 cells (top). Plots show specific
staining (black) and isotype control staining (grey shaded), representative of 2 experiments.
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that these cells could be stimulated by LPS, and to determine whether they up-regulated MICA in a
manner similar to primary human macrophages.
After 48h treatment with 5ng/ml PMA, the dTHP-1 cells were checked for morphological signs
of differentiation by light microscopy. The media was then replaced and the dTHP-1 cells stimulated
with different doses of LPS (20, 200, or 1000ng/ml) for 48h. A high dose of LPS (1000ng/ml) was
included because of the documented possibility of the differentiation protocol masking the effects of
weak stimuli at doses sufficient to activate primary human macrophages (Park et al., 2007).
After stimulation, the supernatant was analysed by ELISA for the concentration of secreted TNF-
α, a characteristic response of human macrophages to LPS stimulation. LPS induced TNF-α secretion
in a dose-dependent manner (Fig. 3.12). LPS activation of the dTHP-1 cells was confirmed by flow
cytometry to analyse up-regulation of the markers CD54, as used with primary human macrophages,
and class I MHC protein (Fig. 3.13). Although the differentiated THP-1 cells were activated by LPS
stimulation, there was no detectable up-regulation of the NKG2D ligands MICA or MICB (Fig. 3.14).
Therefore, the regulation of NKG2D ligands following LPS stimulation, as observed with primary
human macrophages, could not be analysed in the macrophage-like dTHP-1 cell line.
3.2.4 PMA activates but does not differentiate U937 cells
Since the monocytic cell line, THP-1, did not up-regulate NKG2D ligands after LPS stimulation, U937,
another myeloid-derived cell line, was tested in the same manner to determine if it could be used as an
appropriate model system. U937 are a non-adherent monocytic cell line that can be differentiated by
PMA treatment (Larrick et al., 1980). The optimal dose of PMA treatment to induce differentiation
was determined by treatment of the U937 cells with increasing concentrations of PMA, followed by
analysis of the cells by microscopy, flow cytometry and ELISA.
Flow cytometric analysis of the surface markers of differentiation and activation confirmed that the
U937 cells were sensitive to PMA. Specifically, PMA treatment over 48h induced the up-regulation of
CD11c, CD54 and CD11a (Fig. 3.15A), similar to THP-1 cells. There was no increase in expression of
class I MHC protein, and there was no expression of HLA-DR either before or after PMA treatment.
Although, the up-regulation of CD11c and CD54 resembled that on THP-1 cells, the expression
of CD11a showed a dose-dependent increase, similar to CD11c (Fig. 3.15B), and different to the
trend on THP-1 cells (Fig. 3.9D). Furthermore, analysis of the supernatant by ELISA showed that
the PMA treatment induced secretion of TNF-α in a dose-dependent manner, consistent with their
differentiation (Fig. 3.15C).
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Figure 3.15 : U937 cells are activated by PMA treatment. U937 cells were treated with 2.5, 5, or 10 ng/ml
of PMA, or left untreated, for 48h and then analysed by flow cytometry for surface expression
of CD11c, CD54, CD11a, HLA-DR, and class I MHC protein. A Representative plots showing
isotype control (grey shaded) and specific staining (black histogram). B Graphs showing median
surface expressions, calculated as geomean of fluorescence, for three independent experiments.
Error bars show range. C The supernatant was harvested from the stimulated cells and analysed
by ELISA for the concentration of TNF-α. Graph shows median values of TNF-αconcentration
from three independent experiments, error bars show the range.
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Figure 3.16 : U937 cells are not differentiated by PMA treatment. U937 cells were treated with 2.5, 5,
or 10 ng/ml of PMA (as indicated at top), or left untreated, for 48h. A After 48h, the cells were
imaged by widefield microscopy for morphological signs of differentiation. B The stimulated
cells were harvested and analysed by flow cytometry for the expression of TLR4 (black) against
the isotype control (grey shaded). B The stimulated cells were harvested and analysed by flow
cytometry for the expression of CD14 (black) against the isotype control (grey shaded). C Data
from 3 independent experiments for expression of CD14, THP-1 cells were stimulated with PMA
(5ng/ml) as a positive control. Graph shows medians and ranges.
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Although analysis of the expression of markers of activation showed that the U937 cells were
sensitive to the PMA treatment, their morphology and CD14 expression was not consistent with
differentiation to a macrophage-like cell type. Imaging the PMA treated U937 cells revealed no
change in morphology at any of the PMA concentrations used, they retained a rounded cell body
and did not become adherent (Fig. 3.16A). Similarly, analysis of the expression of components of the
LPS recognition complex by flow cytometry showed that undifferentiated U937 cells expressed TLR4
but not CD14, and PMA treatment did not change the expression of either (Fig. 3.16B, C). A direct
comparison with a THP-1 cell control showed that under the same conditions U937 cells were not
differentiated to a macrophage-like cell type by PMA treatment (Fig. 3.16D).
Thus, U937 cells did not differentiate to a macrophage-like cell type. They did not undergo
the morphological changes exhibited by THP-1 differentiation, or by primary monocytes differenti-
ating to macrophages, specifically changing from a non-adherent rounded cell body to a flattened,
or elongated adherent type with lamellipodia. Importantly, unlike differentiated THP-1 they did not
up-regulate CD14, which is a component of the LPS recognition complex. This study was focussed
on human macrophages, rather than monocytes, so because U937 failed to terminally differentiate to
an appropriate macrophage-like phenotype, they were not studied further for their responses.
3.2.5 Expression of the LPS recognition complex is not sufficient to confer NKG2D
ligand responsiveness
Although neither of the monocytic cell lines, THP-1 nor U937, cells exhibited NKG2D ligand up-
regulation in response to LPS stimulation, a model to understand the signalling and mechanisms of
regulation would still have been useful for the study. Having tested monocytic cell lines, a different
approach was taken, to see whether ectopic expression of the LPS recognition complex, comprising
TLR4, MD-2 and CD14 (Jerala, 2007), was sufficient to confer NKG2D ligand responsiveness to a
previously insensitive cell type. For this, the human embryonic kidney cell line (HEK293T, hereafter
293T) was used. 293T cells have no endogenous expression of the LPS recognition complex and are
therefore unresponsive to LPS stimulation. However, they can be readily transfected to express it,
and upon doing so become responsive to LPS stimulation (Medvedev and Vogel, 2003).
A 293T cell line transfected to express TLR4, MD-2 and CD14 (hereafter 293T-TLR4, Invivogen),
was stimulated with different doses of LPS and then analysed by flow cytometry for expression of
the NKG2D ligands, MICA and MICB, and compared to the parental line, not expressing the LPS
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Figure 3.17 : Expression of the LPS recognition complex is not sufficient to confer LPS induced MICA
up-regulation. The expression of MICA in response to LPS was compared between 293T cells,
which have no endogenous expression of TLR4, and 293T-TLR4 (Invivogen) cells, a derived line
transfected to express the LPS recognition complex (TLR4/MD-2/CD14). A 293T cells were
stimulated with increasing doses of LPS, or left unstimulated, for 48h and then analysed by
flow cytometry for expression of CD14, class I MHC protein, MICA, and MICB. B Data from
3 independent experiments. C 293T-TLR4 cells were stimulated with increasing doses of LPS,
or left unstimulated, for 48h and then analysed by flow cytometry for expression of CD14, class
I MHC protein, MICA, and MICB. D Data from 3 independent repeats. Plots show specific
staining (black) and isotype control staining (grey shaded). Graphs show medians and ranges of
expression (geomean of fluorescence).
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Figure 3.18 : LPS activates 293T cells expressing the LPS recognition complex. 293T-TLR4 cells were
tested for their activation by LPS, upstream of MICA expression, by looking at activation of NF-
κB. A 293T-TLR4 cells were transfected, by lipofectamineTM , with a construct for expression of
GFP driven by the promoter for NF-κB (NF-κB-GFP) and then analysed by flow cytometry for
their basal expression of GFP after 12h. Plots indicate the percentage of GFP+ cells (as gated)
and the expression level (geomean) of those GFP+ cells. B The 293T-TLR4(NF-κB-GFP) cells
were stimulated with 50ng/ml LPS (left) or 500ng/ml LPS (right) for 4h (top) or 12h (bottom)
and then analysed by flow cytometry for the expression of GFP. Plots indicate the percentage of
GFP+ cells (as gated) and the expression level (geomean of fluorescence) of those GFP+ cells.
recognition complex. To confirm the phenotype, both cell lines were analysed by flow cytometry for
expression of CD14. Whilst 293T cells did not express any CD14 (Fig. 3.17A, B), the 293T-TLR4 cells
expressed a high level (Fig. 3.17C, D). In addition, in the unstimulated cell lines there was constitutive
expression of MICA, but not MICB, on the 293T cells (Fig. 3.17A, B), and constitutive expression of
both on the 293T-TLR4 cells (Fig. 3.17C, D).
Both cell lines were stimulated with an increasing dose of LPS (1ng/ml – 10µg/ml) and then
analysed by flow cytometry to test for up-regulation of MICA, MICB and the expression of class I
MHC protein as a control. 293T cells, lacking the LPS recognition complex exhibited no change
in their expression level of class I MHC protein or MICA, and no induced expression of CD14, or
MICB (Fig. 3.17A, B). In contrast, the 293T-TLR4 cells, sensitive to LPS stimulation, exhibited a
slight down regulation of CD14, consistent with internalisation following engagement of LPS, and no
significant change in expression of class I MHC protein, used as a control.
Unexpectedly, the expression of MICA also decreased slightly at the higher LPS concentrations
(Fig. 3.17C), in a manner consistent over 3 repeats (Fig. 3.17D), although there was no appreciable
change in the expression of MICB (Fig. 3.17C, D). This slight decrease occurred at the highest levels of
LPS stimulation (1–10µg/ml), which is well in excess of the physiological concentrations, and at a level
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reported to be chemotoxic. Thus, the slight down-regulation at these excessive LPS concentrations
was likely to be an artifact of LPS induced damage, rather than a specific cellular response to LPS
detection.
Although the recognition of LPS by the sensitive 293T-TLR4 cell line was demonstrated by the
down-regulation of CD14, and indirectly by the slight down-regulation of MICA, it was confirmed
directly by analysis of the TLR4 signalling pathway. TLR4 signals via the MyD88 adaptor protein
leading to nuclear translocation and activation of the NF-κB transcriptional activator that induces
downstream effects (Akira and Yamamoto, 2005; Banerjee and Gerondakis, 2007; O’Neill and Bowie,
2007; Watters et al., 2007). To confirm that this signalling pathway was engaged during LPS stimu-
lation of the 293T-TLR4 cells, they were transfected with an additional construct from which GFP is
expressed under an NF-κB responsive promoter (kind gift from Marco Purbhoo, Imperial College).
There was a relatively high basal expression of GFP in these cells (8% GFP+, Fig. 3.18A), consistent
with NF-κB playing a role in many pathways and thus being activated in non-LPS induced situations.
However, stimulation of these 293T-TLR4(NF-κB-GFP) cells with LPS (50–500ng/ml) increased the
percentage of GFP expressing cells and the intensity of expression in these cells (Fig. 3.18B). After
4h stimulation with 50ng/ml LPS there was a 35% increase in the percentage of GFP expressing cells
and a 28% increase in the fluorescence intensity in the GFP expressing cells (Fig. 3.18B). Therefore,
LPS did induce activation of the TLR4 signalling pathway in the 293T-TLR4 cells.
Although the 293T-TLR4 cells, which express the LPS recognition complex, were sensitive to LPS
stimulation, as indicated by NF-κB activation and CD14 down-modulation at the surface, they did
not up-regulate expression of MICA, nor MICB. There are two plausible explanations for this; that
the macrophage MICA up-regulation requires additional signalling components, or that the signalling
pathway involved is already constitutively active in these cells. 293T cells are an immortalised line,
with high constitutive expression of MICA (Fig. 3.17A, B), the 293T-TLR4, which were transfected
to express 3 constructs (CD14, TLR4, and MD-2), also constitutively expressed MICB, and their
expression of MICA was even higher (Fig. 3.17C, D). Therefore, the expression of NKG2D ligands on
these cells is already being induced, possibly in part through the DNA damage-sensing pathway, so
the additional stimulus of LPS may not induce additional expression against this background.
Alternatively, expression of the LPS recognition complex alone may not be sufficient to elicit the
up-regulation of MICA; although the signalling via NF-κB is active, additional signals, such as an
autocrine pathway may be required. Although the cause was not investigated further, it was clear
that the 293T-TLR4 cells were not a suitable model in which to continue the investigation of LPS
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induced MICA up-regulation on macrophages. Thus, the study was continued using primary human
macrophages matured in vitro.
3.2.6 LPS induced up-regulation of MICA occurs after 24h–48h
After establishing that the model cell lines, THP-1, U937 and 293T-TLR4, did not up-regulate MICA
in response to LPS stimulation, the investigation continued with primary human macrophages. The
next step was to characterise the up-regulation, beginning with the kinetics of MICA expression.
Macrophages were stimulated with LPS for 4h, 10h, 24h, or 48h and compared to macrophages left
unstimulated for 48h for expression of CD54, MICA, and MICB by flow cytometry.
Whilst the macrophages were activated within 4h, as shown by up-regulation of CD54 (Fig. 3.19
right), the up-regulation of MICA was not observed until 24h, and was up-regulated further at 48h
(Fig. 3.19 left). As before, MICB was not up-regulated at any timepoint (Fig. 3.19 middle). Thus,
although macrophages can respond with changes in protein expression associated with activation within
4h, the specific response of MICA up-regulation did not manifest until much later. This suggested
that there could be multiple mechanisms involved in its regulation.
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Figure 3.19 : MICA up-regulation occurs 24–48h after LPS stimulation. Matured human macrophages
were stimulated with LPS for 4h, 10h, 24h, or 48h, or left unstimulated for 48h, and then
analysed by flow cytometry for expression of MICA, MICB and CD54. Plots show staining with
specific staining (black) or isotype control (grey shaded). Representative of 3 donors.
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3.2.7 LPS induced up-regulation of MICA requires sustained LPS signalling
In order to investigate the delayed up-regulation of MICA, relative to the activation marker CD54,
following LPS stimulation of macrophages, the requirement for continued stimulation was studied.
Here, macrophages were stimulated with LPS, or left unstimulated, as before, but an additional
sample was included, in which the macrophages were pulsed with LPS for 4h. In these samples the
macrophages were stimulated with LPS for 4h, after which the LPS containing media was removed and
the cells carefully rinsed with fresh media three times before being incubated in fresh media lacking
LPS for a further 44h, so that the total incubation time was 48h, as for the normally stimulated
samples.
When analysed by flow cytometry for expression of MICA, MICB and CD54, it was found that
these LPS-pulsed samples up-regulated CD54, but not MICA (Fig. 3.20A). Although there was some
variability, analysis of 6 donors confirmed that there was no significant up-regulation of MICA in the
LPS-pulsed samples, relative to the 48h stimulation (Fig. 3.20B). Thus, the up-regulation of MICA
after 48h stimulation by LPS, required persistent stimulation rather than just an initial activation signal.
This was consistent with the delayed up-regulation observed in the kinetic experiment (Fig. 3.19), and
further supports additional levels of regulation required for increased expression of MICA following
LPS stimulation.
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Figure 3.20 : LPS induced up-regulation of MICA is abrogated by removal of stimulus. Matured human
macrophages were stimulated with LPS, or left unstimulated, for 48h. An additional sample was
stimulated with LPS for 4h, after which the media was removed and the macrophages rinsed
carefully three times with fresh media before being incubated for a further 44h. After the total
48h incubation, the samples were analysed by flow cytometry for expression of MICA, MICB,
and CD54. A Representative plots of MICA, MICB, and CD54 expression on unstimulated (grey
shaded), 48h LPS stimulated (black), and 4h LPS stimulation followed by 44h without LPS
stimulated (dashed) macrophages. B Data from 6 donors showing the fold change in expression
of MICA relative to unstimulated samples, medians ± interquartile ranges, *P<0.05 tested by
Wilcoxon matched pairs.
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3.2.8 LPS induces transcription of MICA, but does not affect transcript stability
To begin to understand the regulation of MICA, and why its expression on the surface is delayed
following activation of the macrophages by LPS, we began by studying transcription. To test whether
transcription is involved in the up-regulation of MICA in response to certain stimuli, other than LPS,
293T cells were stimulated with Trichostatin A (TSA, (Olaharski et al., 2006)), a histone deacetylase
that is thought to induce the DNA damage-sensing pathway (Gasser et al., 2005), and may cause
chromatin remodelling that can lead to MICA transcription (Venkataraman et al., 2007). Indeed, 24h
treatment of 293T cells with TSA (100ng/ml) induced the up-regulation of MICA, from a level that
was already relatively high (Fig. 3.21A left). To determine whether de novo transcription was involved
in this response, the 293T cells were transfected with a construct to express GFP under the MICA
promoter (pMICA-GFP).
Analysis by flow cytometry confirmed that these transfected cells remained responsive to TSA-
induced up-regulation of MICA (Fig. 3.21A). Furthermore, the percentage of GFP expressing cells
increased after TSA treatment for 24h or 48h (Fig. 3.21B). The increase was not high (0.95% increased
to 2.27% at 24h); however, the transfection efficiency was not determined, so this low percentage
could be limited by the proportion of transfected cells. Nevertheless, these data were consistent with
previous reports that up-regulation of MICA can involve de novo transcription. The next step was to
investigate the role of transcription in primary human macrophage up-regulation of MICA in response
to LPS.
Unfortunately, transfection of primary macrophages is difficult (Zhang et al., 2009), and yields at
best a very low transfection efficiency (<0.1%, data not shown), thus an alternative approach was
taken, analysing the endogenous transcript levels and stabilities under different conditions of LPS
stimulation. To study the affect of LPS stimulation on transcription, macrophages were stimulated
for 4h or 48h and then the MICA and MICB transcript levels were analysed by qRT-PCR, relative to
the 18S rRNA control.
Interestingly, this revealed that whilst both increased rapidly within 4h of LPS stimulation, the
transcript levels of MICB had returned to unstimulated levels by 48h, in contrast to the MICA transcript
levels, which remained at the 4h post-stimulation levels (Fig. 3.22A). The data also confirmed previous
reports of the presence of MICA and MICB mRNA in unstimulated macrophages (Nedvetzki et al.,
2007). Thus, LPS induced transcription of both MICA and MICB genes, but the elevated levels of
MICB transcript were transient.
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Figure 3.21 : TSA induced MICA up-regulation on 293T cells involves de novo transcription. 293T
cells were transfected with the pMICA-GFP construct, from which GFP expression is driven by
the MICA promoter, using 500ng/well and 3ul (low) or 6ul (high) of Lipofectamine LTX reagent.
After transfection, the 293T cells were stimulated with TSA (100ng/ml), or left unstimulated, for
24h. After 24h the 293T cells were analysed by flow cytometry for expression of MICA. A 293T
cells were stained for MICA surface expression (black) relative to isotype control (shaded grey).
B The same samples were analysed for GFP expression, gate labels indicate percentage of cells
expressing GFP. The experiment was conducted in parallel but the samples stimulated for 48h
with TSA, percentages of GFP+ cells are indicated in brackets in the relevant 24h stimulation
plots.
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Eissmann P, Evans JH, Mehrabi M, et al. Multiple mechanisms downstream of TLR4 stimulation
allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J. Immunol.
2010;184:6901-6909.
These experiments performed by Philipp Eissmann.
Figure 3.22 : LPS induces MICA transcription but does not affect transcript stability. A Quantitative
real-time PCR was used to assess MICA and MICB mRNA expression in macrophages after
stimulation with LPS (200ng/ml) for either 4h (dark grey bar) or 48h (white bar). Relative
expression compared with unstimulated macrophages (light grey bar) is shown. Expression of
MICA and MICB was normalized to 18S rRNA, error bars show SEM. Results are representative
of three independent experiments. B-C Macrophages were either left unstimulated (light grey
curve) or stimulated with LPS (200 ng/ml, dark grey) for 4h, and quantitative real-time PCR was
used to assess MICA (B) and MICB (C) mRNA expression at different times after the addition
of 10mg/ml actinomycin D. Log2 of relative expression compared with that directly before the
addition of actinomycin D is shown. Expression of MICA and MICB mRNA was normalized to
18S rRNA. Graphs are the result of four independent experiments, error bars represent SEM.
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The level of a gene transcript is a function of the rates of transcription and degradation, so in
the absence of sustained transcription, the levels of a more stable transcripts will exceed those that
degrade more rapidly. Since qRT-PCR only assesses the levels of transcripts, not transcription, the
previous results, showing a distinction between MICA and MICB levels after 48h could have arisen
from two situations. Either, both transcripts were degraded at a similar rate, but MICB transcription
was transient, whilst MICA continued to be transcribed for the duration of the 48h stimulation, or
both were transiently transcribed but the MICA transcript was more stable than that of MICB.
To distinguish between these possibilities, the stability of MICA and MICB transcripts was assessed
directly. mRNAs of both MIC genes were elevated following 4h stimulation by LPS (Fig. 3.22A), so
macrophages were stimulated for 4h with LPS and then treated with actinomycin D, an inhibitor of
transcription. After termination of transcription, the stimulated macrophages were harvested at dif-
ferent timepoints, up to 8h, and analysed for the levels of MICA and MICB transcripts by qRT-PCR.
Strikingly, the MICA transcript proved to be far more stable, with a half-life of >8h (Fig. 3.22B), than
the MICB transcript, which had a half-life of <2h (Fig. 3.22C). However, comparison of unstimulated
and LPS stimulated samples, analysed in the same way, revealed that LPS did not significantly mod-
ulate stability of the transcripts of either MICA or MICB (Fig. 3.22B, C). Thus, although the stability
of MICB transcript was substantially lower than that of MICA, neither was directly affected by LPS
stimulation.
This was consistent with the elevated transcript levels of MICA and MICB 4h post-LPS stimulation
deriving from increased transcription, rather than decreased degradation. Moreover, the intrinsic
difference in transcript stabilities between the two NKG2D ligands is sufficient to explain the striking
difference in transcript levels after 48h LPS stimulation, which in turn could explain why LPS induces
surface expression of MICA, but not MICB, after 48h stimulation. However, this did not entirely
explain why no surface expression of MICA is observed until 48h after stimulation, when the transcript
was already at its maximum level after 4h.
3.2.9 MICA is in the top 2.5% of human genes predicted to be targeted by many
distinct miRNAs
Although availability of a gene transcript is required for final protein expression, it is not the only
mechanism regulating final protein expression. Once the transcript is present, either through up-
regulated transcription, or reduced degradation, it needs to be translated to the protein, and then
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Figure 3.23 : Bioinformatic analyses of human miRNAs and their target genes. The analysis used
the human genome predicted miRNA target database MicroCosm (EMBL-EBI), containing all
predicted target genes (from EnsEMBL) for each human miRNA. Pivot-table analysis was used
to generate the list of distinct miRNAs predicted to target each gene. Where there was more
than one transcript for a gene, the one with the highest predicted number of targeting miRNAs
was included, and where a miRNA had more than one predicted target site in a gene’s 3’ UTR,
it was counted only once. A All genes in MicroCosm were grouped by the number of distinct
miRNAs predicted to target each one, and the distribution plotted. The NKG2D ligands were
ranked against this distribution, percentages indicate the proportion of target genes in the human
genome that are predicted to be recognised by fewer miRNAs. B The number of predicted target
genes was compiled for each miRNA and the distribution was plotted. The miRNAs of interest
were ranked against this distribution, percentages indicate the proportions of miRNAs predicted
to target fewer genes.
J. Henry Evans 116
Chapter 3: MULTIPLE MECHANISMS REGULATE TLR-INDUCED MICA UP-REGULATION
transported to the surface for expression. Therefore, possible opportunities for post-transcriptional
regulation of MICA to introduce the delay into final expression include: sequestering of the transcript
away from the translational machinery, regulation of translation, and regulation of surface trafficking
(Dunn et al., 2003; Welte et al., 2003; Wu et al., 2003; Wills et al., 2005; Zou et al., 2005; McSharry
et al., 2008; Ashiru et al., 2009). A mode of translational inhibition that has been recently described
for MICA and MICB, is microRNA (miRNA) mediated silencing of the transcript.
As discussed in the introduction, miRNA are short (21–23nt) lengths of RNA that target the
3’ UTR of specific transcripts, in a target sequence determined manner, and either mark the target
transcript for degradation, or repress translation. Several microRNAs have been shown to regulate
expression of MICA and MICB, acting as a threshold mechanism to prevent spurious translation of
low steady-state transcript levels (Stern-Ginossar et al., 2007a, 2008; Nachmani et al., 2009). This
process was studied in transformed cell lines, or stressed cells treated with genotoxic or chemotoxic
reagents, which elicit up-regulation of MICA and MICB.
In the present study, bioinformatic analyses explored an important role for miRNA in the regulation
of MICA. MicroCosm is an online repository of known and predicted miRNAs, which also includes their
predicted target genes, based on the results of target site recognition algorithms applied to the 3’ UTRs
of all human genes (Griffiths-Jones, 2006; Griffiths-Jones et al., 2006, 2008; Griffiths-Jones, 2010).
This information is stored as individual entries for each miRNA, listing the putative target genes. To
execute a genome-wide comparison, the database was exported as a flat-file and reconstructed as a
relational database to enable comparisons by either miRNA or target gene. Using this database, the
number of miRNAs predicted to target each individual gene’s 3’ UTR was compiled and the results
ranked.
Interestingly, this revealed that MICA was predicted to be targeted by a markedly high number
of miRNAs relative to other genes in the human genome (Fig. 3.23A). Indeed it was found to lie in
the top 2.5% of genes most targeted by miRNAs, suggesting it may be particularly regulated by this
recently discovered mechanism. In addition, the miRNAs that have been experimentally proven to
target MICA and MICB are among the top 5% most promiscuous, being predicted to target more
genes than 95% of the identified miRNAs (Fig. 3.23B).
Moreover, whilst MICA is predicted to be targeted by a distinctly high number of miRNAs, the
other NKG2D ligands show no such preferential targeting (Fig. 3.23A). Thus, MICA may be uniquely
sensitive, among NKG2D ligands, to control by miRNA-mediated translational repression. Because of
this distinct trait of MICA, together with its preferential up-regulation following LPS stimulation, the
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next step was to test the role of miRNAs in its regulation directly.
3.2.10 MicroRNAs that target MICA are down-regulated following LPS stimulation
As discussed, MICA is predicted to be targeted by a distinctly high number of miRNAs, and indeed
four of these have been demonstrated to play a role in its regulation experimentally. MiRNAs miR17-
5, miR20a, miR93 and miR106b have all been shown to exert a threshold on the translation of
MICA and MICB transcripts (Stern-Ginossar et al., 2008). Surface expression of MICA can render a
cell susceptible to NK cell-mediated lysis, thus its expression must be tightly controlled (Cerwenka,
2009). The threshold on translation imposed by the miRNAs ensures that spurious expression of any
transcripts produced by basal transcription does not result in the elimination of the cell. Previously,
the levels of MICA and MICB-targeting miRNAs were demonstrated to remain constant to exert their
threshold, and expression was a result of increased transcription, sufficient to overcome the threshold
(Levine and Hwa, 2008; Stern-Ginossar et al., 2008).
The presence, and responses, of the MICA-targeting miRNAs was analysed following stimulation
of the macrophages by LPS to determine whether they play a similar role in regulation of MICA
expression in this system. The miRNAs were quantified directly by qRT-PCR performed on the total
RNA isolation of LPS stimulated, and unstimulated, macrophages, which included the small RNA
compartment. After LPS stimulation for 48h, the macrophages were harvested and analysed by flow
cytometry to confirm up-regulation of CD54 and MICA (Fig. 3.24A) on each donor. Parallel samples
were used to isolate the RNA, prepare cDNA by reverse transcription, and then quantify the relative
levels of each miRNA. MiR16, the expression of which has been shown not to change in response to
LPS stimulation, was included to control for the total amount of RNA used in each sample.
qRT-PCR works by using fluorescence to quantify the amount of dsDNA detectable after each
cycle of the PCR. This was plotted against the cycle number for each sample, which were performed
in triplicate. A detection threshold level of fluorescence was determined, and from this the cycle
on which this threshold was surpassed was calculated, giving a CT (Threshold cycle) value for each
sample in triplicate (Fig. 3.24B). Where one of the triplicates was different from the other two, by
more than 1 standard deviation, they were discarded from the analysis as an outlier (Fig. 3.24B red
square). During the exponential phase of the PCR, the number of copies of the gene doubles at each
cycle, thus a CT value that is 1 greater than another, equates to half the level of transcript in the
original samples.
The CT values for each macrophage stimulation condition were adjusted relative to the miR16
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Figure 3.24 : LPS down-modulates expression of microRNAs that target MICA on macrophages that
up-regulate MICA. Matured human macrophages were stimulated with LPS (200ng/ml), or
left unstimulated, for 48h and then analysed by flow cytometry for expression of CD54, MICA
and MICB, and also by qRT-PCR for the relative levels of miRNAs that target MICA. A Plots
comparing surface expression of CD54, MICA, and MICB on LPS stimulated (black) and unstim-
ulated (grey shaded) macrophages. B Raw data from qRT-PCR analysis of relative expression of
miRNAs that target MICA: miR17-5, miR20a, miR93, miR106b, and the loading control miR16.
Total RNA, including small RNAs, was isolated from the same macrophages (A) and used to
generate cDNA, by reverse transcription, which was then quantified by qRT-PCR. Graph shows
example raw data indicating the cycle at which the miRNA passed the detection threshold. Trip-
licates were included for each miRNA, where one was an outlier it was removed from the dataset,
indicated here by red squares. C Example of processed data for the same experiment showing
the fold change in expression of each miRNA from unstimulated to stimulated samples.
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Figure 3.25 : LPS stimulation down-modulates expression of microRNAs that target MICA. Quanti-
tative real-time PCR was used to assess miRNA expression in human macrophages after 48h
stimulation with LPS (200ng/ml). A Log2 of relative expression compared with unstimulated
macrophages is shown for representative donors (with the relative frequency across 16 donors
indicated). Error bars are SEM. B The change in relative expression of individual miRNAs for
macrophages isolated from 16 donors following LPS stimulation. P-values as indicated, signif-
icance tested by Wilcoxon matched pairs, graphs shows medians and interquartile ranges. 5
donors analysed by JHE, 11 donors analysed by PE.
J. Henry Evans 120
Chapter 3: MULTIPLE MECHANISMS REGULATE TLR-INDUCED MICA UP-REGULATION
loading control to enable comparison between samples. Then, they were compared between LPS
stimulated and unstimulated, to calculate the fold change in miRNA levels induced by the stimulation
(Fig. 3.24C). In a donor that up-regulated expression of MICA, the MICA targeting miRNAs were
down-regulated (Fig. 3.24B). This response was tested across 16 donors that all up-regulated MICA
in response to LPS stimulation (Fig. 3.25).
There was considerable variation between donors in the down-regulation of MICA targeting miR-
NAs. In 14/16 donors at least two of the miRNAs were down-regulated, although in the remaining
2 donors, there was even a slight up-regulation of their expression. There were some donors (4/16)
in which all 4 miRNAs were down-regulated, and almost half (7/16) showed down-regulation of 3
specific miRNAs (Fig. 3.25A). When analysed by miRNA, rather than by donor, we saw a 40% down-
regulation of miR17-5 (P=0.066), miR20a (P=0.019), and miR93 (P=0.007), but not of miR106b
(P=0.816) across all donors that up-regulated MICA in response to LPS stimulation (Fig. 3.25B).
Thus, although it has been previously demonstrated that miRNAs limit spurious expression of
MICA by imposing a threshold on translation (Levine and Hwa, 2008; Stern-Ginossar et al., 2008),
here we have shown that in response to LPS stimulation, the same miRNAs are specifically down-
regulated. In conjunction with the increased transcription of MICA, this could enhance the expression
of MICA protein on the surface. To test this directly, the levels of miRNA in macrophages were
artificially modulated.
3.2.11 Quenching microRNAs that target MICA up-regulates MICA
Having demonstrated the down-regulation of MICA targeting miRNAs following LPS stimulation, the
next step was to test directly whether modulating miRNA levels can lead to MICA surface expres-
sion. To modulate the effects of the MICA targeting miRNAs, cells were treated with antagomirs.
Antagomirs are short synthetic RNA molecules with sequences complementary to the miRNAs that
bind them irreversibly, thus an excess of antagomirs means that the miRNAs are quenched by them
and no longer bind the 3’ UTR of MICA; therefore, the translational repression is removed (Krützfeldt
et al., 2005, 2007).
Antagomirs to miR17-5, miR20a, miR93 and miR106b were used separately, or together, to treat
THP-1 cells or primary macrophages, which were then analysed by flow cytometry for their expression
of MICA. First, THP-1 cells were treated with a mixture of all four antagomirs, which resulted in up-
regulation of MICA (Fig. 3.26A). Moreover, treatment of the THP-1 cells with each of the antagomirs
individually also up-regulated the expression of MICA, although with different efficacies (Fig. 3.26B).
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Eissmann P, Evans JH, Mehrabi M, et al. Multiple mechanisms downstream of TLR4 stimulation
allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J. Immunol.
2010;184:6901-6909.
These experiments performed by Philipp Eissmann.
Figure 3.26 : MiRNAs control MICA protein expression in human macrophages. A THP-1 cells were
transfected with a mixture of four antagomirs: anti-miR17-5, anti-miR-20a, anti-miR-93, and
anti-miR-106b (open black histogram), or an equal amount of a control antagomir (dashed
gray histogram), and surface expression of MICA and MHC class I protein was analyzed by
flow cytometry. The solid gray histogram represents staining with the secondary mAb only.
Results are representative of more than five independent experiments. B THP-1 cells were
transfected separately with each of the four antagomirs, as in A (open black histograms), or
an equal amount of a control antagomir (dashed gray histograms). Surface expression of MICA
was analyzed by flow cytometry. Data are representative of three independent experiments.
C Primary human macrophages were transfected with a mixture of the four antagomirs, as in
panel A (anti-miR, right panel), or an equal amount of a control antagomir (control, left panel),
and surface expression of MICA (open black histogram) was analyzed by flow cytometry. The
solid gray histogram represents staining with an isotype control Ab. Results from one of three
experiments are shown. D THP-1 cells were transfected with a mixture of the four antagomirs, as
in A (anti-miR), or an equal amount of a control antagomir (control) and labeled with 35S-Met.
Percent-specific lysis of transfectants by human NK cells was determined by 35S release after
5h co-incubation at an E:T ratio of 10:1. Data represent mean and SD of three independent
experiments. Significance was determined using a one-tailed t test. *P<0.05. E Lysis assay as
in D, except that samples were additionally pretreated with either an anti-NKG2D mAb (dark
gray bars) or an isotype-matched control mAb (light gray bars). Data represent mean and SD
of triplicates.
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Next, the impact of the antagomirs on the MICA expression of primary macrophages was tested.
Here, the macrophages were treated with a mixture of all four antagomirs, or an equal concentration
of a control antagomir (a scrambled sequence). Quenching the MICA specific miRNAs was sufficient
to induce up-regulation MICA, to a level consistent with LPS stimulation (Fig. 3.26C). To determine
whether this MICA up-regulation had functional consequences, the macrophages were used in a 35S-
Methionine release cytotoxicity assay with autologous NK cells. Significantly more (25% increase) of
the antagomir-treated macrophages were killed, by the autologous NK cells, than the control treated
ones (Fig. 3.26D). Furthermore, inclusion of an anti-NKG2D blocking mAb in the culture medium
demonstrated that this killing was NKG2D-mediated (Fig. 3.26E).
Therefore, having demonstrated that LPS stimulation specifically down-regulates the MICA-targeting
miRNAs, here we showed that artificial down-regulation of the same miRNAs similarly induces an up-
regulation of MICA on primary macrophages, rendering them more susceptible to NKG2D-mediated
lysis by autologous NK cells.
3.2.12 TLR4, and TLR7/8, but not TLR3, stimulation induces up-regulation of
MICA
Having explored the mechanisms involved in the up-regulation of MICA, the next step was to inves-
tigate the signalling pathway involved. In murine macrophages, the up-regulation of NKG2D ligands
on TLR stimulated bone marrow-derived macrophages was found to be MyD88-dependent, being ab-
rogated in MyD88−/− knockout mice (Hamerman et al., 2004). Because such genetic manipulations
are not possible in primary human samples, a different approach was taken to investigate the role of
MyD88 signalling in human macrophages. Here, the macrophages were stimulated with agonists for
different TLRs: LPS for TLR4, CL097 for TLR7/8, and Poly(I:C) for TLR3.
Early studies on TLR7/8 used synthetic oligonucleotide based anti-viral compounds to stimulate
them (Hemmi et al., 2002; Lee et al., 2003), although the natural ligand has since been identified
as GU-rich ssRNA (Heil et al., 2004). Discriminating between host and foreign ssRNA is thought
to depend on the GU content, and the cellular compartment in which the ligand is encountered,
endosomal or lysosomal being indicative of foreign ssRNA. In the current study CL097 was used,
this is a water-soluble synthetic derivative of an imidazoquinoline amine analogue to guanosine, which
activates NF-κB in a MyD88-dependent manner. TLR3 also recognises nucleotide associated patterns,
specifically dsRNA, a replication intermediate characteristic of positive-strand RNA and DNA viruses,
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Figure 3.27 : Stimulation of TLR3 does not induce MICA up-regulation. Matured human macrophages
were stimulated with LPS (200ng/ml), CL097 (2.5µg/ml), Poly(I:C) (50µg/ml), or left unstim-
ulated, for 48h and were then analysed by flow cytometry for expression of MICA, MICB, or
CD54. A Representative plots show expression levels on stimulated macrophages (black) rel-
ative to unstimulated macrophages (grey shaded). B Data for macrophages from 10 donors
showing the fold increase in expression relative to the unstimulated cells. **P<0.01, tested by
Wilcoxon matched pairs, graphs show medians and interquartile ranges.
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but not negative-strand RNA viruses. Here, a common synthetic dsRNA analogue was used, Poly(I:C),
which is a generated by annealing a strand of polyinosinic acid to polycytidylic acid, and strongly
stimulates TLR3 leading to NF-κB activation (Alexopoulou et al., 2001).
Whilst TLR4, TLR7, and TLR8 all signal through the MyD88 adaptor protein, TLR3 does not,
and instead signals via the TRIF pathway (Akira and Takeda, 2004). The TRIF-dependent pathway
is a MyD88-independent signalling cascade also used by TLR4 (O’Neill and Bowie, 2007; Watters
et al., 2007). Thus, by comparing TLR4 signalling with both TLR3, exclusively TRIF-dependent, and
TLR7/8, exclusively MyD88-dependent, the pathway involved in the LPS-induced, TLR4-mediated,
MICA up-regulation can be tested.
To assess this, macrophages from the same donor were stimulated with LPS (200ng/ml), CL097
(2.5µg/ml), Poly(I:C) (50µg/ml), or left unstimulated, for 48h and were then analysed by flow cytom-
etry for their expression of CD54, MICA and MICB (Fig. 3.27A). Strikingly, whilst all three agonists
induced activation of the macrophages, as indicated by CD54 up-regulation (Fig. 3.27B), only LPS
and CL097 induced a significant MICA up-regulation (Fig. 3.27C). Poly(I:C) stimulation did not induce
an up-regulation of MICA relative to the unstimulated macrophages. Furthermore, in contrast LPS,
which specifically up-regulated MICA but not MICB, stimulation with CL097 induced up-regulation
of both MICA and MICB (Fig. 3.27C, D).
Therefore, two insights into TLR-induced NKG2D ligand expression on human macrophages
emerged from these data. First, in the context of understanding the LPS induced up-regulation
of MICA, it is likely that this occurs via signalling through the MyD88-dependent pathway. Second,
in the broader picture of NKG2D ligand expression on macrophages, different stimulations can elicit
different NKG2D ligand expression profiles.
3.2.13 MyD88 inhibition blocks LPS induced activation and MICA up-regulation
Pursuing the role of MyD88 signalling in LPS induced MICA up-regulation, a specific inhibitor of
MyD88 was used to treat the macrophages prior to LPS stimulation to confirm the requirement for
MyD88-mediated signal transduction. TLR signalling through MyD88 requires its homodimerisation,
enabling the recruitment and activation of the kinase IRAK. The inhibitor peptide contains a sequence
from the MyD88 TIR homodimerisation domain (Loiarro et al., 2005), which binds to endogenous
MyD88, thereby blocking MyD88 homodimerisation and signalling. The MyD88 homodimerisation
inhibitory peptide (MyD88-I) also contains a protein transduction (PTD) sequence, derived from
antennapedia, which renders the peptide cell permeable (Derossi et al., 1994). A control peptide
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Figure 3.28 : MyD88 inhibition abrogates LPS induced MICA up-regulation. Matured human
macrophages were pretreated with a specific MyD88 inhibitor peptide (top), or a control pep-
tide (bottom, both at 100mM), for 24h and then stimulated with LPS (200ng/ml) or CL097
(2.5µg/ml) for 48h. After stimulation, the macrophages were analysed by flow cytometry for
the expression of MICA, MICB and CD54. Plots show up-regulation on stimulated macrophages
(black) relative to unstimulated (grey shaded).
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(MyD88-C), which consisted of only the PTD sequence, was also used.
The macrophages were treated with the inhibitor or control peptides (100mM each) for 24h prior
to stimulation with LPS (200ng/ml) or CL097 (2.5µg/ml) for 48h. The peptides were also included
in the media for the duration of the stimulation. After stimulation, the macrophages were analysed
by flow cytometry for expression of CD54, MICA and MICB. Although the changes in expression were
very small, the modest up-regulations of MICA and CD54 observed in the control peptide treated
macrophages (Fig. 3.28 top), were abrogated in those treated with the inhibitory peptide (Fig. 3.28
bottom).
Although only performed once, and with inconclusive results when considered in isolation, the
results were consistent with TLR signalling via the MyD88-dependent pathway, as demonstrated by
the absence of MICA up-regulation following Poly(I:C) stimulation.
3.2.14 TLR stimulation of macrophages induces classical activation
A vital role of macrophages, following stimulation by foreign, potentially pathogenic, organisms, is the
secretion of cytokines. A spectrum of macrophage phenotypes have been described, classified according
to their inflammatory status, commonly by their cytokine secretion profile. A common classification is
into classically activated and alternatively activated macrophages (also called M1 and M2 respectively),
primarily based on the profile of cytokines they secrete. Classically activated macrophages secrete high
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Figure 3.29 : TLR stimulation of macrophages induces secretion of IL-10, IL-12, and TNF-α. Ma-
tured human macrophages were stimulated with LPS (200ng/ml), CL097 (2.5µg/ml), Poly(I:C)
(50µg/ml), or left unstimulated, for 48h. The supernatants were harvested and analysed by
ELISA for the secreted concentration of A IL-10, B IL-12, or C TNF-α. Graphs show data for
macrophages from 12 donors showing the concentrations of cytokines in the media. *P<0.05,
***P<0.005, tested by Wilcoxon matched pairs, graphs show medians and interquartile ranges.
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levels of IL-12 and low levels of IL-10, whilst alternatively activated macrophages are characterised
by secretion of high levels of IL-10 relative to IL-12. These profiles of secreted cytokines reflect the
physiological roles of the different macrophage activation states. Specifically, classically activated
macrophages have a pro-inflammatory microbicidal role, whereas alternatively activated macrophages
are poorly microbicidal but fulfill an immunomodulatory role (Benoit et al., 2008). In addition, like
THP-1 cells, activated macrophages secrete the pro-inflammatory cytokine TNF-α, which mediates
many of the effects of activated macrophages, and is implicated in aberrant inflammatory disorders,
such as sepsis, rheumatoid arthritis, and TNF-mediated inflammatory disease.
To investigate the relationship of these macrophages to the up-regulation of MICA following TLR
stimulation, the supernatants from the stimulations were collected and analysed by ELISA for the con-
centration of IL-10, IL-12 and TNF-α. Stimulation by all three TLR agonists induced secretion of IL-10
(Fig. 3.29A), IL-12 (Fig. 3.29B), and TNF-α (Fig. 3.29C) relative to the unstimulated macrophages.
LPS and CL097 stimulations induced a greater than 10-fold secretion of IL-12 than IL-10, suggestive
of classical activation, and the polarisation was greater with CL097; more IL-12, less IL-10.
In contrast, stimulation with Poly(I:C) induced the same production of IL-12, but 10-fold less IL-12
on average, with 5/12 donors not producing any IL-12. This profile was consistent with Poly(I:C)
inducing a more alternative activation state. Irrespective of these differences, all three stimulations
induced secretion of similar levels of the pro-inflammatory cytokine TNF-α (Fig. 3.29C), although
CL097 elicited slightly greater secretion.
Thus, the profiles of macrophage activation, as revealed by relative secretion of IL-10 and IL-12, are
similar following stimulation via TLR4 and TLR7/8, and different to that following TLR3 stimulation.
This result parallels the up-regulation of MICA, and if the further polarisation to classical activation
by CL097 is considered, then may also reflect the additional up-regulation of MICB by stimulation of
TLR7/8 with this agonist.
3.2.15 TNF-α and IL-12, but not IL-10, secretion correlate with MICA, but not
CD54, up-regulation
To explore the relationship of classical activation and NKG2D ligand up-regulation further, the asso-
ciation between cytokine secretion and NKG2D ligand expression was tested explicitly. The data from
the previous two sections was compared by donor for correlations between the concentrations of each
cytokine and the up-regulation of CD54, MICA, or MICB. Briefly, the macrophages were stimulated
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Figure 3.30 : TLR induced MICA up-regulation correlates with concentrations of secreted IL-10 and
IL-12. Matured human macrophages were stimulated with LPS (200ng/ml), CL097 (2.5µg/ml),
or Poly(I:C) (50µg/ml) for 48h and then analysed by flow cytometry for the up-regulation of
MICA, MICB and CD54. In addition, the supernatants were harvested and analysed by ELISA
for the secreted concentration of IL-10, IL-12, and TNF-α. Graphs show data for macrophages
from 10 donors, stimulated with each of the TLR agonists, comparing the secreted cytokine
concentrations to the up-regulation of MICA, MICB, or CD54 on individual samples. The data
was assessed for correlations: strength of correlations was tested by Spearman correlations (r)
as indicated, significance of correlations was determined by permutation *P<0.05, **P<0.01,
***P<0.005.
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with LPS (200ng/ml), CL097 (2.5µg/ml), or Poly(I:C) (50µg/ml), or left unstimulated, for 48h. In
the same experiment, the supernatants were analysed by ELISA for the concentrations of secreted
IL-10, IL-12, and TNF-α, and the macrophages were analysed by flow cytometry for up-regulation of
CD54, MICA and MICB.
Interestingly, when the cytokine concentrations were plotted against the protein up-regulations for
each donor, correlations between certain combinations were observed (Fig. 3.30). The up-regulation
of CD54 was independent from any of the cytokine concentrations, and similarly, the concentration
of IL-10 was not correlated to the up-regulation of CD54, MICA, or MICB. In contrast, there were
significant positive correlations between MICA and MICB up-regulation and the concentrations of
each of IL-12 and TNF-α. The correlations were strongest, and most significant for MICA, and for
MICA, the best correlation was with IL-12 (P<0.005, r=0.65).
These data, explicitly comparing cytokine secretion to NKG2D ligand up-regulation, strongly sup-
ported a functional connection between the two. Specifically, both IL-12 and TNF-α correlated with
MICA up-regulation, and to a lesser extent MICB up-regulation. The next step was to determine
whether this was a causal relationship.
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Figure 3.31 : Exogenous IL-12 and TNF-α together are sufficient to induce MICA up-regulation.
Matured human macrophages were stimulated with LPS (200ng/ml), or rIL-12 and rTNF-α
together (3ng/ml each), or left unstimulated, for 48h, and were then analysed by flow cytometry
for expression of CD54, MICA, and MICB. A Representative plots from one donor showing specific
staining (black) compared to the isotype control (grey shaded). B Data for macrophages from 3
donors showing the fold change in expression of CD54 and MICA following stimulation relative
to the unstimulated samples.
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3.2.16 Exogenous TNF-α and IL-12 are sufficient to up-regulate MICA
Following the result that IL-12 and TNF-α secretion correlated with MICA up-regulation, it was
tested directly whether these cytokines could induce the up-regulation of MICA independently from
LPS stimulation. To investigate this, macrophages were stimulated with LPS (200ng/ml), IL-12 and
TNF-α together (both at 3ng/ml), or left unstimulated for 48h before analysis by flow cytometry
for expression of CD54, MICA and MICB (Fig. 3.31A). On donors in which LPS induced MICA up-
regulation, IL-12 and TNF-α together were sufficient to both activate the macrophages, as indicated
by CD54 up-regulation, and also to up-regulate MICA (Fig. 3.31B).
The data so far therefore show that up-regulation of MICA occurs 24h-48h after LPS stimulation,
that the stimulation induces secretion of IL-12 and TNF-α, that IL-12 and TNF-α concentrations
correlate with MICA up-regulation, and that IL-12 and TNF-α together are sufficient to induce MICA
in the absence of LPS stimulation. This is consistent with an autocrine signalling pathway mediated
by IL-12 and TNF-α. An earlier result demonstrated that pulsing macrophages with LPS for 4h before
replacing the media with LPS free media abrogated the up-regulation of MICA (Fig. 3.20). Rather
than indicating that sustained LPS signalling was required for MICA up-regulation after 48h, these
current data suggest that this persistent signal may be the requirement for autocrine signals.
3.2.17 TNF-α activates macrophages but does not up-regulate MICA
After finding that stimulation of human macrophages with exogenous IL-12 and TNF-α together
could induce MICA, the investigation went on to determine whether they were both required for
the response. A previous study on acute graft-versus-host disease (aGVHD) following hematopoietic
stem cell transplantation, found that an upregulation of MICA/B was associated with TNF-α in the
skin, including large mononuclear cells resembling macrophages (Gannagé et al., 2008). Indeed, they
demonstrated that treatment of the epithelial cell line HaCat with TNF-α in vitro was sufficient to
induce MICA/B up-regulation. Based on this, primary human macrophages were tested to determine
whether TNF-α alone was similarly sufficient to induce MICA up-regulation here. Macrophages were
stimulated with LPS (200ng/ml), TNF-α (50ng/ml), or left unstimulated, for 48h, and then analysed
by flow cytometry for their expression of CD54 and MICA (Fig. 3.32A).
Analysis of macrophages from four donors in which LPS induced up-regulation of both CD54 and
MICA, demonstrated that TNF-α could reproducibly activate the macrophages, indicated by CD54
up-regulation. However, in contrast to the response of the epithelial cell line HaCat reported by
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Figure 3.32 : Exogenous TNF-α alone activates macrophages but does not induce MICA up-
regulation. A Matured human macrophages were stimulated with LPS (200ng/ml), rTNF-α
(50ng/ml), or left unstimulated for 48h before being analysed by flow cytometry for expres-
sion of CD54 and MICA. Representative plots showing up-regulation of CD54 and MICA on
macrophages stimulated for 48h (black) with LPS (top) or TNF-α (bottom) relative to the un-
stimulated macrophages (grey shaded). B Data for macrophages from 4 donors showing the fold
change in expression of CD54 and MICA following stimulation compared to the unstimulated
samples. *P<0.01, tested by Wilcoxon matched pairs.
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Figure 3.33 : TNF-α stimulation of macrophages: dose response and timecourse. Matured human
macrophages were stimulated with LPS (200ng/ml) or TNF-α and then analysed by flow cy-
tometry for expression of CD54, MICA and MICB. Plots show surface expression of CD54 (left),
MICA (middle), and MICB (right) on unstimulated (grey shaded), LPS (200ng/ml, 48h) stimu-
lated positive control (black), and TNF-α stimulated (red) macrophages. A Macrophages were
stimulated with increasing doses of TNF-α (0.1, 1, 50ng/ml) for 48h. B Macrophages were
stimulated with TNF-α (50ng/ml) for 4h, 10h, 24h, or 48h.
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Gannagé et al., TNF-α alone was not sufficient to induce MICA up-regulation (Fig. 3.32B). Thus,
although it activated the macrophages, stimulation by TNF-α alone was not sufficient to induce the
MICA up-regulation observed following LPS stimulation, or with IL-12 and TNF-α together.
Based on the hypothesis that MICA up-regulation is delayed for 24h–48h following LPS stimulation
in part because of the autocrine component to the pathway, it was possible that up-regulation following
stimulation with TNF-α may have occurred much earlier. Therefore, to ensure that the absence of
MICA up-regulation observed at the 48h timepoint was not because the expression peaked earlier and
subsequently down-regulated again, the kinetics of TNF-α stimulation were analysed.
Macrophages were stimulated for 48h with LPS (200ng/ml), or left unstimulated, as controls. In
addition, they were stimulated either with different doses of TNF-α (0.1, 1, 50ng/ml) for 48h, or with
50ng/ml for different durations (4h, 10h, 24h, 48h). After 48h stimulation, there was no up-regulation
of MICA or MICB with any dose of TNF-α relative to the unstimulated macrophages, although there
was slight up-regulation of CD54 at 1ng/ml, and at 50ng/ml there was full up-regulation to the
same level as the LPS stimulation (Fig. 3.33A). Similarly, when stimulated with 50ng/ml of TNF-α
there was no up-regulation of MICA or MICB at any timepoint up to 48h, although the macrophages
were activated, as indicated by CD54 up-regulation, within the first 4h, and to the same level as
48h LPS stimulation by 24h (Fig. 3.33B). Therefore the lack of MICA up-regulation following TNF-α
stimulation, compared to LPS stimulation, was not because of a change in kinetics of up-regulation.
Together with the abrogation of MICA up-regulation seen when the media is changed 4h post-
stimulation, these data are consistent with an autocrine component to the signalling pathway from
TLR stimulation to MICA up-regulation. Specifically, this pathway requires both TNF-α and IL-12,
unlike epithelial cells in which TNF-α is sufficient, both of which are pro-inflammatory. In contrast, no
association was observed with IL-10, which has an immunomodulatory role. Thus, MICA up-regulation
in macrophages appears to be intrinsically linked to a pro-inflammatory state.
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3.3 Summary of results
This study aimed to explore the recently reported response of human macrophages to up-regulate
NKG2D ligands following stimulation with high doses of LPS. In particular, the mechanisms regulating
expression were studied, and the signalling pathways mediating the response were investigated. The
results, predominantly obtained in the most relevant model available, primary human macrophages,
showed that:
• LPS stimulation of human macrophages induced an up-regulation of surface expression of the
NKG2D ligand MICA, but not MICB.
• LPS-induced up-regulation of MICA expression was heterogeneous between donors. This het-
erogeneity is likely to have a genetic basis, because donors responded consistently over repeated
stimulations.
• The monocytic cell line THP-1 was induced to a macrophage-like phenotype by PMA treatment,
but did not up-regulate MICA in response to LPS stimulation.
• Although macrophages were activated 4h after LPS stimulation, MICA was not up-regulated
until 24h–48h, and was abrogated by replacing the media after 4h.
• LPS stimulation initiated de novo transcription of both MICA and MICB. However, only MICA
mRNA was elevated after 48h, which is likely to be because the intrinsic stability of MICA
mRNA was far higher than MICB mRNA.
• MICA was in the top 2.5% of human genes most targeted by miRNA. LPS induced a down-
regulation of miRNAs that target MICA mRNA. Furthermore, experimental down-modulation
of the same miRNAs induced up-regulation of MICA, rendering the macrophages susceptible to
increased NKG2D-mediated lysis by autologous NK cells.
• Stimulation of different TLRs induced different profiles of NKG2D ligand up-regulation. Absence
of MICA up-regulation following ligation of TLR3, which signals through a MyD88-independent
pathway, was consistent with TLR-induced MICA up-regulation being mediated by the MyD88
adaptor protein.
• Up-regulation of MICA on TLR-stimulated macrophages correlated with their secretion of IL-12
and TNF-α. Furthermore, IL-12 and TNF-α together, but not TNF-α alone, were sufficient to
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Figure 3.34 : Multiple pathways for the regulation of MICA expression in human macrophages in
response to LPS stimulation. Schematic diagram summarises how several pathways link
TLR4 ligation to cell surface expression of MICA protein (as discussed in detail in the text).
Green arrows imply stimulatory links, and red connections depict inhibition.
induce MICA up-regulation.
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3.4 Discussion
3.4.1 Background
It is well established that expression of the stress inducible ligands for NKG2D can render the target
cells susceptible to NK cell-mediated lysis (Raulet, 2003; Gonzalez et al., 2008), and regulation of
expression of NKG2D ligands is the focus of intensive research (Eagle and Trowsdale, 2007; Mistry and
O’Callaghan, 2007; Cerwenka, 2009; Stern-Ginossar and Mandelboim, 2009). Endogenous regulation,
both suppression of expression in healthy cells, and appropriate up-regulation to a range of signals,
related to viral infection or malignant transformation, is well documented. These signals include the
DNA damage-sensing pathway, mediated by ATM/ATR–NF-κB (Molinero et al., 2004; Gasser et al.,
2005; Cerboni et al., 2007; Wu et al., 2006), and heat shock or hypoxia, mediated by the heat shock
factor protein 1 (HSF1) transcription factor (Venkataraman et al., 2007). The host mechanisms of
regulation predominantly act at the transcriptional level, orchestrated by the MICA/B gene promoter
architecture, which includes heat shock elements (Venkataraman et al., 2007), an NF-κB binding site
(Molinero et al., 2004), and is chromosomally located to respond to chromatin remodelling in the region
of the MHC. In addition, miRNAs suppress translation of mRNA resulting from basal transcription
(Stern-Ginossar et al., 2008). Similarly, extensive literature describes diverse strategies employed by
tumours and viruses to limit surface expression of NKG2D ligands and thus evade immunosurveillance
by patrolling NK cells. These strategies include virally encoded miRNAs (Stern-Ginossar et al., 2007a;
Nachmani et al., 2009, 2010), intracellular protein retention (Dunn et al., 2003; Welte et al., 2003;
Wu et al., 2003; Wills et al., 2005; Zou et al., 2005; McSharry et al., 2008; Ashiru et al., 2009),
ubiquitination or proteolysis (Thomas et al., 2008; Butler et al., 2009), and enzymatic shedding of the
protein from the surface (Salih et al., 2002; Doubrovina et al., 2003; Wu et al., 2004; Kaiser et al.,
2007; Waldhauer et al., 2008; Boutet et al., 2009; Nolting et al., 2010).
A recent area of research has extended the role of NKG2D ligand expression beyond the classical
view of stress, to include TLR stimulation. In mice, it was demonstrated that stimulation of TLRs
can induce the up-regulation of murine NKG2D ligands on bone marrow-derived macrophages, in
a MyD88-dependent manner (Hamerman et al., 2004). MyD88 is an adaptor molecule recruited by
TLR4 to stimulate via an NF-κB-mediated pathway, LPS stimulation of macrophages from MyD88−/−
knockout mice did not up-regulate NKG2D ligands. In humans, TLR stimulation of freshly isolated
monocytes induces an up-regulation of MICA, leading to NK cell IFN-γ secretion (Kloss et al., 2008),
and our own lab showed that stimulation of in vitro matured human macrophages with a high dose,
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but not a low dose, of LPS induced up-regulation of MICA, rendering them susceptible to elimination
by autologous NK cells (Nedvetzki et al., 2007). Thus, the induction of NKG2D ligands by TLR
stimulation has been proposed as a mechanism of NK cell-mediated immunoregulation, in which over-
activated macrophages are eliminated to restrict the inflammatory response spatially and temporally.
The previous report of LPS induced up-regulation of MICA on human macrophages left two aspects
open; the expression of MICB was not explicitly studied, and the mechanisms regulating MICA were not
addressed (Nedvetzki et al., 2007). Nedvetzki et al. analysed the LPS stimulated macrophages using
an anti-MICA antibody and an anti-MICA/B antibody, but did not specifically address the expression
of MICB, and whether it mirrored MICA. This is an important consideration because the rationale
for multiple distinct ligands for a single receptor remains unclear (Eagle and Trowsdale, 2007), and
understanding the profile of ligands expressed in different scenarios may help to resolve it. Secondly,
although expression of MICA protein was induced by LPS stimulation, the MICA transcript was
present in unstimulated macrophages (Nedvetzki et al., 2007). Thus, there appears to be constitutive
transcription of MICA, but more importantly, it implies regulation of MICA expression in macrophages
by at least one endogenous post-transcriptional mechanism. Together, these outstanding questions led
this investigation into the mechanisms of regulation of MICA on LPS stimulated human macrophages.
However, the results suggested wider implications for this response, regarding the diversity of ligands
and the functional consequences of the macrophage/NK cell interactions.
3.4.2 LPS induced MICA up-regulation on human macrophages, but not in model
systems
Up-regulation of MICA protein expression on primary human macrophages
The up-regulation of MICA surface expression on human macrophages as reported by Nedvetzki et al.,
was confirmed. Although there was significant heterogeneity, discussed in detail later, an important
consideration is the extent of MICA up-regulation, even on responding donors. Specifically, the
up-regulation observed on macrophages from most donors was modest (median of 80% increase).
Whilst this may not appear to be a large change in expression, it is consistent with previous studies
of TLR-induced up-regulation of NKG2D ligands. LPS induced a MICA up-regulation on human
monocytes of 55% (Kloss et al., 2008), and on matured human macrophages of 50% (Basu et al.,
2009). Importantly, these studies, together with the previous data from our lab, and the results in
this current investigation, validate that this modest increase is sufficient to drive a different functional
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outcome. On monocytes, the increased MICA expression induced NK cell secretion of IFN-γ (Kloss
et al., 2008), and on macrophages it induced IFN-γ secretion, and rendered them susceptible to
NKG2D-mediated lysis, by NK cells (Nedvetzki et al., 2007). The data presented in this current study
were consistent with the increased susceptibility to NKG2D-mediated lysis. Thus, a small increase in
MICA expression can yield significant functional consequences.
Data in a recent report on NK cell nanotubes supports this observed impact of small changes in
MICA expression. MICA and NKG2D were found to accumulate at the point of contact between an
NK cell derived nanotube and a MICA expressing target cell, an assembly termed a “sub-micrometer
scale immune synapse” (Chauveau et al., 2010). To understand whether the accumulation of a small
number of MICA–NKG2D interactions could induce sufficient signalling for functional consequences,
such as killing, Chauveau et al. determined the absolute number of MICA molecules required on the
surface to render a target cell susceptible to NKG2D-mediated lysis. Murine P815 cells, that do not
express ligands for human NK cell receptors, were transfected and used to generate clonal populations
that expressed human MICA at different levels. These P815–MICA transfectants were analysed by
flow cytometry, and compared to standardised bead assays in which polystyrene beads have known
numbers of fluorophores attached, to quantify the number of MICA molecules expressed on the surface
of each clone. P815–MICA clones expressing different numbers of MICA molecules were then used as
target cells in cytotoxicity assays with primary human NK cells.
Strikingly, a threshold of approximately 2,000 MICA molecules was detected, below which target
killing was less than 10% and above which target killing plateaued at about 50%. Thus, the functional
consequences of MICA recognition by NKG2D exhibited a clear threshold based on the level of MICA
expressed, and only a small increase in MICA expression can be sufficient to dramatically change the
outcome of an interaction between NK cells and target cells, such as macrophages. It is important
to note that the MICA expressing target cells used to identify the threshold expressed no ligands to
human NK cell inhibitory receptors. However, it can be speculated that although inhibitory signalling
may quantitatively change the level of the MICA threshold, it is likely that the response would still
be characterised by a threshold, albeit at a higher number of MICA molecules. This is consistent
with, and could explain how, a small increase in MICA expression on human macrophages can elicit a
different functional response during their interaction with autologous NK cells.
A similar approach could be taken to test this directly with human macrophages stimulated with
LPS. Flow cytometry, using comparison to standardised beads, could determine the distribution of
numbers of surface expressed MICA molecules on LPS-stimulated macrophages. A parallel sam-
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ple could be co-incubated with autologous NK cells, and then fixed and imaged for MICA on the
macrophages, and a marker of NK functional response, such as the degranulation marker CD107a. By
analysing the total intensity of MICA staining on a sample of macrophages, the distribution could be
compared to the distribution from the flow cytometric analysis, and the numbers of MICA molecules
surface expressed on each macrophage could be estimated by interpolation from the linear regression.
This could be used to compare the functional outcome of an individual macrophage/NK cell interac-
tion with the surface expression of MICA by the macrophage. This could determine whether a similar
threshold of NK activation exists in an autologous human system, in which inhibitory receptors are
likely to be engaged, Furthermore, it could help to resolve whether the change in NK responses ob-
served following a small increase in MICA expression can be explained by this characteristic threshold
of activation.
In contrast to MICA, MICB was not up-regulated on the same macrophages, suggesting that
different activation signals, or mechanisms of regulation operate for MICA and MICB. This is consistent
with a recent report that demonstrated LPS-induced up-regulation of MICA, but not MICB, nor the
ULBPs, on human monocytes stimulated with LPS (Kloss et al., 2008). Also of interest was the
surprising level of heterogeneity observed between donors in the extent of MICA up-regulation by their
macrophages, macrophages from over half of the donors did not up-regulate MICA at all, although
they were activated by LPS stimulation as indicated by up-regulation of the activation marker ICAM-
1/CD54 (Sheikh and Jones, 2008). This unanticipated result was confirmed by analysing the response
on macrophages isolated from the same donor over sequential bleeds, and by preparation and analysis of
macrophages from the same donor in parallel by two independent researchers. Thus, the heterogeneity
is unlikely to be an artifact of experimental protocol or a reflection of a transient inflammatory state
in the donor. This heterogeneity is discussed in detail later (Sect. 6.2), where possible causes and the
impact on clinical outcome are considered. Whilst the variability provides an interesting approach for
appreciating the impact of LPS induced MICA up-regulation on macrophages in vivo, it impeded data
acquisition in vitro to analyse the mechanisms of regulation.
Model cell systems to analyse LPS-induced MICA up-regulation on macrophages
Because of the limitations imposed by use of primary human samples, namely heterogeneity and
accessibility to genetic manipulation, two monocytic cell lines were tested for their capacity for MICA
up-regulation following LPS stimulation. Unfortunately, neither model responded appropriately. THP-
1 cells (Tsuchiya et al., 1980), a monocytic cell line that could be successfully terminally differentiated
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by PMA treatment to an adherent, CD14 expressing macrophage-like cell (Tsuchiya et al., 1982; Park
et al., 2007), did not exhibit MICA up-regulation following LPS stimulation, despite being activated.
U937 cells (Larrick et al., 1980) were activated by PMA but did not differentiate to a macrophage-like
state. Although MICA was not up-regulated on THP-1 cells, other signs of macrophage activation were
induced. Considering the heterogeneity observed between primary macrophages from different donors,
it can be speculated that THP-1 cells may derive from a non-responsive donor. However, another
explanation could be that one or more of the mutations that enabled its original transformation
included a dominant suppression of MICA expression for immunoevasion.
In addition, a cell line lacking TLR4 expression, 293T cells, transfected to express the LPS recog-
nition complex, similarly proved unresponsive with respect to MICA up-regulation following LPS stim-
ulation. Whilst it may be tempting to conclude that expression of the LPS recognition complex alone
is not sufficient to confer MICA responsiveness to LPS, it is equally likely to be a reflection of the
cellular state of 293T cells. The untransfected 293T cells constitutively express a relatively high level
of MICA, and the transfected ones additionally express MICB. This could be a consequence of con-
stitutive activation of the DNA damage-sensing pathway in these tumour lines, leading to enhanced
transcription. Thus, the additional stimulus of TLR4 stimulation by LPS may not be sufficient to
induce increased MICA up-regulation against this background.
Investigation of cellular pathways of MICA regulation would have been facilitated by use of a
model cell line, accessible to genetic manipulation and genetically homogeneous. However, in three
models tested, two monocytic cell lines and an LPS recognition complex transfected epithelial cell line,
it was not possible to recapitulate the response observed in primary human macrophages. Therefore,
the investigation was completed in these donor derived macrophages, which ultimately increased its
relevance to human immunology.
3.4.3 Multiple mechanisms mediate LPS-induced MICA up-regulation on human
macrophages
Whilst human macrophages up-regulated MICA protein expression in response to LPS stimulation,
MICA mRNA was constitutively expressed in unstimulated macrophages (Nedvetzki et al., 2007).
Constitutive MICA gene expression without protein expression is not exclusive to macrophages, but is
found in a range of human tissues, all organs excluding brain (Schrambach et al., 2007). A potential
explanation lies in understanding the MICA gene promoter architecture, which includes a heat shock
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responsive element (HSE), that can be bound by HSF1 transcription factor to enhance transcription
(Venkataraman et al., 2007), and intron 1 includes an NF-κB binding site, which similarly enhances
transcription (Molinero et al., 2004). However, the core promoter, extending 200bp upstream of the
start site, includes a constitutively bound and activated Sp1 site, which drives a low basal transcription
of MICA (Venkataraman et al., 2007). This may explain the constitutive MICA mRNA found in many
tissues, but also suggests that at least one mechanism of post-transcriptional regulation operates,
potentially across many tissue types.
MicroRNA regulation of MICA
A likely candidate is miRNA, small non-coding RNAs capable of binding to specific target sequences in
the 3’ UTR of mRNA to suppress translation, through inhibition or directing the mRNA for degradation.
MiRNAs that target MICA and MICB were discovered by studying HCMV, although have subsequently
been identified in a diverse range of herpes viruses. Initially, it was found that viral miRNAs targeted
conserved sites in the 3’ UTRs of MICA and MICB mRNAs, resulting in protein expression inhibition
(Stern-Ginossar et al., 2007a). Subsequently, these conserved sites, and viral miRNAs were used
to identify a set of endogenous human miRNAs that similarly repressed protein expression (Stern-
Ginossar et al., 2008). These were found in a range of tissues, and interestingly were found to be
over-expressed in certain tumours, suggesting they are exploited as an NK cell evasion mechanism in
some transformed cells. Stern-Ginossar et al. demonstrated that following heat shock, or treatment
with the histone deacetylase TSA, MICA up-regulation was driven by increased transcription, and
the miRNAs targeting MICA remained constant. This is consistent with other examples that suggest
miRNAs act by imposing a threshold on translation, to prevent spurious protein expression from leaky
transcription, which can be overcome by increased levels of transcript (Eulalio et al., 2008; Levine and
Hwa, 2008; Bartel, 2009).
Strikingly, the data presented here suggest a revision to this model. Following LPS stimulation
of human macrophages, miRNAs that target MICA are down-modulated. Furthermore, quenching of
these miRNAs specifically was sufficient to induce an up-regulation of MICA that was consistent with
that seen following LPS stimulation. Thus, although miRNAs act as a threshold to expression in many
scenarios, including repression of basal transcription, following LPS stimulation of TLR4 on human
macrophages their down-modulation actively contributes to MICA up-regulation.
Although the miRNAs tested have previously been experimentally determined to directly target the
3’ UTR of MICA and MICB, it is possible that in this system, LPS stimulation of human macrophages,
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the effect could be indirect. For example, the miRNAs could modulate expression of an intermediate
protein that in turn regulates MICA at the transcription level. Such an effect has been postulated
for the reported IFN-γ-induced down-regulation of MICA (Yadav et al., 2009). Yadav et al. showed
that IFN-γ induced elevated levels of miRNAs, specifically miR520b, that resulted in a decrease in
MICA transcription, they suggested that this could either arise from miRNAs directly impacting the
MICA promoter, or via regulation of a MICA transcription factor, such as Sp1, Sp3, or NF-κB. To
confirm direct activity of miRNAs on the 3’ UTR of MICA, a reporter system was used, based on
a plasmid encoding GFP fused to the MICA 3’ UTR, or a scrambled control (kind gift from Noam
Stern-Ginossar, (Stern-Ginossar et al., 2008)). Unfortunately, consistent with difficulties described
in previous reports (reviewed in Zhang et al., 2009), successful transfection of the primary human
macrophages was not achieved, so indirect activity, although unlikely, cannot be excluded.
MICA, and other NKG2D ligands, are key mediators in the immunological arms race between host
and pathogens, particularly viruses. The discovery of viral miRNAs that target MICA and MICB (Stern-
Ginossar et al., 2007b; Nachmani et al., 2009), and the subsequent identification of several human
ones (Stern-Ginossar et al., 2008), prompts speculation about the significance of this mechanism to
NKG2D ligand expression. To explore this, bioinformatic analyses were performed on the databases
of miRNAs, miRBase (Griffiths-Jones, 2006; Griffiths-Jones et al., 2006, 2008; Griffiths-Jones, 2010),
and all predicted miRNA targets in the human genome, microCosm. MicroCosm was generated by
application of the miRNA target sequence algorithm to the entire published human genome, thus
yielding the putative target genes of each miRNA.
In this current study, my own bioinformatic analyses revealed surprising results. By reversing the
data associations, to group miRNAs by the individual genes they are predicted to target, a list of all
genes in the human genome was generated, with the number of unique miRNAs that are predicted
to target each of them. Ranking the genes according to the number of unique miRNAs predicted to
target them yielded an interesting distribution. MICA is predicted to be targeted by more miRNAs
that most other genes in the human genome (>98.5%), thus it appears remarkably sensitive to miRNA
regulation. Furthermore, the ranking revealed that the other NKG2D ligands were far less targeted,
for example, MICB is in the bottom 16% of genes. Thus, compared to the other NKG2D ligands,
MICA expression may be uniquely sensitive to miRNA-mediated regulation.
Although we observed here a down-modulation of specific MICA-targeting miRNAs, and others
have reported increased expression in tumours or by viruses, the full significance of miRNAs remains
unclear. Whilst miRNAs are recognised to limit the functional use of mRNAs, through target mRNA
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degradation or inhibition of translation, there are three issues that confound simple explanations for
the roles of miRNAs. As the bioinformatic analyses here clarify, a single miRNA can have multiple
target genes, some with hundreds, and individual genes can be targeted by many distinct miRNAs.
The third issue is that their effects are often small, as seen in this study. Thus a model for the role of
miRNAs is required that can accommodate these observed features.
The relatively small effects that miRNAs often seem to exert supports their proposed role as a
threshold to limit spurious translation of mRNA. In bacteria this mode of operation by small RNAs
is used to limit translation to mRNAs that are transcribed in a sustained manner, thus restricting
production of proteins in response to transient or low signals. A similar role can be speculated in
mammalian cells, particularly in the context of basal transcription of certain genes, including MICA
and MICB.
At first consideration, our own data demonstrating that quenching the MICA-targeting miRNAs
induced an up-regulation of MICA that was comparable to that observed following LPS stimulation,
may seem to contradict this simple view. However, if the translation of MICA mRNA was particularly
efficient, such that only relatively few transcripts were required for substantial protein synthesis, then
a significant response to depletion of the miRNAs may be expected. Indeed, as discussed later, we
also found the MICA mRNA to be remarkably stable, with a half-life exceeding 8h. Thus, miRNAs
may play an important role in limiting translation of mRNAs that can contribute significantly to the
protein expressed by the cell. Although this is speculative, it is interesting to consider the result of
the bioinformatic analysis: MICA mRNA, which is significantly more stable than MICB, is predicted
to be targeted by far more miRNAs than MICB mRNA. Such a hypothesis could be tested directly by
comparing the half-lives of mRNAs of genes at either end of the distribution of genes ranked according
to the number of miRNAs that are predicted to target them.
The other issues arise from the apparent diversity of miRNA target genes and miRNAs that target
individual genes. It is likely that this is explained, in part, by tissue or cell type specificity and by
temporal or developmental specificity. The recent development of a miRNA expression atlas has
provided preliminary information on the tissue specificities of miRNAs (Landgraf et al., 2007). Only
a third of the miRNAs analysed showed a high level of specificity, primarily to the liver, to embryos,
or to hematopoiesis. The remaining ones showed low levels of specificity, or high ubiquity.
The specific issue raised with our data is that although 4 MICA-targeting miRNAs were analysed,
changes in the level of a single one was sufficient to affect the expression of MICA protein. Quenching
of any of the four was sufficient to induce MICA up-regulation, and over-expression of any of the
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four was sufficient to down-regulate MICA expression. This complicates the interpretation of the
contribution of each individual miRNA to the control of MICA expression. Similar results were found
when analysing the primary human macrophages for changes in expression of miRNAs following LPS
stimulation. Whilst most of the donors down-regulated one or more of the four miRNAs, the specific
combination of those that down-regulated varied between donors. Thus, MICA regulation by miRNA
appears to represent a relatively flexible mechanism in terms of the specific miRNAs that can play a
role.
One technical consideration is that the analysis compared the relative levels of the miRNAs between
LPS-stimulated and unstimulated macrophages, not the absolute levels. Therefore, in the samples
where specific miRNAs showed no down-modulation, these miRNAs may already have been absent, or
at low levels, in the unstimulated macrophages. Thus, only the down-modulation of those that were
present to restrain translation may have been required to up-regulate MICA.
Another possibility is that the activity of miRNAs follows a more complicated, possibly synergistic
or antagonistic, pattern, such that changes in the levels of individual miRNAs can have a dispro-
portionately large effect on the target mRNA. Indeed, a very recent study reported an example of
antagonism between cellular miRNAs in the regulation of MICB expression (Nachmani et al., 2010).
RKO cells, which constitutively express MICB, were transfected with miR376a, miR433, or both to-
gether. Nachmani et al. demonstrated that whilst each one alone induced a modest down-regulation
of MICB expression, when expressed together the effect was abrogated. This was not seen with all
pairs of cellular miRNAs so was not likely to be an artifact of double transfections. This provides
the first indication that miRNAs do not act as a translational threshold in a simple additive way, but
that there are interactions between certain miRNAs, particularly those with target sequences in close
proximity (<50bp) within the 3’ UTR.
A similar approach applied to the MICA-targeting miRNAs studied here would be an interesting
area of future research. Although we demonstrated that each of miR17-5p, miR20a, miR93, and
miR106b can individually reduce MICA expression when expressed in human macrophages, the results
of Nachmani et al. suggest that they could have antagonistic, or synergistic effects, when acting
together.
Transcriptional regulation of MICA and MICB
Although miRNAs were demonstrated to be involved in the up-regulation of MICA expression, via
their down-modulation, several observations suggest that this was not the only mechanism involved,
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and that increased transcription may also contribute to the expression. Increased MICA transcription
commonly accompanies protein expression in a range of systems, and although there was constitutive
MICA transcript in unstimulated macrophages, there appeared to be a modest increase following
LPS stimulation (Nedvetzki et al., 2007). In addition, elevated levels of NKG2D ligand mRNAs
were detected in murine macrophages stimulated with LPS. Furthermore, one of the mediators of
TLR signalling is the transcription factor NF-κB, which is released from Inhibitor of kappa B (IκB)
control by IκB kinase (IKK) and relocates to the nucleus to initiate transcription of target genes (Sun,
2008). Intron 1 of MICA has an NF-κB binding site, which has previously been shown to mediate the
ATM/ATR-directed transcription of MICA in activated T cells (Molinero et al., 2004). Based on this,
we hypothesised that that TLR signalling may enhance MICA and MICB transcription beyond basal
levels.
Indeed, we found that within 4h of LPS stimulation, the level of MICA transcript had increased
significantly, and was maintained until at least 48h post-stimulation. However, the level of mRNA is
a balance between transcription and mRNA degradation, thus the elevated levels could have resulted
from reduced levels of degradation against a background of constant transcriptional activity. This
reduced degradation could in turn have been mediated by the down-modulation of miRNAs that
can act to target specific mRNAs for degradation. A construct to express GFP under the MICA
promoter was available to test transcription rates directly; however, as with the MICA 3’ UTR-GFP
construct, the macrophages could not be successfully transfected. Therefore, an indirect approach
was adopted, by investigating the impact of LPS stimulation on the stability of MICA mRNA. LPS
stimulation did not modify the stability of MICA mRNA. Thus, the enhanced transcript levels detected
post-stimulation are likely to be a result of increased transcription.
Interestingly, these results for the levels and stability of MICA mRNA were markedly different to
those for MICB mRNA. The levels of MICB mRNA increased to a similar level as MICA mRNA after
4h LPS stimulation, however, by 48h they had returned to basal levels. Even more striking was the
difference in intrinsic mRNA stability; although the stability of MICB mRNA was not modified by LPS
stimulation either, it was considerably lower than that of MICA mRNA. Thus, the stabilities of MICA
and MICB mRNAs are not regulated by LPS stimulation, but show large differences that may reflect
functional differences.
Furthermore, although not tested directly, these data suggest a particular transcriptional pattern
following LPS stimulation. The levels of both MICA and MICB mRNAs were increased by similar
levels within 4h of LPS stimulation, yet by 48h post-stimulation MICB mRNA returned to basal levels
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whilst MICA remained at a similar level to the 4h point, but not higher. Whilst MICA mRNA is quite
stable, with a half-life significantly over 8h, MICB mRNA degrades rapidly, with a half-life of less than
2h. This is consistent with a model in which there is a transient pulse of transcription of both MICA
and MICB within the first 4h of stimulation, but which ceases soon after, and then MICB mRNA
degrades quickly, whilst the more stable MICA mRNA remains available for translation.
This is consistent with the data showing that although macrophages stimulated with LPS ex-
hibit phenotypic markers of activation, namely up-regulation of ICAM-1/CD54, after 4h, MICA up-
regulation is only observed marginally at 24h and further at 48h. Thus, whilst MICA mRNA is available
for translation at 4h, protein is not expressed until much later, mediated in part by miRNA repres-
sion of translation, to which it may be particularly sensitive. Similarly, the absence of MICB protein
up-regulation can be explained, at least in part, by the lower intrinsic stability of its mRNA, resulting
in lower available transcript levels, following the transient pulse of transcription, at the timepoint
required for translation.
Here we see that MICA and MICB expression on macrophages stimulated with LPS are regulated
by multiple mechanisms, that through the intrinsic properties of the genes and transcripts are orches-
trated to yield a distinct profile of protein expression. These multiple mechanisms acting together
generate particular emergent properties in the response that support MICA’s expression playing a role
in immunoregulation of an inflammatory response.
3.4.4 NKG2D ligand expression to mediate an NK cell immunoregulatory role
A proposed role for NK cells enabled by the emergent properties of regulating MICA expression by
the multiple mechanisms described, is that of NK cell-mediated immunoregulation of an excessive
inflammatory response involving macrophages. Stimulation of macrophages with a high dose, but not
a low dose, of LPS up-regulated MICA, suggesting that it was not an inherent consequence of TLR4
stimulation, but of excessive stimulation (Nedvetzki et al., 2007). This hypothesis is supported by the
data in this investigation regarding the potential involvement of an IL-12/TNF-α autocrine loop.
IL-12 and TNF-α autocrine signalling
Interestingly, comparison of MICA and MICB expression following stimulation with agonists for dif-
ferent TLRs revealed that MICA was upregulated in a MyD88-dependent manner, consistent with
previous data in mice (Hamerman et al., 2004). Specifically, stimulation of TLR4 with LPS, or
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TLR7/8 with CL097 elicited an up-regulation of MICA, whereas stimulation of TLR3 with Poly(I:C)
did not. Furthermore, whilst stimulation of TLR7/8 with CL097 induced up-regulation of the activa-
tion marker, CD54, to a similar level as LPS stimulation of TLR4, it also induced expression of MICB.
Thus, stimulation of different TLR can elicit different profiles of NKG2D ligand expression. However,
analysis of the cytokines secreted by macrophages stimulated with the different TLR agonists revealed
an additional component to the MICA up-regulation pathway.
The wider relevance of the discrepancy in NKG2D ligand up-regulation following stimulation of
different TLRs was clarified by phenotyping the activated macrophages, in terms of their cytokine
secretion profiles. The stronger the polarisation of the activated macrophages to a classical (M1)
phenotype, characterised by IL-12high/IL-10low (Van Ginderachter et al., 2006), the higher their up-
regulation of NKG2D ligands. Poly(I:C) stimulation of TLR3 induced very little polarisation, with
IL-12 and IL-10 concentrations being very similar, and it elicited no up-regulation of MICA or MICB.
In addition, the concentration of secreted TNF-α was analysed because of its potent pro-inflammatory
effects, and its involvement in diseases associated with excessive inflammation; for example, sepsis
(Rittirsch et al., 2008), atherosclerosis (Ross, 1999; Cole et al., 2010), rheumatoid arthritis (Choy
and Panayi, 2001), and TNF-mediated inflammatory disease (Bradley, 2008). When secreted levels
of each of these cytokines were compared to MICA and MICB for the same macrophages, MICA,
and to a lesser extent MICB, up-regulation correlated with concentrations of IL-12, and to a lesser
extent TNF-α, but not IL-10. Moreover, up-regulation of the activation marker ICAM-1/CD54, did
not correlate with levels of any of the cytokines. Thus, we see that macrophages making a greater
contribution to an inflammatory response, are precisely those that become most susceptible to NK
cell-mediated elimination, which is consistent with an immunoregulatory role for NK cells to limit
potentially immunopathologic inflammatory responses.
Furthermore, rather than just a correlation, IL-12 and TNF-α together were sufficient to induce
the MICA up-regulation, and changing the media after 4h LPS stimulation, thus removing any au-
tocrine components, abrogated the up-regulation of MICA. Therefore, it constitutes an intrinsic link
between inflammation and subsequent regulation mediated by the NK cells. This is supported by a
recent discovery that IL-12 also induces up-regulation of the corresponding receptor NKG2D on NK
cells (Zhang et al., 2008a), thus complementing the MICA expression by enhancing the detection
component of the system.
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NKG2D ligand expression on macrophages to control excessive inflammation
The integration of these distinct regulatory mechanisms, IL-12/TNF-α-mediated autocrine signalling,
transcription, and miRNA-mediated translational repression, yields a finely tuned response ideally
suited to an immunoregulatory role. For NK cells to play an immunoregulatory role in eliminating
inappropriately activated macrophages, the regulation of NKG2D ligands should include two key fea-
tures. Specifically, NKG2D ligands should only be up-regulated on activated macrophages, and the
up-regulation should occur after sufficient time for the macrophages to have performed their intended
role of initiation of inflammation and pathogen control. Interestingly, the combination of the IL-
12/TNF-α autocrine loop and the MICA-targeting miRNA down-modulation confers these two key
emergent properties on the NKG2D ligand up-regulation following TLR stimulation.
Therefore, the proposed model is one in which initial TLR stimulation primes the response through
a transient pulse of MICA transcription, potentially via NF-κB activation (Molinero et al., 2004;
Banerjee and Gerondakis, 2007), thus making it available for transcription later. If the macrophage
continues to experience a high inflammatory response, correlated with IL-12 and TNF-α, without
any signs of resolution for more than 24h, post-transcriptional repressions, including MICA-targeting
miRNAs, are lifted and MICA is expressed on the surface, thus breaking the inflammatory circuit by
NK cell mediated lysis. Indeed, during sepsis, the hyper-immune state associated with inflammation
peaks at approximately one day post infection (Hotchkiss and Karl, 2003).
Although operating at a different level, the principle here is similar to that proposed for the
progress of inflammation being directed by differences in the intrinsic characteristics of involved genes
(Hao and Baltimore, 2009). Hao et al. assigned genes to three groups based on their expression
profiles, which was shown to be a function of their transcription, and the stability of the transcripts.
The kinetics of gene expression following stimulation by the pro-inflammatory cytokine TNF-α were
dependent on these two intrinsic characteristics of the genes involved. Similarly, here we showed that
intrinsic properties of the multiple mechanisms involved in NKG2D up-regulation integrate to precisely
eliminate the macrophages at greatest risk of causing immunopathology, on a timecourse that does
not impair the normal functional role of inflammation.
This demonstrates that the up-regulation of MICA in response to LPS stimulation could provide an
important mode of immunoregulation to limit excessive inflammation, such as in sepsis (Hotchkiss and
Karl, 2003; Rittirsch et al., 2008), or even to eliminate immunopathologic macrophages in, for example
atherosclerosis (Boyle, 2005). However, the importance of such a role remains to be demonstrated in
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vivo. To investigate this, a sepsis model is being tested in NK cell knockout mice. E4BP4 is a critical
gene in the development of the mature NK cell compartment, and mice lacking E4BP4 are completely
NK cell deficient (Gascoyne et al., 2009). Preliminary results in these E4BP4−/− knockout mice,
suggest that they are more susceptible to sepsis, exhibiting greater weight loss and some mortality
following inoculation with Streptococcus pneumoniae (personal communication, Hugh Brady, Imperial
College). The next step will be to analyse the expression of NKG2D ligands on the macrophages in
this model of sepsis to determine whether activation has resulted in the same response observed in
vitro.
These preliminary results are in contrast to some previous studies of the role of NK cells in models
of sepsis. Anti-asialo GM1 depletion of NK cells conferred a protective effect on mice intraperitoneally
challenged with E. coli (Badgwell et al., 2002). Similarly, scid mice are more susceptible to Strepto-
coccus pneumoniae infection, suffering higher bacteraemia and elevated levels of pro-inflammatory cy-
tokines TNF-α, IL-1β, IL-6 and IFN-γ (Kerr et al., 2005). However, depletion of NK cells in this model
reduced bacteraemia and inflammation, suggesting they do not play a protective or anti-inflammatory
role. This model assessed the impact of NK cells in an already severely immunocompromised host
(scid), and thus did not include all the cellular interactions that would normally contribute to an
immune response. Therefore, our study, using mice deficient in only NK cells will provide a superior
model to determine the contribution of NK cells within a full immune system.
Hemophagocytic Lymphohistiocytosis: an example of NKG2D mediated control of inflam-
mation?
Although our preliminary results in these NK cell-deficient mice are consistent with the proposed
role of NK cells to limit excessive inflammation in a sepsis model, it is important not to disregard
previous evidence too early. Thus, if NK cells do not eliminate over-activated macrophages during
excessive inflammation, the question remains are there other scenarios in which the up-regulation
of NKG2D ligands on TLR-stimulated macrophages may be important? One possibility is that the
NK cell elimination of activated macrophages is not a control for excessive inflammation, but rather
is part of the normal course of an immune response. An interesting observation here is that LPS
induced long-term survival of macrophages (>5d) in the absence of M-CSF, in a MyD88-, NF-κB-,
and autocrine TNF-α-dependent manner (Lombardo et al., 2007). Thus the enhanced survival that
LPS induces could be limited by the associated up-regulation of MICA after 24h–48h; thus, NK cells
could act as a component of a self-limiting macrophage activation pathway.
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The LPS induced long-term survival of macrophages was observed in vitro out of a complete
immune response situation. However, a possible clinical setting for this NK cell-mediated limitation
of macrophage activation can be seen with Hemophagocytic Lymphohistiocytosis (HLH). HLH is a
hyperimmune syndrome that describes a collection of sepsis-like symptoms including sustained fever,
pancytopenia and hemophagocytosis by activated macrophages (Janka, 2007). It is also characterised
by severe hypercytokinemia, in particular high levels of TNF-α (Henter et al., 1991). Familial, primary
HLH (FHLH) is caused by genetic immunodeficiencies and often manifests early in young infants;
however, infection associated, secondary (IAHLH) occurs in adults with no known immunodeficiencies,
but often following infection. Both forms share the same symptoms, and involve sustained activation
of macrophages, indeed, a specific sub-type associated with Rheumatic disease is commonly termed
Macrophage Activation Syndrome (MAS) (Grom et al., 2003; Wulffraat, 2003; Zhang et al., 2008b).
Thus, a class of immunopathologies are characterised by uncontrolled and persistent activation of
macrophages, that present sepsis-like symptoms.
However, unlike sepsis that occurs following infection of otherwise healthy individuals, all forms
of HLH share one other important characteristic, defective cytotoxicity in NK cells and CD8+ T
cells (Egeler et al., 1996). In IAHLH, although the cause remains unknown, patients either present
drastically decreased NK cell numbers, or their NK cells exhibit impaired cytotoxicity when tested in
vitro against K562 target cells (Sullivan et al., 1998; Schneider et al., 2002). Most identified genetic
causes of FHLH are involved in the cytotoxic response (Horne et al., 2008), indeed the syndrome has
been classified according to known mutations (Ueda et al., 2006; Zur Stadt et al., 2006). Type 2
is associated with mutation of PRF1 leading to a perforin deficiency (Stepp et al., 1999), type 3 is
associated with mutation of UNC13D which impairs lysosome docking and degranulation (Santoro
et al., 2006; Yoon et al., 2010), and type 4 is associated with mutation of STX11 which similarly
impairs lytic granule docking (Bryceson et al., 2007). In addition, there are several associated diseases,
which present similar core symptoms and are also caused by defects in lytic granule biogenesis and
secretion, such as Griscelli syndrome type 2, arising from mutations in the gene coding for Rab27a
(Meeths et al., 2010). Thus, the underlying cause of this class of diseases, characterised by sepsis-like
symptoms arising from persistent macrophage activation, is a failure in cytotoxicity by lymphocytes,
in particular NK cells.
The particular importance of NK cells, rather than CD8+ T cells was clarified by results showing
that the T cells of infants exhibited significantly less degranulation than those from adults, and that
NK cells in cord blood are the dominant source of perforin (Bryceson et al., 2007). Thus, HLH is
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a syndrome that presents sepsis-like symptoms, resulting from uncontrolled macrophage activation,
including secretion of high levels of TNF-α, that is associated with a failure of cytotoxicity, or decreased
NK cell numbers. Therefore, one interpretation is that in healthy immunocompetent individuals an
NK cell, or CD8+ T cell, cytotoxic response controls the persistent activation of macrophages.
In light of the data presented in this current investigation, it can be speculated that this control
may be mediated, at least in part, by the expression of NKG2D ligands on the macrophages following
activation and sustained stimulation by TNF-α. The implication of this being the normal course of an
immune response is that NKG2D ligands would be expressed on macrophages following infection that
is controlled, not just during a subsequent out-of-control immunopathologic inflammatory response.
In this study we have analysed macrophages from healthy donors and tested their response to TLR
stimulation. To explore the possibility that this is part of the course of a normal immune response,
macrophages from individuals known to be infected could be analysed by flow cytometry for expression
of NKG2D ligands. However, since the model predicts that those macrophages that do up-regulate
NKG2D ligands will be eliminated, then this analysis may be biased against detecting their expression.
A complementary study would be to analyse expression of NKG2D ligands on macrophages from
HLH patients to determine whether, in the absence of cytotoxicity, the NKG2D ligand-expressing
macrophages that should be eliminated instead persist. This could also be studied initially in the
same NK cell-deficient murine model discussed earlier (Gascoyne et al., 2009). Rather than use high
levels of Streptococcus pneumoniae to induce sepsis, a sub-septic dose could be used to determine
whether the NK cells play a role in the resolution of the immune response. An important consideration
here is that in humans, it is not NK cell deficiency per se, but impaired cytotoxicity, which can be
performed in a redundant manner by CD8+ T cells. Thus, use of murine models of FHLH might be
more appropriate, such as a PRF1−/− perforin-knockout mouse(van Dommelen et al., 2006), or an
Unc13dJinx mouse that expresses an aberrant UNC-13D protein (Crozat et al., 2007). Using these
murine models of FHLH, experiments could be conducted as before, but the macrophages analysed
explicitly for expression of NKG2D ligands. This could test directly whether emergent properties from
the multiple mechanisms regulating TLR-induced NKG2D ligand expression on macrophages enables
NK cells to function as immunoregulatory components of inflammatory responses.
3.4.5 Summary
Expression of ligands for the NK cell activating receptor NKG2D renders a cell susceptible to lysis, thus
their control is tightly regulated. Indeed, inappropriate expression, leading to NK cell-mediated lysis,
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has been implicated in a number of autoimmune diseases (Champsaur and Lanier, 2010), including
celiac (Bilbao et al., 2003; Hüe et al., 2004; Tinto et al., 2008), Crohn’s (Perera et al., 2007) and some
arthritic conditions (Groh et al., 2003; Schrambach et al., 2007). However, their correct expression is
critical for the elimination of a range of “stressed” cells, including transformed cells, virally infected
cells, and even classic “heat-shocked” cells (Vivier et al., 2008). In these scenarios, the expression
of NKG2D ligands initiates the immune response, the primary function of which is to eliminate these
hazardous cells. However, TLR stimulation of macrophages, both murine (Hamerman et al., 2004)
and human (Nedvetzki et al., 2007; Basu et al., 2009), has also been demonstrated to up-regulate
expression of these ligands. It has been proposed that this could represent a form of regulation to limit
excessive inflammatory responses, by targeting the cells responsible for many of the pro-inflammatory
cytokines for NK cell-mediated lysis (Nedvetzki et al., 2007).
The investigation presented here characterised the TLR-induced up-regulation of NKG2D ligands
on macrophages, in terms of the signalling and the mechanisms responsible. Interestingly, the reg-
ulation involved multiple mechanisms including transcription, down-modulation of specific miRNAs,
and an IL-12/TNF-α autocrine component. The integration of these multiple mechanisms conferred
two key emergent properties on the system; a 24h–48h delay, and a specificity to pro-inflammatory
cells. These are consistent with a role for NK cells as an immunoregulatory component of a healthy
immune response to limit excessive, or normal, inflammation spatially and temporally, mediated via
their interaction with macrophages. The results of this study suggest a new avenue of research into
control of activated macrophages by NK cells that could be investigated in HLH patients and relevant
HLH murine models.
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Chapter 4: NK CELLS THAT EXPRESS HLA-DR EXPAND AND AID IMMUNE RESPONSES
4.1 Introduction
Natural killer (NK) cells are lymphocytes of the innate immune system that are usually considered
to have two main functions. They can directly kill transformed or virally infected target cells and
are a key source of a variety of cytokines, such as IFN-γ (Vivier et al., 2008; Caligiuri, 2008). In
addition, there are limited reports that NK cells expressing the class II MHC protein HLA-DR can
act as antigen presenting cells, eliciting T cell proliferation and IL-2 secretion (Roncarolo et al., 1991;
Hanna et al., 2004). Furthermore, a model is emerging in which NK cells play an important role
as an early source of IFN-γ during an adaptive immune response (Bihl et al., 2010; Horowitz et al.,
2010b). This investigation considers NK cells and their interactions with other lymphocytes during
an adaptive immune response, in particular, the mode of HLA-DR expression on NK cells, their role
within PBMC during the initiation of the response to BCG, and how NK cells also contribute to the
resulting immune response.
4.1.1 NK cell activation markers
As described in the main introduction (Sect. 1.2), NK cells have two well characterised effector
functions, cytotoxicity and secretion of IFN-γ, however, not all NK cells respond to a stimulus (Walzer
et al., 2007b). Furthermore, NK cells can respond to a wide range of stimuli. These include recognition
of “missing self” cells lacking expression of class I MHC protein, engagement of activating receptors
such as NKG2D by stress ligands, engagement of CD16 by the Fc domains of antibodies during ADCC,
and engagement of TLRs, such as TLR3, by their ligands (Lanier, 2005). In addition, they can be
activated in a contact independent manner by cytokines, for example they can be induced to proliferate
by IL-2 or IL-15 and can be induced to secrete IFN-γ by a combination of IL-12 and IL-18 (for example
Newman et al., 2006).
The best established marker of NK cell activation is expression of CD69, which is also an activation
marker for T cells. Following stimulation of NK cells in vitro with IL-2, CD69 expression exhibits two
characteristics that make it ideally suited as an activation marker. Specifically, it is up-regulated on
most (>95%) of NK cells in the population, and it is rapidly up-regulated, within 18h of stimulation
(Lanier et al., 1988). However, other markers of activation have been used for stimulated NK cells,
including calcium flux, and expression of HLA-DR. Calcium flux can be induced by engagement of
CD16, NKp46 and 2B4 (Bryceson et al., 2006b), however, its use as a general marker of activation is
limited because it is transient (<5mins).
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Expression of HLA-DR is has also been used as a marker of activation within a population of NK
cells (Galea-Lauri et al., 1999; Ferlazzo et al., 2003). However, in contrast to expression of CD69, its
use as an activation marker has two limitations. Within a population of IL-2 stimulated NK cells it is
only observed on a proportion of them, between 20% (for example, Bozzano et al., 2009; Ingram et al.,
2009) and 60% (for example, Skak et al., 2007; Pokkali et al., 2009), dependent on the study, strength
of IL-2 and duration of stimulation. So, whilst it can be used to indicate activation of a population,
on an individual cell basis it is not suitable. Also, the up-regulation is far slower than that of CD69,
and no increase was observed at the 18h timepoint used with CD69 (Lanier et al., 1988). Indeed it is
often only detected at significant levels after 3d (for example, Skak et al., 2007) and sometimes later,
at for example 7–10d (Neves et al., 2009). Despite its clear limitations, the expression of HLA-DR on
NK cells continues to be used as an activation marker even in current studies (for example, Li et al.,
2009a; Rutjens et al., 2010), but the reasons for its limitations have not been explored.
An early study looked at HLA-DR expression on NK cells in another clinical situation, IgA nephropa-
thy (IgAN), a proinflammatory autoimmune disease of the kidneys. Here, they found that in peripheral
blood from IgAN patients, compared to healthy control donors, there was an increased proportion of
HLA-DR expressing NK cells. Furthermore, there was a correlation between the percentage of NK cells
expressing HLA-DR and the intensity of NK cell derived IFN-γ transcript, supporting a proinflamma-
tory role for these NK cells (Yano et al., 1996). Indeed, patients with increased numbers of HLA-DR
expressing NK cells, and higher IFN-γ levels, had a significantly worse prognosis for disease progression.
Thus, there is an association between HLA-DR-expressing NK cells and a proinflammatory condition.
4.1.2 Antigen presentation
The adaptive immune system, including T cells and B cells, recognise and respond to challenge by
foreign organisms via encounter of specific peptides not normally present in the host, namely antigens.
In order to be recognised by the specific T cell clone, the antigen must be presented by a special class of
molecules called the Major Histocompatibility Complex (MHC) proteins. These immunoglobulin based
surface proteins have a peptide-binding groove into which short peptides are loaded, after which they
can be assessed by the T cell receptor (TCR). When the TCR of a particular T cell clone encounters
cognate peptide presented in MHC protein, with appropriate co-stimulation from CD4 or CD8, the
T cell can respond with the appropriate effector function, either proliferation and IL-2 secretion or
cytotoxicity respectively.
MHC class I proteins are expressed on the surface of most healthy nucleated human cells and
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present peptides derived by proteasomal cleavage of intracellular proteins, thus continually sampling
the cellular proteome, in a process termed the endogenous pathway. When cells are infected, for
example by a virus, non-host proteins will be included in this sampling and the cell will subsequently
be identified by cytotoxic CD8+ T cells for lysis. In contrast, MHC class II proteins, the expression
of which is exquisitely regulated by the master transcriptional regulator CIITA (Ting and Trowsdale,
2002), are only expressed on a particular class of immune cells, called antigen presenting cells (APCs).
MHC class II also presents antigen to T cells, eliciting IL-2 secretion and a proliferative response, but
the antigen is derived from a different source, via the exogenous pathway. In this case, the APCs
acquire non-host antigens by phagocytosis or endocytosis, after which it is processed by the lysosome
into fragments which are trafficked to the MHC class II loading compartments for surface presentation.
The conventional APCs include monocytes, macrophages, dendritic cells (DCs) and B cells.
Although far less studied, the expression of HLA-DR by activated NK cells has also been shown
to enable antigen presentation, thus suggesting a new member of the APC class of immune cells.
4.1.3 HLA-DR-expressing NK cells as APCs
As described earlier, expression of HLA-DR on NK cells is well documented, where it has frequently
been used as an activation marker, because of its up-regulation following IL-2 stimulation (Galea-Lauri
et al., 1999; Ferlazzo et al., 2003; Skak et al., 2007; Bozzano et al., 2009; Ingram et al., 2009; Li
et al., 2009a; Neves et al., 2009; Pokkali et al., 2009; Rutjens et al., 2010). However, a limited body
of research has also explored the capability of these HLA-DR-expressing NK cells to act as APCs, and
functionally present antigen to T cells. An early study, that noted HLA-DR expression on NK cell
clones, demonstrated that they could present tetanus toxin and house dust mite derived peptides to
the relevant T cell clones (Roncarolo et al., 1991). This occurred in an HLA-DR restricted manner
and resulted in T cell proliferation and IL-2 secretion.
A more recent study explored antigen presentation by NK cells in more depth, looking at the
complete pathway of antigen acquisition, processing and presentation (Hanna et al., 2004). Hanna
et al. demonstrated that the NK cells could bind antigen via a range of NK cell activating receptors,
including NKp46, NKp30, NKG2D, and CD16 and internalise it via endocytosis. Next, the internalised
antigen was localised to the MHC class II loading compartments, and subsequently presented at the
surface, eliciting T cell proliferation and IL-2 secretion . Possible roles for these MHC class II expressing
NK cells were also explored in vivo, where they were found to be present at elevated numbers in
inflammatory situations. Specifically, these included chronically inflamed tonsil tissue and decidual
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NKs from CMV infected mothers. Furthermore, a recent study has identified NK cell presentation of
influenza hemagglutinin in murine models (GeurtsvanKessel et al., 2009).
In addition to antigen presentation (Hanna et al., 2004; Roncarolo et al., 1991) it has been demon-
strated that the HLA-DR-expressing sub-population of NK cells can present superantigen to autologous
T cells in vitro (D’Orazio and Stein-Streilein, 1996). Here they confirmed HLA-DR expression on a
minority of circulating NK cells (varying from 1.9%–19.1%) and through depletion studies showed
that these cells are responsible for presenting SEB to T cells, resulting in activation, marked by CD25
up-regulation, of the T cells. In addition, they showed that the percentage of NK cells expressing
HLA-DR increases following 24h stimulation of unfractionated PBMC with SEB, suggesting a feedback
loop in which the T cells reciprocally activate the NK cells.
4.1.4 NK cells as effectors of the adaptive immune response
Although classically considered to be lymphocytes of the innate immune system, because of their
capacity to kill target cells without prior antigen-specific sensitisation, recent studies have implicated a
role for NK cells as effectors of the adaptive, antigen-specific immune system. When human PBMC are
stimulated in vitro with Plasmodium falciparum infected erythrocytes (iRBCs), the NK cells respond
by secreting IFN-γ (Artavanis-tsakonas and Riley, 2002; Artavanis-Tsakonas et al., 2003; Korbel et al.,
2005; Newman et al., 2006; Korbel et al., 2009; Horowitz et al., 2010b; Horowitz and Riley, 2010).
Recently, in collaboration with Amir Horowitz and Eleanor Riley at the London School of Hygiene and
Tropical Medicine, we showed that this NK cell IFN-γ secretion is dependent on an adaptive immune
response (Horowitz et al., 2010b). The response is reduced by depletion of monocytes or by blocking
MHC class II protein, but not MHC class I, so is likely to be antigen specific. Furthermore, it is
similarly abrogated by depletion of T cells, primarily CD4+, and by blocking IL-2, which is secreted
by the CD4+ T cells, thus the response appears to be mediated by CD4+ T cell specific antigen
recognition eliciting IL-2 secretion, which in turn activates the NK cells to secrete IFN-γ.
A strikingly similar CD4+ T cell mediated NK cell IFN-γ secretion response has been observed
in PBMC stimulated by Leishmania major (Bihl et al., 2010), suggesting that it may be a feature
of the immune response to a range of infectious agents. Indeed, it has also been demonstrated that
NK cells can be critical early effectors during vaccine recall responses. NK cells were activated to
secrete IFN-γ via a T cell-derived IL-2 pathway in the vaccine recall responses to influenza A (He
et al., 2004; Long et al., 2008), and yellow fever (Neves et al., 2009). and NK cell degranulation and
IFN-γ secretion, in PBMC stimulated with inactivated rabies virus, was only observed in the PBMC of
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previously vaccinated donors, and occurred in a memory CD4+ T cell dependent manner. Critically,
it was demonstrated that the NK cell recall response was not merely a side-effect, with NK cells
accounting for over 70% of the IFN-γ secreting and degranulating lymphocytes in the initial 12–18h
post-stimulation with rabies (Horowitz et al., 2010a).
Thus, when considering the roles of NK cells, it is important to look beyond their cytotoxic
function, and also to view them in the context of a full immune response. Even responses such as IFN-
γ secretion, which can be elicited directly in an antigen-independent target cell recognition mediated
manner, can also be engaged in the same cells as part of a more elaborate immune response. Because
concepts of the roles that NK cells and antigen specific T cells play during different immune responses
are well established, these additional, overlapping features have, until recently been overlooked or
disregarded.
4.1.5 Aims
NK cells that express the class II MHC protein, HLA-DR, have the ability to present antigen in certain
circumstances (Roncarolo et al., 1991; Hanna et al., 2004; GeurtsvanKessel et al., 2009). However,
the pathway leading to up-regulation of HLA-DR is yet to be understood and the importance of NK
cells that express HLA-DR during an immune response are major unknowns in this research area.
Therefore, the first aim of this investigation is to study the increase in expression of HLA-DR on
fresh primary human NK cells in response to different cytokine stimuli known to activate NK cells,
particularly IL-2. In addition, NK cells in human PBMC have recently been reported to secrete IFN-γ
in response to BCG stimulation (Korbel et al., 2009), so this will be studied to determine whether
their activity exhibits the characteristics of adaptive immunity recently observed for other intracellular
pathogens. BCG is of particular importance because of its wide use as a vaccine for tuberculosis,
and because of the variability that its efficacy as a vaccine displays (Finan et al., 2008). Thus, the
objectives of this investigation can be summarised as follows:
• To understand the mode of expression of HLA-DR on human NK cells. Specifically, to study
the inconsistencies between its expression patterns and its use as an activation marker; that
expression, even after extended IL-2 stimulation, is limited to a subset of NK cells, and that it
takes days, rather than hours, to manifest.
• To compare the functional responses, cytotoxicity and IFN-γ secretion, of NK cells that express
HLA-DR and those that do not.
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• To determine the expression pattern of CXCR3 on NK cells that express HLA-DR, and test
whether this is sufficient to drive their enrichment in the fraction responding optimally to the
chemokine I-TAC.
• To determine whether the NK cell IFN-γ secretion response requires contribution from compo-
nents of the adaptive immune system.
• To test whether the NK cell IFN-γ secretion response exhibits the remarkable heterogeneity
observed during the PBMC response to malaria.
• To determine the immunological importance of the HLA-DR-expressing NK cells in a disease
scenario. Specifically, to use the model systems of superantigen or BCG stimulation of whole
PBMC to investigate the impact on HLA-DR expression on NK cells and how this relates to the
outcome of the immune response in vitro.
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4.2 Results
4.2.1 The proportion of NK cells that express HLA-DR increases after 6d culture
with IL-2
Freshly isolated NK cells were analysed by flow cytometry for expression of HLA-DR (Fig. 4.1A), and
NK cells from the same isolation were analysed after 6d culture with IL-2 (Fig. 4.1B). Data from 9
donors showed that 2.5-5% (median 3.5%) of freshly isolated, primary human NK cells express HLA-
DR ex vivo, and after 6d culture with recombinant (r)IL-2 this increased to 25-41% (median 34%)
(Fig. 4.1C). This was consistent with previous studies that had observed a small (≈5-15%) circulating
population of HLA-DR+ NK cells in human peripheral blood (D’Orazio and Stein-Streilein, 1996; Skak
et al., 2007; Burt et al., 2008; Neves et al., 2009). Similarly, the observed increase in the proportion
of HLA-DR+ NK cells has been previously documented. Indeed, HLA-DR up-regulation on human
NK cells has been used as a marker of activation (for example Galea-Lauri et al., 1999; Ferlazzo et al.,
2003), and is still used as such in many current publications (Bozzano et al., 2009; Ingram et al.,
2009; Li et al., 2009b; Neves et al., 2009; Pokkali et al., 2009; Rutjens et al., 2010).
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Figure 4.1 : NK cells increase HLA-DR expression after 6d culture with IL-2. A Human NK cells were
isolated from purified PBMC and analysed ex vivo by flow cytometry for expression of CD56,
CD3 and HLA-DR. The isolation was confirmed by CD56+/CD3− staining (left) and then HLA-
DR expression on these was analysed (right), as indicated by arrow, gate in right plot indicates
percentage of HLA-DR+ NK cells. B After 6d culture with IL-2, the same NK cells were analysed
again in the same manner. C Summary data for 9 independent donors, NK cells gated on
CD56+/CD3−, ***P<0.005 tested by Wilcoxon matched pairs test.
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4.2.2 HLA-DR-expressing NK cells preferentially proliferate following IL-2 stimula-
tion
CD69 is also commonly used as a marker of activation for NK cells, because of two important char-
acteristics: it is up-regulated on almost all NK cells in a population, and this occurs within 18h of
stimulation by IL-2 (Lanier et al., 1988). Our results support this, CD69 was expressed on most
(>95%) of the IL-2 stimulated NK cells at the first timepoint, 48h (Fig. 4.2A), therefore all the
NK cells were sensitive to the IL-2 stimulus. In contrast to this rapid up-regulation of CD69 on all
NK cells, the expression of HLA-DR exhibited characteristics that were inconsistent with its use as
an activation marker. Namely, the increase in proportion of expressing cells was only detected after
4–6 days (Fig. 4.2A) and was limited to a subset of the total stimulated population (Figs 4.1, 4.2),
consistent with previous reports using it as an activation marker (for example, Skak et al., 2007).
%
 o
f M
ax
.
Proliferation
(CFSE)
2d 0d
4d
6d
HLA-DR CD69
Generation
 (CFSE peak)
5420 1 3
0
1
2
3
Fo
ld
 in
cr
ea
se
 o
f H
LA
-D
R
+ 
N
K
 
ce
lls
 (l
og
2,
 re
la
tiv
e 
to
 0
 d
iv
is
io
ns
)
10
0
100
Intensity of H
LA
-D
R
 on positive 
cells relative to total N
K
 population
* * * * *
A B
Figure 4.2 : HLA-DR+ NK cells preferentially proliferate but do not increase their expression level.
Freshly isolated human NK cells were labeled with CFSE and cultured with rIL-2 for up to 6d.
Samples were analysed by flow cytometry, every other day, for expression of HLA-DR and CD69.
A Representative data from one donor showing the dilution of CFSE marking proliferation (left).
The NK cells were gated on their CFSE levels for those that had not proliferated (highest CFSE
peak) and those that had undergone one or more divisions (less intense peaks), as marked on
the plots. The expression of HLA-DR (middle) and CD69 (right) were compared between non-
proliferating (grey shaded) and proliferating (green line) NK cells, as indicated by the arrows
(4d). CD69 expression level on day 0 is included (dotted black trace). B Summary data for 6
independent donors comparing the percentage of HLA-DR+ NK cells (left axis, black line) and
the level of expression of HLA-DR (right axis, grey shaded) between each generation (distinct
CFSE peaks). The level of expression was calculated as the fold increase in the geomean of the
HLA-DR+ NK cells relative to the total NK population and the percentage of HLA-DR+ NK cells
was calculated as a fold increase over the 0 generation. Graph shows medians and interquartile
ranges, *P<0.05, tested by Wilcoxon matched pairs test.
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Comparing expression of HLA-DR to dilution of CFSE in labelled, IL-2 stimulated NK cells, to moni-
tor proliferation, revealed that the expression of HLA-DR was preferentially on the proliferating cells
(Fig. 4.2A, B). Furthermore, although the proportion of HLA-DR+ cells was higher in the proliferating
population, the level of expression, measured as intensity of fluorescence by flow cytometry, remained
constant (Fig. 4.2B). Therefore, the use of CFSE labeling to monitor proliferation suggested that there
was a relationship between proliferation and HLA-DR expression on primary human NK cells following
stimulation with IL-2.
4.2.3 Increase in HLA-DR-expressing NK cells is associated with proliferation not
activation
To investigate the relationship with NK cell proliferation and expression of HLA-DR stimulation with
increasing IL-2 concentrations was used to compare the thresholds of different markers of activation
with proliferation. Freshly isolated human NK cells were labeled with CFSE to monitor proliferation
and then stimulated with IL-2 over a log10 range centred around the normal concentration used in tissue
culture (200U/ml). The forward scatter/side scatter (FSC/SSC) plots showed a clear progression as
the IL-2 dose increased, with the NK cells getting larger and more granular (Fig. 4.3A). As expected,
at the usual tissue culture IL-2 concentration (200U/ml) the FSC/SSC plot looked normal, and the
CFSE plot revealed the greatest proliferation (Fig. 4.3B). Of greatest interest was the relationship
between proliferation (Fig. 4.3B), CD69 expression (Fig. 4.3D), and HLA-DR expression (Fig. 4.3E).
At 20U/ml of IL-2 ≈50% of the NK cells expressed CD69, but there was no expression of HLA-DR,
and very little proliferation. At the higher IL-2 dose of 200U/ml both proliferation and HLA-DR
expression, in addition to CD69 expression, were observed. Thus, although IL-2 stimulates NK cells at
20U/ml, indicated by CD69 expression, HLA-DR expression requires a concentration that also induces
proliferation, 200U/ml. The threshold for proliferation and increase in the proportion of HLA-DR-
expressing cells is the same, but quantitatively different to that for CD69 up-regulation.
This association between proliferation and HLA-DR expression was also tested by stimulation of the
NK cells with different cytokines, rIL-12 and rIL-15, both of which are involved in NK cell activation
(Ferlazzo and Münz, 2004; Huntington et al., 2009). As before, freshly isolated human NK cells
were labelled with CFSE and then stimulated with either rIL-2, rIL-12, rIL-15, or left unstimulated.
After 6d the NK cells were analysed by flow cytometry for HLA-DR expression, and for their CFSE
profile to determine their proliferation. All three cytokines induced the change in the FSC/SSC plots
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Figure 4.3 : IL-2 induced HLA-DR expression on NK cells is associated with proliferation but not
CD69 up-regulation. Freshly isolated human NK cells were labelled with CFSE and cultured
for 6d with IL-2 at different concentrations (indicated), or no IL-2. After 6d the NK cells were
analysed by flow cytometry for A forward scatter (FSC)/side scatter (SSC), B proliferation as
measured by CFSE dilution, or the expression of the activation markers C CD54 (ICAM-1), D
CD69 or E HLA-DR.
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Figure 4.4 : NK cell proliferation is associated with up-regulation of HLA-DR. Freshly isolated human
NK cells were labelled with CFSE and cultured for 6d with rIL-2 (200U/ml), rIL-12 (10ng/ml),
rIL-15 10ng/ml), or no cytokine before analysis by flow cytometry. A Representative plots from
a single donor showing the forward scatter (FSC) and side scatter (SSC) plot (left), proliferation
tracking by CFSE (middle), and expression of HLA-DR on CD56+ NK cells (right). B The
percentage of proliferating cells was determined by gating for NK cells in the CFSE plot that
were in not in the brightest (generation 0) peak, n = 7 donors. C The percentage of CD56+ NK
cells expressing HLA-DR after 6d cytokine stimulation for 10 donors. Graphs show medians and
interquartile ranges, *P<0.05, **P<0.01, ***P<0.005, tested by Wilcoxon matched pairs test.
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that indicated survival of a healthy NK population (Fig. 4.4A, left), rather than the smaller, tighter
population seen with unstimulated NK cells (Fig. 4.4A, top), therefore all were successfully activated.
However, analysis of the CFSE profile indicated that only IL-2 and IL-15 induced extensive proliferation
at the concentrations used, IL-12 only induced very limited proliferation (Fig. 4.4A middle, B). Finally,
the same cells were analysed for expression of HLA-DR, and here it was observed that again IL-2
and IL-15 induced expression, whilst IL-12 did not (Fig. 4.4A middle, C). Therefore, although all
three cytokine stimulations activated the NK cells, HLA-DR expression after 6d only occurred on
populations of NK cells that also proliferated, as seen with the IL-2 dose response (Fig. 4.3). This
suggested that proliferation was involved, and possibly required for the increase in the proportion of
NK cells expressing HLA-DR following stimulation.
In combination with the relatively long period required for the up-regulation (>3d), a model was
proposed in which HLA-DR is not expressed de novo on previously non-expressing cells, but rather,
the increase in HLA-DR+ NK cells is driven by the preferential proliferation of a subset of NK cells in
peripheral blood that already express it.
4.2.4 HLA-DR expression is clonally restricted on NK cells
The data so far suggested that the small population of peripheral blood NK cells that express HLA-DR
proliferate preferentially when stimulated with IL-2 or IL-15. To test this directly, proliferation and
expression of HLA-DR was analysed on individual NK cells using NK cell clones, clonal populations
expanded from single seed cells (Cella and Colonna, 2000). Unlike T cells, which use somatic mutation
and rearrangement to generate a huge repertoire of T cell receptors, with each cell able to recognise
a different epitope, NK cells have a germ-line encoded repertoire of receptors, but each individual NK
cell only expresses a subset of the inhibitory receptors. For many studies, particularly those focused
on the roles of specific KIR interactions, it is useful to have a homogeneous population of NK cells
that all express the same set of receptors. NK cell cloning is used to generate such a population. To
understand whether HLA-DR is similarly clonally restricted, NK cell clones were analysed for expression
of HLA-DR by flow cytometry.
After preparation and culture of the clonal populations, each one was analysed by flow cytometry
for expression of HLA-DR and CD56 (Fig. 4.5A) and compared to the HLA-DR expression on a 6d
IL-2 cultured polyclonal NK cell line from the same NK cell isolation (Fig. 4.5B). Although most
NK cell clones, from 5 donors, expressed HLA-DR (94%), the level of expression varied between the
clones, including some that had very low levels, or did not express it at all (6%) (Fig. 4.5C). The
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Figure 4.5 : HLA-DR is expressed at different levels on NK cell clones. A NK clones were prepared by
limiting dilution of freshly isolated NK cells from a single donor and cultured for 4w, then analysed
for HLA-DR expression by flow cytometry. Plots show 20 clones from a single donor. Grey shaded
histograms are the isotype control, black open are the HLA-DR specific staining. All plots have
been gated for PI−, and CD56+ cells. B A polyclonal NK cell line from the same donor isolation
was cultured for 2w with IL-2 and then analysed for HLA-DR expression by flow cytometry. C NK
cell clones from 5 independent donors were analysed by flow cytometry for the level of expression
(geomean) of HLA-DR. Expression levels were binned on a logarithmic scale, based on the scale
used for acquisition.
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Figure 4.6 : Individual NK cell clones express a homogeneous level of HLA-DR. NK clones were prepared
by limiting dilution of freshly isolated NK cells and cultured for 4w. The coefficient of variation
of the expression of HLA-DR on clones and lines was calculated in FlowJo. A Representative
histograms of an NK clone (top) and polyclonal NK line (bottom), the coefficient of variation of
the expression of HLA-DR is displayed in the top right corner. Grey shaded histograms are the
isotype control, black open are the HLA-DR specific staining. B Data from 143 clones (from 4
donors) and 10 polyclonal NK lines. Graph shows medians and interquartile ranges, *P<0.05,
***P<0.0005, tested by Mann-Whitney. All data was acquired for PI−, and CD56+ cells.
identification of some clonal populations that did not express HLA-DR supports the fact that it is not
simply a marker of proliferation. From inspection of the expression of HLA-DR on NK cell clones,
compared to the polyclonal NK cell lines of the same donor, it was clear that the distribution of
HLA-DR expression within a single clone was restricted.
In contrast to the heterogeneous distribution characteristic of polyclonal NK lines (Fig. 4.6A, bot-
tom), HLA-DR expression within individual clonal populations was restricted to a tight peak (Fig. 4.6A,
top). This observed difference was quantified by analysing the coefficient of variation of the expression
of HLA-DR, a measure for the spread of the expression within an individual population. The coefficient
of variation of the expression was calculated in the analysis software, FlowJo, and was found to be
significantly lower for the HLA-DR expression on NK clones than on polyclonal NK lines (Fig. 4.6C).
The coefficient of variance is independent of the level (intensity) of expression, rather it is a
measure of the uniformity or homogeneity of expression within different populations. This more
uniform expression of HLA-DR on clonal populations than polyclonal ones is consistent with HLA-DR
being clonally restricted, and therefore its expression being an intrinsic property of an individual NK
cell. The association between proliferation and the increase in HLA-DR+ NK cells following IL-2
stimulation, and the discovery that the level of HLA-DR expression is clonally restricted on individual
NK cells, suggests that the up-regulation of HLA-DR may in fact represent the preferential proliferation
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of the small circulating population in peripheral blood.
4.2.5 Mathematically modelled clonal expansion of HLA-DR-expressing NK cells is
consistent with observed profiles
To understand whether clonal expansion of the small initial population of HLA-DR+ NK cells could be
sufficient to generate the profiles of HLA-DR expression that were observed in polyclonal populations,
an approach employing mathematical simulations and empirical data was used. A model was developed
that used empirical data, regarding the proliferation rates of fresh NK cells following IL-2 stimulation,
the expression levels of HLA-DR on individual NK cell clones, and their relative rates of proliferation,
to simulate HLA-DR expression on a hypothetical, mathematically modelled 6d polyclonal population
(Fig. 4.7).
The model used data from two distinct sources:
• A calculation of the average proliferation of a polyclonal NK cell population over 6d culture
with IL-2, acquired using CFSE labelling and subsequent dilution to determine the distribution
of the NK cells between the different generations (Figs 4.7A, 4.8; Table 4.1).
• Characterisation of the initial, ex vivo, population including the proliferative potential and level
of HLA-DR expression of each cell. This was inferred by characterisation of each individual clone
from a donor; assessing their expression level of HLA-DR and their relative rate of proliferation
(Figs 4.7B, 4.9).
To calculate the average proliferation profile for a polyclonal population of NK cells stimulated
with IL-2, freshly isolated NK cells from 7 donors were labelled with CFSE and cultured with IL-2
for 6d. These were analysed by flow cytometry to quantify the numbers of cells in each CFSE peak
(representative example, Fig. 4.8A), corresponding to each generation of proliferation (Hawkins et al.,
2007a). From these profiles a median distribution was calculated to use in the model (Fig. 4.8B). The
extreme distributions, both least proliferation (Fig. 4.8C) and most (Fig. 4.8D) were also quantified
to determine the range of the model’s predictions later.
To simplify the model, an assumption was made to interpret the growth patterns of the NK cells:
that the distribution of cells in each generation was reached via the minimum proliferation (number
of cell divisions) required. This assumed that all of the cells in each generation reached that level
by undergoing successive divisions, so each generation was achieved by exponential growth. Thus, a
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Proliferation trackering by CFSE
•	 CFSE labelled NK cells cultured with IL-2 for 6d
•	 Final distribution of generations used to determine distribution of 
“proliferative potential” in cells of the original ex vivo population.
Assumption:	minimum	proliferation	to	arrive	at	final,	observed	
population
Analysis of NK clones
•	 Only a subset of seeded cells proliferate to clonal populations (~13-32%).
•	 Use	final	clones	(4wks)	to	infer	potential	in	population	used	to	seed	them.
CFSE
C
el
l C
ou
nt
012345
Rate of growth HLA-DR expression
Output: matrix of proliferative potentials in seed population
Acidification	of	media
Flow cytometry
Measure colour change of media 
with phenol red
Rank rates of growth
Assign proliferative potentials to 
each clone based on matrix (A) 
For each individual clone:
Use model to simulate HLA-DR 
expression on a theoretical 6d 
polyclonal population generated 
from the inferred seed population 
A
B
Figure 4.7 : Overview of algorithm for modelling clonal expansion of HLA-DR+ NK cells. Expression of
HLA-DR on a hypothetical 6d expansion of human NK cells can be modelled by analysing the rate
of proliferation and HLA-DR expression on each clone, and assigning it a proliferative potential
based on ranking against an empirically generated matrix. A The proliferative potential matrix is
generated from observed distributions of cells between generations when using CFSE labelled NK
cells. B Schematic of algorithm used to generate simulated expression model.
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Figure 4.8 : Calculating the average proliferation profile for 6d IL-2 culture. Freshly isolated NK cells
were labelled with CFSE and then cultured with IL-2 for 6d before being analysed by flow cytom-
etry. A Representative plot, showing dilution of CFSE over successive generations of NK cells.
Gates indicate percentage of the total population in each generation. B Summary data from
CFSE dilution plots, using the gates indicated in A, for 7 donors, showing medians and interquar-
tile ranges. C CFSE dilution plot for donor showing least proliferation. D CFSE dilution plot for
donor showing most proliferation.
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Table to derive proliferative potential of cells in seeded population
v Description Calculation
Generation
(CFSE peak)
0 1 2 3 4 5
FPx Percentage of cells in final (6d) population Derived from 
CFSE plots
22.6 17.0 9.3 14.0 18.5 18.5
x Generation, dilution peak in CFSE plots 0 1 2 3 4 5
Number of cells in each generation of final 
population per seed cell in initial population
2x 1 2 4 8 16 32
Ox Number of cells in initial population that 
gave rise to FPx in final population
Ox=FPx/ 2x 22.6 8.5 2.3 1.8 1.2 0.6
OPx Percentage of cells in original population 
that gave rise to FPx in final population. Ox 
for each peak, divided by the sum of all Ox 
values, expressed as a percentage.
OPx=(Ox/∑O0-5)
x100
61.2 23.0 6.3 4.7 3.1 1.6
Cs Seeded clones 160
Number of cells in seeded clones that have 
each level proliferative potential (x)
Cs x OPx 294 111 30 23 15 8
Ch Harvested clones varies by expt D3 = 51
Number of clones of those that harvested 
that have each level of proliferative potential 
(x)
Ch x OPx 31 12 3 2 2 1
Table 4.1 : Derivation of proliferative potential matrix. Calculation steps used to determine the percentage
of cells of each proliferative potential in an ex vivo seed population (OPx) and therefore the numbers
of seeded clones in an experiment. Shaded grey rows indicate an alternative model in which the
distribution of proliferative potentials is distribution only between those clones that grew.
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Figure 4.9 : Ranking the proliferative capacity of NK cell clones. NK clones were prepared by limiting
dilution of freshly isolated NK cells from a single donor and cultured for 4w in 96-well plates. Before
harvesting the clones for analysis by flow cytometry, the plates were scanned for absorbance of the
media at 435nm, the peak absorbance wavelength of the yellow, acidic form of phenol red. Wells
in which clones have proliferated undergo gradual acidification of the media, and the wells that
have gone most yellow have the largest clonal populations when assessed by visual inspection.
Thus, absorbance at 435nm, indicating acidification of the media, is used as a measure of total
proliferation. Figure shows a representative plate scan; numbers are absorbance at 435nm, black
borders indicate wells in which clones grew and were subsequently analysed by flow cytometry.
single cell in the original population would seed 32 cells in generation 5 (25= 32), and conversely if
there were 64 cells in generation 5, these derived from just 2 cells in the original population (64/25 =
2). The model assigned each cell in the original (ex vivo) population a specific proliferative potential
(also called precursor percentage (Hawkins et al., 2007b)) of 0–5, indicating the number of rounds of
successive cell division it would undergo during a 6d IL-2 stimulated culture. The distribution of these
proliferative potentials between cells in the ex vivo population was calculated by dividing the number
of cells in each CFSE peak in the 6d culture, representing each generation (x), by 2x. The result was
a matrix, derived from an average ex vivo population, with the percentage of NK cells in that average
seed population assigned to each proliferative potential (Table 4.1). This matrix was then applied
to a population of NK cells, used to seed NK cell clones, to determine how many cells would derive
from each individual seed cell if it was cultured with IL-2 for 6d. From this a hypothetical polyclonal
population, derived from the cells used to seed the clones initially, was simulated.
However, to apply this matrix, a method was needed to determine which NK cell clones, and their
corresponding level of HLA-DR expression, should be assigned which proliferative potential. When
culturing NK clones normally, not all seeded cells proliferate into clonal populations, approximately 4–
12% of seeded wells will contain detectable populations. Whilst culturing the NK clones, it was noted
that in the wells in which clones were detectable, by flow cytometry or visual inspection for a pellet,
there was also a colour change in the media of that well. The clone media contained phenol red, a
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Figure 4.10 : Simulated HLA-DR expression on mathematically reconstructed polyclonal NK cell pop-
ulations. Plots show the simulated distribution of HLA-DR on modelled polyclonal NK cell pop-
ulations from 3 donors. The simulations were generated using: the median CFSE distribution
(Fig. 4.8) to determine proliferation capacity, the ranking of actual proliferation estimate from
the acidification of the media (Fig. 4.9), with the number of clones obtained from each donors
480 wells, and the HLA-DR expression on each clone according to the algorithm described in
the text. Shaded grey plots indicate the ex vivo population, black lines describe the simulated
6d expression of HLA-DR. Percentage of HLA-DR positive NK cells is indicated in top right of
each plot.
pH indicator, that is red at neutral pH but turns yellow with acidification. As with all cells, metabolic
waste from the NK clones acidifies the media and increased growth increases the rate at which the
media yellows. Therefore, wells containing proliferating clonal populations were identified by analysing
plates for wells in which the media turned yellow (Yang and Balcarcel, 2003). Furthermore, it was
not a binary distinction between red or yellow and non-proliferating or proliferating, but a spectrum
of media colour change. Thus, the wells in which the clones were proliferating were screened for their
absorption at 435nm, the absorption peak for the yellow, acid form of phenol red (Fig. 4.9). This was
used as an indication of their proliferation rate, so the clones were then ranked according to the level
of absorption at 435nm.
Having ranked the clones by their observed, relative proliferation rates, the matrix of proliferative
potentials was applied to the ranking to assign a proliferative potential of 0–5 to each of the clones.
Because the size of the original population of seeded cells was known, and each clone, although grown
into a population, derived from just a single seed, it was possible to simulate the growth of cells at 6d.
Each clone, representing a single cell at 0d, would become 1, 2, 4, 8, 16, or 32 cells in the hypothetical
6d population, depending on the assigned proliferative potential. Thus, a hypothetical 6d polyclonal
population could be constructed by using observed patterns of proliferation and properties of individual
cells determined by analysis of clonally expanded populations. However, the model was designed to
simulate HLA-DR expression on this polyclonal population, so additional data was required.
In addition to assessing the change in media colour, each clonal population was analysed by flow
cytometry for the level of expression of HLA-DR. The expression level of HLA-DR was then linked to
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Proliferation model Donor 1 Donor 2 Donor 3
Median 47 49 70
Low 35 36 65
High 59 61 81
Table 4.2 : Ranges of simulated HLA-DR expression derived from extreme proliferation parameters.
The model used to the generate the hypothetical distributions of HLA-DR seen on 3 donors
(Fig. 4.10) has two parameters that can be altered: the initial seed population used (varies by
donor), the proliferation model used. The table shows the percentage of HLA-DR positive NK
cells in the simulated populations. Different donors (columns) had different initial seed popula-
tions. Proliferation model (rows) indicates the CFSE profile used to generate the distribution of
proliferative capabilities; median was that used to generate predicted plots (Fig. 4.10), low used
the minimum observed proliferation distribution (Fig. 4.8C), and high used the maximum observed
proliferation distribution (Fig. 4.8D).
the proliferative potential of each individual clone. The expression levels were binned on a logarithmic
scale, thus matching the scales that were used in the flow cytometric analysis of empirical polyclonal
6d populations of NK cells, and then applied to their appropriate seed cell/clone in the model. The
distributions of HLA-DR in the reconstructed polyclonal populations for 3 independent donors were
plotted against the ex vivo populations (distribution of clonal HLA-DR expression without the modelled
expansion) and displayed in a format analogous to a FACS histogram to enable simple comparison
(Fig. 4.10). In addition, the percentage of HLA-DR+ cells in this modelled population was calculated
and included. Importantly, the distributions of HLA-DR resemble those observed in actual polyclonal
populations, and the proportions of HLA-DR+ cells fall within the observed ranges (Figs 4.1, 4.3, 4.4).
To determine the robustness of these predictions different parameters were used. The model was
run for 3 individual donors to compare differences in HLA-DR expression levels and numbers of pro-
liferating NK cells. In addition, different models of proliferation were used: median, corresponding to
the calculated median distribution of NK cells in different CFSE peaks (Fig. 4.8B), low, corresponding
to the least proliferation observed by CFSE monitoring (Fig. 4.8C), and high, corresponding to the
greatest proliferation observed by CFSE monitoring (Fig. 4.8D).
Most permutations of the model yielded theoretical polyclonal populations after 6d of growth
in which the percentage of HLA-DR+ NK cells were as high as those observed in real polyclonal
populations (Fig. 4.1). These models made various assumptions, concerning the rate of proliferation,
and the number of NK cells that were seeded/proliferated, but these spanned the extreme possibilities,
and even in this simplified system predicted proportions of HLA-DR+ NK cells that fall within observed
ranges. In conclusion, this simulation shows that the preferential clonal expansion of a small circulating
subset of HLA-DR-expressing NK cells in peripheral blood is sufficient to yield the increased proportions
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observed after 6d culture with IL-2.
4.2.6 HLA-DR expression marks a distinct subset of NK cells that preferentially in
response to IL-2
The next step was to test directly this model of HLA-DR up-regulation, whereby the increase in num-
bers of HLA-DR-expressing NK cells derives from the preferential proliferation of the small population
that express it ex vivo. This was achieved by isolating HLA-DR-expressing and non-expressing NK cells
ex vivo and then culturing each population with IL-2 for 6d and comparing the expression of HLA-DR
in each. Following isolation from PBMC, the NK cells were stained for CD56 and HLA-DR and then
separated into HLA-DR− and HLA-DR+ populations by flow cytometric cell sorting (Fig. 4.11A left).
These two populations were then cultured for 6d with IL-2 and then analysed by flow cytometry for
their expression of HLA-DR (Fig. 4.11A right). Although there were HLA-DR expressing NK cells in
the sorted negative population, and HLA-DR negative NK cells in the sorted positive population, the
proportions of HLA-DR-expressing NK cells in the sorted positive populations after 6d IL-2 culture
were far higher. However, there was also a striking difference in the proliferation rates. Specifically, the
sorting process resulted in relative population sizes of 3–15% (median = 7%) HLA-DR+ and 85–7%
(median = 93%) HLA-DR− (Fig. 4.11B left). In contrast, after 6d culture with IL-2, the sizes of the
sorted negative and positive populations was equal (Fig. 4.11B right); thus, HLA-DR expression ex
vivo marks a subset of NK cells that are particularly sensitive to IL-2 stimulation and proliferate more
than their HLA-DR negative counterparts.
When the difference in proliferation was accounted for, the percentage of the HLA-DR-expressing
NK cells after 6d that derived from the initial positive population could be calculated. This was
calculated by weighting the HLA-DR+ percentages by the relative sizes of the sorted populations,
and then determining the fraction of the HLA-DR-expressing cells that came from each of the two
sorted populations (positive and negative). When performed for 6 donors, the result was that 54–
81% (median = 73%) of the HLA-DR-expressing NK cells after 6d culture with IL-2 derived from
the initial small population of NK cells that expressed HLA-DR ex vivo. This proportion was high,
and significantly higher than the 7% that would have been predicted if there was no preferential
proliferation and HLA-DR was expressed de novo on random NK cells (Fig. 4.11C).
One aspect to note is that there were HLA-DR-expressing NK cells in the 6d cultures of those
that had been sorted to be HLA-DR negative. Although this may indicate de novo expression of
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Figure 4.11 : More than 70% of HLA-DR-expressing NK cells after 6d culture with IL-2 derive from
an initial 7% of the NK cell population. A Freshly isolated human NK cells were stained for
HLA-DR and CD56 and then sorted into CD56+HLA-DR− (I) and CD56+HLA-DR+ (II) NK cell
populations (left) and then cultured for 6d with IL-2. After 6d, the sorted HLA-DR− (I, top) and
HLA-DR+ (II, bottom) populations were analysed by flow cytometry for expression of CD56 and
HLA-DR. B The relative population sizes of the sorted populations were determined during the
sorting process (sorted) and after 6d culture with IL-2. Graph shows medians and interquartile
ranges. C The percentage of HLA-DR-expressing NK cells was analysed by flow cytometry for
the sorted negative and positive populations after 6d culture with IL-2. The percentages were
applied to the relative population sizes from B and used to calculate the HLA-DR+ percentage
for the two sorted populations combined. From this, the percentage of the HLA-DR-expressing
NK cells in the total population that derived from the initial HLA-DR-expressing population ex
vivo was determined. Graph shows percentages of HLA-DR-expressing NK cells that derived
from initial positive ex vivo population in a null model (H0) where both populations proliferated
equally and the expression of HLA-DR was not clonally restricted (left) and the observed values
(right). *P<0.05, tested by Wilcoxon matched pairs test.
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HLA-DR on previously non-expressing NK cells, the possibility of contamination cannot be excluded.
Although the gates used to sort for HLA-DR expression were conservative, in favour of reducing the
contamination of the negative population with positive cells, there was some contamination. Negative
sorted populations that were analysed for HLA-DR expression immediately after sorting were found
to have a low level of HLA-DR expressing NK cells (~1%, data not shown). However, based on the
same algorithms used in the mathematical modelling above, if there was no proliferation in the sorted
negative population, except the contaminating HLA-DR-expressing NK cells, then after 6 culture with
IL-2, 1% contamination could expand to a 30% proportion of the total population. Thus, the 23%
HLA-DR+ NK cell population is within the range that would be expected from a small contaminating
population.
In summary, these results confirm the two key aspects of the proposed model of increased HLA-DR-
expressing NK cells following IL-2 culture. In particular, NK cells that were sorted for their expression
of HLA-DR exhibited markedly higher proliferation than those that lacked HLA-DR expression ex vivo.
Importantly, the proportion of HLA-DR-expressing NK cells was much higher in the populations that
were sorted for expression of HLA-DR relative to those that lacked HLA-DR, thus supporting the
clonal restriction of HLA-DR expression suggested by the analysis of NK cell clones. Together, these
indicate that HLA-DR marks a distinct subset, or a particular phenotype of NK cell, found at low
numbers in peripheral blood that exhibits enhanced proliferation in response to IL-2 stimulation.
4.2.7 HLA-DR-expressing NK cells are a subset of the CD56brightpopulation
Thus, the expression of HLA-DR marks a distinct subset of NK cells, the next step was to understand
how these related to known subsets, primarily the CD56dim /CD56bright distinction most commonly
used. During the characterisation of the HLA-DR-expressing subset, it was observed that often HLA-
DR was expressed on NK cells with more intense CD56 staining. Classification of human NK cells
as CD56dim and CD56bright based on the surface density of CD56 is a common distinction when
analysing NK cells (Ellis and Fisher, 1989), and it is often considered that the CD56dim NK cells have
have a greater cytolytic potential, whilst the CD56bright NK cells preferentially respond with IFN-γ
secretion (Cooper et al., 2001a).
NK cells were co-stained for HLA-DR and CD56 and analysed by flow cytometry ex vivo and after
6d culture with IL-2 (Fig. 4.12A). Both ex vivo and after 6d culture with IL-2 the HLA-DR-expressing
NK cells expressed a higher intensity of CD56. Comparison of the CD56 expression intensity between
HLA-DR-expressing and non-expressing NK cells showed that across 9 donors, HLA-DR-expressing
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Figure 4.12 : CD56 expression is higher on HLA-DR+ NK cells. Freshly isolated NK cells were analysed
by flow cytometry for expression of CD56 and HLA-DR ex vivo and after 6d culture with IL-2.
A Representative FACS plots from the same donor ex vivo (left) and after 6d culture with IL-2
(right). B Summary data from 9 donors comparing the expression level (geomean) of CD56 on
either HLA-DR negative or positive NK cells ex vivo (left) or after 6d culture with IL-2 (right).
Lines link NK cells from the same donor, **P<0.01, tested by Wilcoxon matched pairs test.
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NK cells also expressed more CD56 (Fig. 4.12A). Thus the HLA-DR expressing NK cells are likely to
be subset of the commonly identified CD56bright population.
4.2.8 HLA-DR-expressing NK cells have greater cytolytic capacity
It is already well reported that certain subsets of NK cells have distinct effector response profiles, for
example the CD56dim subset are regarded primarily as cytotoxic lymphocytes, whilst the CD56bright
subset have a greater role in IFN-γ secretion. To understand the possible physiological role of the
HLA-DR-expressing NK cells, they were tested for their ability to degranulate against target cells, and
also to secrete IFN-γ in response to target cells or general stimulation with PMA/ionomycin.
Using a heterogeneous population of HLA-DR-expressing and non-expressing NK cells, as is found
after 6d stimulation with IL-2, it would not have been possible to dissect the contribution of each subset
to total target killing if a radioactivity release cytotoxicity assay had been used. Therefore, a flow
cytometry based assay analysing surface expression of the degranulation marker LAMP-1/CD107a
was used. CD107a is a marker of lytic granules that is expressed at the surface when a cytotoxic
lymphocyte degranulates (Alter et al., 2004), but not during secretion of other effectors, such as
IFN-γ (Anfossi et al., 2006).
An anti-CD107a antibody was included in the culture media whilst the NK cells were co-incubated
with the target cells K562 for 1m, 1h, or 2h. After co-incubation the samples were stained for cellular
markers and analysed by flow cytometry. When analysing the bulk NK cell population, there was
a clear and consistent degranulation of the NK cells against the K562 target cells after 1h and 2h
(P<0.05, Fig. 4.13).
To understand the relative contribution of the HLA-DR-expressing NK cells to this degranulation,
the NK cells were also stained for expression of HLA-DR (Fig. 4.13A). With this data, the proportions
of degranulating cells within each of the HLA-DR− and HLA-DR+ NK populations could be calculated
for 6 donors. Whilst 45% of HLA-DR− NK cells degranulated, over 75% of HLA-DR-expressing NK
cells responded over a 2h incubation (P=0.03, Fig. 4.13B). This significant difference was also observed
after a 1h incubation. Thus, the HLA-DR-expressing NK cells degranulate more readily, so are likely
to have a greater cytotoxic capacity as a subset.
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Figure 4.13 : NK cells expressing HLA-DR have a greater lytic capacity. Human NK cells were isolated
and cultured with IL-2 for 6d, after which they were used in a standard degranulation assay
with K562 target cells, co-incubated for 1m, 1h or 2h and then analysed by flow cytometry for
degranulation, marked by CD107a expression. NK cells were identified as CD56+ and were also
stained for expression of HLA-DR to allow gating of and discrimination between the negative
and positive NK cell populations. A Representative plots from one donor showing the CD107a
staining against HLA-DR for all three time points. B Data for 6 donors comparing the percentage
of CD107a+ cells in the HLA-DR negative and positive NK populations at each timepoint,
showing medians and interquartile ranges. *P<0.05, tested by Wilcoxon matched pairs test.
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4.2.9 HLA-DR-expressing NK cells do not have a greater potential for IFN-γ pro-
duction
In addition to cytotoxicity, NK cells have another important effector function, IFN-γ secretion. As with
the assessment of the HLA-DR-expressing NK cells’ degranulation activity, there is a common assay
to quantify IFN-γ secretion from a bulk population, in this case ELISA of the supernatant. However,
to compare the relative contributions of the HLA-DR− and HLA-DR+ NK cells to this secretion, a
flow cytometric assay was used to determine IFN-γ secretion by individual cells.
To test their IFN-γ secretion response against K562 cells, the NK cells and target cells were co-
incubated for 5h, with Brefeldin A (BFA) added after 1h. BFA is an inhibitor of protein trafficking
between the endoplasmic reticulum and the Golgi Apparatus, thus inhibiting secretion and leading to
an intracellular accumulation of proteins destined for secretion (Misumi et al., 1986). Addition of BFA
to the culture media ensures that there is sufficient IFN-γ present in the cell for easy detection by
flow cytometry, and means that the intensity of staining can be used to assess relative amounts of
IFN-γ produced by individual NK cells over the 4h period. The NK cells were also stimulated with
PMA/ionomycin in the absence of target cells, as a positive control. NK cells of 5 out of 6 donors
secreted IFN-γ in response to K562 target cells, and to a greater extent PMA/ionomycin stimulation
(4 out of 5 donors, Fig. 4.14).
NK cells were also stained for expression of HLA-DR, and the relative IFN-γ secretion by the HLA-
DR− and HLA-DR+ NK cells was compared (Fig. 4.14). HLA-DR-expressing NK cells had a slightly
increased capacity for IFN-γ secretion upon stimulation by K562, 22% compared to 13% for other
NK cells, but this was not statistically significant (P=0.09, Fig. 4.14B). No such distinction was seen
when the cells were activated with PMA/ionomycin, demonstrating that HLA-DR− and HLA-DR+
NK cells have the same intrinsic capacity for IFN-γ production.
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Figure 4.14 : HLA-DR+ NK cells do not show enhanced IFN-γ production. Human NK cells were isolated
and cultured for 6d with IL-2 and then analysed by flow cytometry for intracellular IFN-γ after
5h incubation with K562 target cells or stimulation with PMA and ionomycin. Brefeldin A was
added at the beginning of the 5h incubation. NK cells were identified as CD56+ cells and were
also stained for HLA-DR to allow gating of and discrimination between the negative and positive
populations. A Representative plots from one donor showing the intracellular IFN-γ staining
against expression of HLA-DR for NK cells alone, NK cells with K562, and NK cells stimulated
with PMA/ionomycin. B Data for 6 donors showing the percentage of IFN-γ+ cells in each
of the HLA-DR− and HLA-DR+ NK cell populations, lines link donor matched data points.
*P<0.05, non-significant P-values as indicated, tested by Wilcoxon matched pairs.
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4.2.10 HLA-DR-expressing NK cells express the chemokine receptor CXCR3
NK cells, have been identified in the parafollicular T cell areas of histologically normal lymph nodes
(LN) (Fehniger et al., 2003; Martín-Fontecha et al., 2004). Greater than 95% of these lymph node NK
cells were CD56bright in contrast to circulating NK cells which are mostly (≈90%) CD56dim, therefore
the authors concluded a distinct population of CD56bright NK cells are found in the anatomic site
of ongoing adaptive immune responses. Characterisation of the HLA-DR-expressing subset suggested
that they may be a subset of the CD56bright population. Furthermore, if the expression of HLA-DR
enabled them to present antigen to T cells, as has been demonstrated previously, then the lymph node
would provide an ideal site in which to encounter T cells.
Consequently, the potential trafficking program of the HLA-DR-expressing NK cells, leading to their
lymph node recruitment, was explored by analysis of their chemokine receptor expression. Lymphocyte
trafficking around the body is directed by chemokine gradients generated by specific tissues and
expression of specific chemokine receptors on the trafficking cells. Previously, two chemokine receptors
have been described that are expressed on NK cells in certain conditions and are also associated with
homing to the lymph node: CCR7 and CXCR3. CXCR3 has been specifically linked to lymph node
recruitment in a study that demonstrated CCR7-independent, CXCR3-mediated recruitment of NK
cells to lymph nodes in mice (Martín-Fontecha et al., 2004). In addition, CXCR3-mediated chemotaxis
has been implicated in the recruitment of lymphocytes to sites of inflammation (Lacotte et al., 2009).
Profiling the HLA-DR-expressing NK cells following IL-2 stimulation, we found the HLA-DR-
expressing NK cells expressed a high level of CXCR3 expression (Fig. 4.15). Following the same
strategy as used to analyse expression of HLA-DR on proliferating NK cells, freshly isolated NK
cells were labelled with CFSE and then cultured them with IL-2 for up to 6d before analysing them
by flow cytometry for CXCR3 expression. Comparison of the unproliferated (CFSE undiluted) and
the proliferating cells (CFSE diluted peaks) showed that proliferating NK cells express a higher level
of CXCR3 (Fig. 4.15A), as observed for the expression of HLA-DR (Fig. 4.2). Two colour flow
cytometric analysis of non CFSE labelled isolated NK cells showed that 6d culture with IL-2 led to an
up-regulation of both HLA-DR and CXCR3. Although only ≈40% of CXCR3+ cells were HLA-DR+,
over 80% of HLA-DR+ cells were CXCR3+. Higher expression of HLA-DR was not concomitant with
higher expression of CXCR3; cells that expressed CXCR3 did so at a similar level, regardless of the
HLA-DR level.
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Figure 4.15 : HLA-DR-expressing NK cells have higher expression of the chemokine receptor CXCR3.
A Freshly isolated NK cells were labelled with CFSE and cultured with IL-2 for up to 6d, then
analysed by flow cytometry. The left plots show the CFSE dilution peaks, representing successive
rounds of cell division. The right plots show the expression of CXCR3; the grey shaded histograms
are the unproliferated cells and the green open histogram are the proliferating cells (as gated
in the corresponding CFSE histogram). The duration of culture is indicated in the top left of
the CFSE plots. B Representative flow cytometry plots showing expression of CXCR3 versus
HLA-DR ex vivo and after 6d culture with IL-2. C Data for 10 donors comparing the intensity
of CXCR3 expression (geomean) between HLA-DR− and HLA-DR+ NK cells. **P<0.01, tested
by Wilcoxon matched pairs.
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4.2.11 HLA-DR-expressing NK cells are enriched via CXCR3-mediated chemotaxis
It was important to determine whether this preferential expression of CXCR3 on the HLA-DR-
expressing NK cells was sufficient to drive their segregation or enrichment during CXCR3 mediated
chemotactic migration. This was achieved by testing the responsiveness of the CXCR3 expressing
NK cells to CXCR3 ligation, because expression alone does not necessarily confer functionality. For
example, the immortalised NK cell line, NKL, expresses CXCR3, but during chemotaxis assays this was
found to be non-functional (Berahovich et al., 2006). CXCR3 is a promiscuous chemokine receptor,
responding to IP-10 (CXCL10), Mig (CXCL9), and I-TAC (CXCL11). I-TAC/CXCL11 has the highest
affinity for CXCR3 and is the most potent agonist (Clark-Lewis et al., 2003), so this was selected as
the chemokine to use to determine the impact of the CXCR3 expression in chemotaxis assays.
Chemotaxis assays, testing the transmigration of cells across a porous membrane in response to
a solution of the ligand in the bottom chamber, were used to determine whether CXCR3 could drive
enrichment of the HLA-DR-expressing population, as predicted by the association of protein expression.
The wells of chemotaxis plates were loaded with I-TAC in media, with a 5µm pore-size membrane
placed over the top. The assays used a log scale range of I-TAC concentrations (0.05–500nM), a
common practice with chemotaxis assays, to determine the optimal chemotaxis dose. At relatively
high concentrations of chemokines, sufficient to engage all of the surface chemokine receptors on an
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Figure 4.16 : Chemokinesis masks chemotaxis over a 5h incubation period. Isolated NK cells were
cultured with IL-2 for 6d and then used for a transmigration chemotaxis assay to the CXCR3
ligand I-TAC with a 5h incubation time. A Expression of CXCR3 on the migrating cells was
analysed by flow cytometry and the geomean was plotted. B Chemotaxis was determined by
haemocytometer counting of migrated cells, plotted as percentage of the total NK cells loaded
on to assay.
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individual cell, the cell is unable to discern a gradient, and therefore cannot respond chemotactically.
So, in chemotaxis assays, ranges of chemokine concentrations are often established that exceed this,
resulting in a characteristic decline in chemotaxis at the highest concentration.
2x105 NK cells were loaded on to the membrane above each well and the plate incubated for up
to 5h. After incubation, the cells remaining on the membrane were discarded and the cells that had
transmigrated into the lower chamber were analysed. NK cells were counted by haemocytometer to
determine the percentage of cells that had migrated, and they were also analysed by flow cytometry
for expression of CXCR3 and HLA-DR. When CXCR3 binds its ligands, it is internalised and degraded
(Meiser et al., 2008). So, as a control for the I-TAC quality and concentration, the expression of CXCR3
on cells that had transmigrated the membrane, i.e. those in the bottom chamber, was analysed by flow
cytometry. At higher I-TAC concentrations the surface staining of CXCR3 was drastically reduced, to
almost undetectable levels, consistent with its internalisation.
Initially, chemotaxis assays were performed with a 5h incubation period. At higher I-TAC con-
centrations the surface staining of CXCR3 was drastically reduced, to almost undetectable levels,
consistent with its internalisation, and therefore recognition of I-TAC (Fig. 4.16A). However, there
was no discernible transmigration in response to I-TAC beyond that observed in the buffer only control
samples (Fig. 4.16B). However, the percentage of transmigrating NK cells was particularly high at
all I-TAC concentrations, and with the buffer control. One possible explanation for this was the high
motility of NK cells, rather than specific chemotaxis. Indeed, NKL cells have a reported speed of
15µm/min (Culley et al., 2009), and primary human NK cells cultured for 6d with IL-2 have a similar
average speed of 12µm/min (personal communication, Alice Brown, Imperial College).
To address this, the assay was repeated using a 2h incubation to reduce the basal migration
“noise”. IL-2 cultured NK cells from three donors were tested, with all showing the same trends. As
with the 5h incubation, the I-TAC dose dependent decrease in CXCR3 expression confirmed that the
cells were sensitive to the chemokine (Fig. 4.17A). The assays showed that the NK cells migrated in
an I-TAC dose dependent manner, peaking at 5–50nM (Fig. 4.17B). Importantly, this transmigration
led to an enrichment of the HLA-DR-expressing subset in the fraction responding optimally to I-TAC
(Fig. 4.17C).
As mentioned previously, although the NK cells from the three donors showed the same trends,
there were differences between them. Different donors responded optimally at different concentrations
of I-TAC, as demonstrated by CXCR3 internalisation (Fig. 4.17D). Crucially, the peak of chemotaxis
(Fig. 4.17E) corresponded to the peak enrichment of HLA-DR-expressing NK cells (Fig. 4.17F) for NK
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Figure 4.17 : Elevated CXCR3 expression drives enrichment of HLA-DR-expressing NK cells in the NK
cells that migrate optimally to I-TAC. Isolated NK cells from three independent donors were
cultured with IL-2 for 6d and then used for transmigration chemotaxis assays to the CXCR3 ligand
I-TAC with a 2h incubation time. A Expression of CXCR3 on the migrating cells was analysed by
flow cytometry and plotted as percentage MFI relative to the buffer only sample. B Chemotaxis
was determined by haemocytometer counting of migrated cells, plotted as percentage of the
total NK cells loaded on to assay. C Percentage of the migrated cells expressing HLA-DR was
analysed by flow cytometry and plotted as the percentage increase relative to the buffer only
(DR
+
[I−TAC]−DR
+
buffer
DR+
buffer
∗ 100). Graphs show means and SEMs of 3 independent donors. D–F
As A–C, but individual plots show the responses of NK cells from distinct donors. Graphs show
medians and ranges from triplicate wells of same experiments.
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cells from each donor. Thus, expression of the chemokine receptor CXCR3 on the HLA-DR-expressing
subset can lead to their enrichment in response to a cognate chemokine, I-TAC, and is consistent with
their recruitment to sites of inflammation (Lacotte et al., 2009), and potentially to the lymph node
(Martín-Fontecha et al., 2004; Burt et al., 2008).
4.2.12 Superantigen induces expansion of the HLA-DR-expressing NK cell popula-
tion in PBMC
To understand the functional capacity of the HLA-DR expressed on NK cells, its contribution to su-
perantigen presentation was studied. Superantigen is a bacterial product that cross-links the invariant
region of MHC class II protein with the T cell receptor, resulting in T cell activation and IL-2 se-
cretion (Herman et al., 1990). It has previously been shown that HLA-DR expression on NK cells in
fresh PBMC increases after 24h stimulation with staphylococcal enterotoxin B (SEB) (D’Orazio and
Stein-Streilein, 1996). Here we confirmed the HLA-DR expression pattern, extended the observation
to staphylococcal enterotoxin E (SEE) and demonstrated that the up-regulation continued beyond
24h.
Whole PBMC were isolated from blood and stimulated for 24h or 48h with SEB or SEE before
being analysed by flow cytometry for expression of HLA-DR or CD69 on CD56+CD3− NK cells.
Consistent with our analysis of HLA-DR expression of isolated NK cells, in whole PBMC there was a
small positive distribution extending from the non-expressing population (Fig. 4.18B). Similarly, after
24h stimulation with SEB or SEE relative to media alone, there was an increase in the percentage of
NK cells that express HLA-DR, though not the level of expression (Fig. 4.18D, E 24h). This increase
in the percentage of HLA-DR-expressing NK cells continued when the stimulation was extended to
48h (Fig. 4.18D, E 48h). Differences between the level of NK cell responses to SEB and SEE between
donors could reflect differences in HLA-DR haplotype, which is known to affect the recognition by
different superantigens (Herman et al., 1990).
The same samples, were also stained for expression of the early activation marker CD69 (Lanier
et al., 1988). This showed a more marked response to superantigen stimulation than HLA-DR expres-
sion, with over 75% of NK cells expressing it after 24h SEB stimulation for all three donors (Fig. 4.19).
Similar to the increase in HLA-DR-expressing NK cells, the response to both superantigens was similar
in D2 but a reduced response to SEE was seen with D3 and D5. Thus suggesting that the difference
between the donors was at the level of activation, rather than just HLA-DR expression.
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Figure 4.18 : Superantigen stimulation of whole PBMC drives an increase in HLA-DR-expressing NK
cells. Fresh, whole PBMC were stimulated with SEB, SEE or just media for 24h or 48h and
then analysed by flow cytometry. Plots show representative flow cytometry data for the same
single donor before stimulation (ex vivo, 0h) (A-C) and after superantigen stimulation (D). Plots
of ex vivo cells show A proportion of CD56+/CD3− NK cells in fresh PBMC, B expression of
HLA-DR on CD56+ PBMC, and C proportion of HLA-DR+ cells in NK cells isolated by magnetic
separation. D After stimulation for 24h or 48h the PBMC were analysed for CD56 and HLA-DR
expression. E Data for 3 independent donors showing the percentage of HLA-DR+ NK cells
(HLA−DR+CD56+ cellsall CD56+ cells ∗ 100).
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Figure 4.19 : Superantigen stimulation of whole PBMC up-regulates the early activation marker
CD69. Fresh, whole PBMC were stimulated with SEB, SEE or just media for 24 or 48h and then
analysed by flow cytometry. A Plots show representative flow cytometry data for a single donor
stained for CD69 and CD56. B Summary plots for 3 independent donors show the percentage
of CD69+ NK cells (CD69+CD56+ cellsall CD56+ cells ∗ 100).
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As with the response of isolated NK cells to IL-2 stimulation, a large percentage (>75% at 24h)
of NK cells up-regulated CD69, so were activated; however, a much smaller proportion (<30% at
24h) of NK cells expressed HLA-DR, consistent with the hypothesis that only a subset have potential
for HLA-DR expression. Strikingly, whilst the expression of CD69 didn’t increase greatly for SEB
stimulation between 24 and 48h (≈82% → ≈92%), the proportion of HLA-DR-expressing NK cells
continued to increase (≈27%→ ≈46%). These timescales and increases in percentages are consistent
with proliferation contributing to the increase in the HLA-DR-expressing NK cell subset in response
to superantigen stimulation.
The supernatants from these superantigen stimulated PBMC were also harvested and analysed by
ELISA for concentrations of IFN-γ and IL-2. In all donors, superantigen stimulation (SEE and SEB)
induced secretion of IFN-γ and IL-2 by the PBMC. The percentage of HLA-DR+ NK cells (Fig. 4.20A),
IFN-γ concentration (Fig. 4.20B), and IL-2 concentration (Fig. 4.20C) was compared. Although only 3
donors were analysed, the donor with the highest percentage of HLA-DR+ NK cells (D3) also had the
highest concentration of IL-2 in the supernatant. Together with the earlier data concerning the IL-2
induced proliferation of the HLA-DR-expressing subset, this suggested that secreted IL-2, induced by
the superantigen, may, along with other signals, contribute to the expansion of the HLA-DR-expressing
NK cells in this system too.
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Figure 4.20 : HLA-DR up-regulation on NK cells in PBMC stimulated with superantigen corresponds
to IL-2 secretion. Fresh, whole PBMC from 3 independent donors were stimulated with SEB,
SEE or just media for 24 or 48h. A The PBMC were analysed by flow cytometry for the
percentage of CD56+ NK cells expressing HLA-DR. Supernatants from the same samples were
collected and analysed by ELISA for B IFN-γ, and C IL-2. Bar graphs (B, C) show medians and
ranges of triplicate PBMC stimulations for each donor.
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4.2.13 Superantigen induces expansion of the HLA-DR-expressing NK cell popula-
tion in an IL-2 dependent manner
To investigate further the potential role of IL-2 in the expansion of HLA-DR-expressing NK cells in
PBMC following superantigen stimulation, similar experiments were conducted with the inclusion of
an anti-IL-2 neutralising mAb. Here, the whole PBMC were isolated from blood and stimulated for
24h or 48h with SEB or SEE, with the inclusion of an anti-IL-2 neutralising mAb or an isotype matched
control in the culture media. NK cells were identified as CD56+CD3− by flow cytometry (Fig. 4.21A)
and gated for expression of HLA-DR (Fig. 4.21B). In addition, the expression of CD69 on CD56−
and CD56+ PBMCs was analysed (Fig. 4.21C). The fold increase in HLA-DR-expressing NK cells was
calculated as the increase with stimulation relative to the unstimulated samples, and was compared
between the IL-2 neutralised samples and the control samples for both stimulations at both timepoints
(Fig. 4.22A).
IL-2 blockade had no significant effect on the proportion of HLA-DR-expressing NK cells after 24h
stimulation with either SEB or SEE (Fig. 4.22A top). Interestingly, after 48h there was a significantly
lower expansion of HLA-DR-expressing NK cells for the IL-2 blocked samples stimulated with SEE
(P=0.03, Fig. 4.22A bottom left) and a reduction that was almost significant when stimulated with
SEB (P=0.06, Fig. 4.22A bottom right). This limitation to the increase of HLA-DR-expressing NK
cells is distinct to the up-regulation of the activation marker CD69, which was not impacted by the
IL-2 blockade following SEE stimulation but was reduced at both timepoints with SEB stimulation
(Fig. 4.22B).
Following stimulation of whole PBMC with superantigens, the subset of NK cells expressing HLA-
DR expanded in an IL-2 dependent manner. The IL-2 dependence only manifested after 48h, not 24h,
consistent with the increase being driven by proliferation. Thus, the HLA-DR-expressing NK cells are
likely to be expanded during a reductionist model of a severe inflammatory response.
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Figure 4.21 : IL-2 blockade reduces the superantigen induced increase in HLA-DR+ NK cells, but
not up-regulation of CD69. Fresh, whole PBMC were stimulated with SEB, SEE or just
media for 48h, in the presence of an IL-2 neutralising antibody or an isotype matched control,
and then analysed by flow cytometry. Plots show representative data from one donor. A Plot
showing gating strategy for CD56+/CD3− NK cells in fresh PBMC. B Expression of HLA-DR on
CD56+/CD3− NK cells as gated in A. Gates show HLA-DR+ cells, numbers indicate percentages
of total NK cells. C Plots show expression of CD56 and CD69 in whole, ungated PBMC, numbers
indicate percentage of cells in each quadrant.
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Figure 4.22 : IL-2 neutralisation reduces the superantigen induced increase in HLA-DR+ NK cells.
Fresh, whole PBMC were stimulated with SEB, SEE or just media for 48h, in the presence
of an IL-2 neutralising antibody or an isotype control, and then analysed by flow cytometry.
Graphs display data for 6 donors at 24h and 5 donors at 48h, lines link donor matched samples,
significance tested by Wilcoxon matched pairs test, P-values as indicated.
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4.2.14 BCG stimulates expansion of the HLA-DR-expressing NK cell population in
PBMC
The next step was to test the role of the HLA-DR-expressing NK cells in response to an infectious agent.
Mycobacterium bovis BCG (BCG) is the widely used vaccine for tuberculosis. During inoculation, the
response to BCG is in the context of a complete immune system, rather than isolated NK cells.
Therefore, for these experiments whole PBMC were isolated from donors and stimulated with BCG,
rather than the isolated NK cells that had been used in previous experiments with cytokine stimulation.
Here, PBMC from 10 donors were stimulated with BCG for up to 6d, with BFA added 4h before samples
were harvested, and then analysed by flow cytometry for expression of HLA-DR on CD56+CD3− NK
cells. Samples were analysed ex vivo (0d), and after 1d, 3d and 6d. In contrast to stimulation of PBMC
with superantigen, which elicits a severe inflammatory response and increase in HLA-DR-expressing
NK cells after 48h (Figs 4.18, 4.22), with BCG the proportion of HLA-DR-expressing NK cells only
increased after 6d (Fig. 4.23), which is consistent with it being a result of preferential proliferation.
Thus, the HLA-DR-expressing subset expand in response to BCG stimulation of whole PBMC. This
expansion in response to an infectious agent suggests that they may perform a specific role in the
response, consequently, their impact on the functional response was assessed directly.
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Figure 4.23 : BCG stimulation of PBMC induces the expansion of the HLA-DR-expressing NK cells.
Unfractionated PBMC from 10 donors were stimulated with BCG and cultured for up to 6d. At
0d, 1d, 3d, and 6d the percentage of CD56+CD3− NK cells staining positive for HLA-DR was
measured by flow cytometry. The graphs shows medians and interquartile ranges, **P<0.01
tested by Wilcoxon matched pairs. Data acquired by Amir Horowitz, analysed by JHE.
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4.2.15 NK cell secretion of IFN-γ in response to BCG is heterogeneous
Following stimulation of whole human PBMC with BCG for 24h, we found that the CD56+CD3− NK
cells secrete IFN-γ (Fig. 4.24A). It has emerged recently that NK cells act as an important effector
mechanism in the response of whole PBMC to a number of infectious agents. Interestingly, it has
been their capacity to secrete IFN-γ, rather than their cytotoxic response, and its subsequent impact
on the ensuing adaptive immune response that has received much interest in the context of several
infections including L. major (Bihl et al., 2010), and P. falciparum (Batoni et al., 2005; Korbel et al.,
2005; Newman et al., 2006; Horowitz et al., 2010b). In these models, following stimulation of whole
PBMC with the infectious agent has resulted in an early secretion of IFN-γ by the NK cells, within
6h, peaking at 24h.
Interestingly, the percentage of NK cells that produced IFN-γ after 24h stimulation with BCG
ranged between donors from 0% to over 70% (Fig. 4.24B). This is similar to the reported heterogeneity
in the magnitude of the NK cell IFN-γ secretion response to P. falciparum stimulation of whole PBMC
(Korbel et al., 2005). Analysis of PBMC from 84 donors showed that the median response to BCG
stimulation was 6.5% of NK cells producing IFN-γ (Fig. 4.24B, indicated by red line). Therefore,
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Figure 4.24 : In whole PBMC stimulated with BCG the NK cells secrete IFN-γ. Unfractionated PBMC
were stimulated with BCG for 24h, with BFA added for the last 4h, and then analysed by flow
cytometry for intracellular IFN-γ in CD56+CD3− NK cells. A Plots for a representative donor
showing intracellular IFN-γ in CD56+CD3− NK cells left unstimulated (top) or stimulated with
BCG (bottom), numbers indicate percentage of IFN-γ NK cells. B Data from 84 donors showing
percentage of IFN-γ+ NK cells, each bar represents an individual. The median NK cell IFN-γ
secretion response was 6.5%, as indicated by the red line. Donors were classified as “low” or
“high” responders as indicated if their response was below or above the median respectively. 6
donors (including representative plots) tested by J.H.E and A.H., 78 were screened by A.H.
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the donors were classified as “low” responders if fewer than 6.5% of the NK cells responded, and as
“high” responders if more than 6.5% did so.
4.2.16 NK cells secrete IFN-γ in response to BCG in an IL-2 and MHC class II
dependent manner
In our investigation characterising the response of NK cells in PBMC to P. falciparum stimulation,
it was shown that the NK cell response was dependent on CD4+ T cells, IL-2, and MHC class II
protein, with their depletion or blocking leading to a reduction in the proportion on NK cells secreting
IFN-γ (Horowitz et al., 2010b). Similar results were found for L. major infection (Bihl et al., 2010),
and vaccine recall responses to rabies (Horowitz et al., 2010a) and influenza A (He et al., 2004;
Long et al., 2008). Here, we showed that the NK cell secretion of IFN-γ in response to BCG shares
similar characteristics. Whilst not dependent on MHC class I proteins (Fig. 4.25A), blocked as a
control, the response was shown to be dependent on class II MHC proteins (Fig. 4.25B) and IL-2
(Fig. 4.25C). Furthermore, depleting T cells, particularly CD4+ cells, similarly reduced the NK cell
response (Fig. 4.25D), and it was demonstrated that these T cells also secreted IL-2 rapidly (within
6h) after BCG stimulation (Fig. 4.25E). These data are consistent with the secretion of IFN-γ by
NK cells in PBMC stimulated by BCG being an effector mechanism of an antigen specific adaptive
immune response.
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Figure 4.25 : The NK cell IFN-γ secretion response to BCG is dependent on IL-2 and MHC class II.
PBMC from 10 donors were cultured with BCG for 24h in the presence of blocking antibodies
to A MHC class I, B MHC class II, or C IL-2 or with isotype matched control antibodies. The
samples were analysed by flow cytometry for percentages of CD56+CD3− NK cells staining
positive for intracellular IFN-γ. *P<0.05, **P<0.01 tested by Mann-Whitney. D PBMC from
14 donors were depleted of all T cells (CD3−, left), CD4+ T cells (CD4−, 2nd left), CD8+ T
cells (CD8−, 2nd right) or mature B cells as a control (CD20−, right) and then stimulated with
BCG. The samples were analysed by flow cytometry for intracellular IFN-γ in CD56+CD3− NK
cells, P values as shown, tested by Student t-test. E whole PBMC from 5 donors were stimulated
with BCG for up to 18h, with monensin added 4h before harvesting, and then analysed by flow
cytometry for intracellular IL-2 in CD3+CD56− T cells. Experiments performed by A.H.
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4.2.17 The circulating population HLA-DR-expressing NK cells is a predictor of
responder status to BCG
After establishing that BCG stimulation resulted in an expansion of HLA-DR-expressing NK cells and
that subsequent IFN-γ secretion by NK cells was in an IL-2 and MHC class II dependent manner, it
was investigated whether the HLA-DR-expressing NK cells could have a specific role in the interactions
of immune cells leading up to this. Furthermore, significant heterogeneity in both the donor NK cell
response to BCG and the size of the circulating population of HLA-DR-expressing NK cells had already
been noticed; so, these two aspects of heterogeneity were compared. NK cells were isolated from the
PBMC of known high and low responders and were analysed by flow cytometry for the proportion
of HLA-DR-expressing NK cells ex vivo (Fig. 4.26). Strikingly, there was a significant association
between the proportions of circulating HLA-DR-expressing NK cells and the responder status of the
donors (Fig. 4.26B), with the high responders having a greater proportion of HLA-DR-expressing NK
cells.
Based on the earlier observations that the proportion of HLA-DR-expressing NK cells increased
with IL-2 culture by selective expansion, the isolated NK cells from the known high and low responders,
that were analysed for proportions of HLA-DR-expressing NK cells ex vivo, were also cultured with IL-2
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Figure 4.26 : High responders to BCG have a larger circulating population of HLA-DR-expressing NK
cells. Freshly isolated CD56+CD3− NK cells from donors, that were characterised as low or high
responders to BCG stimulation, were analysed ex vivo by flow cytometry for expression of HLA-
DR. A Representative plots of NK cells from a low and a high responder including percentage
of HLA-DR+/CD56+ cells. B Data for 16 individual donors of known responder status to BCG.
Each dot represents a donor, graph shows medians and interquartile ranges, significance tested
by one tailed non-parametric Mann-Whitney, *P<0.05.
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Figure 4.27 : Comparison of HLA-DR-expressing NK cell populations after in vitro culture with IL-2
between low and high responders. Freshly isolated NK cells from donors, that were char-
acterised as low or high responders to BCG stimulation, were cultured for 6d with IL-2 then
analysed by flow cytometry for expression of HLA-DR. A Representative plots of NK cells from
a low and a high responder including percentage of HLA-DR+/CD56+ cells. B Data for 10
individual donors of known responder status to BCG. Each dot represents a donor, graph shows
medians and interquartile ranges.
for 6d in vitro and then analysed for the proportions of HLA-DR-expressing NK cells. As expected,
there were higher proportions of HLA-DR-expressing NK cells in the cultures from the high responders
than the low responders, reflecting the ex vivo differences (Fig. 4.27A). However, the difference was
no longer significant (Fig. 4.27B). Thus, the proportion of HLA-DR-expressing NK cells in circulation
in peripheral blood is associated with the capacity of a donor to mount an NK cell IFN-γ secretion
response to BCG.
4.2.18 Enriching the HLA-DR-expressing NK cell compartment of PBMC substan-
tially enhances the NK cell IFN-γ response to BCG
To test more directly the association between the size of the HLA-DR-expressing NK cell compartment
of peripheral blood and the downstream NK cell IFN-γ secretion in response to BCG stimulation of
PBMC, the proportion of HLA-DR-expressing NK cells was manipulated artificially. To achieve this,
the PBMC from 5 donors were fractionated into CD56 depleted samples, isolated NK cells, and HLA-
DR-expressing NK cells and then recombined at different ratios to generated reconstituted PBMC with
enriched HLA-DR-expressing NK cell populations. Before stimulation with BCG the normal and HLA-
DR-expressing NK cell enriched PBMC were analysed by flow cytometry to confirm the enrichment
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Enrichment performed at LSHTM in collaboration with Amir Horowitz
Figure 4.28 : PBMC were artificially enriched for HLA-DR-expressing NK cells. PBMC from 5 donors
were fractionated by magnetic separation for CD56 depleted, isolated NK cells and HLA-DR+ NK
cells. These fractions were recombined to generate reconstituted PBMC with ex vivo percentages
of HLA-DR-expressing NK cells or with enriched levels. To confirm the enrichment the recon-
stituted samples were analysed by flow cytometry for expression of HLA-DR on CD56+CD3−
NK cells. A Representative plots from one donor showing percentages of HLA-DR-expressing
NK cells in reconstituted PBMC (top) and in the HLA-DR-expressing NK cell enriched sample
(bottom). B Data from 5 donors showing the percentages of HLA-DR-expressing NK cells in
PBMC and the HLA-DR-expressing NK cell enriched samples. *P<0.05 tested by one-tailed
Wilcoxon matched pairs.
(Fig. 4.28A). Because of the relatively small percentages of HLA-DR-expressing NK cells it was only
possible to gain a modest 1.45 fold enrichment across the 5 donors (Fig. 4.28B). The next step was
test the impact of this NK-DR enrichment on the response of the PBMC to BCG stimulation.
Reconstituted PBMC and HLA-DR-expressing NK cell enriched samples were stimulated with
BCG, or left unstimulated, for 24h, with BFA added 4h before harvesting, and then analysed by flow
cytometry for intracellular IFN-γ in CD56+CD3− NK cells. The NK cells in neither sample produced
IFN-γ when left unstimulated (Fig. 4.29A left), and in both the PBMC and the HLA-DR-expressing
NK cell enriched PBMC the NK cells produced IFN-γ when stimulated with BCG (Fig. 4.29A right).
Strikingly, enrichment of the HLA-DR-expressing NK cell population resulted in a significant, greater
than three-fold increase in the proportion of the NK cells secreting IFN-γ (Fig. 4.29A bottom, B).
However, it should be noted that the HLA-DR-expressing NK cells are not those responsible for the
secretion of IFN-γ. Thus, a modest enrichment of the HLA-DR-expressing NK cell compartment
was sufficient to substantially enhance the NK cell IFN-γ secretion response to BCG. This implies
that although the HLA-DR-expressing NK cells are a small population in peripheral blood, they can
significantly influence the immune response to BCG.
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Figure 4.29 : Enrichment of HLA-DR-expressing NK cells substantially enhances the NK IFN-γ secre-
tion response to BCG. PBMC from 5 donors were artificially enriched for the NK-DR population
and stimulated with BCG for 24h before being analysed by flow cytometry for intracellular IFN-γ
in CD56+CD3− NK cells. A Representative plots from one donor comparing NK cell intracellular
IFN-γ in PBMC (top), or NK-DR enriched samples (bottom), between unstimulated (left) or
BCG stimulated (right) samples. B Data from 5 donors comparing unstimulated (X) and BCG
stimulated (BCG) samples as indicated, **P<0.01, tested by Mann-Whitney.
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4.2.19 Blocking HLA-DR specifically on NK cells
After demonstrating that the HLA-DR-expressing NK cells, although a small population in peripheral
blood, can make a substantial contribution to the NK cell IFN-γ secretion response to BCG stimulation,
we sought to determine whether this was specifically mediated through their expression of HLA-DR.
To achieve this, an experiment was designed in which the HLA-DR was blocked, using an anti-HLA-
DR blocking mAb, on the HLA-DR-expressing NK cells specifically. In order to block on this subset,
and not the other HLA-DR-expressing cells present in PBMC, such as monocytes, dendritic cells and
B cells, a similar approach was taken to the NK-DR enrichment experiments. The purified PBMC
were split into two samples and CD56+ cells were depleted from one, whilst NK cells were isolated
from the other. Each of these samples was then divided into two further samples and incubated for
30m with either an anti-HLA-DR blocking mAb or an isotype matched control. After washing, the
samples were recombined in different combinations to yield four distinct preparations, in which the
HLA-DR was blocked on: (1) none of the cells, (2) all of the HLA-DR-expressing cells, (3) just the
HLA-DR-expressing NK cells, or (4) all the cells expressing HLA-DR except the NK cells (Fig. 2.6).
These samples were then stimulated with BCG for 18h before being analysed by flow cytometry for
intracellular IFN-γ in the CD56+CD3− NK cells.
Before analysing the impact of specifically blocking HLA-DR on the NK cells, the efficacy of pulse
blocking all HLA-DR in the sample was assessed. When the anti-MHC class II mAb was included in
the culture media for the duration of the BCG stimulation, a significant reduction in the NK cell IFN-γ
secretion response was observed (Fig. 4.25B). However, to block HLA-DR on specific cell populations,
it was necessary to incubate with the blocking antibody and then wash the excess out of the media
before recombining the different fractions (hereafter termed “pulse blocking”). Therefore the blocking
effect was expected to be reduced in this scenario because of antibody dissociation from the HLA-DR,
and because of de novo surface expression. Because of these limitations, stimulations were performed
for only 18h rather than the 24h previously used. As anticipated, pulse blocking did not reduce
the NK cell IFN-γ secretion response to BCG (Fig. 4.30A “none”/“total”, B) or SEB (Fig. 4.30C
“none”/“total”, D) to the same extent as including the blocking mAb in the culture media for the
duration of the stimulation (Fig. 4.25B).
In light of the reduced efficacy observed after pulse blocking of HLA-DR on all PBMC, it was not
surprising that no significant and reproducible signal could be detected for blocking of HLA-DR on
either just the NK cells or on all other HLA-DR-expressing cells. This was true for stimulation with
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Figure 4.30 : Targeted pulsed blocking of HLA-DR on NK cells in PBMC does not abrogate NK
IFN-γ secretion. PBMC from 3 donors were fractionated by magnetic separation into CD56
depleted and isolated NK cells. Each fraction was incubated for 30m with an anti-HLA-DR
mAb, or an isotype matched control, before being washed. The HLA-DR blocked and unblocked
fractions were recombined to generate reconstituted PBMC in which the HLA-DR was selec-
tively blocked on the NK cells or all HLA-DR+ cells other than NK cells. These samples were
stimulated with BCG or SEB for 18h before being analysed by flow cytometry for intracellular
IFN-γ in CD56+CD3− NK cells. A Representative plots from one donor indicating percentages
of intracellular IFN-γ+NK cells within reconstituted PBMC stimulated with BCG. HLA-DR was
pulse blocked on none of the cells (none), all of the cells (total), just the NK cells (NK), or all
HLA-DR+ cells except NK cells (CD56−), as indicated. B Data for 3 donors stimulated with
BCG. C Representative plots for one donor stimulated with SEB, laid out as in A. D Data for 3
donors stimulated with SEB.
either BCG (Fig. 4.30A, B) or SEB (Fig. 4.30C, D) over the 18h incubation.
The presentation of antigen by HLA-DR to T cells requires that the peptide is internalised, pro-
cessed and trafficked to the MHC loading compartment, where it can be loaded onto the MHC class
II molecules, which are then presented on the surface. The nature of this pathway means that any
antigen that is acquired and processed following pathogen encounter will be presented on the surface
in HLA-DR that was still intracellular at the point of first encounter with the pathogen. Therefore,
if the PBMC response to BCG involves an antigen specific, MHC class II mediated component then
pulse blocking, with excess antibody removed before addition of the BCG, will not significantly reduce
the response because the surface HLA-DR that is blocked will not be the same individual molecules
that will be involved in the antigen presentation. Hence, these final data are inconclusive.
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4.3 Summary of results
In this investigation, the mode of up-regulation of HLA-DR on human NK cells was explored, and
possible roles of these HLA-DR-expressing NK cells in the immune response to infection was studied.
In particular, it was found that:
• A small population of HLA-DR-expressing NK cells in circulating peripheral blood expanded
following IL-2, or IL-15, stimulation during in vitro culture.
• Mathematical modelling of the clonal expansion of these HLA-DR-expressing NK cells demon-
strated that this was sufficient to yield the increase in HLA-DR-expressing NK cells observed in
IL-2 activated polyclonal NK cell populations.
• The HLA-DR-expressing subset of NK cells exhibited enhanced capacity for degranulation in
response to target cells.
• The HLA-DR-expressing subset of NK cells also expressed the chemokine receptor CXCR3, asso-
ciated with lymphocyte recruitment to sites of inflammation, and homing to lymph nodes, which
enriched them in the fraction responding optimally to the cognate chemokine I-TAC/CXCL11.
• In addition to direct IL-2, or IL-15, stimulation, the HLA-DR-expressing subset of NK cells was
expanded following stimulation of whole PBMC with superantigen, or BCG, in an IL-2 dependent
manner.
• BCG stimulation of whole PBMC in vitro elicited an IFN-γ secretion response by the NK cells,
in an IL-2 and class II MHC protein-dependent manner.
• Although they are only a small subset of NK cells in peripheral blood, the HLA-DR-expressing
NK cells can contribute significantly to the immune response to BCG in vitro: their enrichment
substantially augmented the subsequent NK cell IFN-γ secretion response.
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Figure 4.31 : Proposed model of interactions of HLA-DR-expressing NK cells during BCG stimulation
of PBMC. Based on the data in this investigation, the proposed model for the interactions of
NK cells during the response of human PBMC to BCG stimulation in vitro is presented here. (1)
HLA-DR-expressing NK cells recognise extracellular BCG, potentially via their NKp44 receptor.
(2) Antigenic BCG component acquired and internalised to MHC class II loading compartment
via receptor internalisation. (3) BCG component presented in HLA-DR on the surface of NK cell
to CD4+ T cell. (4) T cell specific for presented antigen responds with IL-2 secretion in proximity
to NK cells. (5) NK cells become activated and proliferate in response to T cell derived IL-2.
(6) Macrophages, or other myeloid accessory cells, also respond to BCG infection, with IL-12
secretion. This is a response to intracellular infection and is likely to occur later than the initial
NK recognition of extracellular BCG. (7) NK cells activated by T cell derived IL-2 and myeloid
derived IL-12 secrete IFN-γ to prime macrophages’ microbicidal mechanisms and to drive a TH1
T cell response.
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4.4 Discussion
Expression of the class II MHC protein HLA-DR has been recorded on NK cells previously. Most
commonly it has been used as an activation marker, although several reports have also investigated its
functional competence to present antigen to T cells. In this study, both of these uses were investigated;
the manner of HLA-DR expression on NK cells, thus its suitability as an activation marker, and the
characteristics of the HLA-DR-expressing NK cells and how they may therefore play a role during an
immune response. In addition, the role of NK cells as effectors of the adaptive immune response,
via their secretion of IFN-γ, was studied, specifically following stimulation with BCG. In this model
system, the contribution of the HLA-DR-expressing NK cells to the final IFN-γ secretion response was
also investigated.
4.4.1 HLA-DR-expressing NK cells: a subset of activated NK cells
The most common activation marker of NK cells is CD69, which following IL-2 stimulation of isolated
NK cells is up-regulated on the whole population within 18h (Lanier et al., 1988). In contrast to this,
the characteristics of HLA-DR expression on IL-2 stimulated NK cells are far less relevant to its use as
an activation marker. Lanier et al. demonstrated that HLA-DR was not up-regulated after 18h, in a
direct comparison with CD69, and routinely up-regulation of HLA-DR takes more than 3d (Skak et al.,
2007; Neves et al., 2009). Even after several days its expression is restricted to a limited proportion
(20%–60%) of the total population (Bozzano et al., 2009; Ingram et al., 2009; Pokkali et al., 2009).
Because of the delay in up-regulation, it cannot be used as a marker in studies with shorter incubation
periods, for example 5h, for target conjugation assays, or 24h for up-regulation of CD25. Despite
these clear shortcomings, HLA-DR expression on NK cells has long been used as an activation marker
(Galea-Lauri et al., 1999; Ferlazzo et al., 2003), and its use continues even in current investigations
(Bozzano et al., 2009; Ingram et al., 2009; Li et al., 2009a; Neves et al., 2009; Pokkali et al., 2009;
Rutjens et al., 2010).
In this investigation, the manner of HLA-DR up-regulation was studied, particularly to understand
the characteristics that limit its use as an activation marker. Interestingly, the results supported an
alternative explanation for the increase in HLA-DR-expressing NK cells, specifically after IL-2 and IL-15
stimulation. Rather than de novo expression on NK cells that previously did not express HLA-DR, it
seems that the increase is primarily driven by preferential proliferation of a small population (≈5%) of
HLA-DR-expressing NK cells already circulating in peripheral blood. Using increasing doses of IL-2, and
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comparison with IL-15 and IL-12 stimulation, demonstrated that the increase in HLA-DR-expressing
NK cells was intimately linked to proliferation, rather than activation. Furthermore, co-analysis with
CFSE-labelled NK cells, to identify proliferating cells, revealed that HLA-DR expression is far enriched
in the proliferating compartment, although the intensity of HLA-DR expression on individual cells did
not show any increase.
Studying clonal populations of NK cells supported this model; there was a wide range of levels
of expression between the clonal populations, but a significantly reduced range within a clonal pop-
ulation. Thus, HLA-DR expression on NK cells shows the hallmarks of clonal restriction, similar to
expression of the inhibitory KIR receptors (Boyton and Altmann, 2007). Indeed, a simple mathemat-
ical model confirmed that the profiles of HLA-DR expression on observed polyclonal populations, and
the proportions of HLA-DR-expressing NK cells, were consistent with clonal expansion of the small
circulating population of HLA-DR-expressing NK cells in peripheral blood.
As is often the case, small exceptions and deviations offered additional support to this model. In
this scenario, whilst the majority of clonal NK populations expressed HLA-DR at some level, a few did
not (≈6%), thus HLA-DR expression does not just indicate proliferation. Similarly, the CFSE labelled
cells revealed that there were some HLA-DR-expressing NK cells that did not proliferate, and not all
proliferating NK cells expressed HLA-DR. This also indicates that HLA-DR expression on NK cells is
not purely a marker of proliferation.
From these results, it is clear that HLA-DR expression is neither a marker of activation, nor of
proliferation. Rather, they are consistent with the increase being driven by a preferential proliferation
of the HLA-DR-expressing NK cells that form part of the baseline NK cell population in peripheral
blood. This was demonstrated directly by analysing the relative proliferation, and expression of HLA-
DR, of NK cells that were sorted into populations based on their expression of HLA-DR ex vivo. These
data clearly showed that the HLA-DR-expressing NK cells ex vivo had a much greater proliferative
capability and maintained a far higher proportion of HLA-DR-expressing NK cells than their negative
counterparts. In light of these findings, it may be possible to re-interpret some previously published
studies. For example, Li et al. used HLA-DR expression to show that NK cells extracted from a
Haemophilus ducreyi induced pustule were activated relative to those in peripheral blood (Li et al.,
2009a). However, rather than activation per se, this could be reinterpreted as their preferential
expansion in situ, or the selective recruitment of this HLA-DR-expressing subset of NK cells to the
site of inflammation, which would be consistent with their observed expression of CXCR3.
Importantly, HLA-DR expression was not observed on all of the IL-2 activated NK cells, nor even
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on all of the proliferating CD56bright subset. Like the expression of certain chemokine receptors,
namely CCR6 and CCR7, HLA-DR is limited to a subset of CD56bright NK cells (Berahovich et al.,
2006), thus supporting its expression as a marker of a subset, rather than simply of activation or
proliferation. However, the distinction of a subset is not an immutable designation within NK cells,
a current theme in NK cell biology is the plasticity observed between phenotypes. For example, even
the most common grouping of CD56dim/CD56bright is not a terminal differentiation. CD56bright NK
cells were differentiated to CD56dim in vitro by co-incubation with synovial fibroblasts, or in vivo
following adoptive transfer into NOD–SCID mice (Chan et al., 2007). Furthermore, longer telomeres
in CD56bright NK cells suggested that they were the precursor state for CD56dim, a view now gaining
ground (Poli et al., 2009). In contrast, IL-2 and IL-21 together can induce the up-regulation of CD56
resulting in CD56dim becoming CD56bright (Skak et al., 2007), so there is plasticity even between
the most notable NK cell subsets. In light of this, it would be interesting to compare the length of
telomeres between NK cells that express HLA-DR and those that do not.
In addition, in the context of HLA-DR expression, after 7d co-incubation with LPS matured DC,
most NK cells have been shown to express HLA-DR (Hanna et al., 2004); however, the activated DCs
are likely to have stimulated the NK cells through multiple pathways. In this current study, the data
do not exclude the possibility subset switching, i.e. of de novo expression of HLA-DR on NK cells,
following stimuli other than IL-2 or IL-15. Nevertheless, an important implication of these results is
that the large volume of human NK cell research that uses peripheral blood NK cells expanded in IL-2
is focused disproportionately on a small subset of NK cells.
4.4.2 The role of HLA-DR-expressing NK cells
Having demonstrated that HLA-DR expression on NK cells is neither a marker simply of activation,
nor proliferation, the question remained: what is the functional importance of HLA-DR expression
on NK cells? Moreover, the distribution of HLA-DR-expressing NK cells in vivo raises similar, and
related, questions. HLA-DR is expressed on a relatively high proportion (≈50%) of lymph node NK
cells (Fehniger et al., 2003; Bajénoff et al., 2006; Burt et al., 2008), and even on a small population
of peripheral blood NK cells (Skak et al., 2007; Burt et al., 2008), which suggests that it may have a
functional role. Indeed, limited reports have explored the capacity for HLA-DR-expressing NK cells to
functionally present antigen to CD4+ T cells, which resulted in their proliferation and secretion of IL-2
(Roncarolo et al., 1991; Hanna et al., 2004). Therefore, this study sought to identify characteristics
that would support such an antigen presentation function.
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Although the antigen presenting capabilities of these HLA-DR-expressing NK cells were not ex-
plicitly tested, many of their characteristics would greatly facilitate such a role. For example, the
enhanced cytotoxicity that was observed for the HLA-DR-expressing NK cell population. The pro-
posed mechanism of antigen presentation by NK cells has been termed “Presentation after killing”,
referring to the nature of antigen acquisition (Hanna and Mandelboim, 2007). Following activating
receptor mediated killing of target cells, NK cells were shown to internalise the receptors, and with
them their ligands, which were subsequently processed via the endosomal–lysosomal compartments
for loading to class II MHC proteins and presentation to T cells (Hanna et al., 2004).
In support of this “presentation after killing” activity, we found that the HLA-DR-expressing NK
cells as a population more readily degranulated in response to K562 target cells. Thus, the HLA-
DR-expressing subset of CD56bright NK cells has an atypical effector response that is consistent with
a functional role of antigen acquisition and presentation. As a control, they exhibited no enhanced
IFN-γ secretion capacity, which is not related to a putative role in antigen presentation.
“Presentation after killing” is an elegant concept proposed for NK cells, and internalisation of var-
ious engaged activating receptors, including NLG2D, CD16, NKp46, and NKp30, was clearly demon-
strated (Hanna et al., 2004). However, although NK cells have a wider array of activating receptors
than T cells, it is still a limited repertoire and may not be relevant during the majority of infections or
tumours. An emerging trend in research may mitigate this potential limit, and indeed add support to
antigen presentation as a viable NK cell function. This trend relates to the ligands of activating NK
cell receptors, particularly to the diversity that appear to be recognised by single receptors.
The previous chapter discussed the potential reasons for a single activating receptor, NKG2D,
having many specific ligands, 8 identified so far in humans (Ch. 3). However, research over the last
decade points to a distinct mode of diversity for the natural cytotoxicity receptors (NCRs), NKp30,
NKp44, and NKp46. Rather than recognising specific protein ligands, these are increasingly thought
to act in a similar manner to the TLRs, recognising pathogen associated molecular patterns (PAMPs)
and damage associated molecular patterns (DAMPs) (Porgador, 2005). Critical to cellular infection by
influenza viruses is their expression of hemagglutinin (HA) and neuraminidase (NA), which are sialic
acid-binding lectins and mediate cellular entry (Gamblin and Skehel, 2010). HA and NA are exposed on
the viral membrane and are highly antigenic; however, they are also highly variable and this variability
underlies epidemics which arise from escape variants not previously encountered by human populations.
Whilst their sequence changes, to escape the adaptive immune system, the functional capability to
bind sialic acid always remains. Interestingly, it was found that NKp46 and to a lesser degree NKp44
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(Mandelboim et al., 2001), but not NKp30 (Arnon et al., 2001), depend on this functionality for
recognition. Their recognition of influenza virus-infected cells requires sialylation of the glycosylated
Thr225 residue in their membrane proximal domain 2 (Arnon et al., 2004). Thus, sialylation of
NKp46 enables recognition of a wide range of viruses through a sequence-independent, indispensable
viral function-dependent manner. Similar recognition of different broad pathogen recognition via
non-proteic moieties is emerging for the other NCRs (Arnon et al., 2006).
NKp44, but not NKp46 or NKp30, appears to directly recognise mycolic acids in the cell walls
of mycobacteria and some related bacterial species, leading to activation of NK cells (Esin et al.,
2008). Trypsin treatment demonstrated that again it recognised a non-protein ligand. NKp46 can
also recognise non-virally-infected tumour cells, through a sialylation-independent ligand recognition
(Arnon et al., 2004). Indeed, recent studies have identified heparan sulphate (HS) proteoglycans as
targets for recognition by NKp30, NKp44, and NKp46, each with different affinities for different highly
sulphated HS/heparin-type structures (Hecht et al., 2009). In particular, they favour above averagely
sulphated heparan sulphates, as are commonly found on tumours, where they assist survival and
progress. Thus, as a class of activating receptors, they use a range of post-translational modifications
as markers of danger or to exploit essential pathogen functions to directly recognise aberrant cells,
acting as PAMP recognition receptors (PRRs), a characteristic feature of innate immunity.
The consequence of this is that a few receptors can mediate direct recognition of a range of infec-
tions and tumours, which in the context of “presentation after killing” may enable antigen acquisition
from a broad spectrum of sources. A recent example supports this as a mode of antigen acquisition
for NK cells, in a murine model, NK cells recruited to the lung during flu infection were shown to be
capable of antigen processing and presentation to HA specific T cell clones in vivo and ex vivo, and
contributed significantly to restricting viral titres in infected mice (GeurtsvanKessel et al., 2009).
It has previously been shown that the CD56bright subset are greatly enriched in the lymph nodes
(>95% of all NK cells) (Fehniger et al., 2003; Martín-Fontecha et al., 2004), and that HLA-DR is
expressed on a disproportionally high fraction of those cells (≈50%) (Burt et al., 2008). This is
consistent with results here, demonstrating expression of a functional CXCR3 chemokine receptor on
the HLA-DR-expressing NK cells, that leads to their enrichment during migration in response to the
cognate ligand I-TAC. CXCR3 is a chemokine receptor associated with lymph node homing, and in
mice has been shown to mediate a CCR7-independent lymph node-recruitment of NK cells (Martín-
Fontecha et al., 2004). The discrepancy between most lymph node NK cells being CD56bright and
only about half expressing HLA-DR, again supports the status of these HLA-DR-expressing cells as a
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subset, rather than an activated population. However, CXCR3-mediated chemotaxis is also implicated
in the recruitment of lymphocytes to sites of inflammation, which could similarly contribute to their
“presentation after killing” acquisition of antigen.
Although classical antigen presentation was not tested explicitly in this study, the impact of super-
antigen presentation was investigated. The proportion of NK cells expressing HLA-DR was demon-
strated to increase following superantigen stimulation of whole PBMC, in a manner that was abrogated
if the HLA-DR-expressing NK cells were depleted prior to stimulation (D’Orazio and Stein-Streilein,
1996). This was confirmed here, and further demonstrated to be dependent, in part on IL-2. This
was consistent with the IL-2 mediated expansion of the HLA-DR-expressing NK cells seen in culture
of isolated NK cells. The residual increase, occurring despite IL-2 blockade, could have resulted from
incomplete neutralisation by the anti-IL-2 mAb, or potentially be explained by the secretion of other
cytokines, such as IL-15, which was also demonstrated to expand the HLA-DR-expressing NK cell
subset.
In summary, having demonstrated that HLA-DR expression on NK cells is neither a suitable marker
for activation, nor for proliferation, we speculated that it may be functional, involved in antigen
presentation to T cells. This is a role that has been characterised before, and is supported here by
their expansion during superantigen stimulation. Furthermore, their functional capabilities are of a
nature to greatly facilitate an antigen presentation role, via “presentation after killing”. Specifically,
the HLA-DR-expressing subset of NK cells exhibit atypically high cytotoxicity as a population, and
express the CXCR3 chemokine receptor, which in addition to recruiting them to sites of inflammation,
could later mediate their recruitment to the lymph node, where they could encounter T cells. Although
we do not explicitly show lymph node recruitment, it has been previously documented that there are
strikingly higher proportions of HLA-DR-expressing NK cells there, than in peripheral blood (Fehniger
et al., 2003; Martín-Fontecha et al., 2004).
4.4.3 NK cells in the adaptive immune response
Although the potential for NK cells to present antigen has been discussed, NK cells play another,
distinct role during an adaptive immune response. There is an emerging model in which they act as
early effectors, and therefore amplifiers, of a pro-inflammatory antigen-specific immune response. It
is their capacity for IFN-γ secretion that is exploited here, via IL-2 mediated activation by CD4+ T
cells. Several reports, studying L. major (Bihl et al., 2010), P. falciparum (Horowitz et al., 2010b),
and vaccine recall responses to rabies (Horowitz et al., 2010a), and influenza A (He et al., 2004; Long
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et al., 2008), have elaborated an antigen-specific CD4+ T cell mediated activation pathway, that is
abrogated by blocking class II MHC or IL-2, leading to the secretion of IFN-γ by NK cells within
12–18h of stimulation.
Here, we have demonstrated, via class II MHC blockade, IL-2 neutralisation, and CD4+ T cell
depletion, that the same pathway is likely to be involved during BCG stimulation of whole PBMC,
which similarly results in the NK cells secreting IFN-γ. Thus NK cells in PBMC may act as early
effectors of the adaptive immune response to BCG stimulation. However, the final outcome of NK
cell IFN-γ secretion displayed a high level of inter-donor heterogeneity.
This question of heterogeneity in the contribution of NK cell IFN-γ secretion to the final response
raises questions about its functional and clinical consequences. In the malarial model, there is evidence
suggesting that a robust early IFN-γ response correlates with improved clinical outcome. In murine
models of malaria, successful parasite clearance and recovery is strongly associated with a robust TH1
type response, and is impaired in mice directed to a TH2 type response. Using P. chabaudi, it was
found that depletion of NK cells from the resistant B6 mice resulted in a more severe course of infection
(Mohan et al., 1997). Similarly, although IL-12 treatment can protect the normally susceptible A/J
mice, depletion of NK cells in treated mice abrogated the protective effect and resulted in 100%
mortality, an effect also seen following depletion of IFN-γ (Mohan et al., 1997). Regarding the timing,
it was found that the primary difference between lethal and non-lethal murine malaria correlated with
the secretion of IFN-γ by 24h post-infection, with any protective effect lost in athymic mice, or mice
depleted of NK cells (De Souza et al., 1997). Thus, early IFN-γ secretion by NK cells is critical in
protective immunity to malaria in mice, in part a result of its rapid polarisation of the ensuing adaptive
response to a pro-inflammatory TH1 type.
A similar effect has been seen in human studies, where serum IFN-γ levels correlated with a milder
course of infection in Gabonese children and protection against reinfection (Luty et al., 1999). In
a Madagascan cohort of children, high IFN-γ levels were found in individuals that did not develop
signs of clinical malaria following infection (Deloron et al., 1991). Similarly, in Ghana, the propensity
to produce IFN-γ correlated with protection against parasitemia and clinical malaria (Dodoo et al.,
2002). In humans, as in mice, there is a protective effect of IFN-γ, that is exerted early in infection,
and can limit initial parasitemia. In PBMC, at least in vitro, human NK cells are the earliest source of
IFN-γ and therefore may underlie the variability seen between individuals in their control of malarial
infection. Therefore, in the context of malarial infection, the capacity for NK cells to act as an early
source of IFN-γ in an antigen-specific manner has a clear protective effect, helping to amplify the TH1
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arm of the subsequent adaptive immune response, in addition to acting as a direct anti-erythrocytic
stage mechanism. BCG, as a model for mycobacterial infections, elicits different, although similar
responses, but early IFN-γ deployment is equally critical.
Our data show, that NK cells in PBMC respond rapidly to stimulation by BCG by secreting IFN-γ
in a CD4+ T cell-derived IL-2 dependent manner, similar to the response elicited by the protozoan
parasite P. falciparum. The impact of this on clinical outcome could be significant. In 1998, a
review of families with immunodeficiencies in the IFN-γ receptor revealed that IFN-γ signalling was
critical for control of mycobacterial infections (Ottenhoff et al., 1998). Mycobacterium tuberculosis
invades macrophages, and following their entry into the phagosome there are three main outcomes:
1. immunity following macrophage apoptosis or phagosomal–lysosomal fusion leading to elimination
of the mycobacterium, 2. latency resulting from restraint of pathogen growth but failure to eradicate
it, and 3. disease, caused by unrestrained pathogen growth (Dietrich and Doherty, 2009). If the
macrophages are primed prior to infection by IFN-γ then they can resist infection leading to immunity,
via production of reactive oxygen intermediates and reactive nitrogen intermediates (Flynn and Chan,
2001; Korbel et al., 2008). Even following infection, IFN-γ can be critical for resolution, through its
ability to stimulate autophagy in infected macrophages, thus helping to eliminate infection (Deretic
et al., 2006). The impact of the early deployment of IFN-γ has independently been modelled, based
on known feedback mechanisms and signalling pathways, and confirmed empirical findings concerning
its importance (Ray et al., 2008).
In mice, NK cells have been shown to accumulate in the lungs following infection, and to produce
IFN-γ (Junqueira-Kipnis et al., 2003), and early secretion of IFN-γ seems to be the primary difference
in response between lethal infections in the susceptible BALB/c mice and non-lethal in the resistant
C57BL/6 mice (Arko-Mensah et al., 2009). Furthermore, depletion of NK cells from Rag−/− knockout
mice showed the NK cells to be an important source of IFN-γ (Feng et al., 2006). Thus, in a similar
manner to malarial resistance, early IFN-γ secretion can significantly contribute to disease resistance
or resolution during mycobacterial infection. Indeed, the current tests for latent tuberculosis infection
use IFN-γ secretion to antigen stimulation as the read-out (Lalvani and Pareek, 2010), and stimulation
of IFN-γ secretion is the principle behind many current vaccine designs (for example, Wang et al.,
2009). In light of our data, it can be speculated that the BCG vaccine works, in part, by priming the
adaptive immune response, that can respond rapidly via engagement of NK cells to secrete IFN-γ. In
this scenario, the heterogeneity observed in this investigation may relate directly to the variability in
BCG vaccination efficacy previously reported (Finan et al., 2008).
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4.4.4 HLA-DR-expressing NK cells in the adaptive immune response
Heterogeneity in NK cell IFN-γ secretion has been observed in other studies, of particular relevance
is that amongst naïve donors in response to malaria-infected red blood cells and may relate to clinical
outcome. A disease scenario in which NK cell IFN-γ is reported to play a role is the kidney targeting
autoimmune condition IgA nephropathy (IgAN), where an aberrant pro-inflammatory response con-
tributes to destruction of the nephrons (Yano et al., 1996). Patients with higher IFN-γ levels suffered
more acute clinical symptoms. Of interest to the current study was the brief observation that patients
with higher levels of NK cell-derived IFN-γ transcript also had higher circulating proportions of HLA-
DR-expressing NK cells. Having already noticed heterogeneity in the circulating HLA-DR-expressing
NK cell proportions in healthy donors, and then encountering another source of heterogeneity in the
BCG stimulated NK cell IFN-γ secretion, the association between the two was tested.
Interestingly, donors which displayed a greater level of NK cell IFN-γ secretion following BCG
stimulation, also had significantly higher proportions of HLA-DR-expressing NK cells in peripheral
blood. This was subsequently tested directly by artificially modulating the proportion of HLA-DR-
expressing NK cells. Strikingly, by specifically enriching the HLA-DR-expressing NK cell compartment,
NK cell secretion of IFN-γ in response to BCG could be substantially enhanced. This suggests that
heterogeneity in human immune responses to BCG, at least in vitro, may be linked to the size of the
HLA-DR-expressing NK cell compartment in peripheral blood.
Heterogeneity in the IFN-γ response by NK cells to P. falciparum, and BCG, has previously been
linked to the activation state of accessory cells (Newman et al., 2006; Newman and Riley, 2007),
and to the KIR genotype (Korbel et al., 2009). The data in this current investigation provide a new
insight into why individuals consistently respond differently to BCG, and other pathogens, and could
have important implications in understanding differences between donors in the efficacy of the BCG
vaccine (Finan et al., 2008). Moreover, these data suggest a specific immunological role for the small
subset of NK cells that express HLA-DR. Indeed, elevated levels of HLA-DR-expressing NK cells have
recently been identified in PBMC of patients with pulmonary tuberculosis (Bozzano et al., 2009), and
in tuberculous pleural fluid (Pokkali et al., 2009).
The enhanced IFN-γ secretion was a result of enriching the HLA-DR-expressing NK cells specifi-
cally, not of activated NK cells. However, we were not able to explicitly test whether this enhancement
was mediated through a functional role of HLA-DR, i.e. antigen presentation. Including an anti-class
II MHC blocking mAb in the culture media during the stimulation did abrogate the IFN-γ secretion
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by NK cells, but this blocked antigen presentation by all APCs. In order to block antigen presentation
by just the NK cells, it was necessary to pulse them with a blocking antibody in isolation before
reconstituting the PBMC; however, our results showed that this method of pulse blocking was not
effective even when applied to unfractionated PBMC. This is likely to be due to blocking antibody
dissociation during the 18h stimulation, and because the HLA-DR molecules that are proposed to
present the BCG-derived antigen would be intracellular at the time of blocking. Using siRNA to
silence expression of HLA-DR was not appropriate because the experiments used fresh PBMC, and
after the time required to knock-down HLA-DR expression the PBMC would no longer be suitable for
BCG stimulation. An alternative approach would be to target the antigen processing pathway, using
inhibitors that would be taken up rapidly (<1–2h), thus enabling reconstitution of the PBMC whilst
still fresh.
One possibility would be an inhibitor of the aspartic proteases cathepsins D and E, which assist
in removal of the MHC class II chaperone Invariant chain (Marić et al., 1994), and fragment proteins
to provide peptides for loading to MHC class II molecules (Bennett et al., 1992). PepA-P was formed
by conjugating the cell penetrating peptide, penetratin, to the potent aspartic protease pepstatin A
(Zaidi et al., 2007). The inhibition of cathepsins D and E by PepA-P is almost complete within 2h
of treatment, and Zaidi et al. demonstrated that when tested with human PBMC stimulated with
tetanus toxoid C-fragment (TTC) it reduced the TTC-specific T cell response by over 50%. This
approach assumes that the antigen processing pathway used by other APCs is also used by NK cells,
but this could be tested explicitly in model systems that have previously demonstrated functional
antigen presentation by NK cells, such as tetanus toxin presentation by NK cell clones (Roncarolo
et al., 1991).
Whilst antigen presentation by HLA-DR-expressing NK cells during the response of PBMC to
BCG stimulation remains to be conclusively demonstrated, the implications of such involvement can
be considered. If we consider a model in which the HLA-DR-expressing NK cells do contribute to the
antigen-specific CD4+ T cell mediated activation pathway via themselves presenting the antigen, a
question remains over the relative contribution that they make. HLA-DR-expressing NK cells in ex vivo
PBMC represent only about 5% of the total potential antigen presenting capability, i.e. 5% of HLA-
DR-expressing cells. Even doubling their number represents a negligible increase to the total antigen
presenting capacity of the PBMC, yet yields a substantial increase (>3-fold) increase in the percentage
of IFN-γ producing NK cells in the final response. This suggests that for antigen presentation to be
involved, HLA-DR-expressing NK cells would have to be uniquely suited to a role in this immune
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response, and able to contribute disproportionately to the final outcome. Different cell types under
the classification of APC have different properties that equip them for antigen presentation in different
circumstances, so the question raised is: what feature of NK cells could render them so important as
potential antigen presenting cells during the immune response to BCG?
One possibility is the mechanism of antigen acquisition proposed for these HLA-DR-expressing
NK cells, “presentation after killing”, discussed earlier (Hanna and Mandelboim, 2007). Briefly, this
describes the manner in which engagement of NK cell activating receptors leads to their internalisation,
with ligand, and subsequent endosomal–lysosomal processing to the MHC-II loading compartment for
surface presentation. Earlier, it was discussed how the NCR preference for glycosylated moieties
appears to increase their target range, by acting as pathogen associated molecular pattern (PAMP)
recognition receptors (PRRs) (Porgador, 2005; Arnon et al., 2006; Hecht et al., 2009). However,
in the context of BCG recognition, specificity already exists. The NCR NKp44 specifically has been
demonstrated to bind mycolic acid components of mycobacterial cell walls, in a manner that activates
the NK cells (Esin et al., 2004, 2008). Thus, direct recognition of, and antigen acquisition from,
extracellular BCG by NKp44 could be the basis for the disproportionate contribution of HLA-DR-
expressing NK cells to the adaptive immune response to BCG.
Because we were unable to specifically block HLA-DR on NK cells for the duration, the role of
HLA-DR-expressing NK cells in enhancing the response to BCG stimulation cannot conclusively be
attributed to antigen presentation. However, it would be possible to test a different aspect of the
model proposed above by including an anti-NKp44 blocking mAb in the stimulation of the PBMC to
see whether this reduced the final IFN-γ secretion response.
4.4.5 Conclusions
Looking beyond the classical roles of NK cells as first line defenders against tumours and viruses,
mediated by cytotoxicity and secretion of IFN-γ, the data here show NK cells interacting at various
levels with T cells from the adaptive immune system, contributing to a robust response to BCG. In
striking parallels to recent reports we see NK cell secretion of IFN-γ acting as an early effector response
to BCG stimulation, at least in vitro, mediated through CD4+ T cell-derived IL-2, in an MHC class
II-dependent manner. This final outcome is in turn dictated by a disproportionate contribution of
the HLA-DR-expressing subset of NK cells. Thus, although the specific mechanism remains untested,
these results implicate a significant immunological role for the HLA-DR-expressing subset of NK cells.
This subset of NK cells has an atypical propensity for cytotoxicity, is enriched through CXCR3-
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mediated chemotaxis and preferentially expands in response to IL-2 or IL-15. This IL-2 driven expansion
can also be observed in the response to PBMC to superantigen stimulation, and may be responsible
for their expansion following BCG stimulation too. Whilst antigen presentation by these HLA-DR-
expressing NK cells was not explicitly tested, it is clear that they have distinct functional properties.
In light of this, HLA-DR expression on NK cells should be used as an activation marker with caution,
and only in conjunction with additional markers. Furthermore, a significant volume of research is
founded on IL-2 cultured human NK cells, so interpretation of results should be careful to account for
the over-representation of this atypical subset that is apparent following extended in vitro IL-2 culture.
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5.1 Introduction
The immune synapse (IS) is a term used to describe the contact between cells of the immune system,
for example APCs and T cells (Grakoui, 1999), or between immune cells and potential target cells
(reviewed in Orange, 2008b; Dustin and Long, 2010). The IS is characterised by specific spatiotemporal
supramolecular organisations of receptors and adhesion molecules between the contacting cells that
stabilise the contact and enables information exchange between them (reviewed in Van Der Merwe
et al., 2000; Lin et al., 2005; Manz and Groves, 2010). Depending on the signals exchanged between
the cells, the synapse may be maintained to facilitate the outcome of the interaction, for example lytic
granule delivery from a cytotoxic lymphocyte to a virally infected target, resulting in target cell death
(Orange, 2008a). Alternatively, inhibitory signalling in NK cells, such as KIR recognition of class I
MHC proteins on the target cell, may protect the target cell from lysis (Davis et al., 1999).
Although NK cells perform a range of functions and roles, the two most commonly studied are
lytic granule release to kill target cells and IFN-γ secretion to initiate and enhance a proinflammatory
adaptive immune response. The killing of target cells through the polarised release of perforin and
granzyme B containing lytic granules is a relatively well characterised response that is closely shared
with CD8+ cytotoxic T cells. During this response, the NK cell spreads around the immune synapse
(Culley et al., 2009), clears cortical actin (Orange et al., 2003), polarises the MTOC and Golgi
Apparatus to the synapse (Kupfer et al., 1983) and finally polarises lytic granules (Orange et al.,
2002)that subsequently degranulate at the synapse. A mature T cell immune synapse has a distinct
organisation, with a peripheral supramolecular activating cluster (pSMAC) of adhesion molecules, such
as LFA-1–ICAM-1, surrounding a central SMAC (cSMAC) of signalling molecules, such as the TCR
(Lin et al., 2005).
In T cells, reports suggest that the cSMAC can be dissected further, with the identification of
a specific secretory domain, a region through which lytic granule delivery to the synapse is focused.
Whilst there is tight juxtaposition of the two cell membranes at the signalling domain, at the secretory
domain there is a small (≈ 500nm) gap, termed the synaptic cleft, which is formed by the target
cell and into which the lytic granules may be delivered (Stinchcombe et al., 2001). Because of its
relatively small size, the synaptic cleft maintains the high concentration of perforin and granzymes
that lead to cell death of the target cell. This focused interaction, mediated via an immune synapse,
enables the NK cell to kill a specific target without affecting bystander cells.
NK cells can also secrete cytokines, such as IFN-γ and TNF-α. Cytokine secretion, in which
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soluble mediators are released into the extracellular environment (supernatant, plasma, or interstitial
fluid), has long been regarded as a communication mechanism by which a population, or populations,
of cells can be affected at a distance. The sensitivity of the exposed cells depends on their expression
of the relevant cytokine receptor. There are advantages to this system in many situations, primarily
no requirement for direct cellular contact, meaning that they can act at a distance and on many cells
simultaneously. However, many of the cytokines, such as IL-2, can have potent effects . Therefore,
although the effects of specific cytokines on particular cells may be important during an immune
response, there may also be occasions in which the broad range of soluble mediators needs to be
controlled to prevent unnecessary activation of proximal immune cells, to spatially restrict inflammation
for example.
This rationale prompted investigation into the possibility of polarised, trans-synaptic, secretion of
cytokines directly to a target cell. Commonly, ELISAs are used to detect cytokines in the media of
cultured cells, or in the plasma of blood samples; this type of experiment yields information on the
bulk population response of all cells in culture. More recently, a flow cytometric approach has been
used, in which cells are fixed, permeabilised and stained for intracellular cytokines; in conjunction
with staining for relevant surface markers, this technique allows identification of the specific cells that
are producing the cytokine. This has made it possible to compare the effector function profile of, for
example, different NK cell subsets, such as IFN-γ secretion preferentially by the CD56bright population
(Jacobs et al., 2001).
However, even with this approach it is assumed that the cytokine of interest can affect any cells
in range that express the receptor. This view of cytokine delivery has been challenged by a series of
studies focussed on T cells that consider their ability to target cytokines to specific recipient cells,
via polarised secretion. The earliest suggestion of polarised secretion used a transwell assay in which
T cell clones were loaded in to a transwell such that each one sat over a 3µm pore; an activating
antibody to the TCR was added to the top chamber and then the concentration of IL-4 in the media
from each chamber (top or bottom) was analysed after 4-16h. It was found that the IL-4 release was
polarised to the side of TCR activation (Poo et al., 1988).
Using early fluorescent microscopy techniques, it was next shown that in some murine T cell clones
IL-2 and TNF-α polarised intracellularly towards the contact formed with an antigen presenting B cell
and in other T cell clones IL-4 and IL-5 behaved the same way (Kupfer et al., 1991). Furthermore,
they later demonstrated selective proliferation of splenic B cells that formed contacts with antigen
specific T cell clones in which IL-4 was polarised towards the contact, but not with unpolarised T cell
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IL-4 (Kupfer et al., 1994).
In the context of NK cells, a more recent investigation reconciled two components of DC activation
of NK cells, understood to require IL-12 and an unknown contact-dependent signal, by establishing
that intracellular IL-12 in DCs is polarised to the synapses formed with NK cells, and that such
polarisation is necessary for the NK cell activation (Borg et al., 2004). The directed secretion of
IL-12 to activate NK cells in a disease scenario was supported by a study of Salmonella infection
of macrophages. Degranulation of the NK cells, resulting in elimination of infected macrophages
was shown to be IL-12 and IL-18 dependent, with the source of the cytokines being the infected
macrophages. Crucially, confocal imaging revealed that the IL-12 receptor on the NK cell localised to
the IS formed between the macrophages and the NK cells (Lapaque et al., 2009).
This approach, of imaging the localisation of the cytokine receptor on the target cells, has been
employed by other studies. A clear example was shown in a study that investigated CD4+ T cell lineage
commitment as directed by matured DCs. During commitment to a TH1 lineage, the receptors for
IFN-γ and IL-2, but not IL-6, IL-7, IL-10 or CD45, were shown to co-localise with the TCR following
TCR cross-linking (Maldonado et al., 2004). Strikingly, IL-4 disrupted the co-localisation of IFN-
γR with the TCR, resulting in commitment of the T cells to a TH2 lineage, thus directed cytokine
secretion can have significant functional consequences. This strategy of observing the behaviour of
the cytokine receptors confirms that the cytokine under investigation is likely to actually be secreted
at the synapse, rather than just be polarised intracellularly.
Building on this analysis of the target cells, trans-synaptic directed secretion of IL-2 was also
demonstrated at homotypic interactions between murine T cells (Sabatos et al., 2008). Here, they
demonstrated clustering of T cells in vivo followed by imaging component parts of IL-2 signalling
in vitro. Specifically, they visualised polarised intracellular IL-2, clustering of IL-2 receptor (CD25
and CD132) to the synapse, and subsequent accumulation of phosphorylated STAT5 puncta facing
the synapse. Thus, polarised secretion was associated with corresponding polarisation of downstream
signalling in the recipient cells.
Directed secretion of cytokines is not restricted to IL-2, IFN-γ was similarly secreted directionally
from murine T cells to antigen presenting cells (APCs) (Huse et al., 2006). Moreover, Huse et al.
demonstrated that it was a cytokine specific occurrence. Whilst IL-2 and IFN-γ polarised to the IS,
together with the MTOC, TNF-α exhibited a non-polarised distribution, dispersed evenly around the
same cells. Through co-localisation analyses with markers of trafficking pathways they determined
that the directed, and non-directed pathways used distinct machinery, and that both were likely to
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be specific to cytokine trafficking because neither was dependent on Rab8, which functions in Golgi
to cytoplasmic membrane transport in other cell types. Furthermore, Rab27a, which is required for
release of lytic granules from cytotoxic T cells, did not co-localise with cytokine in either pathway,
suggesting a different pathway from cytotoxic degranulation. All these studies used in vitro cell
systems; however, IFN-γ was recently also shown to polarise to immune synapses between rat T cells
and antigen presenting, virally infected astrocytes in vivo (Barcia et al., 2008). Therefore, there is a
well established body of evidence to support directed, trans-synaptic secretion of certain cytokines as
a mode of targeted communication between cells of the immune system.
In the context of this investigation into the interactions of NK cells with accessory cells of the
immune system, there are two questions that have not been addressed in the literature. First, although
two distinct pathways for cytokine secretion have been demonstrated in murine T cells, including a
directed, trans-synaptic pathway for IL-2 (Huse et al., 2006), it is not clear whether a similar directed
pathway is present in human T cells, nor to which recipient cells the secretion could be directed.
Second, although directed IFN-γ secretion has been demonstrated, impressively, in vivo from rat T
cells to APCs (Barcia et al., 2008), the signal generating this response was specific antigen presented
by a professional APC, and the response was only investigated in CD8+ T cells.
In contrast to this, a very recent study, comparing secretory pathways for lytic granules and
cytokines in NK cells, suggested that the cytokines, both IFN-γ and TNF-α, may not be secreted
directionally (Reefman et al., 2010), instead both adopting the undirected secretion pathway observed
for TNF-α in murine T cells (Huse et al., 2006). However, the data presented in this study were
not entirely clear. Specifically, NK92 cells were used in two experiments in which IFN-γ and TNF-α
were imaged intracellularly. The first experiment showed no obvious polarisation of either cytokine;
however, the NK92 cells were stimulated with PMA/ionomycin, which does not provide a specific
point of stimulation towards which polarisation could occur. The second experiment used NK92
cells forming conjugates with K562 cells; two representative images were presented, in the first both
cytokines were polarised to the immune synapse, in the second, neither were. However, in this second
image, it was clear that there was no cellular polarisation towards the synapse at all, because the
nucleus was proximal to the synapse. Thus, without a clear marker of an activating synapse, such as
actin cytoskeletal re-arrangement or MTOC polarisation, it is difficult to control for lack of cytokine
polarisation merely reflecting lack of activating synapse activity.
Therefore uncertainty remains regarding the mode of secretion of IFN-γ by human NK cells.
This is a critical question to address because IFN-γ secretion in response to infections (Lieberman,
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2002; Lodoen and Lanier, 2006), such as BCG (Ch. 4), L. major (Bihl et al., 2010) or P. falciparum
(Artavanis-tsakonas and Riley, 2002), is dominated by two cell types, T cells and NK cells. The
precise impact of this IFN-γ remains to be resolved, and understanding the mode of its delivery may
contribute significantly to this. For example, if IFN-γ can be focused to specific recipient cells, then
it may have a more targeted role than driving a broad pro-inflammatory response, such as directing
CD4+ T cells to a TH1 type response (Maldonado et al., 2004).
5.1.1 Aims
This project investigates the phenomenon of directed, trans-synaptic cytokine secretion, described
in murine cells, in human immune cells. In particular, it employs confocal imaging techniques to
investigate the mode of cytokine secretion by human immune cells. Specifically, the objectives were:
• To determine whether intracellular IL-2 in human T cells can polarise to the synapse formed
with B cells following superantigen stimulation.
• To determine whether human NK cells have the capacity to secrete IFN-γ in a polarised manner
to the activating-like synapse formed with a planar surface coated with MICA, a ligand for the
activating receptor NKG2D, and ICAM-1, ligand for the adhesion receptor LFA-1.
J. Henry Evans 225
Chapter 5: DIRECTED CYTOKINE SECRETION
5.2 Results
IL-2 stimulation is sufficient to elicit IFN-γ secretion by human NK cells, and during certain immune
responses, necessary too. Treatment with recombinant IL-2 was shown to drive IFN-γ secretion by
isolated NK cells in vitro, without additional stimulation (Handa et al., 1983; Das and Long, 2010).
In the context of NK cells secreting IFN-γ as effectors of an adaptive immune response, neutralising
IL-2, produced mainly by CD4+ T cells, abrogated the response (Chapter 4; Bihl et al., 2010; Horowitz
et al., 2010b). Thus, whether a directed pathway of cytokine secretion can be employed by human T
cells is of considerable immunological interest, because it could facilitate specific activation of recipient
NK cells during these immune responses.
5.2.1 Intracellular IL-2 can be imaged by confocal microscopy
The aim for this work was to visualise subcellular localisation of IL-2, to determine whether it was
polarised towards the synapse. However, before investigating the localisation, the protocol to image
IL-2 intracellularly was validated. For this, a simple control model, NK92-MI, was used. NK92-MI
cells are an immortalised NK line stably transfected to express IL-2. To generate an accumulation of
IL-2 for staining, the NK92-MI were treated with Brefeldin A (BFA), which inhibits protein transport
from the ER to the Golgi. In contrast to cells untreated with BFA, in which very little IL-2 staining was
imaged (Fig. 5.1A top), those treated with BFA for 4h stained brightly for IL-2 (Fig. 5.1A bottom).
Furthermore, imaging the BFA treated, IL-2+cells at higher resolution revealed a discrete pocket of
IL-2 within the cells (Fig. 5.1B), consistent with ER accumulation resulting from Golgi transport
inhibition. Thus, imaging of intracellular IL-2 was achieved, with the capacity to discriminate sub-
cellular distribution.
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Figure 5.1 : Intracellular IL-2 can be imaged by confocal microscopy. NK92-MI are an immortalised
NK cell line stably transfected to express IL-2. A Confocal images of IL-2 expressing NK92 cells
without Brefeldin A (BFA) (top) or after 4h treatment with BFA (10µM) (bottom). B Zoomed
images, from region marked by white square in A. Images show brightfield (BF), IL-2 staining
(IL-2) and the overlay (IL-2 in red). Scale bars = 10µm.
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5.2.2 Human T cells can polarise IL-2 to immune synapses formed with B cells
In addition to detecting IL-2 intracellularly, this study aimed to analyse its subcellular distribution,
specifically whether it polarises to a synapse between human cells, as has been observed for murine
T cells (Maldonado et al., 2004; Huse et al., 2006; Sabatos et al., 2008). To investigate directed
secretion in a human system we used a model including the cell lines Jurkat T cells and Raji B cells,
or 221 B cells. In the absence of specific antigen for these cell lines, a model system was tested that
used staphylococcal enterotoxin E (SEE) superantigen, which binds the invariant chains of HLA-DR
and TCR in an antigen independent manner (Herman et al., 1990). In this model, the Raji B cells or
the 221 B cells were pulsed with SEE for 1h (SEE-Raji; SEE-221), before being co-incubated with the
Jurkat T cells. Conjugate assays confirmed that pulsing target cells was sufficient to drive conjugate
formation (Fig. 5.2).
To confirm further that this interaction stimulated T cell IL-2 production the cells were co-
incubated for 24h and then tested for evidence of IL-2 production. It has been demonstrated previously
that T cells respond to IL-2 exposure, including autocrine effects, by upregulation of the high affinity
IL-2 receptor, CD25 (Depper et al., 1985). Therefore, the Jurkat T cells were analysed by flow cy-
tometry for expression of CD25, which showed that co-incubation with either SEE-Raji, or SEE-221
cells induced an upregulation of CD25 (Fig. 5.3A). In addition, the supernatants were harvested and
tested for IL-2 concentrations by ELISA, which confirmed production of IL-2 during the co-incubation
CD3 (Jurkat)
- SEE + SEE
C
FS
E
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Figure 5.2 : Superantigen drives conjugate formation between B cell and T cells. Raji B cells, labelled
the previous day with CFSE (1M, 15m), were incubated untreated or pulsed with SEE (1h,
1ng/ml), then co-incubated with Jurkat T cells for 1h. The samples were fixed and analysed by
flow cytometry for CFSE labelling and expression of CD3. Conjugates were identified as events
positive for CFSE and CD3 (top right quadrants) and compared between samples without (left)
and with SEE (right). Representative of 2 experiments.
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Figure 5.3 : Jurkat IL-2 production and APC CD25 upregulation following superantigen co-incubation.
Jurkat T cells were incubated with SEE pulsed Raji B cells (SEE-Raji), SEE pulsed 221 cells (SEE-
221), stimulated with PMA and ionomycin (PMA/I), or left unstimulated for 24h. A The cells
were harvested and analysed for CD25 expression (gated on CD3+ for Jurkats). Histograms
show isotype control staining (grey shaded) and CD25-PE (black). B The supernatant was also
harvested and analysed by ELISA for concentration of IL-2. Graphs show medians and ranges
from three replicates, each replicate derives from the same experiment but different wells of
co-incubated cells.
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Figure 5.4 : Timecourse of IL-2 production by T cells co-incubated with superantigen pulsed B cells.
Raji B cells were pulsed with SEE (1h, 1ng/ml), then co-incubated with Jurkat T cells for 0,
3, 6, 9 or 12h. The supernatant was harvested and tested for IL-2 concentration by ELISA. A
Recombinant IL-2 standards were used to generate the standard curve for quantification. B The
supernatant from each time point were harvested and assessed by ELISA on the same plate as
the standards. Graphs show medians and ranges from three replicates, each replicate derives from
the same experiment but different wells of co-incubated cells.
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Figure 5.5 : IL-2 polarises to the immune synapse between T cells and superantigen pulsed B cells.
Raji B cells were pulsed with superantigen and then co-incubated with Jurkat T cells for 5h
in U-bottom 96-well plates. After co-incubation they were fixed, permeabilised and stained for
intracellular IL-2. Conjugates were imaged by confocal microscopy. In a single sample conjugates
were seen with both A unpolarised IL-2, and B IL-2 polarised to the immune synapse. Images
show brightfield (BF), IL-2 staining (IL-2) and the overlay, acquired from one experiment. Scale
bars = 10µm.
(Fig. 5.3B). As a control, the Jurkat T cells were also stimulated with PMA and ionomycin, which is
known to induce IL-2 production (Tanaka et al., 2005). PMA and ionomycin stimulation induced the
greatest CD25 upregulation, but very little IL-2 was detected in the supernatant (<1% of the SEE-
Raji, SEE-221 concentrations) (Fig. 5.3A, B). A likely explanation is that the high state of activation
induced by the PMA/ionomycin induced relatively high expression of CD25, which would bind and
internalise IL-2, thus removing it from the media.
Before imaging the samples, it was necessary to determine the time scale on which the interactions,
and subsequent IL-2 production occurred. Although the previous data was acquired after 24h co-
incubation, based on the murine model (Huse et al., 2006) and consideration of a timeframe that
might be physiologically relevant, a timecourse was tested that spanned hours rather than days. For
this, Jurkat T cells were co-incubated with SEE-Raji cells for different durations (3h, 6h, 9h, 12h) and
then the supernatant was harvested and tested for IL-2 concentration by ELISA (Fig. 5.4). Although
the concentration of IL-2 was still increasing between the 9h and 12h samples, it was detectable at
3h.
Polarisation of IL-2 was likely to precede secretion; therefore, to image polarised, intracellular IL-2,
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a timepoint was used prior to the increased levels of secretion detected at 6h (Fig. 5.4). Jurkat T cells
were co-incubated with SEE-Raji for 5h before being fixed, permeabilised and stained for intracellular
IL-2. Critically, unlike the NK92-MI imaging protocol (Fig. 5.1), BFA was not added to the cells at any
point during the co-incubation. BFA inhibits ER to Golgi transport and therefore any IL-2 produced
would accumulate in the ER, which would prevent polarisation to the synapse. Imaging the subcellular
distribution of IL-2 in the Jurkat T cells conjugated to SEE-Raji cells was successful (Fig. 5.5).
Imaging of intracellular IL-2 was of sufficient resolution to discriminate two distinct subcellular dis-
tributions of IL-2 in the Jurkat T cells. Strikingly, while one was clustered but unpolarised (Fig. 5.5A),
the other flattened to the synapse (Fig. 5.5B). The latter is clearly polarised to the synapse: the
former resembles the distribution seen in BFA treated NK92-MI cells (Fig. 5.1C), so could be near
the Golgi Apparatus. It is likely that the two distributions represent different temporal stages of the
secretion pathway. The conjugates observed when imaging would not have all formed at the same
time, some would have taken longer to come into contact and initiate synapse formation. Therefore,
at the point of fixation, different conjugates would have been in different stages of the response.
5.2.3 Human NK cells can secrete IFN-γ directionally towards an immune synapse
Reported observations of directed secretion are not limited to IL-2, but also include IFN-γ in T cells
of rats (Barcia et al., 2008), and mice (Huse et al., 2006). The aim here was to determine whether
the IFN-γ produced by human NK cells following an encounter with a target cell expressing activating
ligands could be similarly secreted in a polarised manner towards the immune synapse. A simplified
model was used in which the NK cells were incubated on coverglass, in a chamber slide, that had
been previously coated with either antibody to the activating receptor NKG2D, or with recombinant
human activating ligands (rhMICA) and adhesion receptor ligands (rhICAM-1). We have previously
reported that this model stimulates the formation of activating-like synapses, contacts that exhibit the
characteristics of an activating NK synapse (Culley et al., 2009), but are formed with a planar surface.
This system offers the advantage that all contacts in a field of view are in the same focal plane,
facilitating bulk acquisition. Using this model system, the cells were incubated for different durations
and then fixed, permeabilised and stained for intracellular IFN-γ. Images were acquired by confocal
microscopy, and z-stacks of images for individual cells were acquired to enable the reconstruction of
a 3D image of the cell, in which the localisation of IFN-γ can be quantified.
The first experiments used slides pre-coated with α-NKG2D (Fig. 5.6) on which NKL cells were
incubated for 2h before preparation for imaging. Phalloidin was used to stain the filamentous actin
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Figure 5.6 : NKL cells polarise intracellular IFN-γ towards α-NKG2D antibody coated surfaces. NKL
cells in culture media were loaded into chamber slides pre-coated with α-NKG2D antibody and
incubated for 2h. After fixation and permeabilisation, the cells were stained with Phalloidin, for
actin (green), and A isotype control primary antibody, or B IFN-γ specific primary antibody, and
then an Alexa-633 conjugated secondary. Scale bars = 20µm. C Zoomed image of a single NKL
cell (top) and orthogonal view from a 3D reconstruction (bottom), dotted white line indicates
position of orthogonal view. Representative of 2 experiments. Scale bar = 10µm.
(F-actin) to outline the cells and to identify activated cells through presence of a ring of enriched
actin at the contact, a response we had previously characterised in human NK cell activating immune
synapses (Culley et al., 2009). After using an isotype control primary antibody to confirm that the
IFN-γ staining was specific (Fig. 5.6A, B), an IFN-γ+ NKL cell was identified and a z-stack of images
was acquired to enable a 3D reconstruction (Fig. 5.6C). In the 3D reconstruction, IFN-γ was clearly
observed to localise in a clustered manner, proximal to the contact with the surface; thus, in human
NK cells IFN-γ can polarise intracellularly to an activating contact.
However, when using antibody coated surfaces to stimulate activating synapse-like contacts, it
is possible that some of the observed effects are artifacts. These can arise because of two features
of this system: antibody can bind the target receptor with higher affinity than the native ligand,
and antibody has an Fc domain, which can engage the FcγIII receptor (CD16) on NK cells. We
have previously demonstrated that the higher affinity of antibody for NKG2D can alter the response,
preventing complete retraction following spreading at the contact, and limiting cell motility across
the coated surface (Culley et al., 2009). Therefore, the experiment was repeated using recombinant
human (rh)MICA, one of the native ligands for NKG2D, and rhICAM-1, the ligand for the LFA-1
adhesion molecule. Both were non-Ig fusion proteins to eliminate the potentially confounding effects
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Figure 5.7 : NKL cells produce IFN-γ after ligation of MICA and ICAM-1. NKL cells in culture media
were loaded into chamber slides pre-coated with recombinant human MICA and ICAM-1 and
incubated for up to 20h. A The supernatant was harvested and the concentration of IFN-γ
determined by ELISA. B At different timepoints (indicated in top left corners of images), the
NKL were fixed, permeabilised and stained for IFN-γ (red) and actin (Phalloidin, green). White
squares (I and II) indicate IFN-γ+ NKL cells imaged in higher resolution. C Example NKL cells
identified as positive for IFN-γ after 45m (B, identified by white squares, middle) were acquired
at higher resolution and in z-stacks allowing 3D reconstructions. Zoomed images show top view
acquired 0.2µm above surface (top) and orthogonal view reconstructed from the z-stack (bottom),
dotted white line indicates position of side view. Representative of 2 experiments. Scale bar =
20µm.
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Figure 5.8 : NKL cells polarise IFN-γ to MICA/ICAM-1 coated surfaces after 4h. A NKL cells were
incubated on a planar surface pre-coated with recombinant human MICA/ICAM-1 for 4h and
then fixed, permeabilised and stained for IFN-γ (red) and actin (Phalloidin, green). Images were
acquired by confocal microscopy. Scale bar = 20µm. B An example of an NKL cell identified
as positive for IFN-γ (identified by white square in A) was acquired at high resolution as a
z-stack allowing a 3D reconstruction. Zoomed images show top view acquired 0.2µm above
surface (top left) and orthogonal views reconstructed from z-stack (bottom and top right), dotted
white lines indicate positions of orthogonal views. Scale bar = 5µm. C The IFN-γ fluorescence
was thresholded and the total area in each z-slice was calculated (ImageJ). The total area of
IFN-γ staining was plotted against the distance from the contact with the surface ( z-slice).
Representative of 2 experiments.
of CD16 engagement.
As with the study of directed secretion of IL-2, the kinetic of IFN-γ secretion was determined
by incubating the NKL cells on a MICA/ICAM-1 coated surface for different durations and testing
the concentration of IFN-γ in the supernatant by ELISA (Fig. 5.7A). IFN-γ was detectable in the
supernatant at 45m and rose rapidly to peak at 5h; however, it began decreasing by 6h and had
returned to almost pre-stimulation levels by 20h. IFN-γ has autochrine effects on NK cells, so is
removed from the media via engaged receptor internalisation; the concentration in the supernatant
is therefore a net product of the balance between secretion and internalisation. The kinetic observed
indicated that IFN-γ secretion was an early event, ending within 5h of initial stimulation.
The same samples from which the supernatant was harvested were also fixed, permeabilised,
stained for actin and intracellular IFN-γ before being imaged by confocal microscopy. The detection
of IFN-γ in the supernatant confirmed that MICA/ICAM-1 engagement was sufficient to induce
secretion of IFN-γ (Fig. 5.7A). Imaging the NKL cells for intracellular IFN-γ revealed that it could be
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Figure 5.9 : NKL cells polarise IFN-γ to MICA/ICAM-1 coated surfaces after 90m and 4h. NKL cells
were incubated on a planar surface pre-coated with recombinant human MICA/ICAM-1 for A 90m,
or B 4h and then fixed, permeabilised and stained for IFN-γ (red) and actin (Phalloidin, green).
z-stacks were acquired by confocal microscopy and 3D reconstructions were used to generate
orthogonal views through each cell (images, left). The IFN-γ fluorescence was thresholded and
the total area in each z-slice was calculated (ImageJ). The total area of IFN-γ staining was plotted
against the distance from the contact with the surface (graphs, right). Graphs show total volume
of IFN-γ (vol.), and the percentage of intracellular IFN-γ that is in the closest quartile, or half, of
the cell to the activating surface, as indicated by dotted lines. Representative of 2 experiments.
detected in some cells as early as 45m, and most cells stained strongly at 4h (Fig. 5.7B), consistent
with the timecourse of secretion into the supernatant. Cells positive for IFN-γ at each timepoint were
identified and z-stacks were acquired for detailed analysis of the 3D subcellular distribution of IFN-γ
relative to the contact.
At 45m, although only ≈15% of NKL cells were identified as IFN-γ+, those cells exhibited polarised
localisation toward the contact with the surface, (Fig. 5.7B, C). At 4h, most NKL cells were IFN-
γ+ (Figs 5.7B, 5.8A), and appeared polarised to the contact (Fig. 5.8B). To represent clearly the
polarisation within the NKL cell, the z-stack of the cell was analysed for the IFN-γ staining: each
xy slice was analysed by thresholding to remove noise, and then the total area of IFN-γ+ pixels
was calculated. This area was then plotted against the distance from the contact with the surface,
calculated from the slice number in the z-stack (Fig. 5.8C).
This approach was then applied to three cells incubated for 90m (Fig. 5.9A) and three incubated for
4h (Fig. 5.9B). There was over 4-fold more total IFN-γ in cells at 4h (median 47.3µm3; Fig. 5.9B), than
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at 90m (median 10.1µm3; Fig. 5.9A). Polarisation was assessed by dividing the cells into quadrants
vertically from the surface contact and then quantifying the percentage of total intracellular IFN-γ
that was located in the closest quadrant, and the closest half, of the cell to the contact. At 90m there
was a clear polarisation with 96% of the IFN-γ in the half of the cells facing the contact, and 61% in
the closest quadrant (Fig. 5.9A). Whilst there was a greater total volume of IFN-γ at 4h, polarisation
was still discernible; 86% of IFN-γ was in the contact facing half, and 42% was in the closest quadrant
(Fig. 5.9B).
Thus, imaging of NKL cells forming activating synapse-like contacts, following engagement of
NKG2D and LFA-1, revealed an intracellular distribution of IFN-γ that was consistent with polarisation
to an NK-IS. Together with detection of IFN-γ in the media, this supports a polarised secretion pathway
for IFN-γ in human NK cells.
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5.3 Summary of results
Here, confocal imaging techniques were utilised to visualise cytokine secretion by human immune cells.
Specifically, it was demonstrated that:
• Cytokines, in this study IL-2 and IFN-γ, can be imaged intracellularly, in T cells and NK cells
respectively.
• Visualisation of the intracellular cytokines was sufficiently clear to determine sub-cellular locali-
sation; in particular, polarisation of IL-2 or IFN-γ to an immune synapse.
• Human T cells (Jurkat) can polarise intracellular IL-2 to immune synapses formed with B cells
(Raji) mediated by superantigen, as has been shown previously for murine T cells (Huse et al.,
2006).
• Human NK cells (NKL) can polarise IFN-γ to an immune synapse formed with a planar surface
coated with MICA, a ligand for the activating receptor NKG2D, and ICAM-1, an adhesion
molecule recognised by LFA-1. The IFN-γ was detected in the supernatant, demonstrating that
this polarisation was accompanied by secretion.
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5.4 Discussion
5.4.1 IL-2 polarisation in human T cells
It has been shown that a range of cytokines, including IL-2, IL-4, IL-5, IL-10, IL-12 and IFN-γ, can be
polarised towards a synapse between two immune cells, resulting in trans-synaptic delivery (Poo et al.,
1988; Kupfer et al., 1991; Borg et al., 2004; Maldonado et al., 2004; Huse et al., 2006; Barcia et al.,
2008; Sabatos et al., 2008). Crucially, this is a distinct mechanism and there are other cytokines for
which a non-directed secretion pathway is used, even within the same cell–cell contact, for example
TNF-α (Huse et al., 2006). This mode of interaction has been studied in vitro in murine T cells and
DCs, and in vivo for murine CD8+ T cells (Barcia et al., 2008). However, such a directed secretion
pathway has not been described for IL-2 in human immune cells.
Here, it was demonstrated that IL-2 in human T cells is able, at least in some circumstances, to
polarise to an immune synapse. A simplified model was used, employing immortalised cell lines and
superantigen to drive synapse formation between T cells and B cells. Although this preliminary study
did not investigate specific infectious situations in which T cell IL-2 may be directionally secreted, it
did suggest that the pathway is present and can be engaged during synapse formation.
One possible immunological role for directed IL-2 secretion from T cells is during their activation
of NK cells to secrete IFN-γ. During our investigation of P. falciparum stimulation of whole PBMC,
we found that although T cell derived IL-2 was essential for the activation of NK cells to secrete
IFN-γ, it did not appear to be in a contact dependent manner (Horowitz et al., 2010b). However,
this was an in vitro assay, so the proximity of different immune cells and the small media volume may
have been yielded media IL-2 concentrations sufficient to compensate for absence of cellular contact
between T cells and NK cells. Identifying specific immune responses in which each cytokine secretory
pathway is employed and understanding the differences in cellular contact signals that engage each
mechanism will be a challenging but fascinating area of future research in this field. As technology
improves, this may be tested directly using intravital or in vivo two-photon imaging in rodents.
5.4.2 IFN-γ polarisation in human NK cells
In addition to demonstrating that intracellular T cell IL-2 can polarise to an immune synapse, a
simplified model was used to clarify the same for human NK cell IFN-γ secretion. A very recent
study suggested that IFN-γ shares the non-directed secretion pathway of TNF-α in human NK cells
(Reefman et al., 2010). Reefman et al. compared the polarisation and secretion of IFN-γ, TNF-α and
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lytic granules within the human NK cell line NK92. Their conclusion, that IFN-γ was not secreted in a
polarised manner, was based on two experiments, neither of which fully supported it. No polarisation
was observed following PMA/ionomycin stimulation; however, this is not surprising because they offer
no specific point of stimulation on the NK92 cell surface to which polarisation could be directed.
Two representative images of IFN-γ distribution in NK92 cells conjugated to K562 target cells were
similarly inconclusive; in one, the IFN-γ appeared polarised, in the other it was not. However, in this
second one, the nucleus was adjacent to the synapse, suggesting that there was no polarisation of
any cellular components, even the MTOC. Without a positive control for an appropriate response to
the synapse formation, such as actin enrichment around the synapse (Orange et al., 2003), or MTOC
polarisation (Kupfer et al., 1983), then the absence of IFN-γ polarisation should not be assumed to
be distinct to it, or other cytokines. Therefore, the question of whether IFN-γ can be secreted from
human NK cells via a directed pathway remains unanswered.
To study the secretion of IFN-γ in human NK cells, a reductionist model of synapse formation
was used in this investigation. We have previously demonstrated that a simplified model, in which
ligands for an NK cell activating receptor (NKG2D) and an adhesion molecule (LFA-1) are bound
to a planar surface, can induce the formation of an activating NK cell immune synapse-like contact
(Culley et al., 2009). Here, this system was used to mimic an activating NK cell immune synapse
in a simple context to determine whether IFN-γ in human NK cells could be induced to polarise to
an immune synapse. Indeed, using confocal imaging techniques, polarisation to the synapse, and
subsequent secretion of IFN-γ was clearly demonstrated. Thus, although IFN-γ may not be secreted
in a directional manner in all human NK cell interactions, the pathway to do so is available and can
be engaged in certain circumstances. As with directed secretion of IL-2 in T cells, understanding the
exact stimuli and cellular signals that engage each of these pathways will take considerable further
work. Indeed, further to the data presented here, other results in our lab show polarisation, although
do not confirm secretion, of IFN-γ from fresh primary human NK cells to K562 target cells (personal
communication, Alice Brown, Imperial College). Thus, IFN-γ polarisation to an immune synapse is
unlikely to be an artifact of the activating ligand-coated surface model, nor of particular immortalised
NK cell lines.
The ability of cells to polarise secretion of cytokines to immune synapses raises interesting parallels
with NK cell cytotoxicity, in which lytic granules are polarised to, and released at, the immune synapse.
Several reports have identified distinct signals that polarise or release lytic granules, such that both are
required for effective cytotoxicity. This was undertaken initially using redirected, antibody-dependent
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cytotoxicity assays, in which antibodies to different activating NK cell receptors or LFA-1 were used
to induce the NK cell response (Bryceson et al., 2006b). These findings were complemented by
using SC2 insect cells, that have no endogenous ligands for activating human NK cell receptors nor
for human adhesion molecules. SC2 cells were transfected with different combinations of CD48, the
ligand for the activating receptor 2B4, IgG, recognised by the Fc receptor CD16, and ICAM-1, the
adhesion molecule recognised by LFA-1 (Bryceson et al., 2006a). With this system, Bryceson et al.
showed that engagement of LFA-1 alone could polarise cellular stores of lytic granules, but not induce
degranulation, whilst CD16 engagement alone induced degranulation, but in a non-polarised fashion.
Engagement of both, by SC2 cells expressing ICAM-1 and IgG induced polarisation of the granules
and subsequent degranulation, resulting in cytotoxicity of the target. Thus, these two processes,
polarisation and degranulation, are distinct and can be induced separately by different signals.
Whilst such studies have been important to understand the integration of signals during cytolytic
synapse formation, the rationale for a situation in which undirected degranulation would have a
functional role is unclear, particularly since it was demonstrated not to kill the target cell. In contrast,
it seems more likely that there are situations in which cytokines, such as IL-2 and IFN-γ, are either
secreted directionally or undirectionally. Therefore, the application of an approach in which individual
signals can be controlled, such as the transfected SC2 cell system, would be ideally suited to studying
when, where and how the two possible modes of cytokine secretion are engaged.
5.4.3 Limitations
One of the factors that has contributed to the limited progress in this area of research, until recently,
is the requirement for relatively sophisticated imaging technology. Although the earliest indication of
polarised secretion in T cells was achieved by an elegant, but non-imaging based, study (Poo et al.,
1988), all subsequent research has involved progressively more advanced forms of imaging (reviewed
in Huse et al., 2008). In particular, multicolour fluorescence confocal imaging has yielded improved
resolution, enabling identification of individual vesicles in a reconstructed 3D model of a cell, and co-
localisation analyses, to determine other cellular proteins involved in the pathways. As this technology,
along with the associated computational analytical tools, becomes more prevalent, it seems likely that
the directed secretion of cytokines will be found in a greater range of cells and situations.
An important future development will be the use of in vivo imaging, through the application of two-
photon microscopy in animal models. Already, this technology has been applied to follow interactions
of T cells, DCs and NK cells over time in mouse lymph nodes in vivo (reviewed in Bousso, 2008).
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As the resolution of this technology improves, subcellular localisation of cytokines, or their receptors,
genetically tagged with fluorophores such as GFP, may enable confirmation that the phenomenon of
directed cytokine secretion occurs in vivo during the immune response to infection. Furthermore, if
components of the signalling or trafficking pathways can be identified as unique to directed cytokine
secretion, for example Rab3d and Rab19 (Huse et al., 2006), then there would be the possibility to
specifically deactivate this process exists in animal models. This would enable an assessment of its
contribution to a healthy immune response, and whether its dysregulation could have detrimental
effects.
An important limitation with the data presented here, and therefore a consideration for the design
of future work, is that just imaging the intracellular localisation of a cytokine does not necessarily
prove directed secretion. Firstly, as described above, lytic granule secretion involves two components,
polarisation and degranulation, thus cytokine polarisation does not necessarily imply subsequent se-
cretion. Secondly, polarisation of intracellular cytokines may not reflect a cytokine specific effect but
instead be a result of association with the Golgi Apparatus, which is known to polarise during synapse
formation (Kupfer et al., 1983; Depoil et al., 2005).
Although these possibilities are not tested explicitly here, two aspects of the data argue against
them. Whilst imaging the IFN-γ polarisation to NKL pseudo-synapses, IFN-γ was also detected in the
media, so it was definitely secreted, and because the intracellular stores were polarised to the synapse,
it is likely that this is the point of secretion. In addition, a previous report of directed secretion of IL-2
in murine T cells, imaged undirected secretion of TNF-α in parallel, independent of Golgi Apparatus
polarisation (Huse et al., 2006). Thus a difference in intracellular distribution can be determined,
even with polarisation of the Golgi Apparatus, so the polarisation observed in this experiment is likely
to be genuine. To prove this, future work should exploit the co-localisation of cytokine receptors on
the recipient cell to the immune synapse to demonstrate accumulation of the cytokine in the synaptic
cleft (Maldonado et al., 2004; Sabatos et al., 2008; Lapaque et al., 2009).
5.4.4 Potential roles of directed cytokine secretion
Whilst directed secretion has been reported numerous times in vitro, to date there is only a single
report of in vivo cytokine polarisation, from CD8+ T cells to virally infected astrocytes in rats (Barcia
et al., 2008). This is likely to be, at least in part, a reflection of technological requirements, and
one that may be overcome as two-photon in vivo imaging becomes more established (reviewed in
Celli et al., 2008). However, based on the in vitro results, some predictions can be made regarding
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responses in which directed secretion may occur. For example, directed secretion of IFN-γ to CD4+
T cells may be important for their commitment to the TH1 lineage. This was supported by the
concordance of IFN-γR co-localisation with TCR at the synapse between T cells and DCs with the
polarisation to TH1 lineage T cells in different mice, and the ability of the TH2 directing IL-4 to block
this co-localisation (Maldonado et al., 2004). Thus, directed secretion of IFN-γ may be involved in
the basis of many adaptive immune responses.
Our own data (Chapter 4; Horowitz et al., 2010b), together with other recent reports (Long et al.,
2008; Bihl et al., 2010), have implicated NK cells as early secretors of IFN-γ, which may contribute
to protective immunity, for example to malaria (Deloron et al., 1991; Luty et al., 1999; Dodoo et al.,
2002), by enhancing the protective TH1 response (Shear et al., 1989; De Souza et al., 1997; Mohan
et al., 1997). This could be studied initially by using the same in vitro models of whole PBMC
stimulated with iRBCs or BCG, but with the samples prepared for imaging, rather than analysis by
flow cytometry. In these same models, it is also interesting to note that the NK cell secretion of
IFN-γ is dependent on CD4+ T cell-derived IL-2. Therefore, imaging could also be used to determine
whether this IL-2 is preferentially targeted to NK cells via directed secretion.
In summary, evidence for a distinct directed trans-synaptic secretion pathway for a specific set of
cytokines exists in a range of mammalian immune cells. Here, I present data that supports engage-
ment of the same directed secretion pathways in human cells for IL-2 in T cells and IFN-γ in NK
cells. Although only a preliminary investigation, this has formed the basis for on-going work to inves-
tigate the mechanics of polarised IFN-γ secretion in NK cells, using state-of-the-art super-resolution
microscopy (personal communication, Alice Brown, Imperial College). With the development of ever
more sophisticated imaging technologies, including in vivo two-photon microscopy, it is likely that
the signals and pathways involved in this mode of secretion will be determined. However, the ulti-
mate, and most exciting, aim of this research will be to understand when and where this mode of
communication operates during immune responses to different diseases, and the impact on immune
response resolution of diseases if it is disrupted. Based on the impact of DC-derived IFN-γ directing
TH1 lineage commitment in CD4+ T cells when it is delivered in a trans-synaptic manner (Maldonado
et al., 2004), we can speculate that it could have a more profound impact than previously considered
.
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6.1 Overview
The roles of NK cells in limiting tumours and controlling viral infections (Arnon et al., 2006; Caligiuri,
2008; Vivier et al., 2008), and even some bacterial ones (Ferlazzo et al., 2003; Lapaque et al., 2009), are
well established. Much research focusses on their cytotoxic function (Krzewski and Strominger, 2008),
and secretion of cytokines, most notably IFN-γ (Handa et al., 1983; Lieberman, 2002; Moretta et al.,
2007), and how these are deployed against tumours and viruses. However, as our understanding grows
and we apply our knowledge of NK cells to explore areas of immunology beyond these conventional
roles, potential new and exciting functions of NK cells are emerging. Increasingly, these new roles
are found at the interactions between NK cells and other cells of the immune system (Hanna and
Mandelboim, 2007; Moretta et al., 2007; Newman and Riley, 2007). And so, it is by looking at other
interactions of NK cells that this investigation has approached the exploration of additional roles for
NK cells.
6.1.1 Summary
The results of this study are discussed in detail in the relevant chapters; briefly, this investigation has:
1. studied the signalling and mechanisms that regulate expression of the NKG2D ligand MICA on
macrophages following stimulation of TLRs (Nedvetzki et al., 2007; Eissmann et al., 2010),
2. studied the expression of HLA-DR on NK cells, marking a subset with atypical properties that
have a distinct immunological role during the immune response to BCG, and
3. studied the role of NK cells as effectors of adaptive immunity via their secretion of IFN-γ
following a CD4+ T cell mediated pathway.
• In addition, directed trans-synaptic cytokine secretion was briefly considered, specifically in
relation to NK cells.
6.1.2 Conclusions
This investigation has considered roles for NK cells that are beyond their primary role in the elimination
of aberrant target cells, roles which develop from their interactions with other cells of the immune
system.
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During their interactions with macrophages from the innate immune system they may play a role
in limiting either excessive inflammation, or potentially form a component of the normal inflammation
resolution pathway. These roles were studied from the side of the macrophage, investigating how they
regulate expression of ligands on their surface that mark them for elimination following exposure to
agonists for their TLRs. However, although the scenario which emerges because of this interaction
between TLR-stimulated macrophages and NK cells is only recently discovered, the NK cell mechanism
that underlies it is the well characterised cytotoxic response. In contrast, the other role for NK cells
that was studied here relied on the far less well characterised expression of HLA-DR on their surface.
Investigating the expression of HLA-DR on NK cells identified a novel subset, present at low
numbers in peripheral blood but particularly sensitive to IL-2 stimulation, resulting in preferential pro-
liferation. In a model infectious system, BCG stimulation of human PBMC, the HLA-DR-expressing
NK cells played a significant immunological role in initiating the response, despite their low represen-
tation in the NK cell compartment. In particular, the response relied on IL-2 derived from the CD4+
T cells, and resulted in expansion of the HLA-DR-expressing NK cell subset. The output measured
in this system was the secretion of IFN-γ by the NK cells, however, the target of this IFN-γ was not
studied here. The two likely targets are the T cells, where it would direct the ensuing response to a
TH1 type, and macrophages, where it would prime their microbicidal responses to control intracellular
invasion by BCG. Thus we see the potential for a “menage a trois” of cellular interactions to emerge,
as proposed for macrophage infection by Salmonella (Lapaque et al., 2009). This clearly highlights
the importance of investigating NK cells and their functions in the context of their interactions with
the wider immune system.
Although it was not investigated here, it is possible that scenarios exist where these two responses
studied here may converge. For example, following macrophage activation through TLR4 by a bac-
terium, the macrophage’s up-regulation of MICA would result in its NK cell-mediated lysis. Potentially,
following lysis, NK cell receptors could acquire and internalise bacterial components to the lysosome
for loading to HLA-DR and subsequent presentation to T cells. This could happen early in an infection
and could provide an alternative pathway for recruitment of adaptive immune cells. This speculation
remains to be tested, but illustrates how the specific responses studied in this investigation could
contribute to the wider functioning of the human immune system.
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6.2 Heterogeneity
In addition to the results previously discussed, an unanticipated outcome from these studies was the
degree of heterogeneity encountered when analysing human samples. There was inter-donor variation
in the up-regulation of MICA on TLR stimulated macrophages, with many donors exhibiting no
response at all, and similar heterogeneity in both the proportion of HLA-DR-expressing NK cells in
peripheral blood and in the magnitude of NK cell IFN-γ secretion in PBMC stimulated with BCG. With
many studies using immortalised cell lines, or genetically homogeneous mice, this aspect of variation
does not manifest and is consequently little studied. However, when utilised correctly, heterogeneity
can prove to be useful tool for understanding complex interactions, and is an important aspect of
contemporary immunology (Ottenhoff et al., 1998; Orange, 2002; Carneiro-Sampaio and Coutinho,
2007; Davis, 2008). Heterogeneity can be found in virtually every aspect of immunology, from cellular
differences between NK cells from a single donor, to genetic polymorphisms between individuals within
a population.
6.2.1 Donor heterogeneity
Heterogeneity between donors, as determined by genetic polymorphisms, appears to be commonplace
in the immune system, which is in a constant “arms’ race” with pathogens. In addition, some of the
variation available to cope with the rapidly evolving pathogens is generated within each individual,
such as the massively variable repertoire of T cell receptors generated across the T cell population by
somatic recombination and hypermutation. However, even NK cell receptors, with their characteristic
germ-line encoded specificity exhibit the hallmarks of being under intense selection: ligand diversity
and receptor polymorphisms (Cheent and Khakoo, 2009). For example, the inhibitory KIR receptors
are incredibly polymorphic, reflecting the allelic variation in their ligands, the MHC molecules. This
diversity is driven by intense selection pressure as pathogens evolve to evade detection, and the immune
system evolves to counter this evasion. This diversity and polymorphic variation is also apparent in
the ligands recognised by the activating NK cell receptor NKG2D.
There is a surprising diversity of ligands for this single receptor, currently 8 have been identified,
which is proposed to have arisen as a mechanism to counter pathogen interference in their regulation,
primarily by the herpesvirus family (Radaev et al., 2002; Eagle and Trowsdale, 2007). This increases
the chance for a robust response within an individual; however, there is an additional level of variation
that provides a safety net at the population level. This variation comes from MICA polymorphisms,
J. Henry Evans 246
Chapter 6: DISCUSSION
strikingly MICA is the most polymorphic of non-classical class I MHC molecules, with 65 alleles
currently described (Petersdorf et al., 1999; Choy and Phipps, 2010). Whilst many reports have
demonstrated associations between MICA alleles and different diseases, including autoimmune diseases
(Bilbao et al., 2003; Tinto et al., 2008), tumours (Lavado-Valenzuela et al., 2009; Tamaki et al.,
2009), and herpesvirus infections, these studies have been unable to exclude the possibility of linkage
disequilibrium with MICA’s genomic neighbours HLA-B and HLA-C being the driving factor behind
the association (Gao et al., 2006). For example, an early study into associations of MICA with
diseases showed that Behçet’s disease associated with a MICA polymorphism that had six triplet
repeats (Mizuki et al., 1997). However, subsequent studies determined that the true association was
with HLA-B*51, and that MICA was implicated by linkage disequilibrium (Nishiyama et al., 2006;
Mizuki et al., 2007).
A different approach from association studies is to test the functionality of alleles directly. For ex-
ample, MICA*008 is one of the most common MICA alleles in human populations, with a frequency of
21%–47% in different populations (Ashiru et al., 2010). Whilst the extracellular domain of MICA*008
protein is almost identical to other MICA alleles, the transmembrane (TMD) and cytoplasmic domains
are markedly different, a 4 nucleotide insertion in exon 5 results in a truncation in the TMD and no
cytoplasmic tail (Mizuki et al., 1997). The truncated MICA*008 protein, lacking its cytoplasmic tail,
is resistant to down-regulation by HCMV (Zou et al., 2005) and KSHV (Thomas et al., 2008), and
therefore results in host cell lysis despite the viral mechanisms of MICA suppression. Thus the most
common MICA allele in human populations confers additional protection to certain viral infections.
However, MICA*008 protein is also more readily shed, via exosomes, into the extracellular environ-
ment, and can therefore potentially act in an immunosuppressive manner, for example during tumour
formation (Ashiru et al., 2010).
Moreover, this same allele has been implicated in several other disease by carefully controlled asso-
ciation studies, which may be explained retrospectively by its propensity for being shed. Specifically, it
has been associated with oral squamous cell carcinoma in Japanese populations (Tamaki et al., 2007),
where homozygotes have higher levels of soluble MICA protein and lower survival rates (Tamaki et al.,
2009). Similarly, it is associated with breast cancer in Spanish populations (Lavado-Valenzuela et al.,
2009).
Thus, we see that fundamental differences in MICA protein expression or type can result in sig-
nificantly different clinical outcomes. In this investigation, a high level of donor heterogeneity was
observed in the level of MICA up-regulation on macrophages following TLR stimulation. Indeed, over
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half of the donors tested exhibited no up-regulation at all. From the analyses performed, it is not
possible to exclude the explanation that these donors expressed alleles of MICA that were not de-
tected by the antibodies. However, two different antibodies were used to detect MICA, and there was
still significant heterogeneity in the level to which responders did up-regulate MICA. Together, these
aspects are suggestive of a genuine heterogeneity. Two questions remain, what is the basis for this
heterogeneity, and what are the clinical implications?
As this investigation discovered, the up-regulation of MICA on human macrophages is regulated
by multiple mechanisms. Thus, absence of up-regulation could represent a polymorphism/mutation
in any of the many molecular components contributing to the pathway, and as such determining its
cause was outside the scope of the investigation. However, because of the magnitude of the differ-
ence, approximately half responded and half did not, then it is suggestive of a major polymorphism,
possibly in MICA itself, or in its promoter region. However, an example of an alternative possibility
is a polymorphism in TLR4. A common allele of TLR4, with an Asp299Gly substitution, increases
susceptibility to gram-negative septic shock (Lorenz et al., 2002). However, the same polymorphism
influences the outcome of malaria; whilst it increases susceptibility to malaria, it also decreases the
mortality rate (Mockenhaupt et al., 2006). Population analyses have revealed that Asp299Gly allele
of TLR4 is more prevalent in African populations, consistent with its protective effect against cerebral
malaria, but is far less frequent in European populations, which have experienced greater selective
pressures from bacterial pathogens than malaria (Ferwerda et al., 2007). To understand this differ-
ence functionally, Ferwerda et al. demonstrated that blood from donors carrying the Asp299Gly allele
secreted significantly more TNF-α, but not IL-10, when stimulated with LPS than blood from wild
type donors. Thus, a common polymorphism in TLR4 confers enhanced susceptibility to septic shock,
mediated in part by increased secretion of TNF-α.
We can speculate that donors carrying this allele may be the same donors that up-regulate MICA
in response to TLR4 stimulation, and that the MICA up-regulation, involving the TNF-α autocrine
component, acts as a safety mechanism to limit immunopathology in these individuals. It would be
fascinating study to compare these sources of heterogeneity, TLR4 genotyping and macrophage MICA
responsiveness to LPS, and would help us to understand the role of MICA up-regulation more fully in
the context of full immune responses. Such an investigation is an example of how heterogeneity in
human samples can be exploited to understand better the roles of different components and how they
are orchestrated during immune responses.
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6.2.2 Heterogeneity as a tool
When trying to determine the activity of a specific cellular component, heterogeneity in the response
can be a frustration, and can make it difficult to determine significance, and draw conclusions. This
was the case during the investigation presented here into the up-regulation of MICA on human
macrophages. In the non-responders, the impact of different interventions could not be assessed,
therefore a significantly larger total pool of donors was required, thus under-utilising an important
aspect of the data. However, inter-donor variation is not always a limitation, often, with access to
relevant human samples, variation can be a powerful tool (Davis, 2008).
Murine models and immortalised human cell lines share two characteristics that make them ideally
suited to cell biology studies; they are genetically homogeneous, yet can be genetically manipulated.
Therefore, variation can be introduced in a targeted manner and the effect can be carefully controlled
against the wild-type background. Direct genetic manipulation is not appropriate for human donors,
or samples, so natural variation provides an entry point for similar inferences.
The most striking examples are in diseases caused by a single mutation, or deficiency. Much
which has been inferred from in vitro studies of infections and murine models has been confirmed
by investigating disease susceptibilities associated with NK cell deficiencies, either total, or specific
(Orange, 2002; Carneiro-Sampaio and Coutinho, 2007). Particularly worthy of note is that NK cell
deficiencies are remarkably rare, consistent with a critical protective role for NK cells in humans.
Moreover, patients with total NK cell deficiencies are far more susceptible to herpesviruses (Biron
et al., 1989) and mycobacteria (Wendland et al., 2000), which is consistent with the extensive range
of mechanisms these pathogens employ to modulate NKG2D ligand expression and thus evade NK cell
detection (López-Botet et al., 2004; Eagle and Trowsdale, 2007; Cerwenka, 2009; Stern-Ginossar and
Mandelboim, 2009). A specific example of a corroboration is the role of IL-12. Directed secretion of
IL-12 from Salmonella-infected macrophages to NK cells was found to be critical to the subsequent
NK cell mediated lysis of the infected macrophage (Lapaque et al., 2009). Supporting this, IL-12
receptor deficiency confers susceptibility to Salmonella infection to patients (de Jong et al., 1998).
However, severe deficiencies are not the only option for determining the roles of different cells or
interactions in an immune response, natural variation in healthy populations can also inform, such as
the disease association studies with different polymorphisms in immune related genes described earlier.
Using the response of in vitro PBMC stimulation with P. falciparum-infected erythrocytes (iRBCs) as
a model, various sources of heterogeneity have been studied and compared to help understand the
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course of the response. NK cells in PBMC secrete IFN-γ when stimulated with iRBCs (Artavanis-
tsakonas and Riley, 2002), but there is significant heterogeneity in the magnitude of the response
(Korbel et al., 2005). Several correlations with the magnitude of the NK cell IFN-γ response have
been identified. The IFN-γ secretion by NK cells is dependent on myeloid DCs and monocytes, in a
contact- and cytokine-dependent manner, such that the extent of NK cell response can be predicted
by the up-regulation of co-stimulatory molecules on the accessory cells, thus indicating a deep-rooted
dependency on the innate immune system activation (Newman and Riley, 2007). A subsequent study
confirmed this, and also demonstrated that the proportion of CD56dim NK cells specifically that
secrete IFN-γ correlates with the KIR genotype, with the KIR “A” homozygous haplotype responding
less well than the KIR AB heterozygous (Korbel et al., 2009). So, the roles of the accessory cells and
KIR inhibition of NK cells in the final NK cell IFN-γ secretion response were determined by comparing
these sources of heterogeneity.
This approach to identify unexpected components of an immune response was applied in the current
investigation with similar success. Variation in two parameters, NK cell IFN-γ secretion in response
to BCG stimulation of PBMC and the size of the HLA-DR-expressing NK cell population in peripheral
blood, was recorded independently. Based on an understanding of a potential functional role, that of
antigen presentation by the HLA-DR expressing NK cells, and an early study that reported a correlation
between the proportion of HLA-DR-expressing NK cells and NK cell-derived IFN-γ transcript in IgAN
patients (Yano et al., 1996), I hypothesised that the two may be related during BCG stimulation. By
observation, an association was identified, and by direct manipulation of the HLA-DR-expressing NK
cell compartment a specific immunological role for this subset of NK cells was demonstrated. Thus,
whilst a frustration in some studies, heterogeneity in human responses can be exploited to develop
further our understanding of the interactions of immune cells during an immune response.
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6.3 Closing remarks
NK cells were first identified over 30 years ago, and since then significant progress has been made in
understanding their role in the immune system. However, until recently, much of this has focussed on
the details of their most readily observed functions; in particular, understanding their recognition, and
subsequent elimination, of malignant tumours and virally-infected cells (Caligiuri, 2008; Vivier et al.,
2008). As our knowledge of both NK cells, and the complexities of the wider immune environment,
has developed, NK cells are no longer seen as lone rangers, patrolling the body for warning signs of
danger. Now they are viewed in the context of carefully orchestrated immune responses, mediated via
the co-ordination and interactions of many cell types (Moretta et al., 2007; Newman and Riley, 2007).
These interactions are increasingly understood in the lead up to NK cell responses; licensing via KIR
engagement (Cruz-Munoz and Veillette, 2010), cytokine-mediated activation by DCs (Borg et al.,
2004), and final activation via the balancing of signals from activating and inhibitory receptors at the
immune synapse (Orange, 2008a; Culley et al., 2009). However, recent reports illustrate how NK cells
play a role in an ever growing range of immune responses (Cooper et al., 2009a), achieved through
both conventional and novel mechanisms. Critically, these roles depend on co-ordinated interactions of
NK cells with ever more immune cell types. Thus, the recognition of NK cell involvement in different
immune scenarios is likely to grow as NK cell biologists look outward, and the tools available, such
as 18-colour flow cytometry, the generation of the NK cell-deficient mouse model (Gascoyne et al.,
2009), and in vivo or intravital imaging technologies (Cahalan and Parker, 2008; Deguine et al., 2010;
Wessels et al., 2010), progressively advance.
This investigation has studied the interactions of NK cells with both activated macrophages (Ch. 3)
(Eissmann et al., 2010), and with T cells (Ch. 4). The NKG2D-mediated lysis of LPS-activated
macrophages by NK cells led to the hypothesis that NK cells could be performing a regulatory duty,
to limit a potentially damaging inflammatory response. This hypothesis is supported by the results in
chapter 3, which demonstrated that TLR-activated macrophages control the up-regulation of NKG2D
ligands by multiple mechanisms that together ensure that an inflammatory response can initiate, but
after a sufficient delay, the most pro-inflammatory macrophages are eliminated, thus interrupting the
positive feedback loop. The existence of this “circuit-breaking”, immunoregulatory role for NK cells
is being tested in ongoing work involving models of septic shock in NK cell knockout mice, with
promising preliminary results (personal communication, Hugh Brady, Imperial College).
In a distinct study, we considered how NK cells can act in adaptive immunity, despite being
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considered predominantly as mediators of innate immunity. It was unsurprising that such a role
should involve interactions of the NK cells with the major adaptive lymphocytes, T cells. Here, two
interactions were inferred, with NK cells acting as the input and output of an adaptive response to
BCG, and the T cells performing the role of an antigen-specificity filter. A subset of NK cells was
identified that expressed the class II MHC protein HLA-DR, which has previously been demonstrated
to mediate antigen presentation by NK cells to T cells (Roncarolo et al., 1991; Hanna et al., 2004;
GeurtsvanKessel et al., 2009). Although antigen presentation activity was not explicitly tested here,
HLA-DR-expressing NK cells were expanded in PBMC following BCG stimulation, and their artificial
enrichment substantially enhanced the adaptive immune response of PBMC to BCG stimulation. Thus
they appear to play a significant immunological role in this response. As a consequence of MHC class
II-mediated CD4+ T cell activation and secretion of IL-2 in PBMC stimulated with BCG, NK cells
were activated to secrete IFN-γ, thus contributing to the pro-inflammatory adaptive immune response,
as recently reported for other parasites (Bihl et al., 2010; Horowitz et al., 2010b). Thus, the NK cell
response to an in vitro infection model, can incorporate an antigen specificity through inclusion of
CD4+ T cells in the pathway.
In summary, two recently proposed roles of NK cells were investigated, with the data supporting
their immunoregulatory capacity and integration into the adaptive immune response. The challenge
remains to determine their clinical relevance in vivo, and whether our understanding can promote
novel therapeutic interventions.
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